data_2mnw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mnw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.694 0.206 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.25 54.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -58.19 161.25 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.44 146.99 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.3 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 138.59 54.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.226 0.536 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 p -141.66 133.94 27.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.552 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.447 ' OE1' HD12 ' A' ' 88' ' ' LEU . 2.7 pm0 -130.7 140.73 50.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.371 0.605 . . . . 0.0 112.457 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.37 160.56 26.11 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.986 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.68 -6.06 1.47 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.03 2.486 . . . . 0.0 113.947 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.4 m-20 -135.95 8.91 3.27 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.625 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 65.7 m-85 -168.24 168.41 11.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 111.733 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.72 109.58 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.615 178.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.441 HG23 ' HG2' ' A' ' 75' ' ' ARG . 19.4 m -99.41 147.26 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 38' ' ' PHE . 1.6 mt -125.4 153.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.12 121.94 16.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 112.069 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.08 124.23 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.796 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.8 118.71 37.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.358 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 21' ' ' VAL . 16.4 m -148.25 143.21 19.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.906 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -125.57 -23.22 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.7 m-85 -75.56 -10.05 59.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.534 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.55 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.476 0.485 . . . . 0.0 111.811 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -82.69 10.22 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.287 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.11 127.44 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.785 179.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -55.8 -24.19 34.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.12 153.52 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -108.55 168.39 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.378 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.03 128.51 43.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.95 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.2 117.6 26.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 21.2 p90 -128.86 119.28 24.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.8 OUTLIER -140.71 122.21 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.114 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.87 -70.21 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.642 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -160.38 25.4 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 0.0 110.592 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 6.7 t70 -116.22 110.61 19.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CD2' HD11 ' A' ' 17' ' ' ILE . 26.1 t80 -105.54 111.82 24.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.224 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.28 128.17 50.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 47.8 t80 -104.99 143.08 33.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -135.49 102.81 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 40' ' ' PHE . . . -149.0 112.73 5.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.8 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER 47.02 -175.63 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 84.6 Cg_exo -37.0 -27.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.16 1.907 . . . . 0.0 112.744 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 12.6 m-30 -63.15 120.82 12.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.381 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -125.27 120.05 30.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.648 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -116.98 115.66 25.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.049 0.452 . . . . 0.0 112.024 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.28 110.17 16.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.897 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.9 mt -124.18 130.63 52.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.367 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 m -102.14 107.67 18.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 23.1 mt -65.28 143.89 98.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.199 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.534 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 49.9 Cg_endo -70.27 -23.82 28.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.785 2.323 . . . . 0.0 112.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -116.74 -137.28 5.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.186 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 82.3 mtt-85 -140.47 132.76 28.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 76' ' ' LEU . 52.0 mm -113.78 124.41 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.481 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.54 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.1 p -68.03 162.56 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 7.4 pt-20 -123.74 127.66 48.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.218 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.24 6.68 0.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.96 23.63 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -82.1 -69.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.994 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 31.55 -156.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.698 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mm-40 -179.94 119.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 74' ' ' ILE . . . -170.06 -179.16 41.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.175 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -164.14 148.93 10.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CD1' ' HE2' ' A' ' 29' ' ' PHE . 14.9 t80 -113.85 132.94 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.436 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.93 125.3 43.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.475 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.83 -34.26 26.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.422 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -50.53 65.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.545 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -11.0 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.074 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 63.15 62.21 5.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.259 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' GLY . 6.1 mt -155.05 127.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.514 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.1 t80 -110.49 114.79 28.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -121.7 126.13 48.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.263 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 2.1 tp -133.49 120.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.441 ' HG2' HG23 ' A' ' 16' ' ' THR . 5.1 mtp180 -92.33 145.1 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.487 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.9 mt -134.66 143.17 45.39 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HG2' ' CG1' ' A' ' 56' ' ' VAL . 47.9 Cg_endo -73.18 158.98 48.24 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.789 2.326 . . . . 0.0 112.657 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 1.7 mttt -96.76 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.99 -11.03 51.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.399 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.2 m -147.52 130.49 7.98 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.846 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.06 142.54 81.47 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.99 2.46 . . . . 0.0 112.74 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 2.87 87.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.571 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.1 126.75 31.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.736 0.303 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.526 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -128.35 121.3 28.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 4.8 m-30 -76.16 92.95 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.426 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 170.49 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.736 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.8 40.33 0.2 Allowed Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.541 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.447 HD12 ' OE1' ' A' ' 10' ' ' GLN . 2.6 mt -59.53 -61.52 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.959 0.379 . . . . 0.0 110.382 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.899 0.381 . . . . 0.0 110.943 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.898 0.291 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.26 63.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.6 p90 -68.69 160.28 30.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.062 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.1 149.95 31.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.534 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -117.72 135.19 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.159 0.504 . . . . 0.0 111.465 -179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' THR . 59.5 p -139.33 133.82 31.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.319 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.548 ' NE2' ' NE2' ' A' ' 84' ' ' HIS . 1.1 pm0 -129.94 139.52 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.26 160.35 27.79 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.824 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.54 -6.61 7.37 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.663 2.242 . . . . 0.0 112.982 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 49.4 m-20 -135.01 13.76 3.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.521 0.201 . . . . 0.0 110.713 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.1 m-85 -169.92 171.81 6.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.537 0.684 . . . . 0.0 112.163 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.508 ' HG ' ' CD2' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -135.72 108.32 7.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.685 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 14.1 m -99.72 144.68 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 111.203 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 19.2 mt -119.42 152.77 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -132.78 112.57 12.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 40' ' ' PHE . 17.5 mt -125.09 120.13 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' NH1' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -102.55 120.86 41.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.71 132.77 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -32.1 4.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' ALA . 5.5 m-85 -71.12 -9.9 58.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.016 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -29.8 122.53 0.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.453 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 12.16 30.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.22 138.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -58.95 -40.95 86.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -117.33 141.59 48.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -92.96 168.94 10.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.774 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.0 116.57 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.435 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.96 120.75 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.19 127.83 43.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 23.9 p90 -132.2 121.89 24.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.4 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' SER . 18.9 pt-20 -138.65 119.93 14.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.62 -71.49 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.368 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -159.86 26.47 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.083 0.468 . . . . 0.0 109.961 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m-20 -115.76 104.51 11.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 25.7 t80 -105.68 120.76 42.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -124.77 135.62 53.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.611 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 19' ' ' ILE . 85.3 t80 -129.09 112.35 13.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.78 133.71 46.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 111.234 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.27 -59.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.561 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -163.03 -64.73 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.485 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 48.3 Cg_endo -97.71 -10.76 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.986 2.458 . . . . 0.0 112.782 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -108.52 134.55 51.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 8.5 t80 -123.62 118.42 27.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.069 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 1.1 mt -115.75 111.2 20.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.486 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.2 109.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.699 0.285 . . . . 0.0 110.57 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.67 131.12 53.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.942 0.401 . . . . 0.0 111.549 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 m -101.16 110.3 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 20.9 mt -68.63 129.99 92.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 51.4 Cg_exo -54.53 -23.18 30.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.969 2.446 . . . . 0.0 112.734 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -117.91 -133.58 4.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 23.3 mtt-85 -146.5 141.01 26.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 9.5 mm -118.45 126.06 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.57 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.6 p -58.46 157.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.573 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.451 ' N ' HG21 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -121.06 128.41 52.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.661 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -163.96 -41.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.43 -0.03 26.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -91.06 31.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 77' ' ' PRO . 21.2 mp0 -80.0 -168.76 1.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.943 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -131.96 122.29 25.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.33 135.0 10.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -147.74 104.88 3.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 136.91 54.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.567 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.04 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -43.59 22.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.494 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -60.3 -52.89 63.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 9.6 ttpt -78.71 -24.48 44.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 65.26 61.38 5.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.562 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -149.77 126.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.388 . . . . 0.0 111.6 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' ILE . 5.5 t80 -110.72 108.35 18.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -115.62 120.43 39.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.946 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -130.23 118.54 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.431 . . . . 0.0 111.886 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -85.85 142.77 28.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.059 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 8.7 mt -128.44 132.22 24.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 111.666 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 61' ' ' GLU . 38.1 Cg_endo -64.95 153.26 79.05 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.757 2.304 . . . . 0.0 112.261 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' C ' ' A' ' 13' ' ' ASP . 1.6 mttt -96.67 151.06 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 111.523 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.53 -14.19 49.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.113 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.2 m -146.8 108.15 4.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.565 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.8 148.75 15.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.641 2.228 . . . . 0.0 112.397 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 -1.68 86.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.637 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -79.26 132.0 36.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 10' ' ' GLN . 8.2 t-80 -127.04 119.98 27.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.508 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 9.1 m-30 -77.03 90.93 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 173.6 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 112.213 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.45 37.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.902 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 85' ' ' PHE . 20.2 mt -61.21 -63.58 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.239 0.519 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.334 -0.09 0 CA-C-O 121.039 0.447 . . . . 0.0 110.327 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.463 -0.282 0 CA-C-O 120.73 0.221 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.01 60.1 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.69 159.76 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -144.3 143.73 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.81 134.63 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.512 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -139.35 133.11 30.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.391 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 6.2 pm0 -130.36 140.65 50.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.477 0.656 . . . . 0.0 112.477 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 5.5 m-20 -108.31 160.28 27.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.134 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.44 -0.97 2.7 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.648 2.232 . . . . 0.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 40.6 m-20 -135.75 4.82 3.09 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.451 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 17.8 m-85 -167.07 167.05 14.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.329 0.585 . . . . 0.0 112.303 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.1 tm? -134.8 112.03 10.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.138 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.531 ' CG2' HG23 ' A' ' 73' ' ' THR . 55.0 m -108.78 135.67 49.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.0 111.275 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 38' ' ' PHE . 1.3 mt -109.73 152.65 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.5 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -138.92 119.42 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.66 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.505 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -124.8 129.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -107.29 119.17 38.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.077 0.465 . . . . 0.0 111.6 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.411 ' O ' HG21 ' A' ' 21' ' ' VAL . 33.7 m -145.37 128.65 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.536 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.24 -36.37 7.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.654 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' C ' ' A' ' 24' ' ' ALA . 53.9 m-85 -65.78 -10.21 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.62 118.27 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.709 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -98.76 -69.44 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.757 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -43.41 125.24 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -20.15 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.724 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -137.0 148.13 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.605 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -103.91 166.84 10.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.865 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.31 127.58 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.9 t -123.55 121.17 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -127.6 123.15 34.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 24.0 p90 -134.21 126.03 29.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -139.21 119.57 13.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.98 -68.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.78 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -161.89 26.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 0.0 110.391 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.0 m-20 -116.19 104.54 11.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.561 ' CD1' HD11 ' A' ' 17' ' ' ILE . 42.7 t80 -99.11 112.08 24.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 36.1 mttt -118.24 117.43 29.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.385 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 24.3 t80 -102.68 143.22 32.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.77 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 25.2 m-85 -137.52 112.35 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB1' ' CZ ' ' A' ' 40' ' ' PHE . . . -144.48 104.51 4.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.092 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 2.8 pttt 44.92 -163.34 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 71.0 Cg_exo -41.4 -22.6 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.987 1.791 . . . . 0.0 113.636 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.526 ' CZ ' ' HE2' ' A' ' 43' ' ' LYS . 17.0 m-30 -73.09 122.78 22.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.182 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -129.93 125.4 35.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.324 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -123.13 117.77 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 0.0 111.915 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.2 tmm_? -117.89 113.31 21.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 48' ' ' ARG . 29.3 mt -124.21 132.21 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.941 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m -98.99 106.75 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.8 mt -66.21 126.27 91.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.459 . . . . 0.0 111.456 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 32.1 Cg_exo -57.01 -26.55 69.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.031 2.487 . . . . 0.0 112.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.13 -140.12 7.62 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 5.9 mtt180 -137.63 128.09 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.369 . . . . 0.0 111.368 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 31.0 mm -111.73 123.75 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.916 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.4 p -62.36 158.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.188 0.518 . . . . 0.0 112.376 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -123.17 129.58 51.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.601 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -165.21 -37.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.98 9.25 20.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.711 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.98 33.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 76' ' ' LEU . 2.1 pt-20 -85.77 -172.95 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 14.0 mt-30 -132.37 122.19 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.807 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -123.48 134.81 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.721 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.84 107.89 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -107.05 139.57 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' GLY . 65.6 t0 -116.22 112.72 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.474 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.64 -53.68 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.339 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -53.82 -44.62 70.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG2' HG13 ' A' ' 71' ' ' ILE . 35.1 ttpt -84.73 -26.7 27.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.71 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 69.69 63.4 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.649 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 71' ' ' ILE . 7.0 mt -154.34 119.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 111.65 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -103.12 109.47 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.531 HG23 ' CG2' ' A' ' 16' ' ' THR . 97.5 m -114.3 121.71 44.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.489 HD11 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -131.99 121.1 46.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.59 144.21 26.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.022 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.491 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 10.3 mt -133.51 150.61 75.47 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.542 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 17.7 Cg_endo -86.76 157.74 8.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.226 2.617 . . . . 0.0 112.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 1.5 mtpm? -101.42 156.6 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.939 0.4 . . . . 0.0 111.644 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -90.5 -6.15 55.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 m -156.86 90.03 2.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.8 153.54 0.27 Allowed 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 123.011 2.474 . . . . 0.0 112.929 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.26 -11.2 66.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.887 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.513 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 5.0 tp60 -81.28 136.86 35.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.671 0.272 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 2.2 t-80 -125.72 116.87 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.838 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.586 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.4 m-30 -71.51 94.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.48 174.33 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.9 36.21 0.12 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.569 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 37.8 mt -58.89 -63.41 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.516 0.658 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.333 -0.128 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.55 179.576 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.656 0.19 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.41 ' O ' ' NE ' ' A' ' 20' ' ' ARG . . . -94.1 57.66 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.186 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' CE2' HD23 ' A' ' 47' ' ' LEU . 14.3 p90 -72.58 169.46 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -156.92 164.08 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD23 HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -128.63 141.32 51.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.251 0.548 . . . . 0.0 111.875 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.76 134.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.041 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.484 ' OE1' ' ND1' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -130.76 144.03 51.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.98 160.86 27.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.04 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.61 -0.61 2.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.969 2.446 . . . . 0.0 113.686 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.627 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -135.92 6.31 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.443 -0.161 . . . . 0.0 111.195 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.8 m-85 -168.98 169.17 9.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.394 0.616 . . . . 0.0 111.855 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -133.21 120.19 20.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.419 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' HD23 ' A' ' 15' ' ' LEU . 85.7 m -111.94 149.8 31.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.966 0.412 . . . . 0.0 111.21 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.571 HD11 ' CE1' ' A' ' 38' ' ' PHE . 16.3 mt -124.99 151.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.308 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -140.58 122.63 15.64 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.467 HG22 HD13 ' A' ' 47' ' ' LEU . 6.8 mt -125.61 131.27 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -108.59 119.38 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.35 . . . . 0.0 110.805 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 21' ' ' VAL . 34.8 m -145.84 136.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.103 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.09 -36.06 5.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.02 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' ARG . 28.1 m-85 -64.49 -10.36 25.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.07 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.35 86.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.033 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.3 -72.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.621 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.47 HG12 ' CA ' ' A' ' 43' ' ' LYS . 15.1 m -50.18 137.23 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.981 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.43 -41.12 98.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.64 143.1 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.706 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.36 164.48 12.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.009 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -112.39 118.02 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.84 114.6 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -127.45 124.39 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 44.1 p90 -123.58 116.18 22.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -138.2 121.09 16.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.39 59.97 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.93 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 64.52 22.97 12.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.334 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 16.1 t0 -111.57 103.77 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CE1' HD11 ' A' ' 17' ' ' ILE . 80.7 t80 -101.35 113.18 26.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 111.73 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 89.6 t80 -108.56 110.37 21.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.041 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 77.4 m-85 -113.03 106.29 14.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 111.322 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -136.0 118.85 16.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.568 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 44.48 -169.62 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 43' ' ' LYS . 81.8 Cg_exo -47.11 -14.16 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.133 1.889 . . . . 0.0 113.278 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.547 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 18.0 m-30 -80.83 125.52 30.19 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.844 0.354 . . . . 0.0 111.355 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.76 122.99 36.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.356 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.528 HD23 ' CE2' ' A' ' 6' ' ' PHE . 2.0 mt -117.25 110.08 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 111.363 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -112.27 110.23 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.907 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 HD23 ' A' ' 8' ' ' LEU . 18.5 mt -126.58 130.91 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 111.862 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.7 m -104.73 114.17 28.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.484 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mt -81.47 147.2 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.7 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.95 -17.63 59.95 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.997 2.464 . . . . 0.0 112.163 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -138.47 135.12 7.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -64.22 163.54 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.133 0.492 . . . . 0.0 111.838 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 28.2 mm -123.28 129.31 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 13.9 p -54.51 150.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.568 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' N ' HG21 ' A' ' 56' ' ' VAL . 5.9 mt-10 -108.31 121.33 44.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.251 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -154.44 -40.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.55 -21.28 21.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -57.95 -65.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.626 0.251 . . . . 0.0 110.742 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 60' ' ' SER . 26.6 pt-20 28.07 -145.95 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.136 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -167.54 146.15 4.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.609 0.243 . . . . 0.0 110.512 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -154.16 145.91 13.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.896 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.46 110.48 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.658 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.524 ' CE1' ' CG ' ' A' ' 72' ' ' PHE . 31.7 m-85 -94.73 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.32 112.11 24.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -57.09 -52.27 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -21.03 39.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 66.34 63.11 4.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.697 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 70' ' ' GLY . 21.1 mt -158.59 128.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.947 0.403 . . . . 0.0 111.581 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.524 ' CG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 t80 -106.06 109.71 21.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.489 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.56 119.55 38.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -130.55 119.76 46.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.538 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 46.9 mtp180 -85.8 146.35 26.81 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.637 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 11.3 mt -136.06 133.21 19.56 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.098 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.539 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 Cg_exo -73.59 150.11 44.99 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.789 2.326 . . . . 0.0 111.725 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -90.42 156.55 18.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.147 0.499 . . . . 0.0 112.272 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.54 -20.34 22.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.228 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.6 m -131.64 89.55 39.48 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.599 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -41.72 141.27 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.902 2.401 . . . . 0.0 112.524 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.11 -4.81 83.15 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.084 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.438 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 10.5 tt0 -80.4 131.23 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.827 0.314 . . . . 0.0 110.36 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.484 ' ND1' ' OE1' ' A' ' 10' ' ' GLN . 2.8 t60 -126.75 124.5 39.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.092 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 1.2 m-30 -88.5 93.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.093 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.83 126.44 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.11 57.95 0.66 Allowed Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.065 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' A' ' 85' ' ' PHE . 1.3 mp -48.53 -21.9 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.166 0.483 . . . . 0.0 110.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.52 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.876 0.282 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.73 70.08 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.63 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -78.43 159.6 28.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.469 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.52 144.9 29.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.352 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.31 138.09 51.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.502 . . . . 0.0 111.568 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.72 135.04 31.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.363 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 84' ' ' HIS . 8.3 pm0 -129.86 143.41 50.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.474 0.654 . . . . 0.0 112.337 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -106.66 160.82 24.9 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.052 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.04 -1.08 3.19 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.868 2.378 . . . . 0.0 113.452 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.671 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 10.1 m-20 -136.82 9.59 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.47 -0.144 . . . . 0.0 111.003 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 15.3 m-85 -171.99 173.21 4.48 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.384 0.612 . . . . 0.0 111.839 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.67 117.02 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.424 177.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 17' ' ' ILE . 31.2 m -107.73 150.84 26.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.0 111.138 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.507 ' N ' HG22 ' A' ' 16' ' ' THR . 6.1 mt -125.3 151.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.77 114.46 13.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.964 0.411 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 47' ' ' LEU . 4.5 mt -120.4 125.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.317 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -84.62 121.41 27.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG23 ' OH ' ' A' ' 65' ' ' TYR . 20.0 m -149.99 149.2 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.7 p -140.26 -57.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.227 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' ALA . 11.0 m-30 -56.88 -52.76 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.09 99.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.16 6.16 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.504 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 43' ' ' LYS . 1.6 m -128.02 134.31 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -57.33 -41.68 80.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -123.3 139.39 54.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.18 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -84.7 158.73 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.102 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 23.9 m-20 -109.67 111.66 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -118.08 117.47 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.424 . . . . 0.0 111.334 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.84 112.06 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.372 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 21.2 p90 -119.12 113.28 20.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.762 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 pt-20 -136.66 106.04 6.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.649 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 34.69 88.45 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.886 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.81 -1.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 26.8 t70 -108.32 120.71 43.15 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.03 121.76 27.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.5 mmtt -124.35 128.81 49.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -122.89 111.45 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.736 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 6.1 m-85 -115.09 124.6 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -130.66 29.64 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 91.76 -89.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.931 0.892 . . . . 0.0 111.302 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 92.2 Cg_endo -82.02 -17.4 8.14 Favored 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.739 1.3 . . . . 0.0 111.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.71 117.82 34.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.293 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 41' ' ' TYR . 1.4 t80 -124.77 120.16 30.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.482 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -116.07 111.55 20.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.949 0.404 . . . . 0.0 111.582 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.24 110.61 18.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.933 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.45 138.06 48.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.421 . . . . 0.0 111.811 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.71 111.9 24.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 78.6 mt -67.48 140.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.979 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 17.1 Cg_exo -66.87 -15.73 47.92 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.758 2.305 . . . . 0.0 112.302 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.61 -133.81 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.05 142.82 26.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 111.438 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.537 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 19.7 mm -119.08 125.11 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.758 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.3 p -52.88 142.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.032 0.444 . . . . 0.0 112.024 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.98 122.05 44.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.501 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.4 ' C ' ' ND2' ' A' ' 58' ' ' ASN . 0.6 OUTLIER -167.58 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.18 16.1 9.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.84 28.33 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 pm0 -72.38 -167.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.6 mt-30 -138.39 129.97 27.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.02 136.68 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.675 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.4 t -155.11 116.33 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.461 ' OH ' HG23 ' A' ' 21' ' ' VAL . 2.9 t80 -105.53 123.09 47.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 120.39 42.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.87 55.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.524 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.91 -55.22 24.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -7.92 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.797 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.26 51.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.2 mt -145.82 144.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 0.0 110.498 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -111.72 123.86 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 111.217 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.05 131.22 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -139.55 118.62 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 0.0 111.556 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -90.1 147.24 23.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.7 mt -135.3 131.12 19.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.795 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 38.9 Cg_endo -66.98 144.33 69.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.65 2.234 . . . . 0.0 111.997 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 11' ' ' ASP . 35.6 mttp -88.56 156.65 18.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -87.49 -17.56 31.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.138 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.442 ' HB ' ' NE2' ' A' ' 83' ' ' GLN . 20.0 m -135.94 119.25 12.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.544 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 143.8 70.01 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.496 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.28 2.45 90.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.671 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.466 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 4.5 tt0 -81.77 129.11 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.787 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 20.9 t-80 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.192 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.558 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.9 m-30 -83.29 89.91 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.89 162.48 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 112.121 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.85 49.41 0.76 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.592 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.3 -61.34 2.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.927 0.364 . . . . 0.0 110.921 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.334 -0.108 0 CA-C-O 121.023 0.44 . . . . 0.0 110.619 179.561 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.698 0.208 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.848 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 4.5 p90 -73.3 164.87 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.28 147.47 27.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.16 136.09 53.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.507 . . . . 0.0 111.531 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.8 t -140.7 134.47 30.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HG3' ' HB2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -131.94 145.09 51.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.561 0.696 . . . . 0.0 112.686 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.85 160.56 27.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.893 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.87 -0.31 3.8 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.935 2.423 . . . . 0.0 113.248 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.652 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 72.4 m-20 -134.79 5.81 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.478 0.18 . . . . 0.0 110.866 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.5 m-85 -171.34 171.37 5.59 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.267 0.556 . . . . 0.0 111.212 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -137.67 111.18 8.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.086 178.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 75' ' ' ARG . 4.9 m -104.74 148.51 26.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.134 0.492 . . . . 0.0 111.38 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.571 HD13 ' CE1' ' A' ' 38' ' ' PHE . 4.6 mt -123.39 155.3 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -136.85 111.29 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.932 0.396 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.511 HD11 ' CG ' ' A' ' 40' ' ' PHE . 3.7 mt -118.95 126.84 75.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 11.4 ttt180 -101.85 119.44 38.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.585 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.73 130.44 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.543 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.45 -33.59 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.389 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.2 m-30 -66.92 -10.13 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.8 108.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.502 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 6.8 ttt180 -101.48 11.29 39.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 28' ' ' GLU . 12.5 m -121.88 129.37 75.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.19 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.7 m -56.47 -40.38 74.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' VAL . 22.6 tt0 -125.47 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.355 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -94.0 160.03 14.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -113.7 112.15 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.57 114.55 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -119.36 113.15 20.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.393 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 12.3 p90 -118.57 112.95 20.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.015 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 1.1 tt0 -138.07 112.6 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.347 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 54' ' ' ARG . . . 36.91 77.37 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.442 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 66.45 4.16 3.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.5 m-20 -102.8 104.23 14.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CE1' HD13 ' A' ' 17' ' ' ILE . 89.2 t80 -110.87 116.04 30.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.428 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -121.2 131.78 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.249 179.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.511 ' CG ' HD11 ' A' ' 19' ' ' ILE . 84.5 t80 -128.46 112.05 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.334 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' OH ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -116.45 119.33 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.622 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -133.9 29.53 3.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.484 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 2.1 pttp 122.46 -164.31 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.823 1.327 . . . . 0.0 108.536 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 27.3 Cg_exo -37.33 -26.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.339 1.359 . . . . 0.0 112.66 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.5 m-85 -73.49 124.42 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.04 124.1 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.35 109.29 18.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 112.49 19.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.6 mt -132.31 136.98 47.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.628 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.2 m -102.43 111.32 23.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.648 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.494 HD13 ' CE2' ' A' ' 85' ' ' PHE . 17.0 mt -70.64 146.24 93.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 23.7 Cg_exo -63.75 -19.33 66.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.895 2.397 . . . . 0.0 112.551 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -123.43 -127.98 3.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.809 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.453 ' HG2' ' HA2' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -151.38 145.53 25.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 32.2 mm -116.51 124.69 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.497 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.8 p -55.72 151.81 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.467 . . . . 0.0 111.595 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 56' ' ' VAL . 10.0 pt-20 -122.03 131.4 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.25 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.54 -37.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.46 17.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -97.71 30.25 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HG3' ' CD1' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -79.0 -169.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.663 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' N ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.38 137.74 44.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.61 134.66 7.49 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.067 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -143.79 104.95 4.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -119.17 139.57 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 111.617 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.62 128.9 53.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.32 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.827 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.89 -39.3 65.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -95.78 -20.09 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . 63.96 62.91 4.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.341 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.413 HG13 ' C ' ' A' ' 70' ' ' GLY . 50.4 mt -144.7 118.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -113.3 115.79 28.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.444 HG21 ' CG2' ' A' ' 16' ' ' THR . 25.9 m -119.14 129.35 54.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.467 ' CD1' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -138.13 121.13 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -86.22 144.88 27.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.08 125.36 18.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.497 ' HG2' ' CG1' ' A' ' 56' ' ' VAL . 32.9 Cg_endo -63.42 151.66 83.88 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.445 2.097 . . . . 0.0 111.942 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 13.6 mttt -96.39 157.47 15.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 79' ' ' GLU . 2.9 tm-20 -84.63 -4.93 59.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' OE2' ' A' ' 79' ' ' GLU . 93.0 m -152.09 116.96 3.03 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.93 143.64 48.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.265 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.86 86.09 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.908 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tp-100 -66.98 122.38 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.676 0.274 . . . . 0.0 110.504 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -120.16 112.68 19.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.858 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' A' ' 51' ' ' LEU . 16.2 m-30 -77.46 90.29 3.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.305 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 171.29 11.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 112.011 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 36.61 41.13 0.53 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.73 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.59 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.109 0.454 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.465 -0.2 0 N-CA-C 111.689 -0.158 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.06 58.13 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -68.26 164.91 19.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.35 156.6 42.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.47 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -120.08 139.29 52.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.423 0.63 . . . . 0.0 112.008 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.0 p -140.63 131.54 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.628 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.56 145.16 51.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 0.0 112.738 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m-20 -109.31 160.22 28.44 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.899 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.86 -1.24 2.57 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.974 2.449 . . . . 0.0 113.929 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.7 m-20 -137.19 8.91 2.96 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.3 -0.25 . . . . 0.0 111.037 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.6 m-85 -171.17 171.96 5.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.379 0.609 . . . . 0.0 111.803 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -134.24 118.66 17.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.477 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.0 m -108.26 145.92 33.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 110.293 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' N ' HG22 ' A' ' 16' ' ' THR . 3.1 mt -118.85 154.54 21.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.69 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.71 110.53 9.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.459 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.9 mt -126.26 122.44 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.573 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 120.21 41.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.768 0.318 . . . . 0.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.66 134.76 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.379 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.48 -38.27 5.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.6 m-30 -63.63 -10.74 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -21.82 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.229 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.459 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -70.44 -76.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.431 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.5 m -39.94 128.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -58.91 -28.65 66.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.66 145.07 51.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.474 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -101.59 163.65 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.764 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -118.48 119.04 33.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.12 121.52 65.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 56.4 m-85 -135.34 130.67 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.4 p90 -127.02 122.2 33.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 8.6 tt0 -137.39 109.51 7.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.527 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.15 75.7 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.98 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 66.59 5.17 3.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 34.3 m-20 -103.17 103.75 13.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.685 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 71.0 t80 -105.83 113.14 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.408 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 115.39 27.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 76.3 t80 -113.08 109.29 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 98.5 m-85 -110.29 105.96 15.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 112.034 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -134.07 113.36 12.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.594 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 43.8 -170.23 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 76.4 Cg_exo -42.64 -20.87 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.026 1.817 . . . . 0.0 113.106 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 14.2 m-85 -71.6 121.14 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.9 t80 -118.57 119.21 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.427 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mt -120.26 109.53 15.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 111.911 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 3.9 ttm180 -118.73 116.48 26.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.42 128.04 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 0.0 111.794 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 106.36 18.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.511 ' CD1' HD11 ' A' ' 55' ' ' ILE . 4.4 mt -70.34 128.18 91.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.375 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.0 -20.84 31.67 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.821 2.347 . . . . 0.0 112.199 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -112.18 -138.62 7.43 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.538 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.36 137.81 28.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 51' ' ' LEU . 5.0 mt -118.74 126.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.2 p -58.15 155.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.5 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' N ' HG23 ' A' ' 56' ' ' VAL . 7.7 pt-20 -123.1 133.88 54.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -164.7 -38.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.49 -12.93 25.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.191 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -67.43 -70.33 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.962 0.411 . . . . 0.0 110.318 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' A' ' 62' ' ' GLN . 5.2 pt-20 30.34 -152.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.685 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -156.61 155.56 32.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.68 161.19 34.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.418 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -159.87 121.05 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -119.04 131.32 55.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.522 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.05 126.82 53.04 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.582 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -46.57 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.643 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.66 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.259 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -76.73 -19.87 57.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.82 61.8 6.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.46 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 71' ' ' ILE . 43.5 mt -157.44 129.93 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.921 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.39 110.89 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -108.82 128.04 54.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 16' ' ' THR . 9.0 tt -123.13 162.68 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 0.0 111.468 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 12.3 mtm180 -133.38 140.36 47.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 70.5 mt -136.34 128.31 17.22 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 36.7 Cg_endo -65.87 151.72 83.43 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.784 2.323 . . . . 0.0 112.219 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 83' ' ' GLN . 4.4 mttt -98.55 153.78 18.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.348 . . . . 0.0 110.487 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 4.1 tt0 -83.31 -7.61 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.0 m -156.14 108.0 2.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 111.523 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.43 149.81 36.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.733 2.288 . . . . 0.0 112.035 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.72 83.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.851 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 51.0 tt0 -81.07 135.34 35.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.218 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -124.44 118.61 27.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.227 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 6.2 m-30 -77.42 90.6 3.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 172.87 8.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.61 39.9 0.27 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.925 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 8' ' ' LEU . 1.5 mt -61.67 -61.77 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.266 0.533 . . . . 0.0 111.024 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.739 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.705 0.211 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.46 58.78 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.987 0.422 . . . . 0.0 110.395 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.4 p90 -63.04 165.32 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.46 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -149.0 146.21 27.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.46 135.94 53.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.4 . . . . 0.0 111.167 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -140.43 132.35 27.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.04 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -130.23 140.81 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 0.0 112.174 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.433 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -111.2 160.86 27.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.788 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 22.0 Cg_endo -61.56 -1.94 2.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.974 2.449 . . . . 0.0 113.703 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.1 m-20 -135.95 4.05 2.98 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.331 -0.231 . . . . 0.0 111.502 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.1 m-85 -168.48 169.52 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 112.253 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 tm? -134.59 114.17 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.202 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 m -109.0 139.88 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 110.989 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 54.1 mt -111.85 152.11 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.311 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -132.1 119.06 20.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.587 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.501 HD12 ' CG ' ' A' ' 40' ' ' PHE . 3.8 mt -125.84 128.2 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.866 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 12.2 mtp180 -96.66 118.48 33.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG21 ' OH ' ' A' ' 65' ' ' TYR . 19.4 m -108.43 82.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' TYR . 52.3 p -51.02 -87.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' SER . 3.7 m-30 -38.31 -53.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.75 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.79 45.89 5.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.511 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -59.45 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.476 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.452 HG11 ' CA ' ' A' ' 43' ' ' LYS . 18.4 m -43.5 136.54 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 111.05 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.53 95.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.331 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 147.24 52.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -99.24 167.81 10.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -114.92 125.44 53.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.86 116.36 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.74 124.1 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 39.3 p90 -131.48 121.91 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' SER . 6.4 pt-20 -138.66 119.13 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.87 -76.45 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.639 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 50' ' ' THR . 0.9 OUTLIER -153.03 27.44 0.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.913 0.387 . . . . 0.0 110.665 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.65 110.15 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 17' ' ' ILE . 90.0 t80 -101.43 111.87 24.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -113.67 122.85 48.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.784 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CG ' HD12 ' A' ' 19' ' ' ILE . 75.7 t80 -123.82 114.1 19.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HB3' ' CE1' ' A' ' 46' ' ' PHE . 2.1 m-85 -118.02 104.39 10.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.985 0.421 . . . . 0.0 111.583 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -138.03 121.95 17.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 42.19 -170.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 99.8 Cg_exo -44.57 -19.84 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.72 1.613 . . . . 0.0 112.272 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.8 m-85 -74.23 114.17 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.385 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -121.33 122.7 40.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.836 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 19' ' ' ILE . 1.7 mt -120.14 110.64 16.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.099 0.476 . . . . 0.0 112.121 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 114.28 23.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.873 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.31 142.18 39.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.645 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 36' ' ' SER . 1.5 m -101.23 115.67 31.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.581 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 36' ' ' SER . 92.2 mt -75.75 136.22 70.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -79.95 82.28 2.53 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.917 2.411 . . . . 0.0 112.03 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 143.82 -145.99 16.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.096 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.5 mmt180 -143.65 137.85 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.075 0.464 . . . . 0.0 111.642 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 45.9 mm -118.11 126.23 74.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.661 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' A' ' 77' ' ' PRO . 13.8 p -55.14 149.07 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 131.44 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.601 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -169.06 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . 112.73 9.16 19.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.682 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 28.05 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -78.78 -167.17 1.03 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.522 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -137.59 124.99 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.988 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.432 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -124.81 139.02 11.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.216 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.65 106.62 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.559 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.547 ' CD1' ' HB2' ' A' ' 72' ' ' PHE . 7.9 t80 -109.5 146.02 35.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -123.23 125.96 46.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.324 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -39.93 20.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -53.23 -48.54 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.086 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.52 -18.3 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.294 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.99 63.51 2.81 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mt -154.46 120.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.547 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -110.13 124.59 51.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -127.01 127.38 44.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -128.07 119.22 50.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.587 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -82.45 141.76 32.47 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.55 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 55' ' ' ILE . 10.4 mt -135.4 117.35 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.818 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.4 Cg_endo -60.68 154.33 55.68 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.873 2.382 . . . . 0.0 112.286 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' CD ' ' O ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -94.1 154.81 17.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.931 0.395 . . . . 0.0 111.415 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -82.26 -13.85 56.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 m -142.18 116.71 6.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.702 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.62 142.8 98.69 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.67 2.247 . . . . 0.0 112.067 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.43 86.39 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.998 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 tt0 -80.37 126.08 30.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -128.62 125.68 38.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.517 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 8.3 m-30 -80.29 89.98 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 173.83 9.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.026 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.4 35.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.957 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.05 -61.47 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.14 0.47 . . . . 0.0 110.407 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 p30 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.677 0.199 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.94 66.41 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 10.2 p90 -75.8 163.82 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -147.0 143.26 28.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.91 134.83 54.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.115 0.483 . . . . 0.0 111.143 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.9 t -142.5 135.31 28.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.72 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.597 ' NE2' ' CD2' ' A' ' 84' ' ' HIS . 2.2 pm0 -130.68 141.75 50.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.116 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -104.25 161.37 23.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.842 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 32.4 Cg_endo -62.86 -1.88 3.11 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.701 2.268 . . . . 0.0 113.337 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.621 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 57.4 m-20 -135.86 9.92 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.97 -0.105 . . . . 0.0 110.893 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.5 m-85 -170.94 171.71 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 111.964 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.0 109.61 9.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.181 177.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 75' ' ' ARG . 2.8 m -104.04 146.89 28.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.208 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.573 HD11 ' CE1' ' A' ' 38' ' ' PHE . 27.0 mt -122.64 152.41 27.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.05 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -136.96 120.23 16.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.183 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 19' ' ' ILE . 1.2 mt -123.19 126.58 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.118 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -77.27 118.37 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.066 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 20' ' ' ARG . 10.7 m -143.96 129.76 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 p -121.38 -59.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' ALA . 4.9 m-30 -57.0 -52.96 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.93 97.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.825 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -70.29 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 26' ' ' VAL . 23.4 m -58.83 135.82 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -55.65 -41.11 73.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.62 139.42 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.359 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -87.88 166.83 14.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.959 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -119.03 115.93 25.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.89 116.31 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -112.77 114.25 26.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 25.0 p90 -125.61 115.81 20.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 36' ' ' SER . 15.6 mt-10 -137.35 117.29 13.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.74 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.46 -74.95 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.207 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -148.92 27.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.4 t0 -118.47 130.99 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CE1' HD11 ' A' ' 17' ' ' ILE . 80.4 t80 -125.88 113.96 17.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 111.062 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -121.85 127.58 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.644 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -122.72 110.5 15.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.067 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CE1' ' CE2' ' A' ' 46' ' ' PHE . 6.8 m-85 -110.51 116.25 31.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -127.3 26.21 6.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.166 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 22.0 tptt 95.22 -88.41 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.75 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 70.9 Cg_endo -83.61 -16.97 6.45 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.316 1.344 . . . . 0.0 111.476 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -96.12 105.11 17.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.733 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -111.45 111.95 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.956 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -117.26 109.18 16.54 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -118.0 110.72 18.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.94 137.1 49.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 0.0 111.781 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 m -102.77 112.64 25.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.137 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 HG12 ' A' ' 55' ' ' ILE . 61.7 mt -69.44 137.35 88.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.814 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 31.8 Cg_exo -58.96 -18.43 42.7 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.306 2.671 . . . . 0.0 113.117 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -125.23 -127.42 3.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.819 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -147.61 142.94 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.947 0.404 . . . . 0.0 111.485 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.469 HG12 HD12 ' A' ' 51' ' ' LEU . 12.2 mm -119.79 126.3 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.637 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 8.7 p -52.24 141.07 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.088 0.47 . . . . 0.0 111.979 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.65 130.16 56.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.518 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -176.69 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.452 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.46 17.75 11.01 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -98.63 21.7 10.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.704 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.48 ' OE2' ' CD1' ' A' ' 74' ' ' ILE . 9.6 pt-20 -73.52 -170.62 0.86 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.76 138.6 34.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.05 147.65 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.311 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.14 110.14 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 111.066 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -110.88 126.99 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.8 111.47 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.15 71.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -49.27 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 20.4 ttpt -77.48 -27.41 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.011 0.434 . . . . 0.0 110.174 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 71' ' ' ILE . . . 71.95 48.32 27.57 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 70' ' ' GLY . 2.7 mm -144.22 146.68 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 5.2 t80 -109.73 114.85 28.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -114.49 126.99 55.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.48 ' CD1' ' OE2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -139.74 119.54 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 50.0 mtm180 -87.95 148.56 24.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.154 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 75' ' ' ARG . 45.4 mt -135.52 122.81 14.85 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.584 ' HA ' ' CD1' ' A' ' 14' ' ' PHE . 19.2 Cg_endo -61.27 147.53 95.33 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.719 2.279 . . . . 0.0 112.003 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 20.1 mttp -90.84 156.01 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 111.355 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.65 -17.06 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -135.52 94.46 15.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.843 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.8 143.23 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.821 2.348 . . . . 0.0 112.57 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.82 0.34 89.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.256 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 2.2 tp-100 -84.58 136.06 33.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.976 0.388 . . . . 0.0 110.982 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.597 ' CD2' ' NE2' ' A' ' 10' ' ' GLN . 6.9 t-160 -127.42 123.22 35.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.132 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 15.1 m-30 -79.21 91.5 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.21 170.57 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.859 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.93 41.76 0.21 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.636 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mt -60.83 -61.24 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.068 0.434 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.765 0.235 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.53 65.57 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -79.79 164.36 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.59 154.34 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.975 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 HD13 ' A' ' 49' ' ' LEU . 8.3 mt -115.97 135.46 53.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.118 0.485 . . . . 0.0 111.57 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.47 130.4 28.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.121 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.431 ' CB ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.63 144.61 51.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 112.466 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.4 160.45 27.03 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.199 179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.45 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 30.1 Cg_endo -63.46 -0.8 2.61 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.013 2.475 . . . . 0.0 113.776 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 6.0 m-20 -136.28 8.87 3.18 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.408 -0.183 . . . . 0.0 110.748 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.0 m-85 -171.93 172.23 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.32 0.581 . . . . 0.0 111.331 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -136.24 116.89 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.615 178.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 75' ' ' ARG . 11.3 m -107.15 148.39 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 17' ' ' ILE . 8.2 mt -125.61 152.26 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.266 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.55 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.397 . . . . 0.0 111.568 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.576 HD13 ' CD2' ' A' ' 40' ' ' PHE . 3.5 mt -113.97 125.12 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.754 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HG3' HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.23 121.21 29.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.108 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 20' ' ' ARG . 26.9 m -142.91 131.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.672 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.08 -73.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.441 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.7 m-85 -49.68 -53.29 25.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 43.92 103.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.443 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -81.92 3.9 24.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 26' ' ' VAL . 27.1 m -123.94 130.54 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -56.05 -41.37 74.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.09 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -129.07 143.13 50.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.928 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -90.65 166.86 12.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.417 . . . . 0.0 111.36 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.23 122.28 42.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.44 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.02 116.66 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 111.538 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -112.09 114.05 26.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.788 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.6 p90 -125.95 114.94 19.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' SER . 10.7 mt-10 -134.32 112.22 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.376 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.76 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.768 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -153.34 24.37 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.399 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -114.76 104.92 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.978 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' HD11 ' A' ' 17' ' ' ILE . 81.8 t80 -105.12 117.88 35.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -123.71 130.35 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.868 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.576 ' CD2' HD13 ' A' ' 19' ' ' ILE . 32.6 t80 -127.74 116.86 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -118.93 122.2 41.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.229 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -126.32 29.61 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.612 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.2 tptm 93.85 -89.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.585 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 58.7 Cg_endo -84.44 -16.41 5.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 120.708 1.289 . . . . 0.0 111.516 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -102.15 117.48 34.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.236 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.0 t80 -125.86 120.92 31.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.416 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.23 113.47 21.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.84 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.539 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -116.12 110.78 19.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD13 HD23 ' A' ' 8' ' ' LEU . 5.1 mt -123.74 129.4 51.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.664 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.5 110.31 22.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.334 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.94 136.71 85.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 0.0 111.361 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 28.4 Cg_endo -62.78 -14.69 42.12 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.345 2.697 . . . . 0.0 112.864 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -123.53 -129.31 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.747 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.4 mtm180 -149.16 145.9 27.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.986 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' A' ' 15' ' ' LEU . 35.0 mm -121.08 126.29 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.61 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.5 p -52.37 146.94 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 111.553 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -111.33 124.36 52.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.626 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.88 -41.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.0 -6.49 27.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -72.32 -71.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.424 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.4 OUTLIER 33.34 -156.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.467 ' O ' HG13 ' A' ' 74' ' ' ILE . 9.9 mt-30 -154.02 167.07 31.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.45 152.43 6.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.816 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -153.84 143.31 21.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.17 122.51 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 120.15 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.12 -41.74 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -53.44 50.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.208 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -81.57 -16.55 51.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.038 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.44 55.27 30.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.559 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.454 HG12 ' HG3' ' A' ' 20' ' ' ARG . 58.3 mt -145.3 147.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.407 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -112.88 113.32 25.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.466 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 132.77 56.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -141.42 118.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.744 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HG2' HG23 ' A' ' 16' ' ' THR . 39.2 mtp180 -90.89 148.59 22.37 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.9 mt -134.44 143.71 47.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HA ' ' CD1' ' A' ' 14' ' ' PHE . 6.0 Cg_endo -83.61 148.73 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.759 2.306 . . . . 0.0 111.448 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 1.9 mtmp? -89.16 157.05 18.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.51 -18.86 37.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.165 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -142.97 86.8 9.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -40.82 149.76 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.719 2.279 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.37 -10.12 75.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.26 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.411 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 2.7 tp60 -82.14 134.99 35.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -124.12 118.27 26.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.368 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.48 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 5.2 m-30 -78.16 89.84 4.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.054 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.24 174.56 10.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.529 0.681 . . . . 0.0 112.567 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.74 40.52 1.05 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.812 -1.085 . . . . 0.0 114.072 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -61.55 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.172 0.486 . . . . 0.0 110.016 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.349 179.204 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.464 -0.256 0 CA-C-O 120.817 0.257 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.1 59.55 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -69.74 166.03 20.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.666 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.97 38.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -116.49 133.98 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' THR . 22.6 p -138.74 130.94 28.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.214 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HG2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -131.8 143.34 50.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 112.728 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.02 160.74 24.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.613 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.95 -3.68 5.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.632 2.221 . . . . 0.0 113.408 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.43 9.89 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.488 -0.132 . . . . 0.0 111.236 179.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 39.6 m-85 -170.47 170.17 7.07 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 111.294 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD23 ' CB ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -135.39 111.4 9.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' SER . 23.1 m -103.16 135.56 44.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.13 0.491 . . . . 0.0 111.539 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.57 HD12 ' CE1' ' A' ' 38' ' ' PHE . 20.7 mt -108.28 151.94 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.854 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.13 117.35 14.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.044 0.45 . . . . 0.0 111.789 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.478 HD11 ' CD2' ' A' ' 40' ' ' PHE . 18.6 mt -120.0 125.77 74.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.621 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 118.66 37.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.4 m -155.57 127.72 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.86 -30.25 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.909 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.6 m-85 -68.05 -9.49 46.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.024 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -25.69 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.518 0.511 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.54 16.92 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.688 -178.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.12 130.24 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.4 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 m -56.6 -35.79 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.366 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.59 148.01 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.791 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -101.22 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.605 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -113.36 119.38 37.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.65 114.97 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 83.5 m-85 -125.61 120.27 30.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 40.7 p90 -123.2 119.08 29.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.793 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 3.0 pt-20 -138.07 114.02 9.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.267 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.77 77.66 0.07 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.181 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 60.06 10.99 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 4.1 t70 -108.06 103.31 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 110.092 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.5 t80 -108.42 121.25 44.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -120.85 134.57 55.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.664 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 52.9 t80 -129.56 111.72 13.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 95.7 m-85 -108.15 107.25 17.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.125 0.488 . . . . 0.0 111.843 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -132.47 106.42 7.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 46.86 -175.96 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 38.0 Cg_exo -33.52 -29.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 121.972 1.781 . . . . 0.0 112.587 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 17.4 m-30 -66.3 125.36 25.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.85 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -129.01 128.59 43.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.206 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 6.4 mt -118.21 111.78 19.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 113.07 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.19 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 ' CD2' ' A' ' 8' ' ' LEU . 2.4 mt -124.21 127.83 48.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.495 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.26 110.77 23.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 60.3 mt -78.74 155.17 78.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 85' ' ' PHE . 9.6 Cg_endo -86.21 -17.9 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.166 2.577 . . . . 0.0 112.627 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -112.51 -141.64 8.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.81 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -141.48 132.67 26.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.46 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 27.7 mm -110.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.077 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.508 HG11 ' HG2' ' A' ' 77' ' ' PRO . 8.4 p -61.67 157.57 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.485 . . . . 0.0 111.861 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.35 132.37 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.021 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -165.31 -35.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.46 0.9 26.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.239 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -79.37 -72.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.656 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.1 OUTLIER 26.25 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.335 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 74' ' ' ILE . 21.3 mt-30 -161.7 133.15 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -134.72 139.1 10.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.041 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.95 104.69 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.535 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -108.16 136.88 47.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.44 117.36 27.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.81 -44.07 34.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.42 -46.77 69.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 7.3 ttpp -91.88 -16.25 26.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.76 63.34 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.042 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.452 HG13 ' HG2' ' A' ' 69' ' ' LYS . 3.6 mt -151.46 120.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 111.505 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 2.7 t80 -104.99 111.03 23.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.74 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.45 117.68 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.575 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 1.1 tp -129.11 119.82 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.705 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -86.3 143.48 27.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.4 mp -131.94 124.72 19.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.62 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 25.7 Cg_endo -64.64 155.75 65.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.911 2.407 . . . . 0.0 112.354 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -102.63 157.36 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.247 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 5.9 tt0 -84.6 0.33 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.79 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -160.86 99.79 1.32 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.39 153.24 13.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.812 2.341 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.82 63.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.981 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -81.55 142.63 32.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -130.02 123.45 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.586 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.1 m-30 -77.1 92.87 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.462 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 172.32 8.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.268 0.556 . . . . 0.0 111.708 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.88 37.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.451 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 10' ' ' GLN . 8.0 mt -58.47 -61.27 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.04 0.42 . . . . 0.0 110.319 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--N 1.334 -0.085 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.56 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.699 0.208 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.68 58.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.19 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -61.32 163.17 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.8 140.65 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.2 139.69 50.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.166 0.507 . . . . 0.0 111.579 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.45 132.25 22.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.468 ' OE1' HD13 ' A' ' 88' ' ' LEU . 2.2 pm0 -130.42 141.48 50.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.335 0.588 . . . . 0.0 111.649 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.48 160.73 25.06 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.152 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.95 -2.52 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 113.785 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.644 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 66.4 m-20 -136.6 11.45 3.19 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.314 -0.241 . . . . 0.0 110.748 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.6 m-85 -170.37 171.84 6.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.559 0.695 . . . . 0.0 112.237 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.446 ' HA ' HD21 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -137.4 111.1 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.726 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 75' ' ' ARG . 88.6 m -105.7 151.18 24.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.155 0.502 . . . . 0.0 111.496 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 1.2 mt -124.88 154.58 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.98 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.03 118.97 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 2.7 mt -125.83 128.41 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.091 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 4.0 mtp180 -100.95 121.61 42.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.346 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 135.09 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.708 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -32.8 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.338 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 24' ' ' ALA . 6.2 m-30 -67.06 -10.8 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.04 110.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.445 0.465 . . . . 0.0 111.506 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -72.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.504 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 19.5 m -58.31 141.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.436 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -55.32 -40.75 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.378 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' O ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tt0 -121.07 140.35 52.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -89.59 168.71 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -116.36 115.87 26.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 1.9 t -118.57 121.79 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -119.84 116.46 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 53.1 p90 -126.14 115.67 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.519 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -136.39 113.88 10.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.819 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.7 -72.39 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.454 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -155.9 27.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.481 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -118.37 104.35 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.801 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.541 ' CZ ' HD13 ' A' ' 17' ' ' ILE . 72.4 t80 -104.64 124.51 49.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.766 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -129.0 134.9 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 31.4 t80 -125.23 110.01 13.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.35 119.41 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.37 35.08 4.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 91.72 -91.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.39 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 62.7 Cg_endo -84.43 -14.84 6.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.909 1.36 . . . . 0.0 112.143 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' OH ' ' CD2' ' A' ' 23' ' ' TYR . 22.0 m-30 -102.05 117.64 35.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.584 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -124.78 118.89 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mt -123.54 117.56 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.642 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.46 112.77 23.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.869 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.0 mt -121.0 126.02 48.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.856 0.36 . . . . 0.0 111.601 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 107.87 19.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.383 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 mt -73.2 128.36 87.75 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.799 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.491 ' O ' ' CE1' ' A' ' 85' ' ' PHE . 7.3 Cg_exo -72.05 90.86 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.799 2.333 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.98 -137.58 9.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.409 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -144.83 136.65 25.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.063 0.458 . . . . 0.0 111.592 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -116.8 126.84 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.746 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 2.4 p -61.1 156.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.45 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 30.1 mt-10 -123.22 131.26 53.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.619 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -164.02 -42.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.642 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.37 -1.64 26.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 27.61 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.98 -168.63 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 26.3 mt-30 -134.5 138.62 44.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.515 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.37 154.37 25.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.525 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 p -164.23 118.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' ASP . 4.6 t80 -113.53 137.1 52.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 1.1 m-20 -123.2 125.44 45.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.05 -33.47 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -50.16 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.458 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -6.28 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' ARG . . . 63.45 63.27 4.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.391 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt -144.21 121.0 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.4 t80 -114.73 115.6 27.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.986 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.2 m -115.51 128.49 56.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -136.01 118.21 20.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.904 0.383 . . . . 0.0 112.026 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -88.52 146.97 24.86 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 mt -132.65 139.08 33.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.417 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 73.7 Cg_endo -76.0 149.87 33.3 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.882 2.388 . . . . 0.0 112.169 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 10.3 mttp -96.32 156.07 16.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 -6.98 59.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.616 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.6 m -154.51 89.32 3.26 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -42.2 160.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.092 2.528 . . . . 0.0 112.845 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.35 -6.19 57.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.624 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -83.41 142.85 30.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.518 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 1.7 t-160 -127.25 121.1 30.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 52' ' ' PRO . 7.9 m-30 -82.85 94.46 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.02 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.83 174.01 7.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.344 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.89 40.62 0.22 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.485 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD13 ' OE1' ' A' ' 10' ' ' GLN . 3.8 mt -60.46 -62.01 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.109 0.455 . . . . 0.0 110.045 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.938 0.399 . . . . 0.0 110.65 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 50.7 Cg_exo . . . . . 0 N--CA 1.466 -0.129 0 CA-C-O 120.976 0.323 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.72 57.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -61.28 170.23 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -154.07 148.52 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 88' ' ' LEU . 7.3 mt -116.18 138.21 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' THR . 18.8 t -139.38 131.97 28.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.177 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OE1' ' A' ' 10' ' ' GLN . 4.8 pm0 -130.41 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 112.575 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.82 161.04 24.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.016 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.73 -4.02 5.26 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.745 2.297 . . . . 0.0 113.25 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.656 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 32.6 m-20 -136.59 12.31 3.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.327 0.108 . . . . 0.0 110.834 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.656 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 48.8 m-85 -170.4 171.58 6.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 111.908 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -136.94 112.22 9.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.101 178.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . 83.4 m -106.16 146.18 30.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.077 0.465 . . . . 0.0 111.011 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 38' ' ' PHE . 15.0 mt -117.75 155.5 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.101 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -143.2 122.96 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.602 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.23 132.74 70.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.961 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 1.1 ttt180 -104.08 118.0 35.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.322 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 5.4 m -146.94 128.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.597 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -100.71 -50.75 3.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 25' ' ' ARG . 4.3 m-85 -59.49 -15.25 16.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 21' ' ' VAL . . . -56.12 81.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -98.74 86.52 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.999 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -144.57 145.92 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.582 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.6 12.72 30.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.695 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -171.07 108.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 26' ' ' VAL . 2.5 m-30 -86.09 148.78 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.786 0.327 . . . . 0.0 110.505 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -105.35 110.99 23.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 114.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -122.88 118.39 27.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 45.5 p90 -118.58 112.37 19.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -138.98 124.96 19.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 0.0 111.846 -179.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 38.72 62.78 1.11 Allowed Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.699 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 67.32 22.26 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -117.7 103.21 9.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 17' ' ' ILE . 89.8 t80 -103.14 122.38 44.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.38 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 15.8 mttt -125.11 129.33 49.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -126.99 121.51 31.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 39' ' ' LYS . 36.8 m-85 -131.5 127.95 38.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -109.93 -81.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 6.2 tptt -146.32 -64.88 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 38.7 Cg_endo -99.59 -6.26 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.089 2.526 . . . . 0.0 111.921 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.56 122.67 47.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.19 120.44 36.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.693 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.86 110.6 16.52 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.9 114.79 23.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.516 178.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 48' ' ' ARG . 77.6 mt -138.01 144.05 40.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 112.016 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -112.78 119.95 39.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.312 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 17.2 mt -76.16 155.47 84.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.097 0.475 . . . . 0.0 111.517 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 15.1 Cg_exo -69.27 -16.28 39.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.175 2.584 . . . . 0.0 112.592 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -122.99 -127.81 3.31 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.628 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.468 ' HG3' ' OG ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -154.1 149.37 27.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 15' ' ' LEU . 51.0 mm -118.69 125.62 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.5 p -59.25 156.64 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.444 . . . . 0.0 111.898 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.39 124.06 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.96 -44.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.68 0.77 30.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 32.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.661 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.35 -173.52 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -135.88 130.91 34.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.35 136.38 8.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.838 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.7 104.89 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.726 0.298 . . . . 0.0 110.583 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -97.13 115.11 26.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 107.62 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.73 -41.0 31.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -50.37 69.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HG2' HD13 ' A' ' 71' ' ' ILE . 3.5 ttpm? -87.97 -16.76 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.438 ' C ' HG13 ' A' ' 71' ' ' ILE . . . 66.24 63.2 4.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.233 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.438 HG13 ' C ' ' A' ' 70' ' ' GLY . 75.7 mt -158.59 120.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 11.1 t80 -100.11 116.31 31.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.36 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -114.45 118.61 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.439 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -128.25 119.72 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.889 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.448 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 12.6 mtp180 -85.95 142.63 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.702 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -131.47 140.63 39.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.512 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.52 ' HG2' ' CG1' ' A' ' 56' ' ' VAL . 74.3 Cg_endo -76.9 148.48 28.19 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.756 2.304 . . . . 0.0 112.02 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -93.36 155.86 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.074 0.464 . . . . 0.0 111.433 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.35 -15.36 50.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.129 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 m -138.36 102.28 8.1 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.7 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.97 148.86 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 111.944 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.3 57.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.731 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.43 133.06 41.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.774 0.321 . . . . 0.0 110.499 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.448 ' CD2' ' HG2' ' A' ' 10' ' ' GLN . 6.7 t-80 -128.01 124.52 37.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.2 m-30 -83.04 90.48 7.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.49 173.94 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.06 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.09 36.1 0.32 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.809 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.408 HD22 HD13 ' A' ' 8' ' ' LEU . 8.8 mt -58.23 -61.98 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.195 0.498 . . . . 0.0 110.219 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 178.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.79 0.246 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.05 67.41 4.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' A' ' 49' ' ' LEU . 31.2 p90 -72.36 160.03 33.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.725 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -148.79 149.67 31.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -115.35 134.7 54.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.687 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' THR . 8.1 m -142.86 134.2 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.489 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.4 pt20 -132.35 144.84 50.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -100.84 159.94 28.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.718 178.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 13.6 Cg_endo -57.16 -8.14 3.23 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.783 2.322 . . . . 0.0 113.604 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 61.9 m-20 -135.89 17.09 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.29 -0.256 . . . . 0.0 110.808 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.1 m-85 -169.46 170.39 8.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.947 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -135.69 108.26 7.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.952 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 91.5 m -101.07 143.4 31.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.172 0.511 . . . . 0.0 110.962 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 73' ' ' THR . 7.5 mt -116.3 155.12 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -125.93 121.46 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.06 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 40' ' ' PHE . 15.3 mt -124.81 118.61 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -88.07 119.05 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.223 0.535 . . . . 0.0 112.001 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -141.24 113.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.225 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -58.08 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.992 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' ALA . 2.1 m-85 -68.84 -53.58 20.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.004 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 46.81 106.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.73 6.97 13.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 m -133.28 135.59 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.808 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -58.62 -41.54 86.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -125.33 142.63 51.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.893 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -90.65 168.43 11.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.56 115.59 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.965 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.05 115.81 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.466 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -126.69 120.08 28.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -129.23 124.0 33.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 114.09 9.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.581 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.46 -70.85 0.16 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.186 -0.531 . . . . 0.0 113.006 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.45 25.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.086 0.469 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -115.02 107.24 15.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 17' ' ' ILE . 70.1 t80 -102.84 111.0 23.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 14.6 mttt -116.07 121.95 43.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.658 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' CD2' HG23 ' A' ' 19' ' ' ILE . 58.2 t80 -124.93 117.77 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 39' ' ' LYS . 16.6 m-85 -124.27 124.73 43.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.63 31.49 4.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 1.3 tppm? 92.59 -88.83 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 111.183 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 63.6 Cg_endo -85.04 -15.97 5.36 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.237 1.291 . . . . 0.0 111.573 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.08 115.6 30.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.569 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 119.49 29.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.443 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mt -121.78 115.91 23.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.48 111.65 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.952 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 6' ' ' PHE . 83.2 mt -125.59 130.54 51.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.573 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.81 113.03 24.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.2 mt -72.2 137.59 81.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.07 0.462 . . . . 0.0 111.502 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.3 Cg_endo -68.38 -18.91 44.02 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.289 2.659 . . . . 0.0 112.717 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.63 -136.79 5.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.71 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -143.53 138.3 29.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.958 0.409 . . . . 0.0 111.069 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.462 HG23 ' HB3' ' A' ' 76' ' ' LEU . 19.3 mm -116.12 124.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.834 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 4.9 p -64.83 159.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.531 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 130.15 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.378 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.73 17.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.77 3.3 27.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.753 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 m -98.49 44.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 164.36 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 74' ' ' ILE . 8.3 mm-40 -127.49 129.72 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.35 147.89 18.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.588 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.3 p -153.62 104.36 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.717 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -96.82 103.83 15.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -89.49 99.55 12.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.221 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.26 69.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -52.44 -50.59 62.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -76.27 -23.13 54.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.033 0.444 . . . . 0.0 110.174 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.34 46.98 84.15 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.936 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 mt -143.44 148.31 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 14.9 t80 -107.05 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.675 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.59 118.38 30.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -126.48 119.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' NE ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.65 147.36 25.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 55' ' ' ILE . 1.3 mp -133.6 149.46 72.18 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 73.5 Cg_endo -79.09 150.13 22.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.613 2.209 . . . . 0.0 111.777 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -96.31 152.86 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.851 0.358 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 1.9 tt0 -84.05 -10.86 57.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.701 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 m -151.36 97.97 3.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.538 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -43.49 153.05 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.663 2.242 . . . . 0.0 112.366 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.57 -1.77 50.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.169 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.95 138.48 39.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.001 0.4 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -127.11 116.97 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.379 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 6.9 m-30 -73.4 91.8 1.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.345 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.51 160.76 13.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.909 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.54 1.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.298 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 8' ' ' LEU . 1.7 mt -63.53 -62.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.621 0.21 . . . . 0.0 111.511 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 37.2 Cg_exo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.662 0.192 . . . . 0.0 111.897 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.14 61.59 6.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.143 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 27.5 p90 -76.03 164.76 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 6.2 t0 -157.46 168.41 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.53 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -124.82 136.98 54.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.227 0.537 . . . . 0.0 111.747 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 16' ' ' THR . 9.6 t -138.43 130.81 28.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.079 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' A' ' 10' ' ' GLN . 7.7 pm0 -135.86 145.53 46.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.72 161.5 22.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.52 -3.58 1.43 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.81 2.34 . . . . 0.0 113.767 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.638 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.6 m-20 -136.05 12.26 3.34 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.367 -0.208 . . . . 0.0 110.909 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.638 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 23.7 m-85 -167.17 167.48 14.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.484 0.659 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -134.79 109.05 8.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.083 178.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.431 HG21 HG21 ' A' ' 73' ' ' THR . 55.3 m -107.01 126.76 52.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.171 0.51 . . . . 0.0 111.836 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.574 HD12 ' CE2' ' A' ' 38' ' ' PHE . 7.7 mt -100.81 155.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.998 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -140.83 112.41 7.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.339 . . . . 0.0 111.691 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.28 128.95 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.502 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -92.49 120.42 32.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.76 126.67 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.365 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.05 -30.96 4.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.709 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 58.8 m-85 -69.54 -9.19 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.284 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.88 108.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.55 0.531 . . . . 0.0 111.512 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -88.19 13.39 11.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.7 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.43 137.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.556 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.6 t -56.66 -35.59 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.14 144.63 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -96.31 168.66 10.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.48 124.23 42.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.75 132.58 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.818 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -121.32 116.21 24.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.938 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 43.3 p90 -116.69 114.19 23.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.067 0.461 . . . . 0.0 111.463 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -138.14 101.6 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.045 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.03 -149.11 17.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.631 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -59.13 -12.12 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.962 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.79 112.09 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 110.63 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CE2' HD12 ' A' ' 17' ' ' ILE . 39.6 t80 -120.73 112.01 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.41 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -119.31 126.54 51.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.081 0.467 . . . . 0.0 111.566 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -110.39 148.66 31.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.954 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -136.1 110.43 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.973 0.416 . . . . 0.0 111.513 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.532 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . -131.26 68.81 1.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.682 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER 32.57 -88.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.888 -178.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 57.2 Cg_endo -69.46 -25.37 30.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.257 1.305 . . . . 0.0 112.579 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' ALA . 21.7 m-85 -105.04 125.61 51.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.722 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -125.62 120.67 31.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.961 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.94 117.9 28.49 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.42 116.2 22.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 49' ' ' LEU . 80.1 mt -142.89 151.46 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 112.25 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.34 105.88 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.071 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 36' ' ' SER . 3.6 mt -72.02 155.79 91.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -83.02 75.0 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.382 2.721 . . . . 0.0 111.966 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 145.85 -147.18 18.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.37 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' GLY . 1.1 mtm180 -146.65 142.09 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.121 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 14.0 mm -115.07 123.11 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.3 p -62.07 154.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 112.536 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.38 130.09 51.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.723 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.68 29.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.661 0.267 . . . . 0.0 111.429 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.55 -32.36 3.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.345 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.58 118.51 10.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.556 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.07 163.37 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 4.5 mt-30 -131.78 138.64 48.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.34 137.51 7.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.905 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.76 105.45 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 0.0 110.408 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -103.12 131.72 49.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -115.53 111.55 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.92 -49.32 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.64 -41.83 67.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -97.06 -19.44 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.9 56.68 13.28 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.929 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.5 mm -137.19 116.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 111.509 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t80 -111.21 114.42 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -121.49 119.04 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -124.38 119.48 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.622 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 76' ' ' LEU . 11.4 mtp180 -87.08 148.26 25.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 15.9 mt -134.24 150.73 74.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.208 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.537 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 94.6 Cg_endo -81.81 157.84 18.51 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.944 2.43 . . . . 0.0 112.162 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -98.0 148.54 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.0 tp10 -85.02 -11.68 54.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.526 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.3 m -148.52 116.87 3.98 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.872 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.3 142.96 45.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.775 2.316 . . . . 0.0 112.441 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 -0.16 89.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.433 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -70.15 119.02 13.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.05 111.95 18.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.13 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.9 m-30 -73.75 90.05 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.487 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' GLY . 22.2 mt-10 -70.7 173.58 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.271 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . 35.98 38.61 0.24 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 8' ' ' LEU . 4.0 mt -57.84 -61.6 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.628 0.251 . . . . 0.0 110.538 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 . . . . . 0 C--N 1.333 -0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.127 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.832 0.263 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.407 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -85.72 65.14 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.532 ' CD2' HD22 ' A' ' 47' ' ' LEU . 7.1 p90 -80.34 159.44 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.043 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -145.33 150.65 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.81 133.46 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.126 0.489 . . . . 0.0 111.761 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -139.51 131.45 27.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.636 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.511 ' CB ' HD23 ' A' ' 15' ' ' LEU . 5.6 pm0 -130.57 140.98 50.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.339 0.59 . . . . 0.0 112.325 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.28 160.84 28.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.997 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 24.2 Cg_endo -61.46 -1.22 1.79 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.107 2.538 . . . . 0.0 114.196 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.667 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -135.35 2.46 3.0 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.163 -0.335 . . . . 0.0 111.74 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 20.8 m-85 -171.78 172.52 4.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 10' ' ' GLN . 1.2 tm? -135.86 117.38 14.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.813 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -110.57 136.84 49.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.389 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.567 HD12 ' CD2' ' A' ' 38' ' ' PHE . 3.4 mt -113.51 150.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . . . -131.05 106.84 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 47' ' ' LEU . 24.1 mt -108.46 121.99 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HD3' ' HB2' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -89.88 120.23 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.502 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 21' ' ' VAL . 18.8 m -143.83 132.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 p -110.65 -82.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.3 m-85 -39.08 -52.58 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.781 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 41.51 97.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.777 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' CG ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -60.36 -73.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.206 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 42' ' ' ALA . 29.6 m -62.84 142.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.32 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -38.02 78.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.7 140.92 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.2 m-30 -89.44 166.34 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.58 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' OD1' ' OH ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -117.42 118.69 32.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 7.2 t -121.68 119.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.788 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' OH ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 m-85 -118.18 118.95 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.144 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 33' ' ' PHE . 28.3 p90 -121.75 112.73 18.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.453 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.2 mt-10 -135.29 116.79 14.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.22 -75.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.139 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -149.8 26.21 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.469 . . . . 0.0 110.14 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -112.97 107.58 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CD2' HD12 ' A' ' 17' ' ' ILE . 50.3 t80 -105.33 111.53 24.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -117.86 131.34 56.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.415 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 55.6 t80 -127.52 110.3 12.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.657 ' CD1' ' CD2' ' A' ' 46' ' ' PHE . 21.9 m-85 -128.51 130.48 47.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -110.78 -68.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' CG ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 tptt -160.35 -72.15 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD3' ' CG ' ' A' ' 43' ' ' LYS . 45.2 Cg_endo -87.76 -20.37 1.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.092 . . . . 0.0 111.059 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -97.95 119.61 36.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.657 ' CD2' ' CD1' ' A' ' 41' ' ' TYR . 9.9 m-85 -120.13 116.34 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.32 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.532 HD22 ' CD2' ' A' ' 6' ' ' PHE . 5.8 mt -118.34 112.63 20.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.53 112.43 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.901 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 134.54 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.664 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m -108.38 113.72 27.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 34.0 mt -78.42 147.75 72.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.484 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.29 -12.94 27.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.089 2.526 . . . . 0.0 112.162 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -139.36 138.95 9.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.847 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -62.74 155.42 26.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.777 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 31.6 mm -119.28 126.35 75.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.186 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.558 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.9 p -64.4 161.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.414 0.626 . . . . 0.0 112.237 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.2 pm0 -125.03 125.75 44.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -150.13 8.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 -1.21 20.26 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.63 49.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.779 0.324 . . . . 0.0 110.997 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 45.4 tt0 -83.59 163.46 20.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 23.9 mm-40 -122.72 126.0 46.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -135.25 138.46 10.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.158 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.1 p -144.76 108.83 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.904 0.383 . . . . 0.0 111.331 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -109.2 118.01 35.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.53 134.03 52.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -47.73 12.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 110.291 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -52.21 -49.75 63.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.709 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 71' ' ' ILE . 16.7 ttpt -83.78 -19.86 34.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.689 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.46 56.97 19.31 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.73 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 71' ' ' ILE . 5.9 mt -146.85 148.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -115.8 120.34 38.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.121 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 m -119.76 133.38 55.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.658 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.473 HD11 ' CA ' ' A' ' 63' ' ' GLY . 0.7 OUTLIER -140.88 118.54 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 20.1 mtp180 -92.34 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.306 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.1 147.5 66.08 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 89.5 Cg_endo -81.31 148.28 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.713 2.275 . . . . 0.0 111.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 55' ' ' ILE . 27.7 mmtp -85.24 156.14 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 0.0 111.448 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.4 tt0 -89.39 -22.35 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.185 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -129.19 128.48 23.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.99 133.13 24.43 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.616 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.09 3.6 88.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.099 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -81.5 128.52 33.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.821 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.48 118.35 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.6 m-30 -77.97 90.69 4.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.155 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.84 170.77 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.56 43.23 0.25 Allowed Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.59 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.98 -62.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.022 0.411 . . . . 0.0 110.952 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 89' ' ' ASN . 11.2 t-20 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 121.034 0.445 . . . . 0.0 110.692 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.898 0.291 . . . . 0.0 112.413 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' PHE . . . -83.87 -64.97 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 53.89 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.731 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.48 158.2 39.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -118.71 136.44 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 111.333 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.77 133.39 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 1.6 pm0 -130.01 143.03 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 160.68 25.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.433 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.4 -2.59 6.26 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.424 2.082 . . . . 0.0 113.02 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.92 11.92 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.902 -0.136 . . . . 0.0 110.956 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 66.5 m-85 -170.76 171.01 6.32 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.25 0.548 . . . . 0.0 111.662 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.447 ' HB3' HD13 ' A' ' 55' ' ' ILE . 1.2 tm? -134.42 115.91 14.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.927 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 74' ' ' ILE . 37.2 m -107.41 132.11 53.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.368 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 ' CE2' ' A' ' 38' ' ' PHE . 3.0 mt -107.12 155.39 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.51 118.36 14.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.932 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 6' ' ' PHE . 44.4 mt -121.13 127.89 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.354 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt85 -107.84 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 111.674 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 m -151.01 141.89 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -119.15 -35.17 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.664 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' ARG . 9.2 m-85 -66.17 -9.11 28.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.605 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.63 85.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.645 0.591 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.43 -71.74 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.831 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 m -43.71 135.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.7 p -57.99 -40.21 80.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -129.7 147.87 51.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -103.54 167.16 9.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 60.9 m-20 -117.32 121.12 40.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.584 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 t -122.85 119.29 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 55.6 m-85 -126.48 119.72 27.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 31.4 p90 -121.0 113.79 20.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.559 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -140.75 117.53 11.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.6 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.14 66.57 1.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.026 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER 65.55 9.85 6.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.642 0.258 . . . . 0.0 111.394 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 8.1 t70 -102.74 103.66 13.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 17' ' ' ILE . 21.5 t80 -110.22 121.11 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.344 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 6.0 mttt -124.77 126.52 45.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.648 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -122.14 112.64 18.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.907 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 13.6 m-85 -114.63 101.77 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.028 0.442 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.532 ' CB ' ' HE2' ' A' ' 43' ' ' LYS . . . -129.25 118.42 22.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 40.99 -166.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 93.0 Cg_exo -44.75 -21.36 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.687 1.591 . . . . 0.0 112.848 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 24.9 m-85 -76.61 123.05 25.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 111.734 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -127.45 124.67 38.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.936 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -120.28 113.87 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -112.02 109.53 19.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.38 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.49 129.55 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 112.201 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.27 109.03 21.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.455 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 14.0 mt -63.15 128.32 92.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 111.126 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.459 ' CD ' HD23 ' A' ' 88' ' ' LEU . 78.0 Cg_exo -49.96 -26.38 14.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.052 2.502 . . . . 0.0 113.176 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -116.51 -132.91 5.04 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -142.37 136.49 29.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 110.804 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.559 ' CD1' ' CD ' ' A' ' 78' ' ' LYS . 41.3 mm -117.29 125.21 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.8 p -62.21 156.97 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 112.063 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.79 131.43 53.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.67 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 21.5 m-80 -171.19 21.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.44 7.03 44.39 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.152 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -97.99 45.81 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.03 172.64 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -141.24 139.32 33.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.52 159.06 27.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.972 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -157.67 118.47 3.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.3 . . . . 0.0 110.429 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -117.62 137.35 52.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -119.11 119.24 33.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.235 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.06 -53.26 15.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.519 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -55.02 -46.17 75.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HG2' HD13 ' A' ' 71' ' ' ILE . 28.3 ttpt -84.38 -26.82 28.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.457 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 66.2 63.02 4.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 69' ' ' LYS . 1.4 mt -148.72 121.04 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.449 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.6 t80 -109.68 110.97 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 147.73 29.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.351 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 16' ' ' THR . 3.8 tp -138.35 154.14 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.101 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -135.32 141.69 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -136.14 149.97 69.72 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 111.752 -178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.533 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 78.1 Cg_endo -78.13 154.71 29.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.906 2.404 . . . . 0.0 112.206 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' CD ' ' CD1' ' A' ' 55' ' ' ILE . 6.6 mmtp -99.76 151.89 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 3.1 tm-20 -87.69 -4.11 58.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.793 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.6 m -157.68 120.84 2.14 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.223 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 146.29 96.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.0 111.938 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 1.79 89.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.55 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -78.66 126.56 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.34 117.42 23.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.0 m-30 -73.92 90.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.2 168.67 11.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.84 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.77 41.81 0.96 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.44 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD23 ' CD ' ' A' ' 52' ' ' PRO . 6.3 mt -60.61 -61.99 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.854 0.327 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 0.0 111.337 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.896 0.29 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.02 57.1 2.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' HB3' HG22 ' A' ' 19' ' ' ILE . 49.0 p90 -66.14 166.73 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.981 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 150.7 32.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.32 133.9 54.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 0.0 111.506 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.6 p -139.4 133.53 31.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.961 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 9.7 pm0 -130.05 141.45 50.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 0.0 112.691 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.37 160.4 26.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.204 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.27 -2.9 3.49 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.473 2.115 . . . . 0.0 113.298 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 7.3 m-20 -135.9 13.74 3.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.672 0.272 . . . . 0.0 110.563 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 73.1 m-85 -168.22 167.35 12.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.469 0.652 . . . . 0.0 111.864 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' A' ' 10' ' ' GLN . 2.0 tm? -134.59 106.24 6.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . 97.2 m -107.75 137.1 46.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 mt -126.88 137.91 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.151 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -126.36 139.17 53.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.997 0.427 . . . . 0.0 111.168 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.59 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -122.43 134.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.792 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -77.47 120.06 21.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.857 0.361 . . . . 0.0 110.641 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.64 139.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 p -127.66 -52.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.344 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' ALA . 9.3 m-30 -66.71 -52.77 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.767 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 42.33 96.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.773 0.32 . . . . 0.0 110.626 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.467 ' CB ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 mpt_? -76.76 3.13 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.699 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 43' ' ' LYS . 4.6 m -128.65 133.58 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -41.54 72.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.606 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.67 138.61 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -85.02 163.46 18.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -110.28 111.75 23.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.722 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 t -117.81 116.18 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.909 0.385 . . . . 0.0 111.479 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -124.02 118.11 26.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.682 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 1.8 p90 -126.79 122.66 35.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.659 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 119.01 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.546 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 63.75 -75.86 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.417 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.27 26.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.601 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 1.4 m-20 -118.23 129.48 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.4 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -123.44 111.48 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -116.67 128.2 55.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.59 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 70.0 t80 -128.93 114.78 16.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.996 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -120.48 127.97 52.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.317 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -134.65 34.18 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.274 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 17.7 tppt? 93.77 -87.95 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.073 0.949 . . . . 0.0 111.218 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.574 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 44.8 Cg_endo -86.87 -16.01 3.67 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.499 1.466 . . . . 0.0 111.921 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.98 117.37 34.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.984 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.59 119.85 28.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -115.61 113.27 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.59 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 109.98 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.16 133.78 51.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 111.621 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.6 m -90.43 105.57 17.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.983 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.68 133.07 95.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.8 Cg_endo -68.41 -23.41 37.96 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.937 2.424 . . . . 0.0 112.75 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.55 -138.35 6.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.623 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -136.02 128.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 111.51 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' ARG . 4.8 mm -116.14 125.6 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.603 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.545 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 7.7 p -60.25 157.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.078 0.466 . . . . 0.0 111.754 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 134.58 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -36.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.25 -11.58 26.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.651 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -68.6 -71.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.023 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 62' ' ' GLN . 5.3 pt-20 32.92 -156.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.2 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.5 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 30.9 mt-30 -143.63 126.61 16.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.7 136.05 9.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.561 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.5 p -152.68 111.42 3.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.34 . . . . 0.0 110.815 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.85 108.5 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.402 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.19 98.62 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.38 83.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -52.69 51.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 71' ' ' ILE . 6.0 mtmt -72.82 -16.54 61.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.87 38.35 94.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.185 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -145.01 151.94 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.323 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 45.3 t80 -111.69 123.33 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -119.07 132.85 56.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -140.07 118.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HA ' ' OG1' ' A' ' 16' ' ' THR . 15.0 mtp180 -86.46 148.59 25.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 17.2 mt -134.04 116.31 13.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 111.887 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 66.2 Cg_exo -53.81 149.17 34.32 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.201 2.6 . . . . 0.0 112.805 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.26 153.75 17.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 1.3 tt0 -81.03 -15.0 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.473 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.443 HG21 ' HD2' ' A' ' 81' ' ' PRO . 69.9 m -144.85 129.27 8.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD2' HG21 ' A' ' 80' ' ' THR . 49.9 Cg_endo -69.4 149.9 69.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.752 2.301 . . . . 0.0 112.836 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.21 77.84 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.787 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.49 129.86 37.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -122.07 115.54 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.6 m-30 -74.88 89.72 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.116 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 162.51 12.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.59 46.53 0.82 Allowed Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.525 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 mt -59.88 -61.98 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.783 0.292 . . . . 0.0 110.668 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 121.098 0.475 . . . . 0.0 110.223 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.464 -0.258 0 CA-C-O 120.791 0.246 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.92 55.88 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.394 . . . . 0.0 110.397 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -61.84 163.25 7.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.12 145.6 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.69 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.75 133.64 55.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t -138.81 130.22 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.613 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' OE1' ' CD1' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -131.12 140.47 49.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 112.123 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.26 160.77 28.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.8 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.51 -2.2 0.93 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.041 2.494 . . . . 0.0 114.243 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.2 m-20 -136.41 3.69 2.83 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 122.058 -0.401 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.64 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.1 m-85 -169.3 169.38 9.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 55' ' ' ILE . 1.2 tm? -135.65 107.87 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.036 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 29.8 m -101.56 143.01 32.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 110.877 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.463 HG21 ' N ' ' A' ' 18' ' ' ALA . 23.1 mt -115.82 154.15 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.647 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -129.79 122.6 29.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.303 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 HG23 ' CD1' ' A' ' 47' ' ' LEU . 1.6 mt -125.95 123.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.481 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 118.39 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.707 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 21' ' ' VAL . 29.7 m -146.02 133.25 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.045 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -120.65 -32.95 3.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.1 m-85 -87.15 -53.35 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . 18.89 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.747 0.655 . . . . 0.0 112.01 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -56.99 -60.0 4.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -33.91 124.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 111.009 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 p -54.84 -39.95 69.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -125.31 139.49 53.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.353 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.0 OUTLIER -85.85 160.32 19.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 9.2 m-20 -112.88 113.11 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.728 0.299 . . . . 0.0 110.998 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' A' ' 38' ' ' PHE . 10.7 t -117.02 115.93 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.991 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 11.2 m-85 -116.67 114.65 24.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 36.3 p90 -124.75 116.27 22.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 42.5 mt-10 -138.22 115.16 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.79 -68.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -157.89 22.66 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.524 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -111.23 104.64 13.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.14 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.423 ' CE1' HG12 ' A' ' 31' ' ' VAL . 82.9 t80 -106.38 116.64 32.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.4 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 37' ' ' ASP . 1.3 mptt -119.92 131.01 55.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 92.5 t80 -130.95 116.78 18.3 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 17.6 m-85 -115.54 110.23 18.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -108.16 24.1 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 95.91 -87.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 O-C-N 124.235 0.959 . . . . 0.0 110.658 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.594 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 80.6 Cg_endo -83.0 -16.38 7.47 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.491 1.461 . . . . 0.0 111.801 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -109.97 131.92 54.62 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.809 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 19.7 t80 -127.35 126.96 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -121.55 112.14 18.11 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.84 115.17 22.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 178.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 48' ' ' ARG . 90.7 mt -137.04 144.03 42.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.69 113.31 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.249 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.3 mt -73.89 135.78 77.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.567 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 36.3 Cg_exo -61.47 -22.09 73.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.071 2.514 . . . . 0.0 113.003 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.589 ' HA3' ' CD1' ' A' ' 85' ' ' PHE . . . -113.07 -142.61 8.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.129 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 2.4 mmt-85 -142.18 139.35 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.864 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 27.9 mm -117.81 124.96 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 6.2 p -56.24 152.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.402 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 123.07 49.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.55 -39.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.96 -19.43 32.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -59.87 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 60' ' ' SER . 1.0 OUTLIER 30.96 -152.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.468 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 1.8 mt-30 -157.33 131.45 8.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.34 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.98 141.69 13.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.065 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -159.51 105.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -107.41 137.81 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.25 115.58 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.14 -46.63 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.33 -50.57 69.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.767 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HD2' ' CD1' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -79.61 -23.21 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 69.4 63.36 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.672 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' HD2' ' A' ' 69' ' ' LYS . 54.0 mt -160.23 126.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.9 t80 -108.12 118.79 37.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.515 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -122.54 122.39 38.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.46 ' O ' HG21 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -130.51 122.93 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.441 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.68 140.93 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.668 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.9 mp -129.37 129.81 23.28 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 38.3 Cg_endo -66.82 150.74 83.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.926 2.417 . . . . 0.0 112.184 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' C ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -92.7 155.81 17.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.36 -19.74 62.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.701 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -146.51 120.88 5.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.0 152.02 54.01 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.886 2.391 . . . . 0.0 112.624 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.75 -4.0 62.31 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -77.53 135.43 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.125 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 3.4 t-160 -125.43 116.45 21.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 5.5 m-30 -67.93 89.76 0.29 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.698 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -74.42 172.78 11.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 112.018 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 45.03 32.66 3.37 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.41 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.503 ' CD1' ' OE1' ' A' ' 10' ' ' GLN . 8.7 mt -43.13 -53.29 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.723 0.761 . . . . 0.0 110.146 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.522 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.463 -0.29 0 CA-C-O 120.829 0.262 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.16 60.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 38.2 p90 -68.65 161.52 27.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.819 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.54 148.22 29.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.81 134.21 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.262 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -141.84 136.05 30.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.301 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.24 141.89 50.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.317 0.58 . . . . 0.0 112.329 -178.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -101.44 157.84 32.9 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.507 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 10.5 Cg_endo -54.75 -8.16 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 113.629 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 47.1 m-20 -135.52 15.48 3.42 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.324 -0.235 . . . . 0.0 111.292 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 13.1 m-85 -169.5 170.71 8.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.481 0.658 . . . . 0.0 112.321 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -132.82 112.67 12.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.6 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 75' ' ' ARG . 30.2 m -104.67 138.02 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 1.9 mt -114.33 149.41 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -129.76 120.26 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 111.074 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 HD12 ' A' ' 47' ' ' LEU . 13.1 mt -126.0 119.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.5 mtt180 -90.69 120.64 31.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.412 . . . . 0.0 111.813 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 m -141.88 129.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -72.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.997 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.4 m-30 -48.42 -52.91 19.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.909 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.504 ' HA ' ' CD ' ' A' ' 43' ' ' LYS . . . 39.49 95.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.89 5.32 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.877 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 43' ' ' LYS . 27.1 m -127.46 133.28 68.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -41.11 82.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.72 148.28 50.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.653 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.67 168.71 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.301 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.95 118.55 36.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.11 115.35 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 0.0 112.027 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -125.39 117.87 24.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -120.41 118.95 31.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.142 0.496 . . . . 0.0 111.72 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.21 96.76 3.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.621 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.09 -146.68 18.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.685 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -54.33 -14.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.628 0.251 . . . . 0.0 111.63 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.83 117.27 26.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' CZ ' HD12 ' A' ' 17' ' ' ILE . 61.2 t80 -127.67 113.27 15.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 131.34 55.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 111.574 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 69.8 t80 -126.64 109.7 12.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.519 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -107.69 108.31 19.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.188 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -140.82 119.42 12.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.194 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.685 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 38.04 -161.66 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.685 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 73.0 Cg_exo -50.91 -17.3 3.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.208 1.272 . . . . 0.0 112.567 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.439 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 51.4 m-85 -74.55 112.81 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.341 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.25 116.21 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.445 HD12 HD12 ' A' ' 19' ' ' ILE . 4.4 mt -119.35 114.65 22.69 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.06 115.84 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.15 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.2 mt -134.0 143.04 47.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 112.16 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -105.21 105.17 15.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.204 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 88.2 mt -62.4 145.3 94.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.178 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 37.5 Cg_exo -60.12 -23.43 73.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.778 2.318 . . . . 0.0 112.055 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -125.36 -125.04 2.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.3 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -154.15 149.54 27.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.975 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 31.5 mm -117.77 123.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 5.3 p -58.12 151.39 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -119.1 125.32 49.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.808 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.45 27.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.412 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.56 -32.73 2.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.154 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.71 120.21 9.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.137 0.468 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.0 163.88 6.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.632 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 6.2 mt-30 -143.53 134.38 25.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 146.06 17.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.661 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -139.27 112.1 7.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 110.65 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -104.57 120.21 40.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.235 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -114.01 110.74 20.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.563 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.99 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -57.26 -50.27 73.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 9.8 ttpt -74.2 -22.13 59.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 61.24 63.21 5.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.267 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 71' ' ' ILE . 14.6 mt -156.84 131.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.118 0.485 . . . . 0.0 112.054 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' A' ' 40' ' ' PHE . 12.9 t80 -116.21 113.76 23.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.505 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 134.05 55.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.194 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -138.58 117.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HG3' HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.13 142.28 27.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.178 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.47 ' HB3' HG23 ' A' ' 55' ' ' ILE . 1.2 mp -134.37 145.88 57.11 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.631 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 59.4 Cg_endo -73.42 151.36 47.87 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.831 2.354 . . . . 0.0 112.433 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -95.47 156.68 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.103 0.478 . . . . 0.0 111.704 -179.414 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 12.0 tt0 -88.22 -6.25 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -159.51 96.09 1.64 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.318 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 157.56 9.42 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.87 -6.42 70.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 37.3 tt0 -84.79 141.0 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.308 . . . . 0.0 110.81 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -124.26 117.06 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 8.2 m-30 -72.72 92.69 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -72.0 173.7 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.311 0.577 . . . . 0.0 111.913 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.9 40.15 0.33 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.667 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 10.5 mt -60.66 -63.04 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.976 0.388 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.087 0.47 . . . . 0.0 110.641 179.773 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.1 mt -125.62 133.38 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -73.54 118.19 66.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.54 139.38 85.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.24 . . . . 0.0 111.78 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.25 54.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -58.19 161.25 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.44 146.99 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.3 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 138.59 54.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.226 0.536 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 p -141.66 133.94 27.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.552 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.447 ' OE1' HD12 ' A' ' 88' ' ' LEU . 2.7 pm0 -130.7 140.73 50.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.371 0.605 . . . . 0.0 112.457 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.37 160.56 26.11 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.986 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.68 -6.06 1.47 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.03 2.486 . . . . 0.0 113.947 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.4 m-20 -135.95 8.91 3.27 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.625 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 65.7 m-85 -168.24 168.41 11.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 111.733 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.72 109.58 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.615 178.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.441 HG23 ' HG2' ' A' ' 75' ' ' ARG . 19.4 m -99.41 147.26 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 38' ' ' PHE . 1.6 mt -125.4 153.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.12 121.94 16.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 112.069 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.08 124.23 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.796 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.8 118.71 37.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.358 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 21' ' ' VAL . 16.4 m -148.25 143.21 19.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.906 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -125.57 -23.22 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.7 m-85 -75.56 -10.05 59.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.534 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.55 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.476 0.485 . . . . 0.0 111.811 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -82.69 10.22 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.287 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.11 127.44 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.785 179.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -55.8 -24.19 34.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.12 153.52 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -108.55 168.39 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.378 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.03 128.51 43.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.95 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.2 117.6 26.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 21.2 p90 -128.86 119.28 24.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.8 OUTLIER -140.71 122.21 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.114 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.87 -70.21 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.642 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -160.38 25.4 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 0.0 110.592 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 6.7 t70 -116.22 110.61 19.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CD2' HD11 ' A' ' 17' ' ' ILE . 26.1 t80 -105.54 111.82 24.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.224 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.28 128.17 50.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 47.8 t80 -104.99 143.08 33.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -135.49 102.81 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 40' ' ' PHE . . . -149.0 112.73 5.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.8 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER 47.02 -175.63 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 84.6 Cg_exo -37.0 -27.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.16 1.907 . . . . 0.0 112.744 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 12.6 m-30 -63.15 120.82 12.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.381 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -125.27 120.05 30.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.648 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -116.98 115.66 25.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.049 0.452 . . . . 0.0 112.024 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.28 110.17 16.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.897 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.9 mt -124.18 130.63 52.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.367 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 m -102.14 107.67 18.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 23.1 mt -65.28 143.89 98.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.199 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.534 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 49.9 Cg_endo -70.27 -23.82 28.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.785 2.323 . . . . 0.0 112.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -116.74 -137.28 5.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.186 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 82.3 mtt-85 -140.47 132.76 28.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 76' ' ' LEU . 52.0 mm -113.78 124.41 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.481 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.54 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.1 p -68.03 162.56 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 7.4 pt-20 -123.74 127.66 48.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.218 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.24 6.68 0.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.96 23.63 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -82.1 -69.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.994 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 31.55 -156.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.698 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mm-40 -179.94 119.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 74' ' ' ILE . . . -170.06 -179.16 41.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.175 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -164.14 148.93 10.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CD1' ' HE2' ' A' ' 29' ' ' PHE . 14.9 t80 -113.85 132.94 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.436 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.93 125.3 43.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.475 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.83 -34.26 26.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.422 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -50.53 65.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.545 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -11.0 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.074 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 63.15 62.21 5.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.259 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' GLY . 6.1 mt -155.05 127.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.514 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.1 t80 -110.49 114.79 28.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -121.7 126.13 48.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.263 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 2.1 tp -133.49 120.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.441 ' HG2' HG23 ' A' ' 16' ' ' THR . 5.1 mtp180 -92.33 145.1 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.487 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.9 mt -134.66 143.17 45.39 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HG2' ' CG1' ' A' ' 56' ' ' VAL . 47.9 Cg_endo -73.18 158.98 48.24 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.789 2.326 . . . . 0.0 112.657 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 1.7 mttt -96.76 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.99 -11.03 51.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.399 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.2 m -147.52 130.49 7.98 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.846 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.06 142.54 81.47 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.99 2.46 . . . . 0.0 112.74 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 2.87 87.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.571 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.1 126.75 31.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.736 0.303 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.526 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -128.35 121.3 28.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 4.8 m-30 -76.16 92.95 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.426 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 170.49 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.736 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 34.8 40.33 0.2 Allowed Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.541 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD12 ' OE1' ' A' ' 10' ' ' GLN . 2.6 mt -59.53 -61.52 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.959 0.379 . . . . 0.0 110.382 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.92 14.94 2.47 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.899 0.381 . . . . 0.0 110.943 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 91' ' ' LEU . 28.7 mtt -115.41 -32.42 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -45.25 177.44 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.828 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.403 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -141.8 163.21 33.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.914 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.93 141.96 35.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 pp -107.93 140.23 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.648 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mp -93.52 131.65 38.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.089 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.99 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.854 0.359 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -120.34 150.22 41.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -70.74 111.34 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.2 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 2' ' ' LEU . 51.8 Cg_exo -54.27 161.8 4.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.26 63.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.6 p90 -68.69 160.28 30.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.062 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.1 149.95 31.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.534 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -117.72 135.19 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.159 0.504 . . . . 0.0 111.465 -179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' THR . 59.5 p -139.33 133.82 31.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.319 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.548 ' NE2' ' NE2' ' A' ' 84' ' ' HIS . 1.1 pm0 -129.94 139.52 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.26 160.35 27.79 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.824 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.54 -6.61 7.37 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.663 2.242 . . . . 0.0 112.982 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 49.4 m-20 -135.01 13.76 3.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.521 0.201 . . . . 0.0 110.713 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.1 m-85 -169.92 171.81 6.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.537 0.684 . . . . 0.0 112.163 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.508 ' HG ' ' CD2' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -135.72 108.32 7.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.685 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 14.1 m -99.72 144.68 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 111.203 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 19.2 mt -119.42 152.77 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -132.78 112.57 12.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 40' ' ' PHE . 17.5 mt -125.09 120.13 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' NH1' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -102.55 120.86 41.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.71 132.77 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -32.1 4.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' ALA . 5.5 m-85 -71.12 -9.9 58.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.016 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -29.8 122.53 0.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.453 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 12.16 30.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.22 138.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -58.95 -40.95 86.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -117.33 141.59 48.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -92.96 168.94 10.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.774 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.0 116.57 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.435 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.96 120.75 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.19 127.83 43.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 23.9 p90 -132.2 121.89 24.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.4 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' SER . 18.9 pt-20 -138.65 119.93 14.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.62 -71.49 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.368 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -159.86 26.47 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.083 0.468 . . . . 0.0 109.961 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m-20 -115.76 104.51 11.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 25.7 t80 -105.68 120.76 42.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -124.77 135.62 53.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.611 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 19' ' ' ILE . 85.3 t80 -129.09 112.35 13.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.78 133.71 46.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 111.234 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.27 -59.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.561 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -163.03 -64.73 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.485 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 48.3 Cg_endo -97.71 -10.76 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.986 2.458 . . . . 0.0 112.782 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -108.52 134.55 51.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 8.5 t80 -123.62 118.42 27.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.069 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 1.1 mt -115.75 111.2 20.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.486 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.2 109.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.699 0.285 . . . . 0.0 110.57 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.67 131.12 53.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.942 0.401 . . . . 0.0 111.549 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 m -101.16 110.3 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 20.9 mt -68.63 129.99 92.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 51.4 Cg_exo -54.53 -23.18 30.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.969 2.446 . . . . 0.0 112.734 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -117.91 -133.58 4.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 23.3 mtt-85 -146.5 141.01 26.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 9.5 mm -118.45 126.06 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.57 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.6 p -58.46 157.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.573 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.451 ' N ' HG21 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -121.06 128.41 52.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.661 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -163.96 -41.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.43 -0.03 26.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -91.06 31.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 77' ' ' PRO . 21.2 mp0 -80.0 -168.76 1.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.943 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -131.96 122.29 25.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.33 135.0 10.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -147.74 104.88 3.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 136.91 54.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.567 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.04 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -43.59 22.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.494 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -60.3 -52.89 63.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 9.6 ttpt -78.71 -24.48 44.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 65.26 61.38 5.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.562 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -149.77 126.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.388 . . . . 0.0 111.6 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' ILE . 5.5 t80 -110.72 108.35 18.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -115.62 120.43 39.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.946 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -130.23 118.54 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.431 . . . . 0.0 111.886 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -85.85 142.77 28.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.059 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 8.7 mt -128.44 132.22 24.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 111.666 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 61' ' ' GLU . 38.1 Cg_endo -64.95 153.26 79.05 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.757 2.304 . . . . 0.0 112.261 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' C ' ' A' ' 13' ' ' ASP . 1.6 mttt -96.67 151.06 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 111.523 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.53 -14.19 49.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.113 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.2 m -146.8 108.15 4.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.565 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.8 148.75 15.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.641 2.228 . . . . 0.0 112.397 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 -1.68 86.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.637 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -79.26 132.0 36.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 10' ' ' GLN . 8.2 t-80 -127.04 119.98 27.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.508 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 9.1 m-30 -77.03 90.93 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 173.6 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 112.213 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 34.45 37.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.902 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 85' ' ' PHE . 20.2 mt -61.21 -63.58 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.239 0.519 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.2 7.36 22.2 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.039 0.447 . . . . 0.0 110.327 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.446 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 2.5 mtt -112.63 15.45 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.176 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mt -96.8 177.3 5.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.149 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 t -110.88 174.01 6.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 110.821 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.65 115.9 28.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.393 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -103.78 112.34 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.4 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 mp -93.69 142.79 26.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.268 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.71 110.24 22.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.463 HG23 ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -42.7 149.92 0.46 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 3' ' ' THR . 43.4 Cg_endo -67.91 172.16 11.2 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.452 2.102 . . . . 0.0 111.994 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.01 60.1 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.69 159.76 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -144.3 143.73 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.81 134.63 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.512 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -139.35 133.11 30.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.391 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 6.2 pm0 -130.36 140.65 50.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.477 0.656 . . . . 0.0 112.477 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 5.5 m-20 -108.31 160.28 27.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.134 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.44 -0.97 2.7 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.648 2.232 . . . . 0.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 40.6 m-20 -135.75 4.82 3.09 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.451 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 17.8 m-85 -167.07 167.05 14.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.329 0.585 . . . . 0.0 112.303 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.1 tm? -134.8 112.03 10.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.138 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.531 ' CG2' HG23 ' A' ' 73' ' ' THR . 55.0 m -108.78 135.67 49.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.0 111.275 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 38' ' ' PHE . 1.3 mt -109.73 152.65 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.5 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -138.92 119.42 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.66 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.505 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -124.8 129.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -107.29 119.17 38.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.077 0.465 . . . . 0.0 111.6 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' O ' HG21 ' A' ' 21' ' ' VAL . 33.7 m -145.37 128.65 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.536 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.24 -36.37 7.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.654 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' C ' ' A' ' 24' ' ' ALA . 53.9 m-85 -65.78 -10.21 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.62 118.27 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.709 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -98.76 -69.44 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.757 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -43.41 125.24 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -20.15 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.724 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -137.0 148.13 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.605 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -103.91 166.84 10.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.865 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.31 127.58 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.9 t -123.55 121.17 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -127.6 123.15 34.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 24.0 p90 -134.21 126.03 29.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -139.21 119.57 13.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.98 -68.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.78 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -161.89 26.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 0.0 110.391 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.0 m-20 -116.19 104.54 11.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.561 ' CD1' HD11 ' A' ' 17' ' ' ILE . 42.7 t80 -99.11 112.08 24.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 36.1 mttt -118.24 117.43 29.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.385 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 24.3 t80 -102.68 143.22 32.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.77 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 25.2 m-85 -137.52 112.35 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB1' ' CZ ' ' A' ' 40' ' ' PHE . . . -144.48 104.51 4.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.092 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 2.8 pttt 44.92 -163.34 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 71.0 Cg_exo -41.4 -22.6 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.987 1.791 . . . . 0.0 113.636 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.526 ' CZ ' ' HE2' ' A' ' 43' ' ' LYS . 17.0 m-30 -73.09 122.78 22.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.182 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -129.93 125.4 35.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.324 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -123.13 117.77 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 0.0 111.915 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.2 tmm_? -117.89 113.31 21.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 48' ' ' ARG . 29.3 mt -124.21 132.21 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.941 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m -98.99 106.75 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.8 mt -66.21 126.27 91.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.459 . . . . 0.0 111.456 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 32.1 Cg_exo -57.01 -26.55 69.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.031 2.487 . . . . 0.0 112.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.13 -140.12 7.62 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 5.9 mtt180 -137.63 128.09 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.369 . . . . 0.0 111.368 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 31.0 mm -111.73 123.75 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.916 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.4 p -62.36 158.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.188 0.518 . . . . 0.0 112.376 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -123.17 129.58 51.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.601 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -165.21 -37.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.98 9.25 20.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.711 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.98 33.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 76' ' ' LEU . 2.1 pt-20 -85.77 -172.95 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 14.0 mt-30 -132.37 122.19 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.807 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -123.48 134.81 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.721 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.84 107.89 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -107.05 139.57 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' GLY . 65.6 t0 -116.22 112.72 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.474 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.64 -53.68 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.339 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -53.82 -44.62 70.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG2' HG13 ' A' ' 71' ' ' ILE . 35.1 ttpt -84.73 -26.7 27.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.71 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 69.69 63.4 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.649 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 71' ' ' ILE . 7.0 mt -154.34 119.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 111.65 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -103.12 109.47 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.531 HG23 ' CG2' ' A' ' 16' ' ' THR . 97.5 m -114.3 121.71 44.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.489 HD11 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -131.99 121.1 46.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.59 144.21 26.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.022 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.491 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 10.3 mt -133.51 150.61 75.47 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.542 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 17.7 Cg_endo -86.76 157.74 8.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.226 2.617 . . . . 0.0 112.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 1.5 mtpm? -101.42 156.6 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.939 0.4 . . . . 0.0 111.644 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -90.5 -6.15 55.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 m -156.86 90.03 2.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.8 153.54 0.27 Allowed 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 123.011 2.474 . . . . 0.0 112.929 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.26 -11.2 66.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.887 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.513 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 5.0 tp60 -81.28 136.86 35.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.671 0.272 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 2.2 t-80 -125.72 116.87 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.838 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.586 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.4 m-30 -71.51 94.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.48 174.33 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 35.9 36.21 0.12 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.569 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 37.8 mt -58.89 -63.41 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.516 0.658 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.11 9.1 26.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.55 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.452 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -118.25 17.94 13.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.432 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mt -91.08 178.76 5.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -133.87 174.18 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.427 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.63 134.78 34.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 94' ' ' LEU . 2.4 pp -123.77 126.2 46.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.78 112.76 24.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.966 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HB3' HD12 ' A' ' 2' ' ' LEU . 12.1 tpt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.734 0.302 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -123.41 137.63 54.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.946 0.403 . . . . 0.0 111.11 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.39 130.41 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.69 137.01 26.64 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.804 2.336 . . . . 0.0 111.891 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.41 ' O ' ' NE ' ' A' ' 20' ' ' ARG . . . -94.1 57.66 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.186 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' CE2' HD23 ' A' ' 47' ' ' LEU . 14.3 p90 -72.58 169.46 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -156.92 164.08 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD23 HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -128.63 141.32 51.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.251 0.548 . . . . 0.0 111.875 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.76 134.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.041 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.484 ' OE1' ' ND1' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -130.76 144.03 51.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.98 160.86 27.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.04 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.61 -0.61 2.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.969 2.446 . . . . 0.0 113.686 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.627 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -135.92 6.31 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.443 -0.161 . . . . 0.0 111.195 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.8 m-85 -168.98 169.17 9.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.394 0.616 . . . . 0.0 111.855 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -133.21 120.19 20.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.419 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' HD23 ' A' ' 15' ' ' LEU . 85.7 m -111.94 149.8 31.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.966 0.412 . . . . 0.0 111.21 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.571 HD11 ' CE1' ' A' ' 38' ' ' PHE . 16.3 mt -124.99 151.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.308 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -140.58 122.63 15.64 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.467 HG22 HD13 ' A' ' 47' ' ' LEU . 6.8 mt -125.61 131.27 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -108.59 119.38 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.35 . . . . 0.0 110.805 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 21' ' ' VAL . 34.8 m -145.84 136.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.103 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.09 -36.06 5.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.02 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' ARG . 28.1 m-85 -64.49 -10.36 25.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.07 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.35 86.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.033 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.3 -72.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.621 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.47 HG12 ' CA ' ' A' ' 43' ' ' LYS . 15.1 m -50.18 137.23 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.981 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.43 -41.12 98.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.64 143.1 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.706 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.36 164.48 12.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.009 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -112.39 118.02 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.84 114.6 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -127.45 124.39 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 44.1 p90 -123.58 116.18 22.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -138.2 121.09 16.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.39 59.97 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.93 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 64.52 22.97 12.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.334 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 16.1 t0 -111.57 103.77 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CE1' HD11 ' A' ' 17' ' ' ILE . 80.7 t80 -101.35 113.18 26.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 111.73 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 89.6 t80 -108.56 110.37 21.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.041 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 77.4 m-85 -113.03 106.29 14.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 111.322 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -136.0 118.85 16.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.568 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 44.48 -169.62 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 43' ' ' LYS . 81.8 Cg_exo -47.11 -14.16 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.133 1.889 . . . . 0.0 113.278 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.547 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 18.0 m-30 -80.83 125.52 30.19 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.844 0.354 . . . . 0.0 111.355 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.76 122.99 36.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.356 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.528 HD23 ' CE2' ' A' ' 6' ' ' PHE . 2.0 mt -117.25 110.08 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 111.363 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -112.27 110.23 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.907 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 HD23 ' A' ' 8' ' ' LEU . 18.5 mt -126.58 130.91 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 111.862 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.7 m -104.73 114.17 28.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.484 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mt -81.47 147.2 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.7 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.95 -17.63 59.95 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.997 2.464 . . . . 0.0 112.163 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -138.47 135.12 7.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -64.22 163.54 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.133 0.492 . . . . 0.0 111.838 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 28.2 mm -123.28 129.31 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 13.9 p -54.51 150.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.568 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' N ' HG21 ' A' ' 56' ' ' VAL . 5.9 mt-10 -108.31 121.33 44.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.251 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -154.44 -40.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.55 -21.28 21.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -57.95 -65.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.626 0.251 . . . . 0.0 110.742 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 60' ' ' SER . 26.6 pt-20 28.07 -145.95 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.136 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -167.54 146.15 4.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.609 0.243 . . . . 0.0 110.512 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -154.16 145.91 13.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.896 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.46 110.48 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.658 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.524 ' CE1' ' CG ' ' A' ' 72' ' ' PHE . 31.7 m-85 -94.73 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.32 112.11 24.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -57.09 -52.27 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -21.03 39.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 66.34 63.11 4.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.697 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 70' ' ' GLY . 21.1 mt -158.59 128.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.947 0.403 . . . . 0.0 111.581 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.524 ' CG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 t80 -106.06 109.71 21.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.489 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.56 119.55 38.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -130.55 119.76 46.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.538 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 46.9 mtp180 -85.8 146.35 26.81 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.637 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 11.3 mt -136.06 133.21 19.56 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.098 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.539 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 Cg_exo -73.59 150.11 44.99 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.789 2.326 . . . . 0.0 111.725 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -90.42 156.55 18.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.147 0.499 . . . . 0.0 112.272 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.54 -20.34 22.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.228 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.6 m -131.64 89.55 39.48 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.599 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -41.72 141.27 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.902 2.401 . . . . 0.0 112.524 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.11 -4.81 83.15 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.084 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.438 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 10.5 tt0 -80.4 131.23 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.827 0.314 . . . . 0.0 110.36 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.484 ' ND1' ' OE1' ' A' ' 10' ' ' GLN . 2.8 t60 -126.75 124.5 39.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.092 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 1.2 m-30 -88.5 93.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.093 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.83 126.44 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 90' ' ' MET . . . 34.11 57.95 0.66 Allowed Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.065 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' A' ' 85' ' ' PHE . 1.3 mp -48.53 -21.9 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.166 0.483 . . . . 0.0 110.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -80.98 14.47 2.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.52 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.528 ' HG3' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.48 -30.43 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.39 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' N ' ' HG3' ' A' ' 90' ' ' MET . 15.3 mt -42.79 158.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.576 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -149.24 154.3 38.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.793 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.39 112.16 13.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.411 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 109.08 12.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.385 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 95' ' ' LEU . 2.6 mp -97.73 109.86 22.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.329 . . . . 0.0 110.751 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.895 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.63 141.52 47.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 t -64.1 121.19 70.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.8 153.02 65.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.918 2.412 . . . . 0.0 112.521 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.73 70.08 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.63 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -78.43 159.6 28.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.469 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.52 144.9 29.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.352 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.31 138.09 51.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.502 . . . . 0.0 111.568 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.72 135.04 31.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.363 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 84' ' ' HIS . 8.3 pm0 -129.86 143.41 50.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.474 0.654 . . . . 0.0 112.337 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -106.66 160.82 24.9 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.052 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.04 -1.08 3.19 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.868 2.378 . . . . 0.0 113.452 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.671 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 10.1 m-20 -136.82 9.59 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.47 -0.144 . . . . 0.0 111.003 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 15.3 m-85 -171.99 173.21 4.48 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.384 0.612 . . . . 0.0 111.839 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.67 117.02 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.424 177.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 17' ' ' ILE . 31.2 m -107.73 150.84 26.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.0 111.138 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.507 ' N ' HG22 ' A' ' 16' ' ' THR . 6.1 mt -125.3 151.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.77 114.46 13.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.964 0.411 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 47' ' ' LEU . 4.5 mt -120.4 125.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.317 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -84.62 121.41 27.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG23 ' OH ' ' A' ' 65' ' ' TYR . 20.0 m -149.99 149.2 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.7 p -140.26 -57.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.227 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' ALA . 11.0 m-30 -56.88 -52.76 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.09 99.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.16 6.16 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.504 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 43' ' ' LYS . 1.6 m -128.02 134.31 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -57.33 -41.68 80.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -123.3 139.39 54.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.18 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -84.7 158.73 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.102 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 23.9 m-20 -109.67 111.66 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -118.08 117.47 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.424 . . . . 0.0 111.334 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.84 112.06 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.372 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 21.2 p90 -119.12 113.28 20.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.762 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 pt-20 -136.66 106.04 6.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.649 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 34.69 88.45 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.886 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.81 -1.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 26.8 t70 -108.32 120.71 43.15 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.03 121.76 27.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.5 mmtt -124.35 128.81 49.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -122.89 111.45 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.736 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 6.1 m-85 -115.09 124.6 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -130.66 29.64 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 91.76 -89.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.931 0.892 . . . . 0.0 111.302 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 92.2 Cg_endo -82.02 -17.4 8.14 Favored 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.739 1.3 . . . . 0.0 111.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.71 117.82 34.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.293 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 41' ' ' TYR . 1.4 t80 -124.77 120.16 30.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.482 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -116.07 111.55 20.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.949 0.404 . . . . 0.0 111.582 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.24 110.61 18.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.933 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.45 138.06 48.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.421 . . . . 0.0 111.811 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.71 111.9 24.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 78.6 mt -67.48 140.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.979 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' A' ' 91' ' ' LEU . 17.1 Cg_exo -66.87 -15.73 47.92 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.758 2.305 . . . . 0.0 112.302 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.61 -133.81 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.05 142.82 26.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 111.438 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.537 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 19.7 mm -119.08 125.11 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.758 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.3 p -52.88 142.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.032 0.444 . . . . 0.0 112.024 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.98 122.05 44.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.501 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.4 ' C ' ' ND2' ' A' ' 58' ' ' ASN . 0.6 OUTLIER -167.58 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.18 16.1 9.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.84 28.33 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 pm0 -72.38 -167.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.6 mt-30 -138.39 129.97 27.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.02 136.68 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.675 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.4 t -155.11 116.33 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.461 ' OH ' HG23 ' A' ' 21' ' ' VAL . 2.9 t80 -105.53 123.09 47.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 120.39 42.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.87 55.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.524 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.91 -55.22 24.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -7.92 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.797 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.26 51.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.2 mt -145.82 144.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 0.0 110.498 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -111.72 123.86 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 111.217 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.05 131.22 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -139.55 118.62 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 0.0 111.556 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -90.1 147.24 23.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.7 mt -135.3 131.12 19.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.795 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 38.9 Cg_endo -66.98 144.33 69.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.65 2.234 . . . . 0.0 111.997 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 11' ' ' ASP . 35.6 mttp -88.56 156.65 18.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -87.49 -17.56 31.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.138 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.442 ' HB ' ' NE2' ' A' ' 83' ' ' GLN . 20.0 m -135.94 119.25 12.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.544 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 143.8 70.01 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.496 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.28 2.45 90.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.671 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.466 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 4.5 tt0 -81.77 129.11 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.787 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 20.9 t-80 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.192 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.558 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.9 m-30 -83.29 89.91 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.89 162.48 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 112.121 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.85 49.41 0.76 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.592 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.3 -61.34 2.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.927 0.364 . . . . 0.0 110.921 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -85.3 13.42 6.52 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.023 0.44 . . . . 0.0 110.619 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 91' ' ' LEU . 6.6 mtm -113.48 -28.77 7.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.337 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.492 HD11 ' HG3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -45.25 178.34 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.606 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.42 -172.62 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.062 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.35 144.79 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.004 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.64 111.07 17.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.849 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 7.7 mp -91.15 116.0 28.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.953 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -110.86 143.07 42.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.716 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -67.19 138.48 94.59 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo -53.71 149.36 32.77 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.807 2.338 . . . . 0.0 112.204 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.848 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 4.5 p90 -73.3 164.87 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.28 147.47 27.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.16 136.09 53.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.507 . . . . 0.0 111.531 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.8 t -140.7 134.47 30.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HG3' ' HB2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -131.94 145.09 51.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.561 0.696 . . . . 0.0 112.686 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.85 160.56 27.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.893 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.87 -0.31 3.8 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.935 2.423 . . . . 0.0 113.248 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.652 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 72.4 m-20 -134.79 5.81 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.478 0.18 . . . . 0.0 110.866 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.5 m-85 -171.34 171.37 5.59 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.267 0.556 . . . . 0.0 111.212 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -137.67 111.18 8.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.086 178.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 75' ' ' ARG . 4.9 m -104.74 148.51 26.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.134 0.492 . . . . 0.0 111.38 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.571 HD13 ' CE1' ' A' ' 38' ' ' PHE . 4.6 mt -123.39 155.3 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -136.85 111.29 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.932 0.396 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.511 HD11 ' CG ' ' A' ' 40' ' ' PHE . 3.7 mt -118.95 126.84 75.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 11.4 ttt180 -101.85 119.44 38.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.585 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.73 130.44 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.543 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.45 -33.59 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.389 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.2 m-30 -66.92 -10.13 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.8 108.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.502 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 6.8 ttt180 -101.48 11.29 39.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 28' ' ' GLU . 12.5 m -121.88 129.37 75.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.19 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.7 m -56.47 -40.38 74.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' VAL . 22.6 tt0 -125.47 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.355 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -94.0 160.03 14.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -113.7 112.15 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.57 114.55 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -119.36 113.15 20.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.393 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 12.3 p90 -118.57 112.95 20.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.015 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 1.1 tt0 -138.07 112.6 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.347 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 54' ' ' ARG . . . 36.91 77.37 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.442 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 66.45 4.16 3.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.5 m-20 -102.8 104.23 14.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CE1' HD13 ' A' ' 17' ' ' ILE . 89.2 t80 -110.87 116.04 30.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.428 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -121.2 131.78 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.249 179.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.511 ' CG ' HD11 ' A' ' 19' ' ' ILE . 84.5 t80 -128.46 112.05 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.334 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' OH ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -116.45 119.33 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.622 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -133.9 29.53 3.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.484 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 2.1 pttp 122.46 -164.31 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.823 1.327 . . . . 0.0 108.536 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 27.3 Cg_exo -37.33 -26.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.339 1.359 . . . . 0.0 112.66 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.5 m-85 -73.49 124.42 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.04 124.1 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.35 109.29 18.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.14 112.49 19.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.6 mt -132.31 136.98 47.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.628 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.2 m -102.43 111.32 23.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.648 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.494 HD13 ' CE2' ' A' ' 85' ' ' PHE . 17.0 mt -70.64 146.24 93.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 23.7 Cg_exo -63.75 -19.33 66.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.895 2.397 . . . . 0.0 112.551 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -123.43 -127.98 3.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.809 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.453 ' HG2' ' HA2' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -151.38 145.53 25.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 32.2 mm -116.51 124.69 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.497 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.8 p -55.72 151.81 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.467 . . . . 0.0 111.595 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 56' ' ' VAL . 10.0 pt-20 -122.03 131.4 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.25 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.54 -37.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.46 17.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -97.71 30.25 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HG3' ' CD1' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -79.0 -169.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.663 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' N ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.38 137.74 44.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.61 134.66 7.49 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.067 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -143.79 104.95 4.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -119.17 139.57 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 111.617 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.62 128.9 53.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.32 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.827 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.89 -39.3 65.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -95.78 -20.09 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . 63.96 62.91 4.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.341 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.413 HG13 ' C ' ' A' ' 70' ' ' GLY . 50.4 mt -144.7 118.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -113.3 115.79 28.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.444 HG21 ' CG2' ' A' ' 16' ' ' THR . 25.9 m -119.14 129.35 54.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.467 ' CD1' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -138.13 121.13 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -86.22 144.88 27.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.08 125.36 18.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.497 ' HG2' ' CG1' ' A' ' 56' ' ' VAL . 32.9 Cg_endo -63.42 151.66 83.88 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.445 2.097 . . . . 0.0 111.942 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 13.6 mttt -96.39 157.47 15.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 79' ' ' GLU . 2.9 tm-20 -84.63 -4.93 59.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' OE2' ' A' ' 79' ' ' GLU . 93.0 m -152.09 116.96 3.03 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.93 143.64 48.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.265 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.86 86.09 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.908 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tp-100 -66.98 122.38 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.676 0.274 . . . . 0.0 110.504 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -120.16 112.68 19.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.858 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' A' ' 51' ' ' LEU . 16.2 m-30 -77.46 90.29 3.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.305 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 171.29 11.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 112.011 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 36.61 41.13 0.53 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.73 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.59 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.109 0.454 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -85.81 12.32 9.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -32.42 7.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mt -48.61 174.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.782 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.2 p -120.41 171.48 8.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.1 130.23 44.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.14 125.15 46.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.989 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 mp -99.9 137.09 38.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.933 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.821 0.344 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.44 134.49 43.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.702 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -83.12 139.92 42.51 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.277 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 3' ' ' THR . 61.2 Cg_endo -73.72 158.3 47.13 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.646 2.231 . . . . 0.0 111.689 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.06 58.13 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -68.26 164.91 19.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.35 156.6 42.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.47 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -120.08 139.29 52.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.423 0.63 . . . . 0.0 112.008 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.0 p -140.63 131.54 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.628 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.56 145.16 51.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 0.0 112.738 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m-20 -109.31 160.22 28.44 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.899 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.86 -1.24 2.57 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.974 2.449 . . . . 0.0 113.929 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.7 m-20 -137.19 8.91 2.96 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.3 -0.25 . . . . 0.0 111.037 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.6 m-85 -171.17 171.96 5.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.379 0.609 . . . . 0.0 111.803 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -134.24 118.66 17.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.477 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.0 m -108.26 145.92 33.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 110.293 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' N ' HG22 ' A' ' 16' ' ' THR . 3.1 mt -118.85 154.54 21.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.69 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.71 110.53 9.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.459 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.9 mt -126.26 122.44 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.573 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 120.21 41.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.768 0.318 . . . . 0.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.66 134.76 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.379 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.48 -38.27 5.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.6 m-30 -63.63 -10.74 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -21.82 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.229 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.459 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -70.44 -76.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.431 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.5 m -39.94 128.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -58.91 -28.65 66.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.66 145.07 51.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.474 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -101.59 163.65 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.764 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -118.48 119.04 33.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.12 121.52 65.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 56.4 m-85 -135.34 130.67 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.4 p90 -127.02 122.2 33.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 8.6 tt0 -137.39 109.51 7.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.527 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.15 75.7 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.98 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 66.59 5.17 3.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 34.3 m-20 -103.17 103.75 13.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.685 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 71.0 t80 -105.83 113.14 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.408 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 115.39 27.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 76.3 t80 -113.08 109.29 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 98.5 m-85 -110.29 105.96 15.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 112.034 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -134.07 113.36 12.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.594 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 43.8 -170.23 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 76.4 Cg_exo -42.64 -20.87 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.026 1.817 . . . . 0.0 113.106 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 14.2 m-85 -71.6 121.14 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.9 t80 -118.57 119.21 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.427 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 mt -120.26 109.53 15.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 111.911 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 3.9 ttm180 -118.73 116.48 26.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.42 128.04 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 0.0 111.794 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 106.36 18.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.511 ' CD1' HD11 ' A' ' 55' ' ' ILE . 4.4 mt -70.34 128.18 91.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.375 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.0 -20.84 31.67 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.821 2.347 . . . . 0.0 112.199 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -112.18 -138.62 7.43 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.538 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.36 137.81 28.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 51' ' ' LEU . 5.0 mt -118.74 126.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.2 p -58.15 155.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.5 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' N ' HG23 ' A' ' 56' ' ' VAL . 7.7 pt-20 -123.1 133.88 54.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -164.7 -38.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.49 -12.93 25.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.191 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -67.43 -70.33 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.962 0.411 . . . . 0.0 110.318 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' A' ' 62' ' ' GLN . 5.2 pt-20 30.34 -152.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.685 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -156.61 155.56 32.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.68 161.19 34.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.418 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -159.87 121.05 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -119.04 131.32 55.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.522 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.05 126.82 53.04 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.582 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -46.57 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.643 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.66 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.259 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -76.73 -19.87 57.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.82 61.8 6.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.46 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 71' ' ' ILE . 43.5 mt -157.44 129.93 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.921 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.39 110.89 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -108.82 128.04 54.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 16' ' ' THR . 9.0 tt -123.13 162.68 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 0.0 111.468 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 12.3 mtm180 -133.38 140.36 47.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 70.5 mt -136.34 128.31 17.22 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 36.7 Cg_endo -65.87 151.72 83.43 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.784 2.323 . . . . 0.0 112.219 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 83' ' ' GLN . 4.4 mttt -98.55 153.78 18.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.348 . . . . 0.0 110.487 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 4.1 tt0 -83.31 -7.61 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.0 m -156.14 108.0 2.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 111.523 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.43 149.81 36.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.733 2.288 . . . . 0.0 112.035 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.72 83.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.851 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 51.0 tt0 -81.07 135.34 35.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.218 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -124.44 118.61 27.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.227 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 6.2 m-30 -77.42 90.6 3.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 172.87 8.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 35.61 39.9 0.27 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.925 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 8' ' ' LEU . 1.5 mt -61.67 -61.77 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.266 0.533 . . . . 0.0 111.024 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.5 14.09 2.19 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.739 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 2.3 ppp? -115.81 -31.03 5.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -52.57 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.908 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.435 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -131.88 170.2 15.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.619 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.14 142.25 30.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.39 110.97 22.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.37 118.05 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.931 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.881 0.372 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.96 148.72 38.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.706 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.502 ' O ' ' CG2' ' A' ' 3' ' ' THR . 2.5 t -78.11 117.62 67.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.349 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo -53.41 148.57 33.18 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.32 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.46 58.78 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.987 0.422 . . . . 0.0 110.395 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.4 p90 -63.04 165.32 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.46 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -149.0 146.21 27.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.46 135.94 53.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.4 . . . . 0.0 111.167 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -140.43 132.35 27.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.04 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -130.23 140.81 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 0.0 112.174 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -111.2 160.86 27.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.788 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 22.0 Cg_endo -61.56 -1.94 2.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.974 2.449 . . . . 0.0 113.703 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.1 m-20 -135.95 4.05 2.98 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.331 -0.231 . . . . 0.0 111.502 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.1 m-85 -168.48 169.52 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 112.253 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 tm? -134.59 114.17 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.202 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 m -109.0 139.88 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 110.989 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 54.1 mt -111.85 152.11 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.311 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -132.1 119.06 20.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.587 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.501 HD12 ' CG ' ' A' ' 40' ' ' PHE . 3.8 mt -125.84 128.2 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.866 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 12.2 mtp180 -96.66 118.48 33.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG21 ' OH ' ' A' ' 65' ' ' TYR . 19.4 m -108.43 82.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' TYR . 52.3 p -51.02 -87.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' SER . 3.7 m-30 -38.31 -53.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.75 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.79 45.89 5.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.511 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -59.45 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.476 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.452 HG11 ' CA ' ' A' ' 43' ' ' LYS . 18.4 m -43.5 136.54 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 111.05 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.53 95.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.331 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 147.24 52.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -99.24 167.81 10.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -114.92 125.44 53.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.86 116.36 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.74 124.1 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 39.3 p90 -131.48 121.91 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' SER . 6.4 pt-20 -138.66 119.13 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.87 -76.45 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.639 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 50' ' ' THR . 0.9 OUTLIER -153.03 27.44 0.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.913 0.387 . . . . 0.0 110.665 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.65 110.15 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 17' ' ' ILE . 90.0 t80 -101.43 111.87 24.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -113.67 122.85 48.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.784 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CG ' HD12 ' A' ' 19' ' ' ILE . 75.7 t80 -123.82 114.1 19.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HB3' ' CE1' ' A' ' 46' ' ' PHE . 2.1 m-85 -118.02 104.39 10.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.985 0.421 . . . . 0.0 111.583 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -138.03 121.95 17.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 42.19 -170.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 99.8 Cg_exo -44.57 -19.84 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.72 1.613 . . . . 0.0 112.272 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.8 m-85 -74.23 114.17 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.385 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -121.33 122.7 40.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.836 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 19' ' ' ILE . 1.7 mt -120.14 110.64 16.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.099 0.476 . . . . 0.0 112.121 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 114.28 23.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.873 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.31 142.18 39.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.645 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 36' ' ' SER . 1.5 m -101.23 115.67 31.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.581 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 36' ' ' SER . 92.2 mt -75.75 136.22 70.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -79.95 82.28 2.53 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.917 2.411 . . . . 0.0 112.03 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 143.82 -145.99 16.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.096 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.5 mmt180 -143.65 137.85 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.075 0.464 . . . . 0.0 111.642 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 45.9 mm -118.11 126.23 74.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.661 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' A' ' 77' ' ' PRO . 13.8 p -55.14 149.07 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 131.44 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.601 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -169.06 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . 112.73 9.16 19.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.682 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 28.05 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -78.78 -167.17 1.03 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.522 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -137.59 124.99 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.988 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.432 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -124.81 139.02 11.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.216 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.65 106.62 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.559 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.547 ' CD1' ' HB2' ' A' ' 72' ' ' PHE . 7.9 t80 -109.5 146.02 35.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -123.23 125.96 46.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.324 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -39.93 20.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -53.23 -48.54 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.086 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.52 -18.3 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.294 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.99 63.51 2.81 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mt -154.46 120.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.547 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -110.13 124.59 51.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -127.01 127.38 44.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -128.07 119.22 50.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.587 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -82.45 141.76 32.47 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.55 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 55' ' ' ILE . 10.4 mt -135.4 117.35 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.818 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.4 Cg_endo -60.68 154.33 55.68 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.873 2.382 . . . . 0.0 112.286 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' CD ' ' O ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -94.1 154.81 17.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.931 0.395 . . . . 0.0 111.415 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -82.26 -13.85 56.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 m -142.18 116.71 6.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.702 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.62 142.8 98.69 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.67 2.247 . . . . 0.0 112.067 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.43 86.39 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.998 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 tt0 -80.37 126.08 30.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -128.62 125.68 38.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.517 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 8.3 m-30 -80.29 89.98 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 173.83 9.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.026 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' MET . . . 38.4 35.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.957 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.05 -61.47 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.14 0.47 . . . . 0.0 110.407 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -69.26 8.58 0.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.432 ' HG3' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -97.68 -26.17 14.85 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.8 mt -71.65 125.7 27.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.482 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.32 155.0 39.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 111.165 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.91 115.96 28.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -126.09 107.81 10.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 5.5 mp -91.35 114.57 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.768 0.318 . . . . 0.0 111.062 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.109 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.886 0.374 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.06 159.45 20.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 m -79.06 110.6 15.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.92 146.43 65.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.712 2.274 . . . . 0.0 112.131 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.94 66.41 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 10.2 p90 -75.8 163.82 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -147.0 143.26 28.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.91 134.83 54.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.115 0.483 . . . . 0.0 111.143 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.9 t -142.5 135.31 28.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.72 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.597 ' NE2' ' CD2' ' A' ' 84' ' ' HIS . 2.2 pm0 -130.68 141.75 50.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.116 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -104.25 161.37 23.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.842 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 32.4 Cg_endo -62.86 -1.88 3.11 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.701 2.268 . . . . 0.0 113.337 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.621 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 57.4 m-20 -135.86 9.92 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.97 -0.105 . . . . 0.0 110.893 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.5 m-85 -170.94 171.71 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 111.964 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.0 109.61 9.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.181 177.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 75' ' ' ARG . 2.8 m -104.04 146.89 28.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.208 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.573 HD11 ' CE1' ' A' ' 38' ' ' PHE . 27.0 mt -122.64 152.41 27.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.05 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -136.96 120.23 16.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.183 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 19' ' ' ILE . 1.2 mt -123.19 126.58 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.118 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -77.27 118.37 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.066 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 20' ' ' ARG . 10.7 m -143.96 129.76 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 p -121.38 -59.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' ALA . 4.9 m-30 -57.0 -52.96 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.93 97.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.825 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -70.29 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 26' ' ' VAL . 23.4 m -58.83 135.82 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -55.65 -41.11 73.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.62 139.42 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.359 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -87.88 166.83 14.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.959 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -119.03 115.93 25.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.89 116.31 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -112.77 114.25 26.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 25.0 p90 -125.61 115.81 20.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 36' ' ' SER . 15.6 mt-10 -137.35 117.29 13.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.74 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.46 -74.95 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.207 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -148.92 27.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.4 t0 -118.47 130.99 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CE1' HD11 ' A' ' 17' ' ' ILE . 80.4 t80 -125.88 113.96 17.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 111.062 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -121.85 127.58 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.644 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -122.72 110.5 15.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.067 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CE1' ' CE2' ' A' ' 46' ' ' PHE . 6.8 m-85 -110.51 116.25 31.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -127.3 26.21 6.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.166 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 22.0 tptt 95.22 -88.41 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.75 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 70.9 Cg_endo -83.61 -16.97 6.45 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.316 1.344 . . . . 0.0 111.476 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -96.12 105.11 17.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.733 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -111.45 111.95 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.956 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -117.26 109.18 16.54 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -118.0 110.72 18.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.94 137.1 49.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 0.0 111.781 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 m -102.77 112.64 25.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.137 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 HG12 ' A' ' 55' ' ' ILE . 61.7 mt -69.44 137.35 88.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.814 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 31.8 Cg_exo -58.96 -18.43 42.7 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.306 2.671 . . . . 0.0 113.117 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -125.23 -127.42 3.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.819 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -147.61 142.94 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.947 0.404 . . . . 0.0 111.485 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.469 HG12 HD12 ' A' ' 51' ' ' LEU . 12.2 mm -119.79 126.3 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.637 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 8.7 p -52.24 141.07 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.088 0.47 . . . . 0.0 111.979 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.65 130.16 56.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.518 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -176.69 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.452 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.46 17.75 11.01 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -98.63 21.7 10.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.704 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' OE2' ' CD1' ' A' ' 74' ' ' ILE . 9.6 pt-20 -73.52 -170.62 0.86 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.76 138.6 34.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.05 147.65 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.311 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.14 110.14 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 111.066 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -110.88 126.99 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.8 111.47 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.15 71.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -49.27 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 20.4 ttpt -77.48 -27.41 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.011 0.434 . . . . 0.0 110.174 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 71' ' ' ILE . . . 71.95 48.32 27.57 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 70' ' ' GLY . 2.7 mm -144.22 146.68 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 5.2 t80 -109.73 114.85 28.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -114.49 126.99 55.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.48 ' CD1' ' OE2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -139.74 119.54 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 50.0 mtm180 -87.95 148.56 24.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.154 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 75' ' ' ARG . 45.4 mt -135.52 122.81 14.85 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.584 ' HA ' ' CD1' ' A' ' 14' ' ' PHE . 19.2 Cg_endo -61.27 147.53 95.33 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.719 2.279 . . . . 0.0 112.003 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 20.1 mttp -90.84 156.01 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 111.355 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.65 -17.06 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -135.52 94.46 15.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.843 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.8 143.23 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.821 2.348 . . . . 0.0 112.57 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.82 0.34 89.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.256 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 2.2 tp-100 -84.58 136.06 33.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.976 0.388 . . . . 0.0 110.982 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.597 ' CD2' ' NE2' ' A' ' 10' ' ' GLN . 6.9 t-160 -127.42 123.22 35.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.132 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 15.1 m-30 -79.21 91.5 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.21 170.57 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.859 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.93 41.76 0.21 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.636 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mt -60.83 -61.24 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.068 0.434 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -80.26 14.68 1.83 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.438 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.66 -28.42 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -46.12 178.4 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -142.46 163.64 32.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.718 0.294 . . . . 0.0 110.703 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.59 125.46 29.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.406 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.85 136.13 53.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 95' ' ' LEU . 2.9 mp -95.85 110.1 22.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.987 179.808 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pp -123.53 133.35 54.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.005 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -64.82 140.82 98.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.22 171.82 17.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.504 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.53 65.57 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -79.79 164.36 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.59 154.34 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.975 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 HD13 ' A' ' 49' ' ' LEU . 8.3 mt -115.97 135.46 53.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.118 0.485 . . . . 0.0 111.57 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.47 130.4 28.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.121 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.431 ' CB ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.63 144.61 51.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 112.466 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.4 160.45 27.03 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.199 179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.45 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 30.1 Cg_endo -63.46 -0.8 2.61 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.013 2.475 . . . . 0.0 113.776 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 6.0 m-20 -136.28 8.87 3.18 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.408 -0.183 . . . . 0.0 110.748 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.0 m-85 -171.93 172.23 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.32 0.581 . . . . 0.0 111.331 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -136.24 116.89 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.615 178.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 75' ' ' ARG . 11.3 m -107.15 148.39 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 17' ' ' ILE . 8.2 mt -125.61 152.26 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.266 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.55 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.397 . . . . 0.0 111.568 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.576 HD13 ' CD2' ' A' ' 40' ' ' PHE . 3.5 mt -113.97 125.12 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.754 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HG3' HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.23 121.21 29.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.108 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 20' ' ' ARG . 26.9 m -142.91 131.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.672 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.08 -73.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.441 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.7 m-85 -49.68 -53.29 25.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 43.92 103.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.443 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -81.92 3.9 24.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 26' ' ' VAL . 27.1 m -123.94 130.54 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -56.05 -41.37 74.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.09 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -129.07 143.13 50.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.928 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -90.65 166.86 12.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.417 . . . . 0.0 111.36 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.23 122.28 42.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.44 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.02 116.66 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 111.538 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -112.09 114.05 26.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.788 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.6 p90 -125.95 114.94 19.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' SER . 10.7 mt-10 -134.32 112.22 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.376 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.76 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.768 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -153.34 24.37 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.399 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -114.76 104.92 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.978 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' HD11 ' A' ' 17' ' ' ILE . 81.8 t80 -105.12 117.88 35.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -123.71 130.35 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.868 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.576 ' CD2' HD13 ' A' ' 19' ' ' ILE . 32.6 t80 -127.74 116.86 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -118.93 122.2 41.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.229 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -126.32 29.61 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.612 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.2 tptm 93.85 -89.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.585 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 58.7 Cg_endo -84.44 -16.41 5.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 120.708 1.289 . . . . 0.0 111.516 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -102.15 117.48 34.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.236 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.0 t80 -125.86 120.92 31.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.416 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.23 113.47 21.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.84 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.539 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -116.12 110.78 19.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD13 HD23 ' A' ' 8' ' ' LEU . 5.1 mt -123.74 129.4 51.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.664 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.5 110.31 22.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.334 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.94 136.71 85.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 0.0 111.361 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 28.4 Cg_endo -62.78 -14.69 42.12 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.345 2.697 . . . . 0.0 112.864 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -123.53 -129.31 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.747 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.4 mtm180 -149.16 145.9 27.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.986 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' A' ' 15' ' ' LEU . 35.0 mm -121.08 126.29 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.61 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.5 p -52.37 146.94 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 111.553 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -111.33 124.36 52.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.626 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.88 -41.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.0 -6.49 27.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -72.32 -71.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.424 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.4 OUTLIER 33.34 -156.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.467 ' O ' HG13 ' A' ' 74' ' ' ILE . 9.9 mt-30 -154.02 167.07 31.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.45 152.43 6.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.816 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -153.84 143.31 21.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.17 122.51 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 120.15 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.12 -41.74 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -53.44 50.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.208 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -81.57 -16.55 51.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.038 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.44 55.27 30.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.559 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.454 HG12 ' HG3' ' A' ' 20' ' ' ARG . 58.3 mt -145.3 147.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.407 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -112.88 113.32 25.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.466 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 132.77 56.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -141.42 118.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.744 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HG2' HG23 ' A' ' 16' ' ' THR . 39.2 mtp180 -90.89 148.59 22.37 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.9 mt -134.44 143.71 47.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HA ' ' CD1' ' A' ' 14' ' ' PHE . 6.0 Cg_endo -83.61 148.73 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.759 2.306 . . . . 0.0 111.448 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 1.9 mtmp? -89.16 157.05 18.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.51 -18.86 37.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.165 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 m -142.97 86.8 9.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -40.82 149.76 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.719 2.279 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.37 -10.12 75.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.26 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.411 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 2.7 tp60 -82.14 134.99 35.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -124.12 118.27 26.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.368 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.48 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 5.2 m-30 -78.16 89.84 4.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.054 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.24 174.56 10.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.529 0.681 . . . . 0.0 112.567 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 38.74 40.52 1.05 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.812 -1.085 . . . . 0.0 114.072 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -61.55 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.172 0.486 . . . . 0.0 110.016 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -87.18 6.84 30.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.349 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.44 7.33 10.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.087 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLY . 3.1 mt -71.22 178.43 3.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.596 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -118.68 -178.08 3.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.898 0.38 . . . . 0.0 111.167 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.66 123.98 46.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.82 107.65 13.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.4 mp -94.92 119.25 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.028 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.854 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.03 119.99 29.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.452 HG23 ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -82.72 137.52 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.578 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 3' ' ' THR . 66.0 Cg_endo -75.04 149.46 36.54 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.1 59.55 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -69.74 166.03 20.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.666 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.97 38.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -116.49 133.98 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' THR . 22.6 p -138.74 130.94 28.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.214 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HG2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -131.8 143.34 50.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 112.728 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.02 160.74 24.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.613 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.95 -3.68 5.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.632 2.221 . . . . 0.0 113.408 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.43 9.89 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.488 -0.132 . . . . 0.0 111.236 179.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 39.6 m-85 -170.47 170.17 7.07 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 111.294 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD23 ' CB ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -135.39 111.4 9.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' SER . 23.1 m -103.16 135.56 44.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.13 0.491 . . . . 0.0 111.539 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.57 HD12 ' CE1' ' A' ' 38' ' ' PHE . 20.7 mt -108.28 151.94 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.854 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.13 117.35 14.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.044 0.45 . . . . 0.0 111.789 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.478 HD11 ' CD2' ' A' ' 40' ' ' PHE . 18.6 mt -120.0 125.77 74.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.621 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 118.66 37.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.4 m -155.57 127.72 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.86 -30.25 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.909 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.6 m-85 -68.05 -9.49 46.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.024 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -25.69 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.518 0.511 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.54 16.92 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.688 -178.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.12 130.24 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.4 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 m -56.6 -35.79 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.366 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.59 148.01 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.791 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -101.22 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.605 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -113.36 119.38 37.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.65 114.97 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 83.5 m-85 -125.61 120.27 30.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 40.7 p90 -123.2 119.08 29.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.793 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 3.0 pt-20 -138.07 114.02 9.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.267 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.77 77.66 0.07 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.181 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 60.06 10.99 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 4.1 t70 -108.06 103.31 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 110.092 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.5 t80 -108.42 121.25 44.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -120.85 134.57 55.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.664 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 52.9 t80 -129.56 111.72 13.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 95.7 m-85 -108.15 107.25 17.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.125 0.488 . . . . 0.0 111.843 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -132.47 106.42 7.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 46.86 -175.96 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 38.0 Cg_exo -33.52 -29.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 121.972 1.781 . . . . 0.0 112.587 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 17.4 m-30 -66.3 125.36 25.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.85 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -129.01 128.59 43.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.206 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 6.4 mt -118.21 111.78 19.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 113.07 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.19 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 ' CD2' ' A' ' 8' ' ' LEU . 2.4 mt -124.21 127.83 48.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.495 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.26 110.77 23.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HB2' ' OG ' ' A' ' 36' ' ' SER . 60.3 mt -78.74 155.17 78.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 85' ' ' PHE . 9.6 Cg_endo -86.21 -17.9 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.166 2.577 . . . . 0.0 112.627 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -112.51 -141.64 8.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.81 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -141.48 132.67 26.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.46 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 27.7 mm -110.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.077 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.508 HG11 ' HG2' ' A' ' 77' ' ' PRO . 8.4 p -61.67 157.57 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.485 . . . . 0.0 111.861 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.35 132.37 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.021 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -165.31 -35.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.46 0.9 26.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.239 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -79.37 -72.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.656 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.1 OUTLIER 26.25 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.335 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 74' ' ' ILE . 21.3 mt-30 -161.7 133.15 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -134.72 139.1 10.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.041 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.95 104.69 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.535 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -108.16 136.88 47.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.44 117.36 27.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.81 -44.07 34.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.42 -46.77 69.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 7.3 ttpp -91.88 -16.25 26.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.76 63.34 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.042 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.452 HG13 ' HG2' ' A' ' 69' ' ' LYS . 3.6 mt -151.46 120.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 111.505 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.575 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 2.7 t80 -104.99 111.03 23.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.74 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.45 117.68 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.575 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 1.1 tp -129.11 119.82 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.705 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -86.3 143.48 27.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.4 mp -131.94 124.72 19.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.62 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 14' ' ' PHE . 25.7 Cg_endo -64.64 155.75 65.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.911 2.407 . . . . 0.0 112.354 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -102.63 157.36 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.247 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 5.9 tt0 -84.6 0.33 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.79 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -160.86 99.79 1.32 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.39 153.24 13.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.812 2.341 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.82 63.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.981 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -81.55 142.63 32.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -130.02 123.45 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.586 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.1 m-30 -77.1 92.87 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.462 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 172.32 8.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.268 0.556 . . . . 0.0 111.708 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.88 37.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.451 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 10' ' ' GLN . 8.0 mt -58.47 -61.27 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.04 0.42 . . . . 0.0 110.319 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -78.78 14.68 1.26 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.56 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -115.03 -32.85 5.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -47.52 170.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.625 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.31 158.48 44.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.024 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.59 141.52 29.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.57 138.73 45.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.1 mp -89.2 130.12 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.098 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.764 0.316 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.464 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pp -118.64 142.01 48.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.69 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 11.3 m -73.51 107.69 3.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.676 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 2' ' ' LEU . 33.3 Cg_endo -64.67 137.8 55.95 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.945 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.68 58.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.19 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -61.32 163.17 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.8 140.65 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.2 139.69 50.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.166 0.507 . . . . 0.0 111.579 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.45 132.25 22.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' OE1' HD13 ' A' ' 88' ' ' LEU . 2.2 pm0 -130.42 141.48 50.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.335 0.588 . . . . 0.0 111.649 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.48 160.73 25.06 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.152 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.95 -2.52 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 113.785 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.644 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 66.4 m-20 -136.6 11.45 3.19 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.314 -0.241 . . . . 0.0 110.748 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.6 m-85 -170.37 171.84 6.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.559 0.695 . . . . 0.0 112.237 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.446 ' HA ' HD21 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -137.4 111.1 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.726 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 75' ' ' ARG . 88.6 m -105.7 151.18 24.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.155 0.502 . . . . 0.0 111.496 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 1.2 mt -124.88 154.58 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.98 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.03 118.97 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 2.7 mt -125.83 128.41 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.091 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 4.0 mtp180 -100.95 121.61 42.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.346 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 135.09 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.708 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -32.8 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.338 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 24' ' ' ALA . 6.2 m-30 -67.06 -10.8 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.04 110.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.445 0.465 . . . . 0.0 111.506 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -72.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.504 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 19.5 m -58.31 141.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.436 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -55.32 -40.75 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.378 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' O ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tt0 -121.07 140.35 52.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -89.59 168.71 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -116.36 115.87 26.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 1.9 t -118.57 121.79 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -119.84 116.46 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 53.1 p90 -126.14 115.67 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.519 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -136.39 113.88 10.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.819 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.7 -72.39 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.454 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -155.9 27.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.481 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -118.37 104.35 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.801 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.541 ' CZ ' HD13 ' A' ' 17' ' ' ILE . 72.4 t80 -104.64 124.51 49.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.766 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -129.0 134.9 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 31.4 t80 -125.23 110.01 13.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.35 119.41 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.37 35.08 4.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 91.72 -91.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.39 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 62.7 Cg_endo -84.43 -14.84 6.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.909 1.36 . . . . 0.0 112.143 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' OH ' ' CD2' ' A' ' 23' ' ' TYR . 22.0 m-30 -102.05 117.64 35.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.584 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -124.78 118.89 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mt -123.54 117.56 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.642 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.46 112.77 23.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.869 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.0 mt -121.0 126.02 48.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.856 0.36 . . . . 0.0 111.601 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 107.87 19.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.383 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 mt -73.2 128.36 87.75 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.799 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.491 ' O ' ' CE1' ' A' ' 85' ' ' PHE . 7.3 Cg_exo -72.05 90.86 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.799 2.333 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.98 -137.58 9.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.409 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -144.83 136.65 25.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.063 0.458 . . . . 0.0 111.592 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -116.8 126.84 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.746 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 2.4 p -61.1 156.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.45 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 30.1 mt-10 -123.22 131.26 53.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.619 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -164.02 -42.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.642 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.37 -1.64 26.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 27.61 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.98 -168.63 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 26.3 mt-30 -134.5 138.62 44.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.515 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.37 154.37 25.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.525 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 p -164.23 118.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' ASP . 4.6 t80 -113.53 137.1 52.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 1.1 m-20 -123.2 125.44 45.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.05 -33.47 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -50.16 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.458 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -6.28 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' ARG . . . 63.45 63.27 4.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.391 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt -144.21 121.0 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.4 t80 -114.73 115.6 27.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.986 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.2 m -115.51 128.49 56.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -136.01 118.21 20.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.904 0.383 . . . . 0.0 112.026 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -88.52 146.97 24.86 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.1 mt -132.65 139.08 33.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.417 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 73.7 Cg_endo -76.0 149.87 33.3 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.882 2.388 . . . . 0.0 112.169 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 10.3 mttp -96.32 156.07 16.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 -6.98 59.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.616 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.6 m -154.51 89.32 3.26 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -42.2 160.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.092 2.528 . . . . 0.0 112.845 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.35 -6.19 57.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.624 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -83.41 142.85 30.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 1.7 t-160 -127.25 121.1 30.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 52' ' ' PRO . 7.9 m-30 -82.85 94.46 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.02 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.83 174.01 7.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.344 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 34.89 40.62 0.22 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.485 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD13 ' OE1' ' A' ' 10' ' ' GLN . 3.8 mt -60.46 -62.01 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.109 0.455 . . . . 0.0 110.045 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.54 12.27 4.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.938 0.399 . . . . 0.0 110.65 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 72.8 mtp -110.94 -31.72 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.476 ' CD1' ' HG3' ' A' ' 52' ' ' PRO . 1.3 mt -49.39 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.556 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.72 174.25 10.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.02 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.79 136.1 42.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.044 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.57 117.41 30.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.07 114.22 26.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.959 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.3 153.98 26.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.79 116.87 66.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 50.7 Cg_exo -52.46 169.55 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.669 2.246 . . . . 0.0 112.534 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.72 57.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -61.28 170.23 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -154.07 148.52 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 88' ' ' LEU . 7.3 mt -116.18 138.21 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' THR . 18.8 t -139.38 131.97 28.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.177 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OE1' ' A' ' 10' ' ' GLN . 4.8 pm0 -130.41 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 112.575 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.82 161.04 24.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.016 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.73 -4.02 5.26 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.745 2.297 . . . . 0.0 113.25 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.656 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 32.6 m-20 -136.59 12.31 3.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.327 0.108 . . . . 0.0 110.834 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.656 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 48.8 m-85 -170.4 171.58 6.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 111.908 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -136.94 112.22 9.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.101 178.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . 83.4 m -106.16 146.18 30.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.077 0.465 . . . . 0.0 111.011 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 38' ' ' PHE . 15.0 mt -117.75 155.5 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.101 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -143.2 122.96 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.602 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.23 132.74 70.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.961 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 1.1 ttt180 -104.08 118.0 35.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.322 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 5.4 m -146.94 128.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.597 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -100.71 -50.75 3.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 25' ' ' ARG . 4.3 m-85 -59.49 -15.25 16.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 21' ' ' VAL . . . -56.12 81.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -98.74 86.52 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.999 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -144.57 145.92 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.582 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.6 12.72 30.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.695 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -171.07 108.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 26' ' ' VAL . 2.5 m-30 -86.09 148.78 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.786 0.327 . . . . 0.0 110.505 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -105.35 110.99 23.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 114.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -122.88 118.39 27.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 45.5 p90 -118.58 112.37 19.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -138.98 124.96 19.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 0.0 111.846 -179.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 38.72 62.78 1.11 Allowed Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.699 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 67.32 22.26 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -117.7 103.21 9.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.529 ' CE1' HD11 ' A' ' 17' ' ' ILE . 89.8 t80 -103.14 122.38 44.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.38 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 15.8 mttt -125.11 129.33 49.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -126.99 121.51 31.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 39' ' ' LYS . 36.8 m-85 -131.5 127.95 38.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -109.93 -81.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 6.2 tptt -146.32 -64.88 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 38.7 Cg_endo -99.59 -6.26 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.089 2.526 . . . . 0.0 111.921 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.56 122.67 47.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.19 120.44 36.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.693 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.86 110.6 16.52 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.9 114.79 23.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.516 178.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 48' ' ' ARG . 77.6 mt -138.01 144.05 40.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 112.016 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -112.78 119.95 39.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.312 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 17.2 mt -76.16 155.47 84.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.097 0.475 . . . . 0.0 111.517 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 15.1 Cg_exo -69.27 -16.28 39.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.175 2.584 . . . . 0.0 112.592 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -122.99 -127.81 3.31 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.628 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.468 ' HG3' ' OG ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -154.1 149.37 27.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 15' ' ' LEU . 51.0 mm -118.69 125.62 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.5 p -59.25 156.64 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.444 . . . . 0.0 111.898 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.39 124.06 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.96 -44.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.68 0.77 30.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 32.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.661 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.35 -173.52 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -135.88 130.91 34.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.35 136.38 8.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.838 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.7 104.89 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.726 0.298 . . . . 0.0 110.583 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -97.13 115.11 26.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 107.62 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.73 -41.0 31.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -50.37 69.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HG2' HD13 ' A' ' 71' ' ' ILE . 3.5 ttpm? -87.97 -16.76 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.438 ' C ' HG13 ' A' ' 71' ' ' ILE . . . 66.24 63.2 4.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.233 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.438 HG13 ' C ' ' A' ' 70' ' ' GLY . 75.7 mt -158.59 120.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 11.1 t80 -100.11 116.31 31.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.36 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -114.45 118.61 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.439 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -128.25 119.72 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.889 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.448 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 12.6 mtp180 -85.95 142.63 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.702 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -131.47 140.63 39.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.512 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.52 ' HG2' ' CG1' ' A' ' 56' ' ' VAL . 74.3 Cg_endo -76.9 148.48 28.19 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.756 2.304 . . . . 0.0 112.02 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -93.36 155.86 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.074 0.464 . . . . 0.0 111.433 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.35 -15.36 50.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.129 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 m -138.36 102.28 8.1 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.7 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.97 148.86 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 111.944 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.3 57.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.731 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.43 133.06 41.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.774 0.321 . . . . 0.0 110.499 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.448 ' CD2' ' HG2' ' A' ' 10' ' ' GLN . 6.7 t-80 -128.01 124.52 37.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.2 m-30 -83.04 90.48 7.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.49 173.94 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.06 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 38.09 36.1 0.32 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.809 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.422 ' O ' HD22 ' A' ' 91' ' ' LEU . 8.8 mt -58.23 -61.98 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.195 0.498 . . . . 0.0 110.219 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -79.85 5.76 12.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.401 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 21.6 mtp -117.5 20.61 13.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.401 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -98.32 177.7 5.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.261 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 11.0 p -135.57 167.91 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.779 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.31 130.2 44.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 111.607 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.439 ' N ' HD21 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -118.91 131.51 56.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.237 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 95' ' ' LEU . 7.7 mp -82.1 120.04 24.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.927 0.394 . . . . 0.0 111.134 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.0 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.0 136.24 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 119.16 61.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.28 137.1 76.26 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.661 2.241 . . . . 0.0 112.149 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.05 67.41 4.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' CE1' HD11 ' A' ' 49' ' ' LEU . 31.2 p90 -72.36 160.03 33.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.725 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -148.79 149.67 31.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -115.35 134.7 54.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.687 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' THR . 8.1 m -142.86 134.2 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.489 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 1.4 pt20 -132.35 144.84 50.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -100.84 159.94 28.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.718 178.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 13.6 Cg_endo -57.16 -8.14 3.23 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.783 2.322 . . . . 0.0 113.604 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 61.9 m-20 -135.89 17.09 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.29 -0.256 . . . . 0.0 110.808 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.1 m-85 -169.46 170.39 8.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.947 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -135.69 108.26 7.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.952 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 91.5 m -101.07 143.4 31.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.172 0.511 . . . . 0.0 110.962 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 73' ' ' THR . 7.5 mt -116.3 155.12 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -125.93 121.46 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.06 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 40' ' ' PHE . 15.3 mt -124.81 118.61 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -88.07 119.05 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.223 0.535 . . . . 0.0 112.001 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -141.24 113.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.225 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -58.08 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.992 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' ALA . 2.1 m-85 -68.84 -53.58 20.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.004 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 46.81 106.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.73 6.97 13.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 m -133.28 135.59 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.808 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -58.62 -41.54 86.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -125.33 142.63 51.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.893 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -90.65 168.43 11.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.56 115.59 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.965 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.05 115.81 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.466 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -126.69 120.08 28.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -129.23 124.0 33.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 114.09 9.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.581 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.46 -70.85 0.16 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.186 -0.531 . . . . 0.0 113.006 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.45 25.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.086 0.469 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -115.02 107.24 15.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 17' ' ' ILE . 70.1 t80 -102.84 111.0 23.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 14.6 mttt -116.07 121.95 43.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.658 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' CD2' HG23 ' A' ' 19' ' ' ILE . 58.2 t80 -124.93 117.77 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 39' ' ' LYS . 16.6 m-85 -124.27 124.73 43.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.63 31.49 4.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 1.3 tppm? 92.59 -88.83 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 111.183 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 63.6 Cg_endo -85.04 -15.97 5.36 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.237 1.291 . . . . 0.0 111.573 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.08 115.6 30.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.569 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 119.49 29.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.443 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mt -121.78 115.91 23.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.48 111.65 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.952 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 6' ' ' PHE . 83.2 mt -125.59 130.54 51.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.573 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.81 113.03 24.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.2 mt -72.2 137.59 81.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.07 0.462 . . . . 0.0 111.502 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.3 Cg_endo -68.38 -18.91 44.02 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.289 2.659 . . . . 0.0 112.717 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.63 -136.79 5.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.71 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -143.53 138.3 29.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.958 0.409 . . . . 0.0 111.069 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.462 HG23 ' HB3' ' A' ' 76' ' ' LEU . 19.3 mm -116.12 124.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.834 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 4.9 p -64.83 159.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.531 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 130.15 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.378 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.73 17.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.77 3.3 27.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.753 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 m -98.49 44.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 164.36 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 74' ' ' ILE . 8.3 mm-40 -127.49 129.72 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.35 147.89 18.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.588 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.3 p -153.62 104.36 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.717 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -96.82 103.83 15.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -89.49 99.55 12.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.221 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.26 69.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -52.44 -50.59 62.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -76.27 -23.13 54.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.033 0.444 . . . . 0.0 110.174 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.34 46.98 84.15 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.936 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 mt -143.44 148.31 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 14.9 t80 -107.05 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.675 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.59 118.38 30.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -126.48 119.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' NE ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.65 147.36 25.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 55' ' ' ILE . 1.3 mp -133.6 149.46 72.18 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 73.5 Cg_endo -79.09 150.13 22.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.613 2.209 . . . . 0.0 111.777 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -96.31 152.86 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.851 0.358 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 1.9 tt0 -84.05 -10.86 57.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.701 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 m -151.36 97.97 3.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.538 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -43.49 153.05 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.663 2.242 . . . . 0.0 112.366 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.57 -1.77 50.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.169 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.95 138.48 39.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.001 0.4 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -127.11 116.97 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.379 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 6.9 m-30 -73.4 91.8 1.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.345 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.51 160.76 13.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.909 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 37.96 46.54 1.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.298 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 8' ' ' LEU . 1.7 mt -63.53 -62.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.621 0.21 . . . . 0.0 111.511 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.36 16.55 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -114.97 -29.4 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mt -52.96 175.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.357 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.67 174.18 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 111.852 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.19 137.47 42.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 145.2 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.037 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.88 121.67 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.929 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.771 0.319 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.4 mt -130.64 122.9 28.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -83.08 129.38 61.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 37.2 Cg_exo -59.7 160.14 22.07 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 111.897 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.14 61.59 6.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.143 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 27.5 p90 -76.03 164.76 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 6.2 t0 -157.46 168.41 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.53 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -124.82 136.98 54.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.227 0.537 . . . . 0.0 111.747 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 16' ' ' THR . 9.6 t -138.43 130.81 28.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.079 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' A' ' 10' ' ' GLN . 7.7 pm0 -135.86 145.53 46.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.72 161.5 22.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.52 -3.58 1.43 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.81 2.34 . . . . 0.0 113.767 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.638 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.6 m-20 -136.05 12.26 3.34 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.367 -0.208 . . . . 0.0 110.909 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.638 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 23.7 m-85 -167.17 167.48 14.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.484 0.659 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -134.79 109.05 8.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.083 178.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.431 HG21 HG21 ' A' ' 73' ' ' THR . 55.3 m -107.01 126.76 52.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.171 0.51 . . . . 0.0 111.836 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.574 HD12 ' CE2' ' A' ' 38' ' ' PHE . 7.7 mt -100.81 155.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.998 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -140.83 112.41 7.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.339 . . . . 0.0 111.691 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.28 128.95 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.502 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -92.49 120.42 32.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.76 126.67 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.365 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.05 -30.96 4.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.709 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 58.8 m-85 -69.54 -9.19 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.284 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.88 108.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.55 0.531 . . . . 0.0 111.512 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -88.19 13.39 11.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.7 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.43 137.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.556 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.6 t -56.66 -35.59 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.14 144.63 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -96.31 168.66 10.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.48 124.23 42.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.75 132.58 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.818 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -121.32 116.21 24.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.938 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 43.3 p90 -116.69 114.19 23.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.067 0.461 . . . . 0.0 111.463 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -138.14 101.6 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.045 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.03 -149.11 17.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.631 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -59.13 -12.12 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.962 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.79 112.09 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 110.63 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CE2' HD12 ' A' ' 17' ' ' ILE . 39.6 t80 -120.73 112.01 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.41 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -119.31 126.54 51.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.081 0.467 . . . . 0.0 111.566 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -110.39 148.66 31.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.954 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -136.1 110.43 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.973 0.416 . . . . 0.0 111.513 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' O ' ' HD2' ' A' ' 44' ' ' PRO . . . -131.26 68.81 1.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.682 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER 32.57 -88.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.888 -178.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 57.2 Cg_endo -69.46 -25.37 30.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.257 1.305 . . . . 0.0 112.579 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' ALA . 21.7 m-85 -105.04 125.61 51.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.722 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -125.62 120.67 31.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.961 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.94 117.9 28.49 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.42 116.2 22.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 49' ' ' LEU . 80.1 mt -142.89 151.46 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 112.25 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.34 105.88 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.071 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 36' ' ' SER . 3.6 mt -72.02 155.79 91.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -83.02 75.0 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.382 2.721 . . . . 0.0 111.966 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 145.85 -147.18 18.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.37 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' GLY . 1.1 mtm180 -146.65 142.09 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.121 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 14.0 mm -115.07 123.11 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.3 p -62.07 154.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 112.536 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.38 130.09 51.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.723 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.68 29.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.661 0.267 . . . . 0.0 111.429 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.55 -32.36 3.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.345 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.58 118.51 10.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.556 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.07 163.37 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 4.5 mt-30 -131.78 138.64 48.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.34 137.51 7.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.905 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.76 105.45 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 0.0 110.408 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -103.12 131.72 49.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -115.53 111.55 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.92 -49.32 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.64 -41.83 67.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -97.06 -19.44 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.9 56.68 13.28 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.929 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.5 mm -137.19 116.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 111.509 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t80 -111.21 114.42 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -121.49 119.04 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -124.38 119.48 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.622 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 76' ' ' LEU . 11.4 mtp180 -87.08 148.26 25.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 15.9 mt -134.24 150.73 74.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.208 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.537 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 94.6 Cg_endo -81.81 157.84 18.51 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.944 2.43 . . . . 0.0 112.162 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -98.0 148.54 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.0 tp10 -85.02 -11.68 54.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.526 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.3 m -148.52 116.87 3.98 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.872 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.3 142.96 45.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.775 2.316 . . . . 0.0 112.441 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 -0.16 89.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.433 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -70.15 119.02 13.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.05 111.95 18.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.13 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.9 m-30 -73.75 90.05 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.487 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' GLY . 22.2 mt-10 -70.7 173.58 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.271 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 35.98 38.61 0.24 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 8' ' ' LEU . 4.0 mt -57.84 -61.6 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.628 0.251 . . . . 0.0 110.538 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -83.67 16.25 2.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.127 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -117.02 -32.24 5.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -45.25 177.11 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.61 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.92 149.53 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.699 0.285 . . . . 0.0 111.183 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.89 137.11 33.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.31 138.33 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 111.607 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.18 114.25 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.857 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.831 0.348 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.94 124.12 24.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.998 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.5 136.95 95.07 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 136.28 65.03 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.695 2.263 . . . . 0.0 112.055 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.407 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -85.72 65.14 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.532 ' CD2' HD22 ' A' ' 47' ' ' LEU . 7.1 p90 -80.34 159.44 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.043 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -145.33 150.65 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.81 133.46 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.126 0.489 . . . . 0.0 111.761 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -139.51 131.45 27.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.636 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.511 ' CB ' HD23 ' A' ' 15' ' ' LEU . 5.6 pm0 -130.57 140.98 50.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.339 0.59 . . . . 0.0 112.325 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.28 160.84 28.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.997 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 24.2 Cg_endo -61.46 -1.22 1.79 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.107 2.538 . . . . 0.0 114.196 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.667 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -135.35 2.46 3.0 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.163 -0.335 . . . . 0.0 111.74 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 20.8 m-85 -171.78 172.52 4.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 10' ' ' GLN . 1.2 tm? -135.86 117.38 14.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.813 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -110.57 136.84 49.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.389 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.567 HD12 ' CD2' ' A' ' 38' ' ' PHE . 3.4 mt -113.51 150.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . . . -131.05 106.84 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 47' ' ' LEU . 24.1 mt -108.46 121.99 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HD3' ' HB2' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -89.88 120.23 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.502 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 21' ' ' VAL . 18.8 m -143.83 132.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.889 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 p -110.65 -82.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.3 m-85 -39.08 -52.58 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.781 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 41.51 97.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.777 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' CG ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -60.36 -73.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.206 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 42' ' ' ALA . 29.6 m -62.84 142.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.32 . . . . 0.0 110.859 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -38.02 78.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.7 140.92 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.2 m-30 -89.44 166.34 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.58 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' OD1' ' OH ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -117.42 118.69 32.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 7.2 t -121.68 119.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.788 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' OH ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 m-85 -118.18 118.95 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.144 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 33' ' ' PHE . 28.3 p90 -121.75 112.73 18.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.453 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.2 mt-10 -135.29 116.79 14.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.22 -75.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.139 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -149.8 26.21 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.469 . . . . 0.0 110.14 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -112.97 107.58 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CD2' HD12 ' A' ' 17' ' ' ILE . 50.3 t80 -105.33 111.53 24.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -117.86 131.34 56.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.415 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 55.6 t80 -127.52 110.3 12.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.657 ' CD1' ' CD2' ' A' ' 46' ' ' PHE . 21.9 m-85 -128.51 130.48 47.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -110.78 -68.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' CG ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 tptt -160.35 -72.15 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD3' ' CG ' ' A' ' 43' ' ' LYS . 45.2 Cg_endo -87.76 -20.37 1.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.092 . . . . 0.0 111.059 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -97.95 119.61 36.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.657 ' CD2' ' CD1' ' A' ' 41' ' ' TYR . 9.9 m-85 -120.13 116.34 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.32 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.532 HD22 ' CD2' ' A' ' 6' ' ' PHE . 5.8 mt -118.34 112.63 20.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.53 112.43 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.901 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 134.54 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.664 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m -108.38 113.72 27.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 34.0 mt -78.42 147.75 72.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.484 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.29 -12.94 27.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.089 2.526 . . . . 0.0 112.162 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -139.36 138.95 9.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.847 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -62.74 155.42 26.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.777 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 31.6 mm -119.28 126.35 75.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.186 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.558 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.9 p -64.4 161.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.414 0.626 . . . . 0.0 112.237 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.2 pm0 -125.03 125.75 44.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -150.13 8.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 -1.21 20.26 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.63 49.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.779 0.324 . . . . 0.0 110.997 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 45.4 tt0 -83.59 163.46 20.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 23.9 mm-40 -122.72 126.0 46.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -135.25 138.46 10.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.158 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.1 p -144.76 108.83 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.904 0.383 . . . . 0.0 111.331 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -109.2 118.01 35.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.53 134.03 52.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -47.73 12.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 110.291 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -52.21 -49.75 63.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.709 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 71' ' ' ILE . 16.7 ttpt -83.78 -19.86 34.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.689 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.46 56.97 19.31 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.73 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 71' ' ' ILE . 5.9 mt -146.85 148.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -115.8 120.34 38.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.121 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 m -119.76 133.38 55.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.658 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.473 HD11 ' CA ' ' A' ' 63' ' ' GLY . 0.7 OUTLIER -140.88 118.54 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 20.1 mtp180 -92.34 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.306 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 14' ' ' PHE . 2.7 mp -132.1 147.5 66.08 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 89.5 Cg_endo -81.31 148.28 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.713 2.275 . . . . 0.0 111.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 55' ' ' ILE . 27.7 mmtp -85.24 156.14 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 0.0 111.448 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.4 tt0 -89.39 -22.35 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.185 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -129.19 128.48 23.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.99 133.13 24.43 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.616 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.09 3.6 88.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.099 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -81.5 128.52 33.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.821 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.48 118.35 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.6 m-30 -77.97 90.69 4.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.155 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.84 170.77 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 91' ' ' LEU . . . 33.56 43.23 0.25 Allowed Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.59 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.98 -62.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.022 0.411 . . . . 0.0 110.952 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 89' ' ' ASN . 11.2 t-20 -84.16 13.71 4.93 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-O 121.034 0.445 . . . . 0.0 110.692 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.3 -27.94 7.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.505 178.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -44.53 177.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.792 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 93' ' ' ALA . 52.9 m -146.73 157.82 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' N ' HG21 ' A' ' 92' ' ' THR . . . -104.07 129.54 51.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.54 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.62 139.76 36.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.978 0.418 . . . . 0.0 111.17 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.13 112.06 24.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.857 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.886 0.374 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.14 144.26 27.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.826 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.04 125.73 88.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.63 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.6 171.91 5.13 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.882 2.388 . . . . 0.0 112.413 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' PHE . . . -83.87 -64.97 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 53.89 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.731 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.48 158.2 39.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -118.71 136.44 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 111.333 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.77 133.39 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 1.6 pm0 -130.01 143.03 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 160.68 25.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.433 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.4 -2.59 6.26 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.424 2.082 . . . . 0.0 113.02 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.92 11.92 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.902 -0.136 . . . . 0.0 110.956 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 66.5 m-85 -170.76 171.01 6.32 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.25 0.548 . . . . 0.0 111.662 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.447 ' HB3' HD13 ' A' ' 55' ' ' ILE . 1.2 tm? -134.42 115.91 14.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.927 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 74' ' ' ILE . 37.2 m -107.41 132.11 53.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.368 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 ' CE2' ' A' ' 38' ' ' PHE . 3.0 mt -107.12 155.39 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.51 118.36 14.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.932 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 6' ' ' PHE . 44.4 mt -121.13 127.89 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.354 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt85 -107.84 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 111.674 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 m -151.01 141.89 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -119.15 -35.17 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.664 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' ARG . 9.2 m-85 -66.17 -9.11 28.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.605 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.63 85.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.645 0.591 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.43 -71.74 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.831 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 m -43.71 135.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.7 p -57.99 -40.21 80.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -129.7 147.87 51.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -103.54 167.16 9.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 60.9 m-20 -117.32 121.12 40.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.584 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 t -122.85 119.29 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 55.6 m-85 -126.48 119.72 27.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 31.4 p90 -121.0 113.79 20.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.559 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -140.75 117.53 11.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.6 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.14 66.57 1.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.026 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER 65.55 9.85 6.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.642 0.258 . . . . 0.0 111.394 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 8.1 t70 -102.74 103.66 13.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 17' ' ' ILE . 21.5 t80 -110.22 121.11 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.344 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 6.0 mttt -124.77 126.52 45.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.648 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -122.14 112.64 18.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.907 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 13.6 m-85 -114.63 101.77 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.028 0.442 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' CB ' ' HE2' ' A' ' 43' ' ' LYS . . . -129.25 118.42 22.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 40.99 -166.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 93.0 Cg_exo -44.75 -21.36 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.687 1.591 . . . . 0.0 112.848 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 24.9 m-85 -76.61 123.05 25.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 111.734 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -127.45 124.67 38.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.936 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -120.28 113.87 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -112.02 109.53 19.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.38 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.49 129.55 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 112.201 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.27 109.03 21.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.455 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 14.0 mt -63.15 128.32 92.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 111.126 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.459 ' CD ' HD23 ' A' ' 88' ' ' LEU . 78.0 Cg_exo -49.96 -26.38 14.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.052 2.502 . . . . 0.0 113.176 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -116.51 -132.91 5.04 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -142.37 136.49 29.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 110.804 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.559 ' CD1' ' CD ' ' A' ' 78' ' ' LYS . 41.3 mm -117.29 125.21 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.8 p -62.21 156.97 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 112.063 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.79 131.43 53.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.67 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 21.5 m-80 -171.19 21.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.44 7.03 44.39 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.152 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -97.99 45.81 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.03 172.64 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -141.24 139.32 33.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.52 159.06 27.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.972 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -157.67 118.47 3.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.3 . . . . 0.0 110.429 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -117.62 137.35 52.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -119.11 119.24 33.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.235 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.06 -53.26 15.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.519 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -55.02 -46.17 75.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HG2' HD13 ' A' ' 71' ' ' ILE . 28.3 ttpt -84.38 -26.82 28.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.457 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 66.2 63.02 4.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 69' ' ' LYS . 1.4 mt -148.72 121.04 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.449 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.6 t80 -109.68 110.97 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 147.73 29.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.351 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 16' ' ' THR . 3.8 tp -138.35 154.14 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.101 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -135.32 141.69 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -136.14 149.97 69.72 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 111.752 -178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.533 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 78.1 Cg_endo -78.13 154.71 29.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.906 2.404 . . . . 0.0 112.206 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' CD ' ' CD1' ' A' ' 55' ' ' ILE . 6.6 mmtp -99.76 151.89 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 3.1 tm-20 -87.69 -4.11 58.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.793 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.6 m -157.68 120.84 2.14 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.223 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 146.29 96.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.0 111.938 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 1.79 89.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.55 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -78.66 126.56 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.34 117.42 23.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.0 m-30 -73.92 90.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.2 168.67 11.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.84 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.77 41.81 0.96 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.44 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD23 ' CD ' ' A' ' 52' ' ' PRO . 6.3 mt -60.61 -61.99 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.854 0.327 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.44 15.22 2.12 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 0.0 111.337 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.49 ' O ' ' O ' ' A' ' 91' ' ' LEU . 34.5 mtt -117.74 -32.26 4.89 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -42.13 170.55 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.991 179.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.8 p -127.34 169.15 13.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.61 133.32 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.57 131.9 55.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 6.9 mp -93.7 125.23 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.752 0.31 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.01 107.93 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.7 m -42.68 115.96 1.79 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.04 154.78 26.18 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.344 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.02 57.1 2.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' HB3' HG22 ' A' ' 19' ' ' ILE . 49.0 p90 -66.14 166.73 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.981 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 150.7 32.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.32 133.9 54.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 0.0 111.506 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.6 p -139.4 133.53 31.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.961 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 9.7 pm0 -130.05 141.45 50.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 0.0 112.691 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.37 160.4 26.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.204 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.27 -2.9 3.49 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.473 2.115 . . . . 0.0 113.298 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 7.3 m-20 -135.9 13.74 3.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.672 0.272 . . . . 0.0 110.563 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 73.1 m-85 -168.22 167.35 12.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.469 0.652 . . . . 0.0 111.864 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' A' ' 10' ' ' GLN . 2.0 tm? -134.59 106.24 6.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . 97.2 m -107.75 137.1 46.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 mt -126.88 137.91 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.151 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -126.36 139.17 53.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.997 0.427 . . . . 0.0 111.168 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.59 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -122.43 134.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.792 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -77.47 120.06 21.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.857 0.361 . . . . 0.0 110.641 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.64 139.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 p -127.66 -52.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.344 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' ALA . 9.3 m-30 -66.71 -52.77 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.767 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 42.33 96.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.773 0.32 . . . . 0.0 110.626 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.467 ' CB ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 mpt_? -76.76 3.13 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.699 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 43' ' ' LYS . 4.6 m -128.65 133.58 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -41.54 72.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.606 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.67 138.61 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -85.02 163.46 18.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -110.28 111.75 23.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.722 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 t -117.81 116.18 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.909 0.385 . . . . 0.0 111.479 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -124.02 118.11 26.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.682 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 1.8 p90 -126.79 122.66 35.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.659 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 119.01 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.546 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 63.75 -75.86 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.417 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.27 26.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.601 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 1.4 m-20 -118.23 129.48 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.4 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -123.44 111.48 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -116.67 128.2 55.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.59 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 70.0 t80 -128.93 114.78 16.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.996 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -120.48 127.97 52.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.317 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -134.65 34.18 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.274 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 17.7 tppt? 93.77 -87.95 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.073 0.949 . . . . 0.0 111.218 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.574 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 44.8 Cg_endo -86.87 -16.01 3.67 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.499 1.466 . . . . 0.0 111.921 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.98 117.37 34.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.984 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.59 119.85 28.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -115.61 113.27 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.59 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 109.98 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.16 133.78 51.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 111.621 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.6 m -90.43 105.57 17.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.983 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.68 133.07 95.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.8 Cg_endo -68.41 -23.41 37.96 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.937 2.424 . . . . 0.0 112.75 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.55 -138.35 6.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.623 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -136.02 128.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 111.51 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' ARG . 4.8 mm -116.14 125.6 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.603 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.545 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 7.7 p -60.25 157.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.078 0.466 . . . . 0.0 111.754 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 134.58 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -36.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.25 -11.58 26.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.651 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -68.6 -71.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.023 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 62' ' ' GLN . 5.3 pt-20 32.92 -156.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.2 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.5 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 30.9 mt-30 -143.63 126.61 16.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.7 136.05 9.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.561 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.5 p -152.68 111.42 3.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.34 . . . . 0.0 110.815 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.85 108.5 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.402 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.19 98.62 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.38 83.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -52.69 51.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 71' ' ' ILE . 6.0 mtmt -72.82 -16.54 61.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.87 38.35 94.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.185 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -145.01 151.94 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.323 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 45.3 t80 -111.69 123.33 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -119.07 132.85 56.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -140.07 118.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HA ' ' OG1' ' A' ' 16' ' ' THR . 15.0 mtp180 -86.46 148.59 25.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 17.2 mt -134.04 116.31 13.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 111.887 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HB2' ' CG1' ' A' ' 56' ' ' VAL . 66.2 Cg_exo -53.81 149.17 34.32 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.201 2.6 . . . . 0.0 112.805 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.26 153.75 17.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 1.3 tt0 -81.03 -15.0 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.473 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.443 HG21 ' HD2' ' A' ' 81' ' ' PRO . 69.9 m -144.85 129.27 8.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD2' HG21 ' A' ' 80' ' ' THR . 49.9 Cg_endo -69.4 149.9 69.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.752 2.301 . . . . 0.0 112.836 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.21 77.84 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.787 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.49 129.86 37.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -122.07 115.54 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.6 m-30 -74.88 89.72 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.116 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 162.51 12.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.442 ' HA2' ' HG3' ' A' ' 90' ' ' MET . . . 35.59 46.53 0.82 Allowed Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.525 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 mt -59.88 -61.98 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.783 0.292 . . . . 0.0 110.668 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.95 13.16 9.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.098 0.475 . . . . 0.0 110.223 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.442 ' HG3' ' HA2' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -108.36 -31.57 7.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.07 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.814 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.415 ' O ' HD21 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -119.02 -177.77 3.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.329 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.88 112.38 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.415 HD21 ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -121.98 125.33 46.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.063 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.51 HD11 ' N ' ' A' ' 95' ' ' LEU . 9.7 mp -98.11 133.88 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.904 179.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 128.72 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.953 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.9 t -60.41 138.32 92.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.91 164.69 2.31 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.73 2.287 . . . . 0.0 112.052 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.92 55.88 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.394 . . . . 0.0 110.397 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -61.84 163.25 7.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.12 145.6 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.69 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.75 133.64 55.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t -138.81 130.22 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.613 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' OE1' ' CD1' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -131.12 140.47 49.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 112.123 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.26 160.77 28.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.8 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.51 -2.2 0.93 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.041 2.494 . . . . 0.0 114.243 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.2 m-20 -136.41 3.69 2.83 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 122.058 -0.401 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.64 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.1 m-85 -169.3 169.38 9.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 55' ' ' ILE . 1.2 tm? -135.65 107.87 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.036 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 29.8 m -101.56 143.01 32.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 110.877 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.463 HG21 ' N ' ' A' ' 18' ' ' ALA . 23.1 mt -115.82 154.15 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.647 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -129.79 122.6 29.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.303 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 HG23 ' CD1' ' A' ' 47' ' ' LEU . 1.6 mt -125.95 123.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.481 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 118.39 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.707 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 21' ' ' VAL . 29.7 m -146.02 133.25 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.045 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -120.65 -32.95 3.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.1 m-85 -87.15 -53.35 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . 18.89 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.747 0.655 . . . . 0.0 112.01 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -56.99 -60.0 4.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -33.91 124.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 111.009 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 p -54.84 -39.95 69.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -125.31 139.49 53.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.353 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.0 OUTLIER -85.85 160.32 19.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 9.2 m-20 -112.88 113.11 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.728 0.299 . . . . 0.0 110.998 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' A' ' 38' ' ' PHE . 10.7 t -117.02 115.93 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.991 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 11.2 m-85 -116.67 114.65 24.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 36.3 p90 -124.75 116.27 22.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 42.5 mt-10 -138.22 115.16 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.79 -68.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -157.89 22.66 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.524 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -111.23 104.64 13.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.14 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.423 ' CE1' HG12 ' A' ' 31' ' ' VAL . 82.9 t80 -106.38 116.64 32.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.4 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 37' ' ' ASP . 1.3 mptt -119.92 131.01 55.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 92.5 t80 -130.95 116.78 18.3 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 17.6 m-85 -115.54 110.23 18.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -108.16 24.1 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 95.91 -87.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 O-C-N 124.235 0.959 . . . . 0.0 110.658 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.594 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 80.6 Cg_endo -83.0 -16.38 7.47 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.491 1.461 . . . . 0.0 111.801 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -109.97 131.92 54.62 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.809 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 19.7 t80 -127.35 126.96 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -121.55 112.14 18.11 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.84 115.17 22.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 178.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 48' ' ' ARG . 90.7 mt -137.04 144.03 42.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.69 113.31 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.249 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.3 mt -73.89 135.78 77.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.567 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HG3' ' CD1' ' A' ' 91' ' ' LEU . 36.3 Cg_exo -61.47 -22.09 73.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.071 2.514 . . . . 0.0 113.003 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.589 ' HA3' ' CD1' ' A' ' 85' ' ' PHE . . . -113.07 -142.61 8.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.129 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 2.4 mmt-85 -142.18 139.35 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.864 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 27.9 mm -117.81 124.96 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 6.2 p -56.24 152.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.402 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 123.07 49.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.55 -39.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.96 -19.43 32.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -59.87 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' ' O ' ' A' ' 60' ' ' SER . 1.0 OUTLIER 30.96 -152.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.468 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 1.8 mt-30 -157.33 131.45 8.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.34 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.98 141.69 13.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.065 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -159.51 105.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -107.41 137.81 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.25 115.58 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.14 -46.63 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.33 -50.57 69.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.767 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HD2' ' CD1' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -79.61 -23.21 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 69.4 63.36 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.672 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' HD2' ' A' ' 69' ' ' LYS . 54.0 mt -160.23 126.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.9 t80 -108.12 118.79 37.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.515 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -122.54 122.39 38.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.46 ' O ' HG21 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -130.51 122.93 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.441 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.68 140.93 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.668 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 1.9 mp -129.37 129.81 23.28 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 38.3 Cg_endo -66.82 150.74 83.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.926 2.417 . . . . 0.0 112.184 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' C ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -92.7 155.81 17.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.36 -19.74 62.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.701 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -146.51 120.88 5.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.0 152.02 54.01 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.886 2.391 . . . . 0.0 112.624 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.75 -4.0 62.31 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -77.53 135.43 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.125 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 3.4 t-160 -125.43 116.45 21.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 5.5 m-30 -67.93 89.76 0.29 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.698 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -74.42 172.78 11.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 112.018 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' LEU . . . 45.03 32.66 3.37 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.41 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.503 ' CD1' ' OE1' ' A' ' 10' ' ' GLN . 8.7 mt -43.13 -53.29 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.723 0.761 . . . . 0.0 110.146 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -97.96 -40.37 8.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.0 mtp -78.18 6.81 7.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.036 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' GLY . 0.9 OUTLIER -51.33 178.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 p -123.45 160.26 27.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.33 113.64 27.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.787 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -123.56 112.33 17.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.834 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.16 116.58 28.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.931 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.801 0.334 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.16 152.22 20.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.034 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.35 105.53 43.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.218 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.91 172.31 12.16 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.985 2.457 . . . . 0.0 112.725 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.16 60.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 38.2 p90 -68.65 161.52 27.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.819 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.54 148.22 29.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.81 134.21 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.262 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -141.84 136.05 30.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.301 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' HB3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.24 141.89 50.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.317 0.58 . . . . 0.0 112.329 -178.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -101.44 157.84 32.9 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.507 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 10.5 Cg_endo -54.75 -8.16 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 113.629 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 47.1 m-20 -135.52 15.48 3.42 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.324 -0.235 . . . . 0.0 111.292 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 13.1 m-85 -169.5 170.71 8.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.481 0.658 . . . . 0.0 112.321 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -132.82 112.67 12.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.6 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 75' ' ' ARG . 30.2 m -104.67 138.02 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.56 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 1.9 mt -114.33 149.41 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -129.76 120.26 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 111.074 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 HD12 ' A' ' 47' ' ' LEU . 13.1 mt -126.0 119.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.5 mtt180 -90.69 120.64 31.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.412 . . . . 0.0 111.813 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 m -141.88 129.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -72.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.997 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.4 m-30 -48.42 -52.91 19.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.909 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.504 ' HA ' ' CD ' ' A' ' 43' ' ' LYS . . . 39.49 95.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.89 5.32 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.877 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 43' ' ' LYS . 27.1 m -127.46 133.28 68.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -41.11 82.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.72 148.28 50.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.653 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.67 168.71 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.301 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.95 118.55 36.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.11 115.35 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 0.0 112.027 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -125.39 117.87 24.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -120.41 118.95 31.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.142 0.496 . . . . 0.0 111.72 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.21 96.76 3.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.621 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.09 -146.68 18.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.685 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -54.33 -14.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.628 0.251 . . . . 0.0 111.63 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.83 117.27 26.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' CZ ' HD12 ' A' ' 17' ' ' ILE . 61.2 t80 -127.67 113.27 15.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 131.34 55.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 111.574 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 69.8 t80 -126.64 109.7 12.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.519 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -107.69 108.31 19.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.188 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . . . -140.82 119.42 12.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.194 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.685 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 38.04 -161.66 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.685 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 73.0 Cg_exo -50.91 -17.3 3.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.208 1.272 . . . . 0.0 112.567 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.439 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 51.4 m-85 -74.55 112.81 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.341 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.25 116.21 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.445 HD12 HD12 ' A' ' 19' ' ' ILE . 4.4 mt -119.35 114.65 22.69 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.06 115.84 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.15 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.2 mt -134.0 143.04 47.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 112.16 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -105.21 105.17 15.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.204 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 88.2 mt -62.4 145.3 94.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.178 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 37.5 Cg_exo -60.12 -23.43 73.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.778 2.318 . . . . 0.0 112.055 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -125.36 -125.04 2.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.3 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -154.15 149.54 27.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.975 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 77' ' ' PRO . 31.5 mm -117.77 123.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 5.3 p -58.12 151.39 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -119.1 125.32 49.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.808 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.45 27.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.412 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.56 -32.73 2.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.154 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.71 120.21 9.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.137 0.468 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.0 163.88 6.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.632 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 6.2 mt-30 -143.53 134.38 25.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 146.06 17.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.661 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -139.27 112.1 7.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 110.65 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -104.57 120.21 40.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.235 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -114.01 110.74 20.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.563 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.99 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -57.26 -50.27 73.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 9.8 ttpt -74.2 -22.13 59.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 61.24 63.21 5.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.267 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 71' ' ' ILE . 14.6 mt -156.84 131.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.118 0.485 . . . . 0.0 112.054 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' A' ' 40' ' ' PHE . 12.9 t80 -116.21 113.76 23.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.505 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 134.05 55.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.194 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -138.58 117.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HG3' HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.13 142.28 27.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.178 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.47 ' HB3' HG23 ' A' ' 55' ' ' ILE . 1.2 mp -134.37 145.88 57.11 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.631 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 59.4 Cg_endo -73.42 151.36 47.87 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.831 2.354 . . . . 0.0 112.433 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -95.47 156.68 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.103 0.478 . . . . 0.0 111.704 -179.414 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 12.0 tt0 -88.22 -6.25 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -159.51 96.09 1.64 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.318 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 157.56 9.42 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.87 -6.42 70.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 37.3 tt0 -84.79 141.0 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.308 . . . . 0.0 110.81 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -124.26 117.06 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 8.2 m-30 -72.72 92.69 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -72.0 173.7 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.311 0.577 . . . . 0.0 111.913 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.412 ' HA2' ' HG3' ' A' ' 90' ' ' MET . . . 35.9 40.15 0.33 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.667 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 10.5 mt -60.66 -63.04 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.976 0.388 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.47 16.18 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.087 0.47 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -115.55 -31.96 5.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 90' ' ' MET . 3.5 mt -46.12 177.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.482 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 p -136.27 176.08 9.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.524 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.12 132.42 50.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' N ' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -105.12 129.14 53.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 95' ' ' LEU . 4.1 mp -99.24 121.28 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.964 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.953 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.694 0.206 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.25 54.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -58.19 161.25 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.44 146.99 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.3 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 138.59 54.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.226 0.536 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 p -141.66 133.94 27.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.552 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.712 ' OE1' HD12 ' A' ' 88' ' ' LEU . 2.7 pm0 -130.7 140.73 50.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.371 0.605 . . . . 0.0 112.457 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.37 160.56 26.11 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.986 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.68 -6.06 1.47 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.03 2.486 . . . . 0.0 113.947 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.4 m-20 -135.95 8.91 3.27 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.625 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 65.7 m-85 -168.24 168.41 11.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 111.733 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.72 109.58 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.615 178.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.649 ' N ' HD22 ' A' ' 15' ' ' LEU . 19.4 m -99.41 147.26 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.799 HD12 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mt -125.4 153.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.12 121.94 16.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 112.069 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.08 124.23 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.796 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.8 118.71 37.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.358 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -148.25 143.21 19.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -125.57 -23.22 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.7 m-85 -75.56 -10.05 59.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.534 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.55 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.476 0.485 . . . . 0.0 111.811 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -82.69 10.22 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.287 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.11 127.44 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.785 179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -55.8 -24.19 34.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.12 153.52 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -108.55 168.39 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.378 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -129.03 128.51 43.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.95 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.2 117.6 26.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 21.2 p90 -128.86 119.28 24.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.8 OUTLIER -140.71 122.21 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.114 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.87 -70.21 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.642 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -160.38 25.4 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 0.0 110.592 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 6.7 t70 -116.22 110.61 19.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.799 ' CE2' HD12 ' A' ' 17' ' ' ILE . 26.1 t80 -105.54 111.82 24.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.224 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.28 128.17 50.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 47.8 t80 -104.99 143.08 33.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 32.7 m-85 -135.49 102.81 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -149.0 112.73 5.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.8 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER 47.02 -175.63 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 84.6 Cg_exo -37.0 -27.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.16 1.907 . . . . 0.0 112.744 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 12.6 m-30 -63.15 120.82 12.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.381 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -125.27 120.05 30.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.648 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -116.98 115.66 25.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.049 0.452 . . . . 0.0 112.024 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.28 110.17 16.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.897 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.9 mt -124.18 130.63 52.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.367 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 m -102.14 107.67 18.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 23.1 mt -65.28 143.89 98.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.199 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 49.9 Cg_endo -70.27 -23.82 28.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.785 2.323 . . . . 0.0 112.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -116.74 -137.28 5.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.186 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 82.3 mtt-85 -140.47 132.76 28.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 77' ' ' PRO . 52.0 mm -113.78 124.41 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.481 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.793 HG13 ' HG2' ' A' ' 77' ' ' PRO . 10.1 p -68.03 162.56 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.4 pt-20 -123.74 127.66 48.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.218 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.24 6.68 0.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.96 23.63 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -82.1 -69.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.994 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 31.55 -156.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.698 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 1.8 mm-40 -179.94 119.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 74' ' ' ILE . . . -170.06 -179.16 41.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.175 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -164.14 148.93 10.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CD1' ' HE2' ' A' ' 29' ' ' PHE . 14.9 t80 -113.85 132.94 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.436 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -124.93 125.3 43.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.475 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.83 -34.26 26.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.422 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -50.53 65.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.545 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -94.15 -11.0 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 63.15 62.21 5.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.259 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 70' ' ' GLY . 6.1 mt -155.05 127.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.514 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.1 t80 -110.49 114.79 28.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.501 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -121.7 126.13 48.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.263 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 2.1 tp -133.49 120.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 5.1 mtp180 -92.33 145.1 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.487 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.579 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.9 mt -134.66 143.17 45.39 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' ILE . 47.9 Cg_endo -73.18 158.98 48.24 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.789 2.326 . . . . 0.0 112.657 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 1.7 mttt -96.76 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.99 -11.03 51.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.399 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.2 m -147.52 130.49 7.98 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.846 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.06 142.54 81.47 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.99 2.46 . . . . 0.0 112.74 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 2.87 87.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.571 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 tt0 -78.1 126.75 31.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.736 0.303 . . . . 0.0 110.845 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -128.35 121.3 28.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 4.8 m-30 -76.16 92.95 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.426 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HA ' ' CE1' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -68.49 170.49 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.736 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.8 40.33 0.2 Allowed Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.541 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.712 HD12 ' OE1' ' A' ' 10' ' ' GLN . 2.6 mt -59.53 -61.52 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.959 0.379 . . . . 0.0 110.382 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.899 0.381 . . . . 0.0 110.943 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.898 0.291 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.26 63.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.6 p90 -68.69 160.28 30.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.062 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.1 149.95 31.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.534 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.72 135.19 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.159 0.504 . . . . 0.0 111.465 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' THR . 59.5 p -139.33 133.82 31.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.319 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.594 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.1 pm0 -129.94 139.52 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.26 160.35 27.79 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.824 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.54 -6.61 7.37 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.663 2.242 . . . . 0.0 112.982 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 49.4 m-20 -135.01 13.76 3.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.521 0.201 . . . . 0.0 110.713 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.1 m-85 -169.92 171.81 6.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.537 0.684 . . . . 0.0 112.163 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.663 HD22 ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.72 108.32 7.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.685 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.653 ' N ' HD22 ' A' ' 15' ' ' LEU . 14.1 m -99.72 144.68 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 111.203 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 19.2 mt -119.42 152.77 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -132.78 112.57 12.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 17.5 mt -125.09 120.13 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' NH1' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -102.55 120.86 41.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.71 132.77 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -32.1 4.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' ALA . 5.5 m-85 -71.12 -9.9 58.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.016 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -29.8 122.53 0.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.453 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 12.16 30.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 42' ' ' ALA . 3.1 m -139.22 138.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -58.95 -40.95 86.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -117.33 141.59 48.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -92.96 168.94 10.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.774 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.0 116.57 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.435 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 ' HD1' ' A' ' 40' ' ' PHE . 21.9 t -121.96 120.75 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.19 127.83 43.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 23.9 p90 -132.2 121.89 24.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.4 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' SER . 18.9 pt-20 -138.65 119.93 14.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.62 -71.49 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.368 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -159.86 26.47 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.083 0.468 . . . . 0.0 109.961 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m-20 -115.76 104.51 11.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 25.7 t80 -105.68 120.76 42.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -124.77 135.62 53.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.611 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' HD1' HG22 ' A' ' 31' ' ' VAL . 85.3 t80 -129.09 112.35 13.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.78 133.71 46.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 111.234 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -105.27 -59.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -163.03 -64.73 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.485 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 48.3 Cg_endo -97.71 -10.76 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.986 2.458 . . . . 0.0 112.782 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -108.52 134.55 51.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 8.5 t80 -123.62 118.42 27.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.069 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 1.1 mt -115.75 111.2 20.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.486 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.2 109.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.699 0.285 . . . . 0.0 110.57 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.67 131.12 53.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.942 0.401 . . . . 0.0 111.549 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 m -101.16 110.3 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 20.9 mt -68.63 129.99 92.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 51.4 Cg_exo -54.53 -23.18 30.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.969 2.446 . . . . 0.0 112.734 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -117.91 -133.58 4.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 23.3 mtt-85 -146.5 141.01 26.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.978 HG23 ' O ' ' A' ' 77' ' ' PRO . 9.5 mm -118.45 126.06 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.57 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.6 p -58.46 157.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.573 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -121.06 128.41 52.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.661 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -163.96 -41.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.43 -0.03 26.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -91.06 31.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.558 ' HG3' ' CD ' ' A' ' 77' ' ' PRO . 21.2 mp0 -80.0 -168.76 1.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.943 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -131.96 122.29 25.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -122.33 135.0 10.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -147.74 104.88 3.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 136.91 54.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.567 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.04 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -43.59 22.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.494 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -60.3 -52.89 63.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 9.6 ttpt -78.71 -24.48 44.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 65.26 61.38 5.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.562 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -149.77 126.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.388 . . . . 0.0 111.6 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' ILE . 5.5 t80 -110.72 108.35 18.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -115.62 120.43 39.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.946 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.49 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -130.23 118.54 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.431 . . . . 0.0 111.886 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -85.85 142.77 28.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.059 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.832 ' HB3' HG21 ' A' ' 55' ' ' ILE . 8.7 mt -128.44 132.22 24.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 111.666 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -64.95 153.26 79.05 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.757 2.304 . . . . 0.0 112.261 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HG3' ' C ' ' A' ' 13' ' ' ASP . 1.6 mttt -96.67 151.06 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 111.523 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.53 -14.19 49.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.113 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.2 m -146.8 108.15 4.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.565 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.8 148.75 15.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.641 2.228 . . . . 0.0 112.397 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 -1.68 86.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.637 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -79.26 132.0 36.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 10' ' ' GLN . 8.2 t-80 -127.04 119.98 27.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.524 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 9.1 m-30 -77.03 90.93 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 173.6 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 112.213 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.45 37.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.902 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 85' ' ' PHE . 20.2 mt -61.21 -63.58 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.239 0.519 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.334 -0.09 0 CA-C-O 121.039 0.447 . . . . 0.0 110.327 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.463 -0.282 0 CA-C-O 120.73 0.221 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.01 60.1 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.69 159.76 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -144.3 143.73 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.81 134.63 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.512 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -139.35 133.11 30.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.391 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 6.2 pm0 -130.36 140.65 50.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.477 0.656 . . . . 0.0 112.477 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 5.5 m-20 -108.31 160.28 27.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.134 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.44 -0.97 2.7 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.648 2.232 . . . . 0.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 40.6 m-20 -135.75 4.82 3.09 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.451 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 17.8 m-85 -167.07 167.05 14.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.329 0.585 . . . . 0.0 112.303 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.1 tm? -134.8 112.03 10.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.138 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' ' CG ' ' A' ' 75' ' ' ARG . 55.0 m -108.78 135.67 49.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.0 111.275 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.567 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.3 mt -109.73 152.65 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.5 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.92 119.42 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.66 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.62 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -124.8 129.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -107.29 119.17 38.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.077 0.465 . . . . 0.0 111.6 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.37 128.65 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.536 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.24 -36.37 7.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.654 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' C ' ' A' ' 24' ' ' ALA . 53.9 m-85 -65.78 -10.21 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.62 118.27 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.709 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -98.76 -69.44 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.757 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -43.41 125.24 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -20.15 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.724 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -137.0 148.13 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.605 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -103.91 166.84 10.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.865 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -124.31 127.58 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.9 t -123.55 121.17 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -127.6 123.15 34.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 24.0 p90 -134.21 126.03 29.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -139.21 119.57 13.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.98 -68.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.78 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -161.89 26.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 0.0 110.391 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.0 m-20 -116.19 104.54 11.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 17' ' ' ILE . 42.7 t80 -99.11 112.08 24.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 36.1 mttt -118.24 117.43 29.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.385 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 19' ' ' ILE . 24.3 t80 -102.68 143.22 32.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.77 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 25.2 m-85 -137.52 112.35 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -144.48 104.51 4.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.092 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.581 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 2.8 pttt 44.92 -163.34 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 71.0 Cg_exo -41.4 -22.6 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.987 1.791 . . . . 0.0 113.636 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.528 ' CZ ' ' HE2' ' A' ' 43' ' ' LYS . 17.0 m-30 -73.09 122.78 22.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.182 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -129.93 125.4 35.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.324 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -123.13 117.77 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 0.0 111.915 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.2 tmm_? -117.89 113.31 21.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 48' ' ' ARG . 29.3 mt -124.21 132.21 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.941 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m -98.99 106.75 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.8 mt -66.21 126.27 91.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.459 . . . . 0.0 111.456 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 32.1 Cg_exo -57.01 -26.55 69.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.031 2.487 . . . . 0.0 112.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.13 -140.12 7.62 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 5.9 mtt180 -137.63 128.09 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.369 . . . . 0.0 111.368 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.0 mm -111.73 123.75 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.916 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.588 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -62.36 158.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.188 0.518 . . . . 0.0 112.376 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -123.17 129.58 51.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.601 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -165.21 -37.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.98 9.25 20.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.711 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.98 33.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 76' ' ' LEU . 2.1 pt-20 -85.77 -172.95 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 14.0 mt-30 -132.37 122.19 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.807 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -123.48 134.81 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.721 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.84 107.89 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -107.05 139.57 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' GLY . 65.6 t0 -116.22 112.72 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.474 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.64 -53.68 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.339 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -53.82 -44.62 70.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' HG13 ' A' ' 71' ' ' ILE . 35.1 ttpt -84.73 -26.7 27.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.71 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 69.69 63.4 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.649 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 69' ' ' LYS . 7.0 mt -154.34 119.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 111.65 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -103.12 109.47 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 97.5 m -114.3 121.71 44.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.474 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -131.99 121.1 46.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.59 144.21 26.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.022 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 HD12 ' A' ' 15' ' ' LEU . 10.3 mt -133.51 150.61 75.47 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.979 ' O ' HG23 ' A' ' 55' ' ' ILE . 17.7 Cg_endo -86.76 157.74 8.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.226 2.617 . . . . 0.0 112.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 1.5 mtpm? -101.42 156.6 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.939 0.4 . . . . 0.0 111.644 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -90.5 -6.15 55.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 80' ' ' THR . 5.6 m -156.86 90.03 2.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.8 153.54 0.27 Allowed 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 123.011 2.474 . . . . 0.0 112.929 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.26 -11.2 66.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.887 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.513 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 5.0 tp60 -81.28 136.86 35.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.671 0.272 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 2.2 t-80 -125.72 116.87 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.838 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.4 m-30 -71.51 94.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.48 174.33 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.9 36.21 0.12 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.569 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 37.8 mt -58.89 -63.41 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.516 0.658 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.333 -0.128 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.55 179.576 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.656 0.19 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.41 ' O ' ' NE ' ' A' ' 20' ' ' ARG . . . -94.1 57.66 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.186 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 14.3 p90 -72.58 169.46 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -156.92 164.08 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -128.63 141.32 51.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.251 0.548 . . . . 0.0 111.875 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.76 134.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.041 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.684 ' OE1' ' CD2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -130.76 144.03 51.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.98 160.86 27.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.04 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.61 -0.61 2.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.969 2.446 . . . . 0.0 113.686 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.627 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -135.92 6.31 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.443 -0.161 . . . . 0.0 111.195 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.8 m-85 -168.98 169.17 9.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.394 0.616 . . . . 0.0 111.855 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.819 HD22 ' N ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -133.21 120.19 20.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.419 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.819 ' N ' HD22 ' A' ' 15' ' ' LEU . 85.7 m -111.94 149.8 31.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.966 0.412 . . . . 0.0 111.21 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.783 HG23 HD23 ' A' ' 8' ' ' LEU . 16.3 mt -124.99 151.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.308 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB1' ' NH1' ' A' ' 20' ' ' ARG . . . -140.58 122.63 15.64 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 47' ' ' LEU . 6.8 mt -125.61 131.27 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -108.59 119.38 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.35 . . . . 0.0 110.805 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -145.84 136.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.103 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.09 -36.06 5.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.02 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' ARG . 28.1 m-85 -64.49 -10.36 25.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.07 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.35 86.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.033 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.3 -72.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.621 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.1 m -50.18 137.23 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.43 -41.12 98.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.64 143.1 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.706 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.36 164.48 12.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.009 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -112.39 118.02 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.84 114.6 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -127.45 124.39 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 44.1 p90 -123.58 116.18 22.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -138.2 121.09 16.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.39 59.97 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.93 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 64.52 22.97 12.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.334 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 16.1 t0 -111.57 103.77 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CD1' ' CD1' ' A' ' 17' ' ' ILE . 80.7 t80 -101.35 113.18 26.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 111.73 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -108.56 110.37 21.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.041 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 77.4 m-85 -113.03 106.29 14.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 111.322 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -136.0 118.85 16.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.4 OUTLIER 44.48 -169.62 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 43' ' ' LYS . 81.8 Cg_exo -47.11 -14.16 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.133 1.889 . . . . 0.0 113.278 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.571 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 18.0 m-30 -80.83 125.52 30.19 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.844 0.354 . . . . 0.0 111.355 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.76 122.99 36.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.356 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 47' ' ' LEU . 2.0 mt -117.25 110.08 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 111.363 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.643 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.2 ttm180 -112.27 110.23 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.907 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 48' ' ' ARG . 18.5 mt -126.58 130.91 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 111.862 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.7 m -104.73 114.17 28.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.484 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.2 mt -81.47 147.2 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.7 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 21.5 Cg_exo -64.95 -17.63 59.95 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.997 2.464 . . . . 0.0 112.163 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -138.47 135.12 7.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -64.22 163.54 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.133 0.492 . . . . 0.0 111.838 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.976 HG23 ' O ' ' A' ' 77' ' ' PRO . 28.2 mm -123.28 129.31 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 13.9 p -54.51 150.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.568 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -108.31 121.33 44.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.251 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -154.44 -40.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.55 -21.28 21.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -57.95 -65.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.626 0.251 . . . . 0.0 110.742 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' OE2' HD11 ' A' ' 74' ' ' ILE . 26.6 pt-20 28.07 -145.95 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.136 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -167.54 146.15 4.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.609 0.243 . . . . 0.0 110.512 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -154.16 145.91 13.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.896 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.46 110.48 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.658 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.524 ' CE1' ' CG ' ' A' ' 72' ' ' PHE . 31.7 m-85 -94.73 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.32 112.11 24.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -57.09 -52.27 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -21.03 39.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 66.34 63.11 4.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.697 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 70' ' ' GLY . 21.1 mt -158.59 128.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.947 0.403 . . . . 0.0 111.581 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.524 ' CG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 t80 -106.06 109.71 21.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.489 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.56 119.55 38.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -130.55 119.76 46.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.538 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 46.9 mtp180 -85.8 146.35 26.81 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.637 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 55' ' ' ILE . 11.3 mt -136.06 133.21 19.56 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.098 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.9 Cg_exo -73.59 150.11 44.99 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.789 2.326 . . . . 0.0 111.725 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HE2' ' N ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -90.42 156.55 18.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.147 0.499 . . . . 0.0 112.272 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.54 -20.34 22.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.228 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.6 m -131.64 89.55 39.48 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.599 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -41.72 141.27 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.902 2.401 . . . . 0.0 112.524 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.11 -4.81 83.15 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.084 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 10.5 tt0 -80.4 131.23 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.827 0.314 . . . . 0.0 110.36 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.684 ' CD2' ' OE1' ' A' ' 10' ' ' GLN . 3.9 t-80 -126.75 124.5 39.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.092 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 88' ' ' LEU . 1.2 m-30 -88.5 93.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.093 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.83 126.44 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.11 57.95 0.66 Allowed Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.065 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 85' ' ' PHE . 1.3 mp -48.53 -21.9 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.166 0.483 . . . . 0.0 110.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.52 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.876 0.282 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.73 70.08 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.63 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -78.43 159.6 28.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.469 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.52 144.9 29.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.352 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 88' ' ' LEU . 2.0 mt -116.31 138.09 51.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.502 . . . . 0.0 111.568 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.72 135.04 31.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.363 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 84' ' ' HIS . 8.3 pm0 -129.86 143.41 50.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.474 0.654 . . . . 0.0 112.337 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -106.66 160.82 24.9 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.052 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.04 -1.08 3.19 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.868 2.378 . . . . 0.0 113.452 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.671 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 10.1 m-20 -136.82 9.59 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.47 -0.144 . . . . 0.0 111.003 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 15.3 m-85 -171.99 173.21 4.48 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.384 0.612 . . . . 0.0 111.839 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.67 117.02 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.424 177.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.596 ' N ' HD22 ' A' ' 15' ' ' LEU . 31.2 m -107.73 150.84 26.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.0 111.138 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.3 151.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.77 114.46 13.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.964 0.411 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.4 125.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.317 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -84.62 121.41 27.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 65' ' ' TYR . 20.0 m -149.99 149.2 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.7 p -140.26 -57.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.227 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' ALA . 11.0 m-30 -56.88 -52.76 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.09 99.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.16 6.16 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.504 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.02 134.31 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -57.33 -41.68 80.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -123.3 139.39 54.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.18 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -84.7 158.73 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.102 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 23.9 m-20 -109.67 111.66 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' A' ' 40' ' ' PHE . 73.1 t -118.08 117.47 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.424 . . . . 0.0 111.334 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.84 112.06 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.372 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 21.2 p90 -119.12 113.28 20.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.762 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 pt-20 -136.66 106.04 6.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.649 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 34.69 88.45 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.886 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.81 -1.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 26.8 t70 -108.32 120.71 43.15 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.03 121.76 27.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.5 mmtt -124.35 128.81 49.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' A' ' 31' ' ' VAL . 77.1 t80 -122.89 111.45 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.736 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 6.1 m-85 -115.09 124.6 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -130.66 29.64 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 91.76 -89.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.931 0.892 . . . . 0.0 111.302 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 92.2 Cg_endo -82.02 -17.4 8.14 Favored 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.739 1.3 . . . . 0.0 111.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.71 117.82 34.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.293 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 41' ' ' TYR . 1.4 t80 -124.77 120.16 30.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.482 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -116.07 111.55 20.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.949 0.404 . . . . 0.0 111.582 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.552 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -116.24 110.61 18.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.933 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.5 mt -131.45 138.06 48.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.421 . . . . 0.0 111.811 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.71 111.9 24.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 78.6 mt -67.48 140.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.979 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 17.1 Cg_exo -66.87 -15.73 47.92 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.758 2.305 . . . . 0.0 112.302 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.56 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.61 -133.81 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.05 142.82 26.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 111.438 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.946 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.7 mm -119.08 125.11 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.758 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.3 p -52.88 142.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.032 0.444 . . . . 0.0 112.024 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.98 122.05 44.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.501 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -167.58 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.18 16.1 9.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.84 28.33 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' HG3' HD11 ' A' ' 74' ' ' ILE . 20.9 pm0 -72.38 -167.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.6 mt-30 -138.39 129.97 27.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.02 136.68 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.675 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.4 t -155.11 116.33 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' OH ' HG23 ' A' ' 21' ' ' VAL . 2.9 t80 -105.53 123.09 47.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 120.39 42.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.87 55.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.524 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.91 -55.22 24.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG3' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -91.25 -7.92 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.797 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.26 51.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.4 ' HB ' ' HG3' ' A' ' 69' ' ' LYS . 91.2 mt -145.82 144.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 0.0 110.498 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.566 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -111.72 123.86 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 111.217 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.05 131.22 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -139.55 118.62 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 0.0 111.556 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -90.1 147.24 23.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.706 ' HB3' HG21 ' A' ' 55' ' ' ILE . 4.7 mt -135.3 131.12 19.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.795 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.946 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.9 Cg_endo -66.98 144.33 69.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.65 2.234 . . . . 0.0 111.997 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 11' ' ' ASP . 35.6 mttp -88.56 156.65 18.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -87.49 -17.56 31.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.138 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 83' ' ' GLN . 20.0 m -135.94 119.25 12.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.544 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 143.8 70.01 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.496 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.28 2.45 90.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.671 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 4.5 tt0 -81.77 129.11 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.787 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 20.9 t-80 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.192 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.9 m-30 -83.29 89.91 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.89 162.48 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 112.121 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.85 49.41 0.76 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.592 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 8' ' ' LEU . 1.3 mt -60.3 -61.34 2.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.927 0.364 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.334 -0.108 0 CA-C-O 121.023 0.44 . . . . 0.0 110.619 179.561 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.698 0.208 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.848 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.617 ' HE2' HD21 ' A' ' 8' ' ' LEU . 4.5 p90 -73.3 164.87 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.28 147.47 27.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -115.16 136.09 53.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.507 . . . . 0.0 111.531 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.8 t -140.7 134.47 30.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.756 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -131.94 145.09 51.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.561 0.696 . . . . 0.0 112.686 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.85 160.56 27.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.893 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.87 -0.31 3.8 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.935 2.423 . . . . 0.0 113.248 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.652 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 72.4 m-20 -134.79 5.81 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.478 0.18 . . . . 0.0 110.866 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.5 m-85 -171.34 171.37 5.59 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.267 0.556 . . . . 0.0 111.212 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -137.67 111.18 8.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.086 178.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 74' ' ' ILE . 4.9 m -104.74 148.51 26.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.134 0.492 . . . . 0.0 111.38 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.742 HD12 ' CE1' ' A' ' 38' ' ' PHE . 4.6 mt -123.39 155.3 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -136.85 111.29 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.932 0.396 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.622 HD13 ' CD2' ' A' ' 40' ' ' PHE . 3.7 mt -118.95 126.84 75.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 11.4 ttt180 -101.85 119.44 38.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.585 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 21' ' ' VAL . 14.4 m -143.73 130.44 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.543 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.45 -33.59 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.389 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.514 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 2.2 m-30 -66.92 -10.13 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.8 108.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 6.8 ttt180 -101.48 11.29 39.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.5 m -121.88 129.37 75.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.19 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.7 m -56.47 -40.38 74.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -125.47 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.355 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -94.0 160.03 14.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -113.7 112.15 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.57 114.55 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -119.36 113.15 20.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.393 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 12.3 p90 -118.57 112.95 20.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.015 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 1.1 tt0 -138.07 112.6 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.347 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA2' ' HG2' ' A' ' 54' ' ' ARG . . . 36.91 77.37 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.442 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 66.45 4.16 3.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.5 m-20 -102.8 104.23 14.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.2 t80 -110.87 116.04 30.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.428 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -121.2 131.78 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.249 179.533 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 19' ' ' ILE . 84.5 t80 -128.46 112.05 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.334 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' OH ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -116.45 119.33 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -133.9 29.53 3.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.484 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 2.1 pttp 122.46 -164.31 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.823 1.327 . . . . 0.0 108.536 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 27.3 Cg_exo -37.33 -26.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.339 1.359 . . . . 0.0 112.66 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.5 m-85 -73.49 124.42 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.04 124.1 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.1 mt -113.35 109.29 18.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -120.14 112.49 19.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 48' ' ' ARG . 32.6 mt -132.31 136.98 47.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.628 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.2 m -102.43 111.32 23.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.648 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 17.0 mt -70.64 146.24 93.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 23.7 Cg_exo -63.75 -19.33 66.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.895 2.397 . . . . 0.0 112.551 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' NE2' ' A' ' 83' ' ' GLN . . . -123.43 -127.98 3.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.809 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HG2' ' HA2' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -151.38 145.53 25.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 77' ' ' PRO . 32.2 mm -116.51 124.69 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.8 p -55.72 151.81 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.467 . . . . 0.0 111.595 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.03 131.4 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.25 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.54 -37.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.46 17.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -97.71 30.25 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.953 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -79.0 -169.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.663 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.38 137.74 44.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.61 134.66 7.49 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.067 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -143.79 104.95 4.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -119.17 139.57 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 111.617 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.62 128.9 53.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.32 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.827 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.89 -39.3 65.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -95.78 -20.09 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . 63.96 62.91 4.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.341 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 70' ' ' GLY . 50.4 mt -144.7 118.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -113.3 115.79 28.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 25.9 m -119.14 129.35 54.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.953 HD11 ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -138.13 121.13 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -86.22 144.88 27.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.76 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.08 125.36 18.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.897 ' O ' HG23 ' A' ' 55' ' ' ILE . 32.9 Cg_endo -63.42 151.66 83.88 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.445 2.097 . . . . 0.0 111.942 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 13.6 mttt -96.39 157.47 15.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 79' ' ' GLU . 2.9 tm-20 -84.63 -4.93 59.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 79' ' ' GLU . 93.0 m -152.09 116.96 3.03 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.93 143.64 48.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.265 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.86 86.09 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.908 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tp-100 -66.98 122.38 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.676 0.274 . . . . 0.0 110.504 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -120.16 112.68 19.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.858 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 16.2 m-30 -77.46 90.29 3.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.305 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 171.29 11.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 112.011 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 36.61 41.13 0.53 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.73 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.59 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.109 0.454 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.465 -0.2 0 N-CA-C 111.689 -0.158 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.06 58.13 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -68.26 164.91 19.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.35 156.6 42.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.47 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -120.08 139.29 52.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.423 0.63 . . . . 0.0 112.008 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.0 p -140.63 131.54 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.628 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.56 145.16 51.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 0.0 112.738 -177.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.447 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m-20 -109.31 160.22 28.44 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.899 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.86 -1.24 2.57 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.974 2.449 . . . . 0.0 113.929 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.7 m-20 -137.19 8.91 2.96 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.3 -0.25 . . . . 0.0 111.037 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.6 m-85 -171.17 171.96 5.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.379 0.609 . . . . 0.0 111.803 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -134.24 118.66 17.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.477 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.851 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.0 m -108.26 145.92 33.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 110.293 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 8' ' ' LEU . 3.1 mt -118.85 154.54 21.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.69 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.71 110.53 9.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.459 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.9 mt -126.26 122.44 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.573 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 120.21 41.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.768 0.318 . . . . 0.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.66 134.76 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.379 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.48 -38.27 5.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.6 m-30 -63.63 -10.74 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -21.82 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.229 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -70.44 -76.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.431 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.5 m -39.94 128.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -58.91 -28.65 66.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.66 145.07 51.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.474 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -101.59 163.65 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.764 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -118.48 119.04 33.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.12 121.52 65.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 56.4 m-85 -135.34 130.67 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.4 p90 -127.02 122.2 33.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 8.6 tt0 -137.39 109.51 7.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.527 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.15 75.7 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.98 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 66.59 5.17 3.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 34.3 m-20 -103.17 103.75 13.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.685 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 71.0 t80 -105.83 113.14 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.408 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 115.39 27.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.434 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 76.3 t80 -113.08 109.29 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 98.5 m-85 -110.29 105.96 15.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 112.034 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -134.07 113.36 12.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.594 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.603 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 43.8 -170.23 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 76.4 Cg_exo -42.64 -20.87 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.026 1.817 . . . . 0.0 113.106 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 14.2 m-85 -71.6 121.14 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.9 t80 -118.57 119.21 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.427 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.6 mt -120.26 109.53 15.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 111.911 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 3.9 ttm180 -118.73 116.48 26.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.42 128.04 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 0.0 111.794 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 106.36 18.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' ILE . 4.4 mt -70.34 128.18 91.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.375 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 46.1 Cg_exo -56.0 -20.84 31.67 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.821 2.347 . . . . 0.0 112.199 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -112.18 -138.62 7.43 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.538 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.36 137.81 28.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.909 HG23 ' O ' ' A' ' 77' ' ' PRO . 5.0 mt -118.74 126.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.911 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.2 p -58.15 155.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.5 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.7 pt-20 -123.1 133.88 54.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -164.7 -38.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.49 -12.93 25.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.191 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -67.43 -70.33 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.962 0.411 . . . . 0.0 110.318 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.614 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.2 pt-20 30.34 -152.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.685 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -156.61 155.56 32.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.68 161.19 34.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.418 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -159.87 121.05 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -119.04 131.32 55.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.522 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.05 126.82 53.04 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.582 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -46.57 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.643 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.66 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.259 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -76.73 -19.87 57.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.82 61.8 6.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.46 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -157.44 129.93 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.921 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' A' ' 74' ' ' ILE . 7.6 t80 -112.39 110.89 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -108.82 128.04 54.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.702 ' O ' HG23 ' A' ' 16' ' ' THR . 9.0 tt -123.13 162.68 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 0.0 111.468 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.676 ' O ' HD23 ' A' ' 76' ' ' LEU . 12.3 mtm180 -133.38 140.36 47.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 55' ' ' ILE . 70.5 mt -136.34 128.31 17.22 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.911 ' HG2' HG13 ' A' ' 56' ' ' VAL . 36.7 Cg_endo -65.87 151.72 83.43 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.784 2.323 . . . . 0.0 112.219 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 83' ' ' GLN . 4.4 mttt -98.55 153.78 18.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.348 . . . . 0.0 110.487 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 4.1 tt0 -83.31 -7.61 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.0 m -156.14 108.0 2.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 111.523 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.43 149.81 36.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.733 2.288 . . . . 0.0 112.035 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.72 83.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.851 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 51.0 tt0 -81.07 135.34 35.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.218 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -124.44 118.61 27.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.227 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 6.2 m-30 -77.42 90.6 3.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 172.87 8.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.61 39.9 0.27 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.925 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.578 HD22 HD13 ' A' ' 8' ' ' LEU . 1.5 mt -61.67 -61.77 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.266 0.533 . . . . 0.0 111.024 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.739 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.705 0.211 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.46 58.78 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.987 0.422 . . . . 0.0 110.395 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.4 p90 -63.04 165.32 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.46 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -149.0 146.21 27.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.46 135.94 53.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.4 . . . . 0.0 111.167 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -140.43 132.35 27.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.04 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.591 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.23 140.81 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 0.0 112.174 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -111.2 160.86 27.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.788 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 22.0 Cg_endo -61.56 -1.94 2.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.974 2.449 . . . . 0.0 113.703 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.1 m-20 -135.95 4.05 2.98 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.331 -0.231 . . . . 0.0 111.502 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.1 m-85 -168.48 169.52 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 112.253 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.776 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.3 tm? -134.59 114.17 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.202 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 73' ' ' THR . 44.2 m -109.0 139.88 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 38' ' ' PHE . 54.1 mt -111.85 152.11 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.311 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -132.1 119.06 20.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.587 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 47' ' ' LEU . 3.8 mt -125.84 128.2 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.866 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 12.2 mtp180 -96.66 118.48 33.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 21' ' ' VAL . 19.4 m -108.43 82.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' TYR . 52.3 p -51.02 -87.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' SER . 3.7 m-30 -38.31 -53.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.75 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.79 45.89 5.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.511 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -59.45 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.476 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 43' ' ' LYS . 18.4 m -43.5 136.54 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 111.05 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.53 95.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.331 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 147.24 52.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.801 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -99.24 167.81 10.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 37.4 m-20 -114.92 125.44 53.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.86 116.36 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.74 124.1 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 39.3 p90 -131.48 121.91 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' SER . 6.4 pt-20 -138.66 119.13 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.87 -76.45 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.639 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -153.03 27.44 0.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.913 0.387 . . . . 0.0 110.665 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.65 110.15 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 17' ' ' ILE . 90.0 t80 -101.43 111.87 24.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -113.67 122.85 48.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.784 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CG ' HD13 ' A' ' 19' ' ' ILE . 75.7 t80 -123.82 114.1 19.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.542 ' HB3' ' CE1' ' A' ' 46' ' ' PHE . 2.1 m-85 -118.02 104.39 10.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.985 0.421 . . . . 0.0 111.583 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -138.03 121.95 17.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 42.19 -170.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 99.8 Cg_exo -44.57 -19.84 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.72 1.613 . . . . 0.0 112.272 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 18.8 m-85 -74.23 114.17 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.385 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -121.33 122.7 40.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.836 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 19' ' ' ILE . 1.7 mt -120.14 110.64 16.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.099 0.476 . . . . 0.0 112.121 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 114.28 23.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.873 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.31 142.18 39.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.645 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -101.23 115.67 31.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.581 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' SER . 92.2 mt -75.75 136.22 70.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -79.95 82.28 2.53 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.917 2.411 . . . . 0.0 112.03 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 143.82 -145.99 16.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.096 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.5 mmt180 -143.65 137.85 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.075 0.464 . . . . 0.0 111.642 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 77' ' ' PRO . 45.9 mm -118.11 126.23 74.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.661 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 13.8 p -55.14 149.07 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 131.44 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.601 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -169.06 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.418 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . 112.73 9.16 19.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.682 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 28.05 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' OE2' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -78.78 -167.17 1.03 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.522 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -137.59 124.99 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.988 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.56 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -124.81 139.02 11.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.216 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.65 106.62 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.559 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.564 ' CD1' ' HB2' ' A' ' 72' ' ' PHE . 7.9 t80 -109.5 146.02 35.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -123.23 125.96 46.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.324 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -39.93 20.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -53.23 -48.54 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.086 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.52 -18.3 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.294 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 72.99 63.51 2.81 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mt -154.46 120.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -110.13 124.59 51.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -127.01 127.38 44.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.56 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -128.07 119.22 50.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.587 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -82.45 141.76 32.47 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.55 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.777 ' HB3' HG21 ' A' ' 55' ' ' ILE . 10.4 mt -135.4 117.35 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.818 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.925 ' O ' HG23 ' A' ' 55' ' ' ILE . 20.4 Cg_endo -60.68 154.33 55.68 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.873 2.382 . . . . 0.0 112.286 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' CD ' ' O ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -94.1 154.81 17.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.931 0.395 . . . . 0.0 111.415 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -82.26 -13.85 56.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 m -142.18 116.71 6.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.702 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.62 142.8 98.69 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.67 2.247 . . . . 0.0 112.067 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.43 86.39 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.998 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 tt0 -80.37 126.08 30.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.445 ' CE1' ' O ' ' A' ' 10' ' ' GLN . 4.1 t60 -128.62 125.68 38.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 8.3 m-30 -80.29 89.98 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 173.83 9.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.026 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.4 35.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.957 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.8 mt -59.05 -61.47 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.14 0.47 . . . . 0.0 110.407 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 p30 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.677 0.199 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.94 66.41 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 10.2 p90 -75.8 163.82 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -147.0 143.26 28.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.91 134.83 54.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.115 0.483 . . . . 0.0 111.143 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.9 t -142.5 135.31 28.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.72 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.933 HE21 HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -130.68 141.75 50.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.116 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -104.25 161.37 23.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.842 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 32.4 Cg_endo -62.86 -1.88 3.11 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.701 2.268 . . . . 0.0 113.337 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.621 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 57.4 m-20 -135.86 9.92 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.97 -0.105 . . . . 0.0 110.893 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.5 m-85 -170.94 171.71 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 111.964 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.0 109.61 9.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.181 177.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 75' ' ' ARG . 2.8 m -104.04 146.89 28.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.208 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.945 HD12 ' CE1' ' A' ' 38' ' ' PHE . 27.0 mt -122.64 152.41 27.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.05 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -136.96 120.23 16.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.183 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.617 HD13 HD12 ' A' ' 47' ' ' LEU . 1.2 mt -123.19 126.58 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.118 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -77.27 118.37 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.066 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.96 129.76 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 p -121.38 -59.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' ALA . 4.9 m-30 -57.0 -52.96 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.93 97.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.825 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -70.29 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 m -58.83 135.82 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -55.65 -41.11 73.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.62 139.42 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.359 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -87.88 166.83 14.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.959 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -119.03 115.93 25.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.89 116.31 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -112.77 114.25 26.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 25.0 p90 -125.61 115.81 20.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 36' ' ' SER . 15.6 mt-10 -137.35 117.29 13.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.74 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.46 -74.95 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.207 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -148.92 27.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.4 t0 -118.47 130.99 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.945 ' CE1' HD12 ' A' ' 17' ' ' ILE . 80.4 t80 -125.88 113.96 17.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 111.062 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -121.85 127.58 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.644 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.4 ' CD2' HD12 ' A' ' 19' ' ' ILE . 87.3 t80 -122.72 110.5 15.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CE1' ' CE2' ' A' ' 46' ' ' PHE . 6.8 m-85 -110.51 116.25 31.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -127.3 26.21 6.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.166 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 22.0 tptt 95.22 -88.41 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.75 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 70.9 Cg_endo -83.61 -16.97 6.45 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.316 1.344 . . . . 0.0 111.476 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -96.12 105.11 17.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.733 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -111.45 111.95 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.956 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -117.26 109.18 16.54 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -118.0 110.72 18.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.94 137.1 49.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 0.0 111.781 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 m -102.77 112.64 25.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.137 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 61.7 mt -69.44 137.35 88.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.814 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 31.8 Cg_exo -58.96 -18.43 42.7 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.306 2.671 . . . . 0.0 113.117 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -125.23 -127.42 3.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.819 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -147.61 142.94 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.947 0.404 . . . . 0.0 111.485 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 77' ' ' PRO . 12.2 mm -119.79 126.3 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.637 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 8.7 p -52.24 141.07 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.088 0.47 . . . . 0.0 111.979 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.65 130.16 56.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.518 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -176.69 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.452 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.46 17.75 11.01 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -98.63 21.7 10.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.704 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.818 ' OE2' HD11 ' A' ' 74' ' ' ILE . 9.6 pt-20 -73.52 -170.62 0.86 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.76 138.6 34.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -131.05 147.65 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.311 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.14 110.14 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 111.066 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -110.88 126.99 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.8 111.47 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.15 71.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -49.27 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 20.4 ttpt -77.48 -27.41 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.011 0.434 . . . . 0.0 110.174 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 1.02 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 71.95 48.32 27.57 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 70' ' ' GLY . 2.7 mm -144.22 146.68 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 5.2 t80 -109.73 114.85 28.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -114.49 126.99 55.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.818 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -139.74 119.54 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.791 ' O ' HD23 ' A' ' 76' ' ' LEU . 50.0 mtm180 -87.95 148.56 24.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.154 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 75' ' ' ARG . 45.4 mt -135.52 122.81 14.85 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' ILE . 19.2 Cg_endo -61.27 147.53 95.33 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.719 2.279 . . . . 0.0 112.003 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 20.1 mttp -90.84 156.01 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 111.355 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.65 -17.06 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -135.52 94.46 15.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.843 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.8 143.23 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.821 2.348 . . . . 0.0 112.57 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.82 0.34 89.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.256 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 2.2 tp-100 -84.58 136.06 33.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.976 0.388 . . . . 0.0 110.982 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.503 ' CE1' ' OE1' ' A' ' 10' ' ' GLN . 6.2 t60 -127.42 123.22 35.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.132 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.568 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 15.1 m-30 -79.21 91.5 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.21 170.57 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.859 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.93 41.76 0.21 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.636 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.933 HD12 HE21 ' A' ' 10' ' ' GLN . 3.5 mt -60.83 -61.24 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.068 0.434 . . . . 0.0 110.995 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.765 0.235 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.53 65.57 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -79.79 164.36 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.59 154.34 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.975 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 mt -115.97 135.46 53.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.118 0.485 . . . . 0.0 111.57 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.47 130.4 28.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.121 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.63 144.61 51.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 112.466 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.4 160.45 27.03 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.199 179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 30.1 Cg_endo -63.46 -0.8 2.61 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.013 2.475 . . . . 0.0 113.776 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 6.0 m-20 -136.28 8.87 3.18 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.408 -0.183 . . . . 0.0 110.748 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.0 m-85 -171.93 172.23 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.32 0.581 . . . . 0.0 111.331 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -136.24 116.89 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.615 178.025 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.522 ' N ' HD22 ' A' ' 15' ' ' LEU . 11.3 m -107.15 148.39 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 38' ' ' PHE . 8.2 mt -125.61 152.26 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.266 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.55 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.397 . . . . 0.0 111.568 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.539 HD13 ' CG ' ' A' ' 40' ' ' PHE . 3.5 mt -113.97 125.12 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.754 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HG3' HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.23 121.21 29.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.108 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.91 131.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.08 -73.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.441 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.7 m-85 -49.68 -53.29 25.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 43.92 103.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.443 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -81.92 3.9 24.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 43' ' ' LYS . 27.1 m -123.94 130.54 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -56.05 -41.37 74.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.09 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -129.07 143.13 50.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.928 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -90.65 166.86 12.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.417 . . . . 0.0 111.36 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.23 122.28 42.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.44 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.02 116.66 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 111.538 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -112.09 114.05 26.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.788 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.6 p90 -125.95 114.94 19.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' SER . 10.7 mt-10 -134.32 112.22 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.376 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.76 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.768 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -153.34 24.37 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.399 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -114.76 104.92 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.978 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 17' ' ' ILE . 81.8 t80 -105.12 117.88 35.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.71 130.35 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CG ' HD13 ' A' ' 19' ' ' ILE . 32.6 t80 -127.74 116.86 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.93 122.2 41.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.229 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -126.32 29.61 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.2 tptm 93.85 -89.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.585 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 58.7 Cg_endo -84.44 -16.41 5.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 120.708 1.289 . . . . 0.0 111.516 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -102.15 117.48 34.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.236 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.0 t80 -125.86 120.92 31.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.416 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -118.23 113.47 21.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.84 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -116.12 110.78 19.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HG ' HD22 ' A' ' 47' ' ' LEU . 5.1 mt -123.74 129.4 51.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.664 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.5 110.31 22.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.334 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.94 136.71 85.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 0.0 111.361 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 28.4 Cg_endo -62.78 -14.69 42.12 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.345 2.697 . . . . 0.0 112.864 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.53 -129.31 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.747 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.4 mtm180 -149.16 145.9 27.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.986 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' PRO . 35.0 mm -121.08 126.29 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.61 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 77' ' ' PRO . 2.5 p -52.37 146.94 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 111.553 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.33 124.36 52.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.626 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -160.88 -41.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.0 -6.49 27.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -72.32 -71.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.424 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.474 ' OE1' ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER 33.34 -156.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 9.9 mt-30 -154.02 167.07 31.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.45 152.43 6.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.816 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -153.84 143.31 21.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.17 122.51 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 120.15 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.12 -41.74 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -53.44 50.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.208 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.494 ' HD2' HD12 ' A' ' 71' ' ' ILE . 3.9 ttpm? -81.57 -16.55 51.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.038 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.44 55.27 30.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.559 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 69' ' ' LYS . 58.3 mt -145.3 147.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.407 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -112.88 113.32 25.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.466 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 132.77 56.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -141.42 118.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.744 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 39.2 mtp180 -90.89 148.59 22.37 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mt -134.44 143.71 47.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 56' ' ' VAL . 6.0 Cg_endo -83.61 148.73 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.759 2.306 . . . . 0.0 111.448 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 1.9 mtmp? -89.16 157.05 18.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.51 -18.86 37.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.165 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 80' ' ' THR . 3.5 m -142.97 86.8 9.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -40.82 149.76 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.719 2.279 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.37 -10.12 75.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.26 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.7 tp60 -82.14 134.99 35.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -124.12 118.27 26.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.368 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 5.2 m-30 -78.16 89.84 4.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.054 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.24 174.56 10.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.529 0.681 . . . . 0.0 112.567 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.74 40.52 1.05 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.812 -1.085 . . . . 0.0 114.072 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -61.55 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.172 0.486 . . . . 0.0 110.016 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.349 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.464 -0.256 0 CA-C-O 120.817 0.257 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.1 59.55 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -69.74 166.03 20.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.666 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.97 38.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.49 133.98 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' THR . 22.6 p -138.74 130.94 28.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.214 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.617 ' CB ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -131.8 143.34 50.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 112.728 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.02 160.74 24.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.613 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.95 -3.68 5.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.632 2.221 . . . . 0.0 113.408 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.43 9.89 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.488 -0.132 . . . . 0.0 111.236 179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 39.6 m-85 -170.47 170.17 7.07 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 111.294 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -135.39 111.4 9.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.749 ' N ' HD22 ' A' ' 15' ' ' LEU . 23.1 m -103.16 135.56 44.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.13 0.491 . . . . 0.0 111.539 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.556 HD12 ' CE1' ' A' ' 38' ' ' PHE . 20.7 mt -108.28 151.94 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.854 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.13 117.35 14.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.044 0.45 . . . . 0.0 111.789 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 47' ' ' LEU . 18.6 mt -120.0 125.77 74.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.621 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 118.66 37.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 21' ' ' VAL . 22.4 m -155.57 127.72 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.145 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.86 -30.25 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.909 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.6 m-85 -68.05 -9.49 46.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.024 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -25.69 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.518 0.511 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.54 16.92 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.688 -178.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.12 130.24 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.4 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 m -56.6 -35.79 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.366 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.59 148.01 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.791 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -101.22 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.605 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -113.36 119.38 37.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.65 114.97 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 83.5 m-85 -125.61 120.27 30.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 40.7 p90 -123.2 119.08 29.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.793 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' HB3' ' A' ' 37' ' ' ASP . 3.0 pt-20 -138.07 114.02 9.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.267 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.77 77.66 0.07 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.181 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER 60.06 10.99 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.398 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 4.1 t70 -108.06 103.31 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 110.092 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.5 t80 -108.42 121.25 44.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -120.85 134.57 55.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.664 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 52.9 t80 -129.56 111.72 13.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.15 107.25 17.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.125 0.488 . . . . 0.0 111.843 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 40' ' ' PHE . . . -132.47 106.42 7.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.613 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 46.86 -175.96 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 38.0 Cg_exo -33.52 -29.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 121.972 1.781 . . . . 0.0 112.587 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 17.4 m-30 -66.3 125.36 25.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.85 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -129.01 128.59 43.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.206 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 19' ' ' ILE . 6.4 mt -118.21 111.78 19.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 113.07 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.19 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.4 mt -124.21 127.83 48.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.495 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.26 110.77 23.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.642 HD13 ' HE2' ' A' ' 85' ' ' PHE . 60.3 mt -78.74 155.17 78.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 85' ' ' PHE . 9.6 Cg_endo -86.21 -17.9 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.166 2.577 . . . . 0.0 112.627 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -112.51 -141.64 8.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.81 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -141.48 132.67 26.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.46 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.7 mm -110.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.077 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 57' ' ' GLU . 8.4 p -61.67 157.57 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.485 . . . . 0.0 111.861 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.2 pt-20 -123.35 132.37 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.021 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -165.31 -35.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.46 0.9 26.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.239 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -79.37 -72.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.656 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER 26.25 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.335 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 21.3 mt-30 -161.7 133.15 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.944 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.72 139.1 10.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.041 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.95 104.69 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.535 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -108.16 136.88 47.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.44 117.36 27.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.81 -44.07 34.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.42 -46.77 69.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 7.3 ttpp -91.88 -16.25 26.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.76 63.34 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.042 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.445 HG13 ' HG2' ' A' ' 69' ' ' LYS . 3.6 mt -151.46 120.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 111.505 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 2.7 t80 -104.99 111.03 23.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.74 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.45 117.68 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.944 HD12 ' CA ' ' A' ' 63' ' ' GLY . 1.1 tp -129.11 119.82 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.705 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -86.3 143.48 27.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.748 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.4 mp -131.94 124.72 19.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.62 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' ILE . 25.7 Cg_endo -64.64 155.75 65.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.911 2.407 . . . . 0.0 112.354 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -102.63 157.36 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.247 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 5.9 tt0 -84.6 0.33 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.79 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -160.86 99.79 1.32 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.39 153.24 13.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.812 2.341 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.82 63.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.981 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -81.55 142.63 32.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 47.1 t60 -130.02 123.45 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.642 ' HE2' HD13 ' A' ' 51' ' ' LEU . 4.1 m-30 -77.1 92.87 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.462 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 172.32 8.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.268 0.556 . . . . 0.0 111.708 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.88 37.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.451 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 85' ' ' PHE . 8.0 mt -58.47 -61.27 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.04 0.42 . . . . 0.0 110.319 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--N 1.334 -0.085 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.56 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.699 0.208 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.68 58.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.19 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -61.32 163.17 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.8 140.65 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.562 ' CD2' HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -116.2 139.69 50.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.166 0.507 . . . . 0.0 111.579 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.45 132.25 22.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.649 ' HB3' HD23 ' A' ' 15' ' ' LEU . 2.2 pm0 -130.42 141.48 50.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.335 0.588 . . . . 0.0 111.649 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.48 160.73 25.06 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.152 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.95 -2.52 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 113.785 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.644 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 66.4 m-20 -136.6 11.45 3.19 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.314 -0.241 . . . . 0.0 110.748 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.6 m-85 -170.37 171.84 6.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.559 0.695 . . . . 0.0 112.237 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -137.4 111.1 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.726 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.76 ' N ' HD22 ' A' ' 15' ' ' LEU . 88.6 m -105.7 151.18 24.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.155 0.502 . . . . 0.0 111.496 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.2 mt -124.88 154.58 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.98 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.03 118.97 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 2.7 mt -125.83 128.41 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.091 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 4.0 mtp180 -100.95 121.61 42.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.346 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 135.09 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.708 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -32.8 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.338 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 24' ' ' ALA . 6.2 m-30 -67.06 -10.8 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.04 110.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.445 0.465 . . . . 0.0 111.506 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -72.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.504 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 19.5 m -58.31 141.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.436 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -55.32 -40.75 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.378 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' O ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tt0 -121.07 140.35 52.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -89.59 168.71 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -116.36 115.87 26.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 1.9 t -118.57 121.79 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -119.84 116.46 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 53.1 p90 -126.14 115.67 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.519 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -136.39 113.88 10.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.819 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.7 -72.39 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.454 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -155.9 27.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.481 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -118.37 104.35 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.801 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE1' HD12 ' A' ' 17' ' ' ILE . 72.4 t80 -104.64 124.51 49.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.766 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -129.0 134.9 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 31.4 t80 -125.23 110.01 13.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.35 119.41 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.37 35.08 4.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 91.72 -91.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.39 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 62.7 Cg_endo -84.43 -14.84 6.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.909 1.36 . . . . 0.0 112.143 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 23' ' ' TYR . 22.0 m-30 -102.05 117.64 35.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.584 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -124.78 118.89 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 47' ' ' LEU . 2.4 mt -123.54 117.56 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.46 112.77 23.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.869 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 8' ' ' LEU . 39.0 mt -121.0 126.02 48.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.856 0.36 . . . . 0.0 111.601 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 107.87 19.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.383 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 mt -73.2 128.36 87.75 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.799 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.05 90.86 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.799 2.333 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.98 -137.58 9.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.409 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -144.83 136.65 25.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.063 0.458 . . . . 0.0 111.592 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -116.8 126.84 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.746 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -61.1 156.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.45 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' N ' HG22 ' A' ' 56' ' ' VAL . 30.1 mt-10 -123.22 131.26 53.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.619 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -164.02 -42.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.642 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.37 -1.64 26.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 27.61 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.98 -168.63 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' O ' HG13 ' A' ' 74' ' ' ILE . 83.2 mt-30 -134.5 138.62 44.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.515 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -149.37 154.37 25.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.525 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 p -164.23 118.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' ASP . 4.6 t80 -113.53 137.1 52.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 1.1 m-20 -123.2 125.44 45.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.05 -33.47 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -50.16 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.458 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.628 ' HE3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -107.33 -6.28 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ARG . . . 63.45 63.27 4.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.391 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.628 HD12 ' HE3' ' A' ' 69' ' ' LYS . 1.3 mt -144.21 121.0 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.4 t80 -114.73 115.6 27.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.986 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.2 m -115.51 128.49 56.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -136.01 118.21 20.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.904 0.383 . . . . 0.0 112.026 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -88.52 146.97 24.86 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 55' ' ' ILE . 30.1 mt -132.65 139.08 33.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.417 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.7 Cg_endo -76.0 149.87 33.3 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.882 2.388 . . . . 0.0 112.169 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 10.3 mttp -96.32 156.07 16.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 -6.98 59.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.616 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.6 m -154.51 89.32 3.26 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -42.2 160.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.092 2.528 . . . . 0.0 112.845 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.35 -6.19 57.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.624 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -83.41 142.85 30.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' N ' ' HG3' ' A' ' 83' ' ' GLN . 1.8 t-80 -127.25 121.1 30.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 52' ' ' PRO . 7.9 m-30 -82.85 94.46 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.02 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.83 174.01 7.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.344 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.89 40.62 0.22 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.485 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD12 ' OE1' ' A' ' 10' ' ' GLN . 3.8 mt -60.46 -62.01 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.109 0.455 . . . . 0.0 110.045 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.938 0.399 . . . . 0.0 110.65 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 50.7 Cg_exo . . . . . 0 N--CA 1.466 -0.129 0 CA-C-O 120.976 0.323 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.72 57.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -61.28 170.23 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -154.07 148.52 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.597 ' CD2' HG23 ' A' ' 17' ' ' ILE . 7.3 mt -116.18 138.21 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' THR . 18.8 t -139.38 131.97 28.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.177 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.571 ' HB3' HD23 ' A' ' 15' ' ' LEU . 4.8 pm0 -130.41 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 112.575 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.82 161.04 24.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.016 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.73 -4.02 5.26 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.745 2.297 . . . . 0.0 113.25 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.656 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 32.6 m-20 -136.59 12.31 3.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.327 0.108 . . . . 0.0 110.834 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.656 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 48.8 m-85 -170.4 171.58 6.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 111.908 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -136.94 112.22 9.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.101 178.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.754 ' N ' HD22 ' A' ' 15' ' ' LEU . 83.4 m -106.16 146.18 30.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.077 0.465 . . . . 0.0 111.011 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.597 HG23 ' CD2' ' A' ' 8' ' ' LEU . 15.0 mt -117.75 155.5 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.101 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -143.2 122.96 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.602 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.482 HD13 HD12 ' A' ' 47' ' ' LEU . 1.1 mt -125.23 132.74 70.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.961 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 1.1 ttt180 -104.08 118.0 35.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.322 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.4 m -146.94 128.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -100.71 -50.75 3.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 25' ' ' ARG . 4.3 m-85 -59.49 -15.25 16.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 81.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -98.74 86.52 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.999 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.57 145.92 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.582 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.6 12.72 30.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.695 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -171.07 108.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 26' ' ' VAL . 2.5 m-30 -86.09 148.78 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.786 0.327 . . . . 0.0 110.505 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -105.35 110.99 23.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 114.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -122.88 118.39 27.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 45.5 p90 -118.58 112.37 19.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -138.98 124.96 19.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 0.0 111.846 -179.154 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 38.72 62.78 1.11 Allowed Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.699 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 67.32 22.26 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.061 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -117.7 103.21 9.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.8 t80 -103.14 122.38 44.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.38 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 15.8 mttt -125.11 129.33 49.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -126.99 121.51 31.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 39' ' ' LYS . 36.8 m-85 -131.5 127.95 38.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.763 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -109.93 -81.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 6.2 tptt -146.32 -64.88 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 38.7 Cg_endo -99.59 -6.26 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.089 2.526 . . . . 0.0 111.921 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.56 122.67 47.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.19 120.44 36.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.693 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -120.86 110.6 16.52 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.682 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.9 114.79 23.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.516 178.421 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.6 mt -138.01 144.05 40.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 112.016 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -112.78 119.95 39.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.312 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 17.2 mt -76.16 155.47 84.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.097 0.475 . . . . 0.0 111.517 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 15.1 Cg_exo -69.27 -16.28 39.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.175 2.584 . . . . 0.0 112.592 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -122.99 -127.81 3.31 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.628 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.482 ' HG3' ' OG ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -154.1 149.37 27.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 77' ' ' PRO . 51.0 mm -118.69 125.62 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 77' ' ' PRO . 7.5 p -59.25 156.64 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.444 . . . . 0.0 111.898 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.39 124.06 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.96 -44.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.68 0.77 30.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 32.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.661 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.35 -173.52 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -135.88 130.91 34.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.405 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -130.35 136.38 8.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.838 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.7 104.89 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.726 0.298 . . . . 0.0 110.583 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -97.13 115.11 26.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 107.62 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.73 -41.0 31.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -50.37 69.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -87.97 -16.76 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 71' ' ' ILE . . . 66.24 63.2 4.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.233 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 70' ' ' GLY . 75.7 mt -158.59 120.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 11.1 t80 -100.11 116.31 31.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.36 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -114.45 118.61 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -128.25 119.72 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.889 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 12.6 mtp180 -85.95 142.63 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.702 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -131.47 140.63 39.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.512 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.817 ' O ' HG23 ' A' ' 55' ' ' ILE . 74.3 Cg_endo -76.9 148.48 28.19 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.756 2.304 . . . . 0.0 112.02 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -93.36 155.86 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.074 0.464 . . . . 0.0 111.433 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.35 -15.36 50.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.129 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 m -138.36 102.28 8.1 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.7 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.97 148.86 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 111.944 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.3 57.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.731 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.43 133.06 41.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.774 0.321 . . . . 0.0 110.499 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 10' ' ' GLN . 6.7 t-80 -128.01 124.52 37.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.2 m-30 -83.04 90.48 7.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.49 173.94 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.06 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.09 36.1 0.32 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.809 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.491 HD22 HD13 ' A' ' 8' ' ' LEU . 8.8 mt -58.23 -61.98 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.195 0.498 . . . . 0.0 110.219 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 178.929 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.79 0.246 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.05 67.41 4.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 31.2 p90 -72.36 160.03 33.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.725 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -148.79 149.67 31.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -115.35 134.7 54.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.687 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' THR . 8.1 m -142.86 134.2 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.489 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.678 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.4 pt20 -132.35 144.84 50.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -100.84 159.94 28.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.718 178.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 13.6 Cg_endo -57.16 -8.14 3.23 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.783 2.322 . . . . 0.0 113.604 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 61.9 m-20 -135.89 17.09 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.29 -0.256 . . . . 0.0 110.808 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.1 m-85 -169.46 170.39 8.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.947 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -135.69 108.26 7.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.952 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 91.5 m -101.07 143.4 31.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.172 0.511 . . . . 0.0 110.962 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 38' ' ' PHE . 7.5 mt -116.3 155.12 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -125.93 121.46 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.06 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.74 HD13 ' CG ' ' A' ' 40' ' ' PHE . 15.3 mt -124.81 118.61 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -88.07 119.05 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.223 0.535 . . . . 0.0 112.001 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 21' ' ' VAL . 32.9 m -141.24 113.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.225 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -58.08 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.992 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' ALA . 2.1 m-85 -68.84 -53.58 20.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.004 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 46.81 106.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 8.1 mtt85 -81.73 6.97 13.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 m -133.28 135.59 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.808 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -58.62 -41.54 86.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -125.33 142.63 51.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.893 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -90.65 168.43 11.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.56 115.59 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.965 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.05 115.81 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.466 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -126.69 120.08 28.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -129.23 124.0 33.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 114.09 9.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.581 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.46 -70.85 0.16 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.186 -0.531 . . . . 0.0 113.006 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.45 25.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.086 0.469 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -115.02 107.24 15.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.827 ' CE1' HD12 ' A' ' 17' ' ' ILE . 70.1 t80 -102.84 111.0 23.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 14.6 mttt -116.07 121.95 43.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.658 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.74 ' CG ' HD13 ' A' ' 19' ' ' ILE . 58.2 t80 -124.93 117.77 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 39' ' ' LYS . 16.6 m-85 -124.27 124.73 43.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.63 31.49 4.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 1.3 tppm? 92.59 -88.83 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 111.183 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.604 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 63.6 Cg_endo -85.04 -15.97 5.36 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.237 1.291 . . . . 0.0 111.573 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.08 115.6 30.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.569 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 119.49 29.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.443 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 19' ' ' ILE . 3.6 mt -121.78 115.91 23.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.48 111.65 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.952 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.705 HD13 HD21 ' A' ' 8' ' ' LEU . 83.2 mt -125.59 130.54 51.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.573 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.81 113.03 24.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.2 mt -72.2 137.59 81.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.07 0.462 . . . . 0.0 111.502 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.3 Cg_endo -68.38 -18.91 44.02 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.289 2.659 . . . . 0.0 112.717 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.63 -136.79 5.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.71 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -143.53 138.3 29.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.958 0.409 . . . . 0.0 111.069 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.3 mm -116.12 124.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.834 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.519 HG13 ' HG2' ' A' ' 77' ' ' PRO . 4.9 p -64.83 159.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.531 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.52 130.15 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.378 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.73 17.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.77 3.3 27.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.753 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 m -98.49 44.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 164.36 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' ILE . 8.3 mm-40 -127.49 129.72 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.35 147.89 18.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.588 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.3 p -153.62 104.36 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.717 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -96.82 103.83 15.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -89.49 99.55 12.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.221 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.26 69.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -52.44 -50.59 62.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -76.27 -23.13 54.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.033 0.444 . . . . 0.0 110.174 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.34 46.98 84.15 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.936 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 mt -143.44 148.31 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.543 ' HD2' HD12 ' A' ' 19' ' ' ILE . 14.9 t80 -107.05 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.675 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.59 118.38 30.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -126.48 119.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.65 147.36 25.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 mp -133.6 149.46 72.18 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.5 Cg_endo -79.09 150.13 22.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.613 2.209 . . . . 0.0 111.777 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -96.31 152.86 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.851 0.358 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 1.9 tt0 -84.05 -10.86 57.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.701 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 m -151.36 97.97 3.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.538 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -43.49 153.05 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.663 2.242 . . . . 0.0 112.366 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.57 -1.77 50.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.169 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.95 138.48 39.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.001 0.4 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -127.11 116.97 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.379 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 6.9 m-30 -73.4 91.8 1.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.345 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.51 160.76 13.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.909 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.54 1.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.298 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.651 HD22 HD13 ' A' ' 8' ' ' LEU . 1.7 mt -63.53 -62.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.621 0.21 . . . . 0.0 111.511 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.852 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 37.2 Cg_exo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.662 0.192 . . . . 0.0 111.897 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.14 61.59 6.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.143 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 27.5 p90 -76.03 164.76 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 6.2 t0 -157.46 168.41 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.53 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -124.82 136.98 54.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.227 0.537 . . . . 0.0 111.747 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 16' ' ' THR . 9.6 t -138.43 130.81 28.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.079 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 88' ' ' LEU . 7.7 pm0 -135.86 145.53 46.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.72 161.5 22.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.52 -3.58 1.43 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.81 2.34 . . . . 0.0 113.767 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.638 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.6 m-20 -136.05 12.26 3.34 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.367 -0.208 . . . . 0.0 110.909 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.638 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 23.7 m-85 -167.17 167.48 14.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.484 0.659 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -134.79 109.05 8.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.083 178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' N ' HD22 ' A' ' 15' ' ' LEU . 55.3 m -107.01 126.76 52.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.171 0.51 . . . . 0.0 111.836 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 38' ' ' PHE . 7.7 mt -100.81 155.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.998 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -140.83 112.41 7.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.339 . . . . 0.0 111.691 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.28 128.95 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.502 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HB2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -92.49 120.42 32.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 21' ' ' VAL . 15.3 m -141.76 126.67 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.365 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.05 -30.96 4.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.709 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 58.8 m-85 -69.54 -9.19 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.284 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.88 108.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.55 0.531 . . . . 0.0 111.512 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -88.19 13.39 11.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.7 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.43 137.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.556 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.6 t -56.66 -35.59 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.14 144.63 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -96.31 168.66 10.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.48 124.23 42.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 40' ' ' PHE . 4.2 t -130.75 132.58 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.818 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -121.32 116.21 24.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.938 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 43.3 p90 -116.69 114.19 23.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.067 0.461 . . . . 0.0 111.463 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -138.14 101.6 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.045 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.03 -149.11 17.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.631 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -59.13 -12.12 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.962 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.79 112.09 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 110.63 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.86 ' CE2' HD12 ' A' ' 17' ' ' ILE . 39.6 t80 -120.73 112.01 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.41 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -119.31 126.54 51.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.081 0.467 . . . . 0.0 111.566 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CD1' HG22 ' A' ' 31' ' ' VAL . 8.6 t80 -110.39 148.66 31.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -136.1 110.43 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.973 0.416 . . . . 0.0 111.513 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -131.26 68.81 1.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.682 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER 32.57 -88.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.888 -178.676 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.625 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 57.2 Cg_endo -69.46 -25.37 30.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.257 1.305 . . . . 0.0 112.579 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.669 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 21.7 m-85 -105.04 125.61 51.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.722 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -125.62 120.67 31.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.961 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -120.94 117.9 28.49 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.542 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -124.42 116.2 22.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 48' ' ' ARG . 80.1 mt -142.89 151.46 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 112.25 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.34 105.88 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.071 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 36' ' ' SER . 3.6 mt -72.02 155.79 91.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -83.02 75.0 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.382 2.721 . . . . 0.0 111.966 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.567 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 145.85 -147.18 18.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.37 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 53' ' ' GLY . 1.1 mtm180 -146.65 142.09 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.121 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 77' ' ' PRO . 14.0 mm -115.07 123.11 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.752 HG13 ' HG2' ' A' ' 77' ' ' PRO . 8.3 p -62.07 154.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 112.536 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.38 130.09 51.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.723 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -177.68 29.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.661 0.267 . . . . 0.0 111.429 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.55 -32.36 3.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.345 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.58 118.51 10.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.556 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.07 163.37 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 4.5 mt-30 -131.78 138.64 48.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.34 137.51 7.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.905 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.76 105.45 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 0.0 110.408 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -103.12 131.72 49.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -115.53 111.55 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.92 -49.32 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.64 -41.83 67.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -97.06 -19.44 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.9 56.68 13.28 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.929 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.634 HD13 ' HB2' ' A' ' 20' ' ' ARG . 21.5 mm -137.19 116.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 111.509 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t80 -111.21 114.42 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -121.49 119.04 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -124.38 119.48 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.622 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HD23 ' A' ' 76' ' ' LEU . 11.4 mtp180 -87.08 148.26 25.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.805 ' HB3' HG21 ' A' ' 55' ' ' ILE . 15.9 mt -134.24 150.73 74.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.208 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.945 ' O ' HG23 ' A' ' 55' ' ' ILE . 94.6 Cg_endo -81.81 157.84 18.51 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.944 2.43 . . . . 0.0 112.162 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -98.0 148.54 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.0 tp10 -85.02 -11.68 54.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.526 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.3 m -148.52 116.87 3.98 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.872 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.3 142.96 45.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.775 2.316 . . . . 0.0 112.441 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 -0.16 89.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.433 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -70.15 119.02 13.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.05 111.95 18.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.13 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.9 m-30 -73.75 90.05 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.487 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' GLY . 22.2 mt-10 -70.7 173.58 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.271 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . 35.98 38.61 0.24 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.622 HD22 HD13 ' A' ' 8' ' ' LEU . 4.0 mt -57.84 -61.6 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.628 0.251 . . . . 0.0 110.538 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 . . . . . 0 C--N 1.333 -0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.127 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.832 0.263 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -85.72 65.14 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 7.1 p90 -80.34 159.44 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.043 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -145.33 150.65 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -114.81 133.46 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.126 0.489 . . . . 0.0 111.761 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.547 ' O ' HD22 ' A' ' 15' ' ' LEU . 85.5 p -139.51 131.45 27.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.636 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.877 ' OE1' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -130.57 140.98 50.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.339 0.59 . . . . 0.0 112.325 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.28 160.84 28.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.997 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 24.2 Cg_endo -61.46 -1.22 1.79 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.107 2.538 . . . . 0.0 114.196 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.667 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -135.35 2.46 3.0 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.163 -0.335 . . . . 0.0 111.74 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 20.8 m-85 -171.78 172.52 4.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HB3' ' A' ' 10' ' ' GLN . 1.2 tm? -135.86 117.38 14.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.813 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.632 ' N ' HD22 ' A' ' 15' ' ' LEU . 5.5 m -110.57 136.84 49.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.389 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.784 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.4 mt -113.51 150.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 7' ' ' ASP . . . -131.05 106.84 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD13 ' CD2' ' A' ' 40' ' ' PHE . 24.1 mt -108.46 121.99 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -89.88 120.23 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.502 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.83 132.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 p -110.65 -82.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.3 m-85 -39.08 -52.58 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.781 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 41.51 97.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.777 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -60.36 -73.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.206 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.84 142.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.32 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -38.02 78.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.7 140.92 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.2 m-30 -89.44 166.34 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.58 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' OD1' ' OH ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -117.42 118.69 32.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 ' HD1' ' A' ' 40' ' ' PHE . 7.2 t -121.68 119.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.788 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' OH ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 m-85 -118.18 118.95 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.144 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 33' ' ' PHE . 28.3 p90 -121.75 112.73 18.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.453 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.2 mt-10 -135.29 116.79 14.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.22 -75.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.139 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -149.8 26.21 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.469 . . . . 0.0 110.14 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -112.97 107.58 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.784 ' CE2' HD12 ' A' ' 17' ' ' ILE . 50.3 t80 -105.33 111.53 24.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -117.86 131.34 56.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.415 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.6 t80 -127.52 110.3 12.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.657 ' CD1' ' CD2' ' A' ' 46' ' ' PHE . 21.9 m-85 -128.51 130.48 47.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.78 -68.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 tptt -160.35 -72.15 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 45.2 Cg_endo -87.76 -20.37 1.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.092 . . . . 0.0 111.059 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -97.95 119.61 36.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.657 ' CD2' ' CD1' ' A' ' 41' ' ' TYR . 9.9 m-85 -120.13 116.34 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.32 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -118.34 112.63 20.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.812 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.53 112.43 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.901 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -127.02 134.54 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.664 -179.037 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m -108.38 113.72 27.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 34.0 mt -78.42 147.75 72.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.484 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.29 -12.94 27.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.089 2.526 . . . . 0.0 112.162 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -139.36 138.95 9.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.847 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -62.74 155.42 26.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.777 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.6 mm -119.28 126.35 75.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.186 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.9 p -64.4 161.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.414 0.626 . . . . 0.0 112.237 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.2 pm0 -125.03 125.75 44.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -150.13 8.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 -1.21 20.26 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.63 49.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.779 0.324 . . . . 0.0 110.997 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 45.4 tt0 -83.59 163.46 20.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 23.9 mm-40 -122.72 126.0 46.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -135.25 138.46 10.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.158 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.1 p -144.76 108.83 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.904 0.383 . . . . 0.0 111.331 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -109.2 118.01 35.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.53 134.03 52.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -47.73 12.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 110.291 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -52.21 -49.75 63.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.709 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 71' ' ' ILE . 16.7 ttpt -83.78 -19.86 34.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.689 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.46 56.97 19.31 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.73 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 69' ' ' LYS . 5.9 mt -146.85 148.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -115.8 120.34 38.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.121 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 m -119.76 133.38 55.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.658 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -140.88 118.54 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 20.1 mtp180 -92.34 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.306 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB3' HG21 ' A' ' 55' ' ' ILE . 2.7 mp -132.1 147.5 66.08 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.943 ' O ' HG23 ' A' ' 55' ' ' ILE . 89.5 Cg_endo -81.31 148.28 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.713 2.275 . . . . 0.0 111.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 27.7 mmtp -85.24 156.14 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 0.0 111.448 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.4 tt0 -89.39 -22.35 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.185 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -129.19 128.48 23.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.99 133.13 24.43 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.616 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.09 3.6 88.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.099 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -81.5 128.52 33.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.821 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -123.48 118.35 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.6 m-30 -77.97 90.69 4.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.155 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.84 170.77 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.56 43.23 0.25 Allowed Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.59 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.877 HD12 ' OE1' ' A' ' 10' ' ' GLN . 1.7 mt -61.98 -62.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.022 0.411 . . . . 0.0 110.952 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 89' ' ' ASN . 11.2 t-20 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 121.034 0.445 . . . . 0.0 110.692 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 23.9 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.898 0.291 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' PHE . . . -83.87 -64.97 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER 53.89 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.731 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.4 t0 -154.48 158.2 39.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -118.71 136.44 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 111.333 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.77 133.39 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.6 pm0 -130.01 143.03 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 160.68 25.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.433 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.4 -2.59 6.26 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.424 2.082 . . . . 0.0 113.02 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.92 11.92 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.902 -0.136 . . . . 0.0 110.956 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 66.5 m-85 -170.76 171.01 6.32 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.25 0.548 . . . . 0.0 111.662 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.649 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.2 tm? -134.42 115.91 14.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.927 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 74' ' ' ILE . 37.2 m -107.41 132.11 53.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.368 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.787 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.0 mt -107.12 155.39 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -137.51 118.36 14.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.932 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.502 HD13 ' CD2' ' A' ' 40' ' ' PHE . 44.4 mt -121.13 127.89 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.354 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 39.0 ttt85 -107.84 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 111.674 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 m -151.01 141.89 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -119.15 -35.17 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.664 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' ARG . 9.2 m-85 -66.17 -9.11 28.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.605 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.63 85.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.645 0.591 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.43 -71.74 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.831 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 m -43.71 135.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.7 p -57.99 -40.21 80.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -129.7 147.87 51.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -103.54 167.16 9.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 60.9 m-20 -117.32 121.12 40.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.584 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 t -122.85 119.29 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 55.6 m-85 -126.48 119.72 27.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 31.4 p90 -121.0 113.79 20.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.559 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -140.75 117.53 11.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.6 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.14 66.57 1.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.026 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER 65.55 9.85 6.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.642 0.258 . . . . 0.0 111.394 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 8.1 t70 -102.74 103.66 13.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.787 ' CE2' HD12 ' A' ' 17' ' ' ILE . 21.5 t80 -110.22 121.11 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.344 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 6.0 mttt -124.77 126.52 45.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.648 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.7 t80 -122.14 112.64 18.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.907 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 13.6 m-85 -114.63 101.77 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.028 0.442 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -129.25 118.42 22.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.759 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 40.99 -166.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 93.0 Cg_exo -44.75 -21.36 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.687 1.591 . . . . 0.0 112.848 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 24.9 m-85 -76.61 123.05 25.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 111.734 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -127.45 124.67 38.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.936 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 47' ' ' LEU . 2.0 mt -120.28 113.87 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' O ' HD23 ' A' ' 49' ' ' LEU . 3.2 ttm-85 -112.02 109.53 19.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.38 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 48' ' ' ARG . 14.6 mt -124.49 129.55 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 112.201 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.27 109.03 21.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.455 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 14.0 mt -63.15 128.32 92.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 111.126 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.96 -26.38 14.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.052 2.502 . . . . 0.0 113.176 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -116.51 -132.91 5.04 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -142.37 136.49 29.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 110.804 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -117.29 125.21 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.8 p -62.21 156.97 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 112.063 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.79 131.43 53.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.67 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 21.5 m-80 -171.19 21.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.44 7.03 44.39 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.152 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -97.99 45.81 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.03 172.64 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -141.24 139.32 33.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -147.52 159.06 27.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.972 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -157.67 118.47 3.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.3 . . . . 0.0 110.429 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -117.62 137.35 52.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -119.11 119.24 33.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.235 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.06 -53.26 15.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.519 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -55.02 -46.17 75.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 71' ' ' ILE . 28.3 ttpt -84.38 -26.82 28.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 66.2 63.02 4.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLY . 1.4 mt -148.72 121.04 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.449 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.6 t80 -109.68 110.97 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 147.73 29.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.351 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 16' ' ' THR . 3.8 tp -138.35 154.14 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.101 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -135.32 141.69 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -136.14 149.97 69.72 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 111.752 -178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 56' ' ' VAL . 78.1 Cg_endo -78.13 154.71 29.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.906 2.404 . . . . 0.0 112.206 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HD2' HD13 ' A' ' 55' ' ' ILE . 6.6 mmtp -99.76 151.89 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 3.1 tm-20 -87.69 -4.11 58.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.793 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.6 m -157.68 120.84 2.14 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.223 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 146.29 96.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.0 111.938 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 1.79 89.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.55 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -78.66 126.56 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -125.34 117.42 23.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.0 m-30 -73.92 90.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.2 168.67 11.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.84 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.77 41.81 0.96 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.44 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 88' ' ' LEU . 6.3 mt -60.61 -61.99 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.854 0.327 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 0.0 111.337 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.896 0.29 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.02 57.1 2.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 49.0 p90 -66.14 166.73 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.981 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 150.7 32.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -113.32 133.9 54.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 0.0 111.506 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.6 p -139.4 133.53 31.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.961 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.603 ' HB3' HD23 ' A' ' 15' ' ' LEU . 9.7 pm0 -130.05 141.45 50.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 0.0 112.691 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.37 160.4 26.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.204 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.27 -2.9 3.49 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.473 2.115 . . . . 0.0 113.298 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 7.3 m-20 -135.9 13.74 3.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.672 0.272 . . . . 0.0 110.563 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 73.1 m-85 -168.22 167.35 12.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.469 0.652 . . . . 0.0 111.864 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.671 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.0 tm? -134.59 106.24 6.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 74' ' ' ILE . 97.2 m -107.75 137.1 46.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.554 HG23 HD23 ' A' ' 8' ' ' LEU . 6.7 mt -126.88 137.91 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.151 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -126.36 139.17 53.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.997 0.427 . . . . 0.0 111.168 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.64 HD12 ' CD2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -122.43 134.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.792 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -77.47 120.06 21.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.857 0.361 . . . . 0.0 110.641 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.64 139.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 p -127.66 -52.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.344 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' ALA . 9.3 m-30 -66.71 -52.77 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.767 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 42.33 96.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.773 0.32 . . . . 0.0 110.626 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 mpt_? -76.76 3.13 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.699 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 43' ' ' LYS . 4.6 m -128.65 133.58 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -41.54 72.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.606 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.67 138.61 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -85.02 163.46 18.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -110.28 111.75 23.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.722 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' HD1' ' A' ' 40' ' ' PHE . 4.3 t -117.81 116.18 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.909 0.385 . . . . 0.0 111.479 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -124.02 118.11 26.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.682 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 1.8 p90 -126.79 122.66 35.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.659 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 119.01 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.546 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 63.75 -75.86 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.417 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -151.27 26.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.601 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 1.4 m-20 -118.23 129.48 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.4 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -123.44 111.48 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -116.67 128.2 55.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.64 ' CD2' HD12 ' A' ' 19' ' ' ILE . 70.0 t80 -128.93 114.78 16.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.996 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -120.48 127.97 52.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.317 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -134.65 34.18 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.274 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 17.7 tppt? 93.77 -87.95 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.073 0.949 . . . . 0.0 111.218 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 43' ' ' LYS . 44.8 Cg_endo -86.87 -16.01 3.67 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.499 1.466 . . . . 0.0 111.921 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.98 117.37 34.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.984 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -126.59 119.85 28.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -115.61 113.27 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.59 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 109.98 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 8' ' ' LEU . 75.8 mt -126.16 133.78 51.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 111.621 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.6 m -90.43 105.57 17.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.983 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 55' ' ' ILE . 10.5 mt -64.68 133.07 95.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.148 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.8 Cg_endo -68.41 -23.41 37.96 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.937 2.424 . . . . 0.0 112.75 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.55 -138.35 6.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.623 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -136.02 128.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 111.51 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.714 HG21 ' HB3' ' A' ' 76' ' ' LEU . 4.8 mm -116.14 125.6 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.603 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 7.7 p -60.25 157.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.078 0.466 . . . . 0.0 111.754 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.16 134.58 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.903 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -36.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.25 -11.58 26.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.651 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -68.6 -71.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.023 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.597 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.3 pt-20 32.92 -156.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.2 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 70.1 mt-30 -143.63 126.61 16.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.7 136.05 9.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.561 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.5 p -152.68 111.42 3.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.34 . . . . 0.0 110.815 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.85 108.5 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.402 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.19 98.62 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.38 83.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -52.69 51.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -72.82 -16.54 61.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.664 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 65.87 38.35 94.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.185 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -145.01 151.94 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.323 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 45.3 t80 -111.69 123.33 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.47 HG22 HG21 ' A' ' 16' ' ' THR . 3.2 m -119.07 132.85 56.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.107 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.597 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -140.07 118.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HA ' ' OG1' ' A' ' 16' ' ' THR . 15.0 mtp180 -86.46 148.59 25.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.2 mt -134.04 116.31 13.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 111.887 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.704 ' O ' HG23 ' A' ' 55' ' ' ILE . 66.2 Cg_exo -53.81 149.17 34.32 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.201 2.6 . . . . 0.0 112.805 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.26 153.75 17.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 1.3 tt0 -81.03 -15.0 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.473 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m -144.85 129.27 8.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.729 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.4 149.9 69.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.752 2.301 . . . . 0.0 112.836 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.21 77.84 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.787 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.49 129.86 37.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -122.07 115.54 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.584 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.6 m-30 -74.88 89.72 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.116 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 162.51 12.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.59 46.53 0.82 Allowed Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.525 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD12 ' CD ' ' A' ' 10' ' ' GLN . 4.7 mt -59.88 -61.98 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.783 0.292 . . . . 0.0 110.668 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 121.098 0.475 . . . . 0.0 110.223 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.464 -0.258 0 CA-C-O 120.791 0.246 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.92 55.88 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.394 . . . . 0.0 110.397 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 49' ' ' LEU . 35.7 p90 -61.84 163.25 7.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.294 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.12 145.6 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.69 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 49' ' ' LEU . 6.0 mt -113.75 133.64 55.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t -138.81 130.22 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.613 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.995 ' OE1' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -131.12 140.47 49.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 112.123 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.26 160.77 28.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.8 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.51 -2.2 0.93 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.041 2.494 . . . . 0.0 114.243 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.2 m-20 -136.41 3.69 2.83 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 122.058 -0.401 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.64 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.1 m-85 -169.3 169.38 9.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.2 tm? -135.65 107.87 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.036 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 74' ' ' ILE . 29.8 m -101.56 143.01 32.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 110.877 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 8' ' ' LEU . 23.1 mt -115.82 154.15 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.647 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -129.79 122.6 29.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.303 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.6 mt -125.95 123.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.481 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 118.39 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.707 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.02 133.25 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.045 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -120.65 -32.95 3.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.1 m-85 -87.15 -53.35 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . 18.89 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.747 0.655 . . . . 0.0 112.01 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -56.99 -60.0 4.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -33.91 124.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 111.009 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 p -54.84 -39.95 69.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -125.31 139.49 53.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.353 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.0 OUTLIER -85.85 160.32 19.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 9.2 m-20 -112.88 113.11 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.728 0.299 . . . . 0.0 110.998 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 40' ' ' PHE . 10.7 t -117.02 115.93 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.991 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 11.2 m-85 -116.67 114.65 24.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 36.3 p90 -124.75 116.27 22.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 42.5 mt-10 -138.22 115.16 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.79 -68.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -157.89 22.66 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.524 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -111.23 104.64 13.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.14 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 17' ' ' ILE . 82.9 t80 -106.38 116.64 32.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.4 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 mptt -119.92 131.01 55.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 92.5 t80 -130.95 116.78 18.3 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 17.6 m-85 -115.54 110.23 18.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.668 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -108.16 24.1 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 95.91 -87.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 O-C-N 124.235 0.959 . . . . 0.0 110.658 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 80.6 Cg_endo -83.0 -16.38 7.47 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.491 1.461 . . . . 0.0 111.801 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -109.97 131.92 54.62 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.809 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 19.7 t80 -127.35 126.96 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.55 HD12 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -121.55 112.14 18.11 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.84 115.17 22.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 178.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 8' ' ' LEU . 90.7 mt -137.04 144.03 42.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.69 113.31 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.249 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.3 mt -73.89 135.78 77.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.567 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 36.3 Cg_exo -61.47 -22.09 73.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.071 2.514 . . . . 0.0 113.003 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.59 ' HA3' ' CD1' ' A' ' 85' ' ' PHE . . . -113.07 -142.61 8.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.129 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 2.4 mmt-85 -142.18 139.35 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.864 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.9 mm -117.81 124.96 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 77' ' ' PRO . 6.2 p -56.24 152.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.402 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -110.41 123.07 49.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.042 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.55 -39.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.96 -19.43 32.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -59.87 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 30.96 -152.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.468 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mt-30 -157.33 131.45 8.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.34 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.58 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.98 141.69 13.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.065 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -159.51 105.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -107.41 137.81 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.25 115.58 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.14 -46.63 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.33 -50.57 69.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.767 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.761 ' CD ' HD12 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -79.61 -23.21 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 69.4 63.36 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.672 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.761 HD12 ' CD ' ' A' ' 69' ' ' LYS . 54.0 mt -160.23 126.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.9 t80 -108.12 118.79 37.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.515 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.487 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -122.54 122.39 38.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.593 ' C ' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER -130.51 122.93 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.441 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.68 140.93 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.668 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.839 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mp -129.37 129.81 23.28 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.977 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.3 Cg_endo -66.82 150.74 83.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.926 2.417 . . . . 0.0 112.184 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HE3' ' C ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -92.7 155.81 17.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -71.36 -19.74 62.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.701 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -146.51 120.88 5.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.0 152.02 54.01 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.886 2.391 . . . . 0.0 112.624 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.75 -4.0 62.31 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -77.53 135.43 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.125 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.43 116.45 21.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 5.5 m-30 -67.93 89.76 0.29 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.698 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -74.42 172.78 11.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 112.018 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 45.03 32.66 3.37 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.41 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.995 HD11 ' OE1' ' A' ' 10' ' ' GLN . 8.7 mt -43.13 -53.29 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.723 0.761 . . . . 0.0 110.146 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.522 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.463 -0.29 0 CA-C-O 120.829 0.262 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.16 60.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 38.2 p90 -68.65 161.52 27.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.819 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.54 148.22 29.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.81 134.21 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.262 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -141.84 136.05 30.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.301 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.24 141.89 50.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.317 0.58 . . . . 0.0 112.329 -178.651 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -101.44 157.84 32.9 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.507 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 10.5 Cg_endo -54.75 -8.16 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 113.629 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 47.1 m-20 -135.52 15.48 3.42 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.324 -0.235 . . . . 0.0 111.292 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 13.1 m-85 -169.5 170.71 8.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.481 0.658 . . . . 0.0 112.321 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.77 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -132.82 112.67 12.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.6 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.491 ' N ' HD22 ' A' ' 15' ' ' LEU . 30.2 m -104.67 138.02 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 1.9 mt -114.33 149.41 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -129.76 120.26 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 111.074 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 47' ' ' LEU . 13.1 mt -126.0 119.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.5 mtt180 -90.69 120.64 31.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.412 . . . . 0.0 111.813 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 m -141.88 129.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -72.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.997 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.4 m-30 -48.42 -52.91 19.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.909 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.514 ' HA ' ' CD ' ' A' ' 43' ' ' LYS . . . 39.49 95.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.89 5.32 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.877 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 43' ' ' LYS . 27.1 m -127.46 133.28 68.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -41.11 82.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.72 148.28 50.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.653 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -98.67 168.71 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.301 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.95 118.55 36.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.11 115.35 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 0.0 112.027 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -125.39 117.87 24.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -120.41 118.95 31.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.142 0.496 . . . . 0.0 111.72 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.21 96.76 3.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.621 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.09 -146.68 18.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.685 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -54.33 -14.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.628 0.251 . . . . 0.0 111.63 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.83 117.27 26.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' ' 17' ' ' ILE . 61.2 t80 -127.67 113.27 15.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 131.34 55.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 111.574 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.48 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 69.8 t80 -126.64 109.7 12.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.519 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -107.69 108.31 19.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.188 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -140.82 119.42 12.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.194 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 38.04 -161.66 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.716 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 73.0 Cg_exo -50.91 -17.3 3.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.208 1.272 . . . . 0.0 112.567 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 51.4 m-85 -74.55 112.81 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.341 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.25 116.21 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 19' ' ' ILE . 4.4 mt -119.35 114.65 22.69 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.06 115.84 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.15 178.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 48' ' ' ARG . 78.2 mt -134.0 143.04 47.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 112.16 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -105.21 105.17 15.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.204 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 88.2 mt -62.4 145.3 94.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.178 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 37.5 Cg_exo -60.12 -23.43 73.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.778 2.318 . . . . 0.0 112.055 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -125.36 -125.04 2.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.3 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -154.15 149.54 27.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.975 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.907 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.5 mm -117.77 123.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 5.3 p -58.12 151.39 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -119.1 125.32 49.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.808 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.45 27.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.412 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.56 -32.73 2.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.154 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.71 120.21 9.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.137 0.468 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.0 163.88 6.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.632 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 6.2 mt-30 -143.53 134.38 25.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.702 ' HA3' HD12 ' A' ' 74' ' ' ILE . . . -140.38 146.06 17.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.661 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -139.27 112.1 7.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 110.65 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -104.57 120.21 40.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.235 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -114.01 110.74 20.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.563 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.99 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -57.26 -50.27 73.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 9.8 ttpt -74.2 -22.13 59.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 61.24 63.21 5.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.267 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 ' HG3' ' A' ' 20' ' ' ARG . 14.6 mt -156.84 131.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.118 0.485 . . . . 0.0 112.054 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' A' ' 40' ' ' PHE . 12.9 t80 -116.21 113.76 23.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.505 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 134.05 55.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.194 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.702 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.0 OUTLIER -138.58 117.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' NH2' ' OG ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -91.13 142.28 27.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.178 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.2 mp -134.37 145.88 57.11 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.631 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' ILE . 59.4 Cg_endo -73.42 151.36 47.87 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.831 2.354 . . . . 0.0 112.433 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -95.47 156.68 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.103 0.478 . . . . 0.0 111.704 -179.414 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 12.0 tt0 -88.22 -6.25 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 45.1 m -159.51 96.09 1.64 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.318 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 9.8 Cg_endo -53.58 157.56 9.42 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.498 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.87 -6.42 70.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.493 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 37.3 tt0 -84.79 141.0 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.308 . . . . 0.0 110.81 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -124.26 117.06 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 8.2 m-30 -72.72 92.69 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -72.0 173.7 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.311 0.577 . . . . 0.0 111.913 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.9 40.15 0.33 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.667 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 10.5 mt -60.66 -63.04 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.976 0.388 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.087 0.47 . . . . 0.0 110.641 179.773 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.1 mt -125.62 133.38 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -73.54 118.19 66.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.54 139.38 85.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.24 . . . . 0.0 111.78 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.25 54.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -58.19 161.25 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.44 146.99 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.3 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 138.59 54.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.226 0.536 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 p -141.66 133.94 27.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.552 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.712 ' OE1' HD12 ' A' ' 88' ' ' LEU . 2.7 pm0 -130.7 140.73 50.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.371 0.605 . . . . 0.0 112.457 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.37 160.56 26.11 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.986 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.68 -6.06 1.47 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.03 2.486 . . . . 0.0 113.947 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.4 m-20 -135.95 8.91 3.27 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.625 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 65.7 m-85 -168.24 168.41 11.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 111.733 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.72 109.58 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.615 178.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.649 ' N ' HD22 ' A' ' 15' ' ' LEU . 19.4 m -99.41 147.26 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.799 HD12 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mt -125.4 153.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.12 121.94 16.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 112.069 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.08 124.23 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.796 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.8 118.71 37.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.358 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -148.25 143.21 19.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -125.57 -23.22 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.7 m-85 -75.56 -10.05 59.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.534 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.55 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.476 0.485 . . . . 0.0 111.811 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -82.69 10.22 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.287 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.11 127.44 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.785 179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -55.8 -24.19 34.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.12 153.52 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -108.55 168.39 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.378 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -129.03 128.51 43.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.95 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.2 117.6 26.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 21.2 p90 -128.86 119.28 24.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.8 OUTLIER -140.71 122.21 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.114 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.87 -70.21 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.642 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -160.38 25.4 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 0.0 110.592 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 6.7 t70 -116.22 110.61 19.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.799 ' CE2' HD12 ' A' ' 17' ' ' ILE . 26.1 t80 -105.54 111.82 24.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.224 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.28 128.17 50.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 47.8 t80 -104.99 143.08 33.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 32.7 m-85 -135.49 102.81 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -149.0 112.73 5.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.8 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER 47.02 -175.63 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 84.6 Cg_exo -37.0 -27.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.16 1.907 . . . . 0.0 112.744 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 12.6 m-30 -63.15 120.82 12.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.381 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -125.27 120.05 30.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.648 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -116.98 115.66 25.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.049 0.452 . . . . 0.0 112.024 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.28 110.17 16.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.897 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.9 mt -124.18 130.63 52.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.367 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 m -102.14 107.67 18.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 23.1 mt -65.28 143.89 98.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.199 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 49.9 Cg_endo -70.27 -23.82 28.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.785 2.323 . . . . 0.0 112.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -116.74 -137.28 5.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.186 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 82.3 mtt-85 -140.47 132.76 28.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 77' ' ' PRO . 52.0 mm -113.78 124.41 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.481 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.793 HG13 ' HG2' ' A' ' 77' ' ' PRO . 10.1 p -68.03 162.56 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.4 pt-20 -123.74 127.66 48.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.218 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.24 6.68 0.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.96 23.63 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -82.1 -69.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.994 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 31.55 -156.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.698 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 1.8 mm-40 -179.94 119.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 74' ' ' ILE . . . -170.06 -179.16 41.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.175 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -164.14 148.93 10.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CD1' ' HE2' ' A' ' 29' ' ' PHE . 14.9 t80 -113.85 132.94 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.436 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -124.93 125.3 43.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.475 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.83 -34.26 26.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.422 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -50.53 65.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.545 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -94.15 -11.0 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 63.15 62.21 5.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.259 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 70' ' ' GLY . 6.1 mt -155.05 127.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.514 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.1 t80 -110.49 114.79 28.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.501 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -121.7 126.13 48.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.263 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 2.1 tp -133.49 120.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 5.1 mtp180 -92.33 145.1 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.487 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.579 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.9 mt -134.66 143.17 45.39 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' ILE . 47.9 Cg_endo -73.18 158.98 48.24 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.789 2.326 . . . . 0.0 112.657 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 1.7 mttt -96.76 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.99 -11.03 51.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.399 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.2 m -147.52 130.49 7.98 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.846 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.06 142.54 81.47 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.99 2.46 . . . . 0.0 112.74 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 2.87 87.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.571 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 tt0 -78.1 126.75 31.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.736 0.303 . . . . 0.0 110.845 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -128.35 121.3 28.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 4.8 m-30 -76.16 92.95 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.426 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HA ' ' CE1' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -68.49 170.49 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.736 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 34.8 40.33 0.2 Allowed Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.541 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.768 ' O ' HD22 ' A' ' 91' ' ' LEU . 2.6 mt -59.53 -61.52 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.959 0.379 . . . . 0.0 110.382 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.92 14.94 2.47 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.899 0.381 . . . . 0.0 110.943 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 91' ' ' LEU . 28.7 mtt -115.41 -32.42 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.768 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -45.25 177.44 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.828 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.415 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -141.8 163.21 33.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.914 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.93 141.96 35.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 94' ' ' LEU . 2.7 pp -107.93 140.23 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.648 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mp -93.52 131.65 38.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.089 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.99 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.854 0.359 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -120.34 150.22 41.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -70.74 111.34 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.2 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 2' ' ' LEU . 51.8 Cg_exo -54.27 161.8 4.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.26 63.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.6 p90 -68.69 160.28 30.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.062 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.1 149.95 31.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.534 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.72 135.19 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.159 0.504 . . . . 0.0 111.465 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' THR . 59.5 p -139.33 133.82 31.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.319 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.594 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.1 pm0 -129.94 139.52 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.26 160.35 27.79 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.824 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.54 -6.61 7.37 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.663 2.242 . . . . 0.0 112.982 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 49.4 m-20 -135.01 13.76 3.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.521 0.201 . . . . 0.0 110.713 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.1 m-85 -169.92 171.81 6.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.537 0.684 . . . . 0.0 112.163 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.663 HD22 ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.72 108.32 7.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.685 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.653 ' N ' HD22 ' A' ' 15' ' ' LEU . 14.1 m -99.72 144.68 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 111.203 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 19.2 mt -119.42 152.77 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -132.78 112.57 12.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 17.5 mt -125.09 120.13 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' NH1' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -102.55 120.86 41.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.71 132.77 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -32.1 4.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' ALA . 5.5 m-85 -71.12 -9.9 58.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.016 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -29.8 122.53 0.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.453 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 12.16 30.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 42' ' ' ALA . 3.1 m -139.22 138.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -58.95 -40.95 86.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -117.33 141.59 48.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -92.96 168.94 10.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.774 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.0 116.57 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.435 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 ' HD1' ' A' ' 40' ' ' PHE . 21.9 t -121.96 120.75 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.19 127.83 43.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 23.9 p90 -132.2 121.89 24.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.4 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' SER . 18.9 pt-20 -138.65 119.93 14.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.62 -71.49 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.368 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -159.86 26.47 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.083 0.468 . . . . 0.0 109.961 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m-20 -115.76 104.51 11.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 25.7 t80 -105.68 120.76 42.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -124.77 135.62 53.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.611 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' HD1' HG22 ' A' ' 31' ' ' VAL . 85.3 t80 -129.09 112.35 13.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.78 133.71 46.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 111.234 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -105.27 -59.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -163.03 -64.73 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.485 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 48.3 Cg_endo -97.71 -10.76 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.986 2.458 . . . . 0.0 112.782 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -108.52 134.55 51.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 8.5 t80 -123.62 118.42 27.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.069 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 1.1 mt -115.75 111.2 20.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.486 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.2 109.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.699 0.285 . . . . 0.0 110.57 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.67 131.12 53.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.942 0.401 . . . . 0.0 111.549 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 m -101.16 110.3 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 20.9 mt -68.63 129.99 92.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 51.4 Cg_exo -54.53 -23.18 30.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.969 2.446 . . . . 0.0 112.734 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -117.91 -133.58 4.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 23.3 mtt-85 -146.5 141.01 26.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.978 HG23 ' O ' ' A' ' 77' ' ' PRO . 9.5 mm -118.45 126.06 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.57 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.6 p -58.46 157.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.573 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -121.06 128.41 52.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.661 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -163.96 -41.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.43 -0.03 26.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -91.06 31.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.558 ' HG3' ' CD ' ' A' ' 77' ' ' PRO . 21.2 mp0 -80.0 -168.76 1.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.943 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -131.96 122.29 25.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -122.33 135.0 10.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -147.74 104.88 3.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 136.91 54.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.567 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.04 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -43.59 22.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.494 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -60.3 -52.89 63.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 9.6 ttpt -78.71 -24.48 44.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 65.26 61.38 5.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.562 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -149.77 126.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.388 . . . . 0.0 111.6 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' ILE . 5.5 t80 -110.72 108.35 18.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -115.62 120.43 39.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.946 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.49 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -130.23 118.54 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.431 . . . . 0.0 111.886 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -85.85 142.77 28.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.059 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.832 ' HB3' HG21 ' A' ' 55' ' ' ILE . 8.7 mt -128.44 132.22 24.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 111.666 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -64.95 153.26 79.05 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.757 2.304 . . . . 0.0 112.261 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HG3' ' C ' ' A' ' 13' ' ' ASP . 1.6 mttt -96.67 151.06 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 111.523 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.53 -14.19 49.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.113 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.2 m -146.8 108.15 4.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.565 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.8 148.75 15.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.641 2.228 . . . . 0.0 112.397 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 -1.68 86.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.637 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -79.26 132.0 36.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 10' ' ' GLN . 8.2 t-80 -127.04 119.98 27.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.524 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 9.1 m-30 -77.03 90.93 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 173.6 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 112.213 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 34.45 37.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.902 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 85' ' ' PHE . 20.2 mt -61.21 -63.58 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.239 0.519 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.2 7.36 22.2 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.039 0.447 . . . . 0.0 110.327 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.471 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 2.5 mtt -112.63 15.45 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.176 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 91' ' ' LEU . 2.9 mt -96.8 177.3 5.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.149 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 t -110.88 174.01 6.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 110.821 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.65 115.9 28.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.393 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -103.78 112.34 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.4 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 mp -93.69 142.79 26.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.268 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.71 110.24 22.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.733 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -42.7 149.92 0.46 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.733 ' HD2' HG22 ' A' ' 3' ' ' THR . 43.4 Cg_endo -67.91 172.16 11.2 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.452 2.102 . . . . 0.0 111.994 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.01 60.1 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.69 159.76 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -144.3 143.73 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.81 134.63 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.512 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -139.35 133.11 30.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.391 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 6.2 pm0 -130.36 140.65 50.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.477 0.656 . . . . 0.0 112.477 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 5.5 m-20 -108.31 160.28 27.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.134 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.44 -0.97 2.7 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.648 2.232 . . . . 0.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 40.6 m-20 -135.75 4.82 3.09 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.451 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 17.8 m-85 -167.07 167.05 14.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.329 0.585 . . . . 0.0 112.303 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.1 tm? -134.8 112.03 10.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.138 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' ' CG ' ' A' ' 75' ' ' ARG . 55.0 m -108.78 135.67 49.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.0 111.275 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.567 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.3 mt -109.73 152.65 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.5 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.92 119.42 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.66 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.62 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -124.8 129.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -107.29 119.17 38.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.077 0.465 . . . . 0.0 111.6 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.37 128.65 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.536 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.24 -36.37 7.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.654 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' C ' ' A' ' 24' ' ' ALA . 53.9 m-85 -65.78 -10.21 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.62 118.27 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.709 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -98.76 -69.44 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.757 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -43.41 125.24 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -20.15 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.724 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -137.0 148.13 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.605 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -103.91 166.84 10.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.865 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -124.31 127.58 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.9 t -123.55 121.17 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -127.6 123.15 34.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 24.0 p90 -134.21 126.03 29.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -139.21 119.57 13.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.98 -68.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.78 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -161.89 26.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 0.0 110.391 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.0 m-20 -116.19 104.54 11.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 17' ' ' ILE . 42.7 t80 -99.11 112.08 24.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 36.1 mttt -118.24 117.43 29.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.385 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 19' ' ' ILE . 24.3 t80 -102.68 143.22 32.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.77 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 25.2 m-85 -137.52 112.35 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -144.48 104.51 4.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.092 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.581 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 2.8 pttt 44.92 -163.34 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 71.0 Cg_exo -41.4 -22.6 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.987 1.791 . . . . 0.0 113.636 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.528 ' CZ ' ' HE2' ' A' ' 43' ' ' LYS . 17.0 m-30 -73.09 122.78 22.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.182 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -129.93 125.4 35.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.324 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -123.13 117.77 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 0.0 111.915 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.2 tmm_? -117.89 113.31 21.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 48' ' ' ARG . 29.3 mt -124.21 132.21 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.941 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m -98.99 106.75 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.8 mt -66.21 126.27 91.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.459 . . . . 0.0 111.456 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 32.1 Cg_exo -57.01 -26.55 69.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.031 2.487 . . . . 0.0 112.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.13 -140.12 7.62 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 5.9 mtt180 -137.63 128.09 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.369 . . . . 0.0 111.368 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.0 mm -111.73 123.75 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.916 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.588 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -62.36 158.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.188 0.518 . . . . 0.0 112.376 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -123.17 129.58 51.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.601 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -165.21 -37.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.98 9.25 20.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.711 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.98 33.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 76' ' ' LEU . 2.1 pt-20 -85.77 -172.95 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 14.0 mt-30 -132.37 122.19 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.807 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -123.48 134.81 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.721 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.84 107.89 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -107.05 139.57 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' GLY . 65.6 t0 -116.22 112.72 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.474 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.64 -53.68 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.339 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -53.82 -44.62 70.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' HG13 ' A' ' 71' ' ' ILE . 35.1 ttpt -84.73 -26.7 27.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.71 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 69.69 63.4 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.649 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 69' ' ' LYS . 7.0 mt -154.34 119.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 111.65 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -103.12 109.47 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 97.5 m -114.3 121.71 44.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.474 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -131.99 121.1 46.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.59 144.21 26.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.022 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 HD12 ' A' ' 15' ' ' LEU . 10.3 mt -133.51 150.61 75.47 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.979 ' O ' HG23 ' A' ' 55' ' ' ILE . 17.7 Cg_endo -86.76 157.74 8.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.226 2.617 . . . . 0.0 112.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 1.5 mtpm? -101.42 156.6 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.939 0.4 . . . . 0.0 111.644 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -90.5 -6.15 55.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 80' ' ' THR . 5.6 m -156.86 90.03 2.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.8 153.54 0.27 Allowed 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 123.011 2.474 . . . . 0.0 112.929 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.26 -11.2 66.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.887 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.513 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 5.0 tp60 -81.28 136.86 35.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.671 0.272 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 2.2 t-80 -125.72 116.87 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.838 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.4 m-30 -71.51 94.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.48 174.33 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 35.9 36.21 0.12 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.569 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 37.8 mt -58.89 -63.41 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.516 0.658 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.11 9.1 26.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.55 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.467 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -118.25 17.94 13.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.432 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mt -91.08 178.76 5.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -133.87 174.18 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.427 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.63 134.78 34.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 94' ' ' LEU . 2.4 pp -123.77 126.2 46.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -97.78 112.76 24.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.966 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.734 0.302 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -123.41 137.63 54.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.946 0.403 . . . . 0.0 111.11 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.39 130.41 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.69 137.01 26.64 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.804 2.336 . . . . 0.0 111.891 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.41 ' O ' ' NE ' ' A' ' 20' ' ' ARG . . . -94.1 57.66 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.186 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 14.3 p90 -72.58 169.46 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -156.92 164.08 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -128.63 141.32 51.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.251 0.548 . . . . 0.0 111.875 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.76 134.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.041 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.684 ' OE1' ' CD2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -130.76 144.03 51.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.98 160.86 27.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.04 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.61 -0.61 2.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.969 2.446 . . . . 0.0 113.686 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.627 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -135.92 6.31 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.443 -0.161 . . . . 0.0 111.195 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.8 m-85 -168.98 169.17 9.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.394 0.616 . . . . 0.0 111.855 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.819 HD22 ' N ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -133.21 120.19 20.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.419 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.819 ' N ' HD22 ' A' ' 15' ' ' LEU . 85.7 m -111.94 149.8 31.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.966 0.412 . . . . 0.0 111.21 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.783 HG23 HD23 ' A' ' 8' ' ' LEU . 16.3 mt -124.99 151.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.308 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB1' ' NH1' ' A' ' 20' ' ' ARG . . . -140.58 122.63 15.64 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 47' ' ' LEU . 6.8 mt -125.61 131.27 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -108.59 119.38 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.35 . . . . 0.0 110.805 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -145.84 136.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.103 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.09 -36.06 5.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.02 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' ARG . 28.1 m-85 -64.49 -10.36 25.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.07 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.35 86.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.033 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.3 -72.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.621 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.1 m -50.18 137.23 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.43 -41.12 98.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.64 143.1 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.706 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.36 164.48 12.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.009 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -112.39 118.02 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.84 114.6 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -127.45 124.39 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 44.1 p90 -123.58 116.18 22.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -138.2 121.09 16.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.39 59.97 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.93 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 64.52 22.97 12.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.334 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 16.1 t0 -111.57 103.77 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CD1' ' CD1' ' A' ' 17' ' ' ILE . 80.7 t80 -101.35 113.18 26.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 111.73 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -108.56 110.37 21.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.041 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 77.4 m-85 -113.03 106.29 14.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 111.322 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -136.0 118.85 16.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.4 OUTLIER 44.48 -169.62 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 43' ' ' LYS . 81.8 Cg_exo -47.11 -14.16 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.133 1.889 . . . . 0.0 113.278 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.571 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 18.0 m-30 -80.83 125.52 30.19 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.844 0.354 . . . . 0.0 111.355 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.76 122.99 36.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.356 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 47' ' ' LEU . 2.0 mt -117.25 110.08 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 111.363 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.643 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.2 ttm180 -112.27 110.23 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.907 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 48' ' ' ARG . 18.5 mt -126.58 130.91 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 111.862 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.7 m -104.73 114.17 28.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.484 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.2 mt -81.47 147.2 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.7 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 21.5 Cg_exo -64.95 -17.63 59.95 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.997 2.464 . . . . 0.0 112.163 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -138.47 135.12 7.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -64.22 163.54 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.133 0.492 . . . . 0.0 111.838 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.976 HG23 ' O ' ' A' ' 77' ' ' PRO . 28.2 mm -123.28 129.31 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 13.9 p -54.51 150.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.568 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -108.31 121.33 44.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.251 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -154.44 -40.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.55 -21.28 21.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -57.95 -65.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.626 0.251 . . . . 0.0 110.742 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' OE2' HD11 ' A' ' 74' ' ' ILE . 26.6 pt-20 28.07 -145.95 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.136 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -167.54 146.15 4.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.609 0.243 . . . . 0.0 110.512 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -154.16 145.91 13.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.896 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.46 110.48 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.658 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.524 ' CE1' ' CG ' ' A' ' 72' ' ' PHE . 31.7 m-85 -94.73 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.32 112.11 24.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -57.09 -52.27 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -21.03 39.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 66.34 63.11 4.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.697 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 70' ' ' GLY . 21.1 mt -158.59 128.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.947 0.403 . . . . 0.0 111.581 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.524 ' CG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 t80 -106.06 109.71 21.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.489 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.56 119.55 38.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -130.55 119.76 46.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.538 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 46.9 mtp180 -85.8 146.35 26.81 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.637 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 55' ' ' ILE . 11.3 mt -136.06 133.21 19.56 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.098 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.9 Cg_exo -73.59 150.11 44.99 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.789 2.326 . . . . 0.0 111.725 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HE2' ' N ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -90.42 156.55 18.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.147 0.499 . . . . 0.0 112.272 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.54 -20.34 22.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.228 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.6 m -131.64 89.55 39.48 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.599 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -41.72 141.27 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.902 2.401 . . . . 0.0 112.524 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.11 -4.81 83.15 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.084 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 10.5 tt0 -80.4 131.23 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.827 0.314 . . . . 0.0 110.36 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.684 ' CD2' ' OE1' ' A' ' 10' ' ' GLN . 3.9 t-80 -126.75 124.5 39.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.092 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 88' ' ' LEU . 1.2 m-30 -88.5 93.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.093 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.83 126.44 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . . . 34.11 57.95 0.66 Allowed Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.065 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 85' ' ' PHE . 1.3 mp -48.53 -21.9 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.166 0.483 . . . . 0.0 110.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -80.98 14.47 2.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.52 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.48 -30.43 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.39 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' N ' ' HG3' ' A' ' 90' ' ' MET . 15.3 mt -42.79 158.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.576 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.773 ' O ' HD23 ' A' ' 94' ' ' LEU . 1.5 m -149.24 154.3 38.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.793 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.39 112.16 13.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.411 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -124.8 109.08 12.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.385 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 2.6 mp -97.73 109.86 22.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.329 . . . . 0.0 110.751 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.895 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.63 141.52 47.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 3' ' ' THR . 8.4 t -64.1 121.19 70.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.8 153.02 65.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.918 2.412 . . . . 0.0 112.521 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.73 70.08 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.63 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -78.43 159.6 28.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.469 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.52 144.9 29.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.352 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 88' ' ' LEU . 2.0 mt -116.31 138.09 51.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.502 . . . . 0.0 111.568 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.72 135.04 31.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.363 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 84' ' ' HIS . 8.3 pm0 -129.86 143.41 50.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.474 0.654 . . . . 0.0 112.337 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -106.66 160.82 24.9 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.052 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.04 -1.08 3.19 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.868 2.378 . . . . 0.0 113.452 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.671 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 10.1 m-20 -136.82 9.59 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.47 -0.144 . . . . 0.0 111.003 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 15.3 m-85 -171.99 173.21 4.48 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.384 0.612 . . . . 0.0 111.839 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.67 117.02 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.424 177.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.596 ' N ' HD22 ' A' ' 15' ' ' LEU . 31.2 m -107.73 150.84 26.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.0 111.138 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.3 151.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.77 114.46 13.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.964 0.411 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.4 125.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.317 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -84.62 121.41 27.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 65' ' ' TYR . 20.0 m -149.99 149.2 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.7 p -140.26 -57.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.227 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' ALA . 11.0 m-30 -56.88 -52.76 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.09 99.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.16 6.16 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.504 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.02 134.31 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -57.33 -41.68 80.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -123.3 139.39 54.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.18 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -84.7 158.73 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.102 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 23.9 m-20 -109.67 111.66 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' A' ' 40' ' ' PHE . 73.1 t -118.08 117.47 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.424 . . . . 0.0 111.334 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.84 112.06 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.372 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 21.2 p90 -119.12 113.28 20.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.762 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 pt-20 -136.66 106.04 6.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.649 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 34.69 88.45 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.886 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.81 -1.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 26.8 t70 -108.32 120.71 43.15 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.03 121.76 27.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.5 mmtt -124.35 128.81 49.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' A' ' 31' ' ' VAL . 77.1 t80 -122.89 111.45 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.736 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 6.1 m-85 -115.09 124.6 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -130.66 29.64 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 91.76 -89.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.931 0.892 . . . . 0.0 111.302 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 92.2 Cg_endo -82.02 -17.4 8.14 Favored 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.739 1.3 . . . . 0.0 111.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.71 117.82 34.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.293 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 41' ' ' TYR . 1.4 t80 -124.77 120.16 30.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.482 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -116.07 111.55 20.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.949 0.404 . . . . 0.0 111.582 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.552 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -116.24 110.61 18.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.933 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.5 mt -131.45 138.06 48.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.421 . . . . 0.0 111.811 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.71 111.9 24.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 78.6 mt -67.48 140.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.979 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 17.1 Cg_exo -66.87 -15.73 47.92 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.758 2.305 . . . . 0.0 112.302 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.56 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.61 -133.81 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.05 142.82 26.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 111.438 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.946 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.7 mm -119.08 125.11 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.758 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.3 p -52.88 142.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.032 0.444 . . . . 0.0 112.024 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.98 122.05 44.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.501 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -167.58 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.18 16.1 9.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.84 28.33 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' HG3' HD11 ' A' ' 74' ' ' ILE . 20.9 pm0 -72.38 -167.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.6 mt-30 -138.39 129.97 27.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.02 136.68 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.675 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.4 t -155.11 116.33 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' OH ' HG23 ' A' ' 21' ' ' VAL . 2.9 t80 -105.53 123.09 47.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 120.39 42.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.87 55.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.524 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.91 -55.22 24.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG3' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -91.25 -7.92 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.797 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.26 51.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.4 ' HB ' ' HG3' ' A' ' 69' ' ' LYS . 91.2 mt -145.82 144.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 0.0 110.498 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.566 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -111.72 123.86 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 111.217 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.05 131.22 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -139.55 118.62 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 0.0 111.556 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -90.1 147.24 23.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.706 ' HB3' HG21 ' A' ' 55' ' ' ILE . 4.7 mt -135.3 131.12 19.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.795 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.946 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.9 Cg_endo -66.98 144.33 69.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.65 2.234 . . . . 0.0 111.997 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 11' ' ' ASP . 35.6 mttp -88.56 156.65 18.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -87.49 -17.56 31.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.138 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 83' ' ' GLN . 20.0 m -135.94 119.25 12.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.544 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 143.8 70.01 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.496 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.28 2.45 90.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.671 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 4.5 tt0 -81.77 129.11 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.787 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 20.9 t-80 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.192 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.9 m-30 -83.29 89.91 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.89 162.48 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 112.121 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.85 49.41 0.76 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.592 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 8' ' ' LEU . 1.3 mt -60.3 -61.34 2.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.927 0.364 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -85.3 13.42 6.52 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.023 0.44 . . . . 0.0 110.619 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 91' ' ' LEU . 6.6 mtm -113.48 -28.77 7.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.337 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -45.25 178.34 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.606 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.42 -172.62 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.062 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.35 144.79 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.004 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.64 111.07 17.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.849 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.7 mp -91.15 116.0 28.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.953 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -110.86 143.07 42.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.716 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -67.19 138.48 94.59 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo -53.71 149.36 32.77 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.807 2.338 . . . . 0.0 112.204 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.848 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.617 ' HE2' HD21 ' A' ' 8' ' ' LEU . 4.5 p90 -73.3 164.87 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.28 147.47 27.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -115.16 136.09 53.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.507 . . . . 0.0 111.531 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.8 t -140.7 134.47 30.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.756 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -131.94 145.09 51.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.561 0.696 . . . . 0.0 112.686 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.85 160.56 27.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.893 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.87 -0.31 3.8 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.935 2.423 . . . . 0.0 113.248 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.652 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 72.4 m-20 -134.79 5.81 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.478 0.18 . . . . 0.0 110.866 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.5 m-85 -171.34 171.37 5.59 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.267 0.556 . . . . 0.0 111.212 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -137.67 111.18 8.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.086 178.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 74' ' ' ILE . 4.9 m -104.74 148.51 26.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.134 0.492 . . . . 0.0 111.38 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.742 HD12 ' CE1' ' A' ' 38' ' ' PHE . 4.6 mt -123.39 155.3 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -136.85 111.29 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.932 0.396 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.622 HD13 ' CD2' ' A' ' 40' ' ' PHE . 3.7 mt -118.95 126.84 75.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 11.4 ttt180 -101.85 119.44 38.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.585 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 21' ' ' VAL . 14.4 m -143.73 130.44 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.543 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.45 -33.59 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.389 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.514 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 2.2 m-30 -66.92 -10.13 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.8 108.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 6.8 ttt180 -101.48 11.29 39.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.5 m -121.88 129.37 75.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.19 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.7 m -56.47 -40.38 74.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -125.47 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.355 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -94.0 160.03 14.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -113.7 112.15 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.57 114.55 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -119.36 113.15 20.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.393 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 12.3 p90 -118.57 112.95 20.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.015 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 1.1 tt0 -138.07 112.6 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.347 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA2' ' HG2' ' A' ' 54' ' ' ARG . . . 36.91 77.37 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.442 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 66.45 4.16 3.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.5 m-20 -102.8 104.23 14.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.2 t80 -110.87 116.04 30.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.428 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -121.2 131.78 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.249 179.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 19' ' ' ILE . 84.5 t80 -128.46 112.05 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.334 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' OH ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -116.45 119.33 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -133.9 29.53 3.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.484 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 2.1 pttp 122.46 -164.31 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.823 1.327 . . . . 0.0 108.536 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 27.3 Cg_exo -37.33 -26.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.339 1.359 . . . . 0.0 112.66 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.5 m-85 -73.49 124.42 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.04 124.1 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.1 mt -113.35 109.29 18.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -120.14 112.49 19.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 48' ' ' ARG . 32.6 mt -132.31 136.98 47.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.628 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.2 m -102.43 111.32 23.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.648 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 17.0 mt -70.64 146.24 93.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 23.7 Cg_exo -63.75 -19.33 66.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.895 2.397 . . . . 0.0 112.551 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' NE2' ' A' ' 83' ' ' GLN . . . -123.43 -127.98 3.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.809 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HG2' ' HA2' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -151.38 145.53 25.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 77' ' ' PRO . 32.2 mm -116.51 124.69 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.8 p -55.72 151.81 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.467 . . . . 0.0 111.595 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.03 131.4 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.25 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.54 -37.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.46 17.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -97.71 30.25 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.953 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -79.0 -169.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.663 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.38 137.74 44.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.61 134.66 7.49 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.067 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -143.79 104.95 4.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -119.17 139.57 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 111.617 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.62 128.9 53.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.32 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.827 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.89 -39.3 65.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -95.78 -20.09 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . 63.96 62.91 4.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.341 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 70' ' ' GLY . 50.4 mt -144.7 118.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -113.3 115.79 28.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 25.9 m -119.14 129.35 54.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.953 HD11 ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -138.13 121.13 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -86.22 144.88 27.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.76 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.08 125.36 18.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.897 ' O ' HG23 ' A' ' 55' ' ' ILE . 32.9 Cg_endo -63.42 151.66 83.88 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.445 2.097 . . . . 0.0 111.942 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 13.6 mttt -96.39 157.47 15.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 79' ' ' GLU . 2.9 tm-20 -84.63 -4.93 59.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 79' ' ' GLU . 93.0 m -152.09 116.96 3.03 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.93 143.64 48.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.265 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.86 86.09 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.908 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tp-100 -66.98 122.38 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.676 0.274 . . . . 0.0 110.504 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -120.16 112.68 19.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.858 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 16.2 m-30 -77.46 90.29 3.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.305 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 171.29 11.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 112.011 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 36.61 41.13 0.53 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.73 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.59 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.109 0.454 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -85.81 12.32 9.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -32.42 7.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mt -48.61 174.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.782 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.2 p -120.41 171.48 8.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.1 130.23 44.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.14 125.15 46.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.989 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 8.7 mp -99.9 137.09 38.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.933 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.821 0.344 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.44 134.49 43.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.702 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.653 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -83.12 139.92 42.51 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.277 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HD2' HG22 ' A' ' 3' ' ' THR . 61.2 Cg_endo -73.72 158.3 47.13 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.646 2.231 . . . . 0.0 111.689 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.06 58.13 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -68.26 164.91 19.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.35 156.6 42.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.47 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -120.08 139.29 52.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.423 0.63 . . . . 0.0 112.008 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.0 p -140.63 131.54 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.628 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.56 145.16 51.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 0.0 112.738 -177.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.447 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m-20 -109.31 160.22 28.44 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.899 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.86 -1.24 2.57 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.974 2.449 . . . . 0.0 113.929 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.7 m-20 -137.19 8.91 2.96 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.3 -0.25 . . . . 0.0 111.037 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.6 m-85 -171.17 171.96 5.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.379 0.609 . . . . 0.0 111.803 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -134.24 118.66 17.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.477 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.851 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.0 m -108.26 145.92 33.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 110.293 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 8' ' ' LEU . 3.1 mt -118.85 154.54 21.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.69 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.71 110.53 9.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.459 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.9 mt -126.26 122.44 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.573 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 120.21 41.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.768 0.318 . . . . 0.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.66 134.76 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.379 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.48 -38.27 5.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.6 m-30 -63.63 -10.74 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -21.82 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.229 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -70.44 -76.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.431 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.5 m -39.94 128.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -58.91 -28.65 66.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.66 145.07 51.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.474 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -101.59 163.65 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.764 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -118.48 119.04 33.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.12 121.52 65.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 56.4 m-85 -135.34 130.67 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.4 p90 -127.02 122.2 33.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 8.6 tt0 -137.39 109.51 7.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.527 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.15 75.7 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.98 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 66.59 5.17 3.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 34.3 m-20 -103.17 103.75 13.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.685 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 71.0 t80 -105.83 113.14 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.408 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 115.39 27.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.434 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 76.3 t80 -113.08 109.29 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 98.5 m-85 -110.29 105.96 15.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 112.034 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -134.07 113.36 12.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.594 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.603 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 43.8 -170.23 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 76.4 Cg_exo -42.64 -20.87 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.026 1.817 . . . . 0.0 113.106 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 14.2 m-85 -71.6 121.14 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.9 t80 -118.57 119.21 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.427 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.6 mt -120.26 109.53 15.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 111.911 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 3.9 ttm180 -118.73 116.48 26.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.42 128.04 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 0.0 111.794 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 106.36 18.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' ILE . 4.4 mt -70.34 128.18 91.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.375 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 46.1 Cg_exo -56.0 -20.84 31.67 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.821 2.347 . . . . 0.0 112.199 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -112.18 -138.62 7.43 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.538 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.36 137.81 28.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.909 HG23 ' O ' ' A' ' 77' ' ' PRO . 5.0 mt -118.74 126.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.911 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.2 p -58.15 155.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.5 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.7 pt-20 -123.1 133.88 54.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -164.7 -38.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.49 -12.93 25.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.191 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -67.43 -70.33 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.962 0.411 . . . . 0.0 110.318 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.614 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.2 pt-20 30.34 -152.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.685 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -156.61 155.56 32.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.68 161.19 34.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.418 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -159.87 121.05 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -119.04 131.32 55.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.522 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.05 126.82 53.04 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.582 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -46.57 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.643 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.66 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.259 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -76.73 -19.87 57.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.82 61.8 6.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.46 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -157.44 129.93 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.921 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' A' ' 74' ' ' ILE . 7.6 t80 -112.39 110.89 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -108.82 128.04 54.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.702 ' O ' HG23 ' A' ' 16' ' ' THR . 9.0 tt -123.13 162.68 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 0.0 111.468 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.676 ' O ' HD23 ' A' ' 76' ' ' LEU . 12.3 mtm180 -133.38 140.36 47.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 55' ' ' ILE . 70.5 mt -136.34 128.31 17.22 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.911 ' HG2' HG13 ' A' ' 56' ' ' VAL . 36.7 Cg_endo -65.87 151.72 83.43 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.784 2.323 . . . . 0.0 112.219 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 83' ' ' GLN . 4.4 mttt -98.55 153.78 18.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.348 . . . . 0.0 110.487 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 4.1 tt0 -83.31 -7.61 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.0 m -156.14 108.0 2.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 111.523 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.43 149.81 36.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.733 2.288 . . . . 0.0 112.035 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.72 83.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.851 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 51.0 tt0 -81.07 135.34 35.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.218 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -124.44 118.61 27.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.227 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 6.2 m-30 -77.42 90.6 3.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 172.87 8.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 35.61 39.9 0.27 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.925 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.682 ' O ' HD22 ' A' ' 91' ' ' LEU . 1.5 mt -61.67 -61.77 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.266 0.533 . . . . 0.0 111.024 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.5 14.09 2.19 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.739 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 2.3 ppp? -115.81 -31.03 5.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -52.57 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.908 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.451 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -131.88 170.2 15.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.619 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.14 142.25 30.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.39 110.97 22.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.37 118.05 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.931 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.881 0.372 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.96 148.72 38.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.706 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 3' ' ' THR . 2.5 t -78.11 117.62 67.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.349 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo -53.41 148.57 33.18 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.32 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.46 58.78 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.987 0.422 . . . . 0.0 110.395 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.4 p90 -63.04 165.32 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.46 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -149.0 146.21 27.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.46 135.94 53.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.4 . . . . 0.0 111.167 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -140.43 132.35 27.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.04 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.591 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.23 140.81 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 0.0 112.174 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -111.2 160.86 27.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.788 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 22.0 Cg_endo -61.56 -1.94 2.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.974 2.449 . . . . 0.0 113.703 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.1 m-20 -135.95 4.05 2.98 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.331 -0.231 . . . . 0.0 111.502 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.1 m-85 -168.48 169.52 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 112.253 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.776 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.3 tm? -134.59 114.17 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.202 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 73' ' ' THR . 44.2 m -109.0 139.88 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 38' ' ' PHE . 54.1 mt -111.85 152.11 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.311 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -132.1 119.06 20.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.587 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 47' ' ' LEU . 3.8 mt -125.84 128.2 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.866 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 12.2 mtp180 -96.66 118.48 33.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 21' ' ' VAL . 19.4 m -108.43 82.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' TYR . 52.3 p -51.02 -87.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' SER . 3.7 m-30 -38.31 -53.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.75 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.79 45.89 5.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.511 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -59.45 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.476 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 43' ' ' LYS . 18.4 m -43.5 136.54 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 111.05 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.53 95.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.331 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 147.24 52.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.801 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -99.24 167.81 10.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 37.4 m-20 -114.92 125.44 53.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.86 116.36 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.74 124.1 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 39.3 p90 -131.48 121.91 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' SER . 6.4 pt-20 -138.66 119.13 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.87 -76.45 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.639 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -153.03 27.44 0.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.913 0.387 . . . . 0.0 110.665 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.65 110.15 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 17' ' ' ILE . 90.0 t80 -101.43 111.87 24.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -113.67 122.85 48.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.784 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CG ' HD13 ' A' ' 19' ' ' ILE . 75.7 t80 -123.82 114.1 19.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.542 ' HB3' ' CE1' ' A' ' 46' ' ' PHE . 2.1 m-85 -118.02 104.39 10.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.985 0.421 . . . . 0.0 111.583 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -138.03 121.95 17.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 42.19 -170.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 99.8 Cg_exo -44.57 -19.84 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.72 1.613 . . . . 0.0 112.272 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 18.8 m-85 -74.23 114.17 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.385 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -121.33 122.7 40.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.836 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 19' ' ' ILE . 1.7 mt -120.14 110.64 16.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.099 0.476 . . . . 0.0 112.121 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 114.28 23.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.873 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.31 142.18 39.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.645 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -101.23 115.67 31.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.581 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' SER . 92.2 mt -75.75 136.22 70.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -79.95 82.28 2.53 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.917 2.411 . . . . 0.0 112.03 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 143.82 -145.99 16.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.096 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.5 mmt180 -143.65 137.85 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.075 0.464 . . . . 0.0 111.642 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 77' ' ' PRO . 45.9 mm -118.11 126.23 74.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.661 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 13.8 p -55.14 149.07 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 131.44 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.601 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -169.06 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.418 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . 112.73 9.16 19.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.682 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 28.05 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' OE2' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -78.78 -167.17 1.03 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.522 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -137.59 124.99 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.988 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.56 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -124.81 139.02 11.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.216 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.65 106.62 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.559 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.564 ' CD1' ' HB2' ' A' ' 72' ' ' PHE . 7.9 t80 -109.5 146.02 35.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -123.23 125.96 46.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.324 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -39.93 20.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -53.23 -48.54 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.086 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.52 -18.3 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.294 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 72.99 63.51 2.81 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mt -154.46 120.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -110.13 124.59 51.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -127.01 127.38 44.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.56 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -128.07 119.22 50.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.587 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -82.45 141.76 32.47 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.55 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.777 ' HB3' HG21 ' A' ' 55' ' ' ILE . 10.4 mt -135.4 117.35 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.818 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.925 ' O ' HG23 ' A' ' 55' ' ' ILE . 20.4 Cg_endo -60.68 154.33 55.68 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.873 2.382 . . . . 0.0 112.286 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' CD ' ' O ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -94.1 154.81 17.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.931 0.395 . . . . 0.0 111.415 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -82.26 -13.85 56.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 m -142.18 116.71 6.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.702 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.62 142.8 98.69 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.67 2.247 . . . . 0.0 112.067 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.43 86.39 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.998 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 tt0 -80.37 126.08 30.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.445 ' CE1' ' O ' ' A' ' 10' ' ' GLN . 4.1 t60 -128.62 125.68 38.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 8.3 m-30 -80.29 89.98 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 173.83 9.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.026 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' MET . . . 38.4 35.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.957 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.8 mt -59.05 -61.47 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.14 0.47 . . . . 0.0 110.407 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -69.26 8.58 0.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.433 ' HG3' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -97.68 -26.17 14.85 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 91' ' ' LEU . 5.8 mt -71.65 125.7 27.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.482 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.32 155.0 39.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 111.165 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.91 115.96 28.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -126.09 107.81 10.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 5.5 mp -91.35 114.57 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.768 0.318 . . . . 0.0 111.062 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.109 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.886 0.374 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -115.06 159.45 20.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 m -79.06 110.6 15.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.92 146.43 65.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.712 2.274 . . . . 0.0 112.131 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.94 66.41 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 10.2 p90 -75.8 163.82 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -147.0 143.26 28.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.91 134.83 54.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.115 0.483 . . . . 0.0 111.143 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.9 t -142.5 135.31 28.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.72 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.933 HE21 HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -130.68 141.75 50.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.116 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -104.25 161.37 23.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.842 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 32.4 Cg_endo -62.86 -1.88 3.11 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.701 2.268 . . . . 0.0 113.337 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.621 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 57.4 m-20 -135.86 9.92 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.97 -0.105 . . . . 0.0 110.893 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.5 m-85 -170.94 171.71 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 111.964 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.0 109.61 9.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.181 177.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 75' ' ' ARG . 2.8 m -104.04 146.89 28.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.208 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.945 HD12 ' CE1' ' A' ' 38' ' ' PHE . 27.0 mt -122.64 152.41 27.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.05 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -136.96 120.23 16.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.183 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.617 HD13 HD12 ' A' ' 47' ' ' LEU . 1.2 mt -123.19 126.58 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.118 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -77.27 118.37 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.066 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.96 129.76 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 p -121.38 -59.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' ALA . 4.9 m-30 -57.0 -52.96 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.93 97.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.825 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -70.29 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 m -58.83 135.82 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -55.65 -41.11 73.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.62 139.42 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.359 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -87.88 166.83 14.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.959 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -119.03 115.93 25.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.89 116.31 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -112.77 114.25 26.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 25.0 p90 -125.61 115.81 20.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 36' ' ' SER . 15.6 mt-10 -137.35 117.29 13.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.74 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.46 -74.95 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.207 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -148.92 27.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.4 t0 -118.47 130.99 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.945 ' CE1' HD12 ' A' ' 17' ' ' ILE . 80.4 t80 -125.88 113.96 17.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 111.062 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -121.85 127.58 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.644 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.4 ' CD2' HD12 ' A' ' 19' ' ' ILE . 87.3 t80 -122.72 110.5 15.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CE1' ' CE2' ' A' ' 46' ' ' PHE . 6.8 m-85 -110.51 116.25 31.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -127.3 26.21 6.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.166 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 22.0 tptt 95.22 -88.41 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.75 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 70.9 Cg_endo -83.61 -16.97 6.45 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.316 1.344 . . . . 0.0 111.476 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -96.12 105.11 17.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.733 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -111.45 111.95 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.956 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -117.26 109.18 16.54 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -118.0 110.72 18.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.94 137.1 49.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 0.0 111.781 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 m -102.77 112.64 25.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.137 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 61.7 mt -69.44 137.35 88.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.814 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 31.8 Cg_exo -58.96 -18.43 42.7 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.306 2.671 . . . . 0.0 113.117 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -125.23 -127.42 3.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.819 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -147.61 142.94 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.947 0.404 . . . . 0.0 111.485 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 77' ' ' PRO . 12.2 mm -119.79 126.3 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.637 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 8.7 p -52.24 141.07 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.088 0.47 . . . . 0.0 111.979 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.65 130.16 56.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.518 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -176.69 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.452 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.46 17.75 11.01 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -98.63 21.7 10.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.704 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.818 ' OE2' HD11 ' A' ' 74' ' ' ILE . 9.6 pt-20 -73.52 -170.62 0.86 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.76 138.6 34.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -131.05 147.65 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.311 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.14 110.14 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 111.066 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -110.88 126.99 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.8 111.47 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.15 71.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -49.27 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 20.4 ttpt -77.48 -27.41 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.011 0.434 . . . . 0.0 110.174 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 1.02 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 71.95 48.32 27.57 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 70' ' ' GLY . 2.7 mm -144.22 146.68 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 5.2 t80 -109.73 114.85 28.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -114.49 126.99 55.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.818 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -139.74 119.54 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.791 ' O ' HD23 ' A' ' 76' ' ' LEU . 50.0 mtm180 -87.95 148.56 24.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.154 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 75' ' ' ARG . 45.4 mt -135.52 122.81 14.85 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' ILE . 19.2 Cg_endo -61.27 147.53 95.33 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.719 2.279 . . . . 0.0 112.003 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 20.1 mttp -90.84 156.01 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 111.355 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.65 -17.06 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -135.52 94.46 15.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.843 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.8 143.23 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.821 2.348 . . . . 0.0 112.57 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.82 0.34 89.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.256 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 2.2 tp-100 -84.58 136.06 33.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.976 0.388 . . . . 0.0 110.982 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.503 ' CE1' ' OE1' ' A' ' 10' ' ' GLN . 6.2 t60 -127.42 123.22 35.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.132 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.568 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 15.1 m-30 -79.21 91.5 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.21 170.57 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.859 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.93 41.76 0.21 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.636 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.933 HD12 HE21 ' A' ' 10' ' ' GLN . 3.5 mt -60.83 -61.24 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.068 0.434 . . . . 0.0 110.995 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -80.26 14.68 1.83 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.438 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.66 -28.42 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.877 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -46.12 178.4 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -142.46 163.64 32.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.718 0.294 . . . . 0.0 110.703 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.59 125.46 29.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.406 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.85 136.13 53.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.85 110.1 22.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.987 179.808 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pp -123.53 133.35 54.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.005 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -64.82 140.82 98.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.22 171.82 17.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.504 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.53 65.57 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -79.79 164.36 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.59 154.34 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.975 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 mt -115.97 135.46 53.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.118 0.485 . . . . 0.0 111.57 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.47 130.4 28.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.121 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.63 144.61 51.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 112.466 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.4 160.45 27.03 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.199 179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 30.1 Cg_endo -63.46 -0.8 2.61 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.013 2.475 . . . . 0.0 113.776 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 6.0 m-20 -136.28 8.87 3.18 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.408 -0.183 . . . . 0.0 110.748 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.0 m-85 -171.93 172.23 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.32 0.581 . . . . 0.0 111.331 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -136.24 116.89 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.615 178.025 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.522 ' N ' HD22 ' A' ' 15' ' ' LEU . 11.3 m -107.15 148.39 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 38' ' ' PHE . 8.2 mt -125.61 152.26 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.266 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.55 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.397 . . . . 0.0 111.568 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.539 HD13 ' CG ' ' A' ' 40' ' ' PHE . 3.5 mt -113.97 125.12 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.754 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HG3' HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.23 121.21 29.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.108 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.91 131.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.08 -73.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.441 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.7 m-85 -49.68 -53.29 25.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 43.92 103.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.443 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -81.92 3.9 24.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 43' ' ' LYS . 27.1 m -123.94 130.54 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -56.05 -41.37 74.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.09 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -129.07 143.13 50.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.928 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -90.65 166.86 12.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.417 . . . . 0.0 111.36 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.23 122.28 42.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.44 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.02 116.66 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 111.538 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -112.09 114.05 26.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.788 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.6 p90 -125.95 114.94 19.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' SER . 10.7 mt-10 -134.32 112.22 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.376 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.76 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.768 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -153.34 24.37 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.399 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -114.76 104.92 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.978 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 17' ' ' ILE . 81.8 t80 -105.12 117.88 35.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.71 130.35 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CG ' HD13 ' A' ' 19' ' ' ILE . 32.6 t80 -127.74 116.86 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.93 122.2 41.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.229 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -126.32 29.61 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.2 tptm 93.85 -89.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.585 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 58.7 Cg_endo -84.44 -16.41 5.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 120.708 1.289 . . . . 0.0 111.516 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -102.15 117.48 34.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.236 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.0 t80 -125.86 120.92 31.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.416 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -118.23 113.47 21.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.84 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -116.12 110.78 19.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HG ' HD22 ' A' ' 47' ' ' LEU . 5.1 mt -123.74 129.4 51.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.664 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.5 110.31 22.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.334 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.94 136.71 85.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 0.0 111.361 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 28.4 Cg_endo -62.78 -14.69 42.12 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.345 2.697 . . . . 0.0 112.864 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.53 -129.31 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.747 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.4 mtm180 -149.16 145.9 27.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.986 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' PRO . 35.0 mm -121.08 126.29 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.61 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 77' ' ' PRO . 2.5 p -52.37 146.94 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 111.553 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.33 124.36 52.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.626 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -160.88 -41.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.0 -6.49 27.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -72.32 -71.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.424 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' OE1' ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER 33.34 -156.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 9.9 mt-30 -154.02 167.07 31.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.45 152.43 6.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.816 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -153.84 143.31 21.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.17 122.51 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 120.15 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.12 -41.74 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -53.44 50.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.208 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.494 ' HD2' HD12 ' A' ' 71' ' ' ILE . 3.9 ttpm? -81.57 -16.55 51.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.038 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.44 55.27 30.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.559 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 69' ' ' LYS . 58.3 mt -145.3 147.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.407 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -112.88 113.32 25.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.466 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 132.77 56.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -141.42 118.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.744 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 39.2 mtp180 -90.89 148.59 22.37 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mt -134.44 143.71 47.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 56' ' ' VAL . 6.0 Cg_endo -83.61 148.73 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.759 2.306 . . . . 0.0 111.448 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 1.9 mtmp? -89.16 157.05 18.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.51 -18.86 37.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.165 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 80' ' ' THR . 3.5 m -142.97 86.8 9.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -40.82 149.76 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.719 2.279 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.37 -10.12 75.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.26 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.7 tp60 -82.14 134.99 35.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -124.12 118.27 26.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.368 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 5.2 m-30 -78.16 89.84 4.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.054 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.24 174.56 10.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.529 0.681 . . . . 0.0 112.567 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 38.74 40.52 1.05 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.812 -1.085 . . . . 0.0 114.072 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -61.55 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.172 0.486 . . . . 0.0 110.016 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.18 6.84 30.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.349 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.44 7.33 10.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.087 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLY . 3.1 mt -71.22 178.43 3.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.596 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -118.68 -178.08 3.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.898 0.38 . . . . 0.0 111.167 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.66 123.98 46.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -118.82 107.65 13.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.4 mp -94.92 119.25 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.028 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.854 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.03 119.99 29.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.589 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -82.72 137.52 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.578 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' A' ' 3' ' ' THR . 66.0 Cg_endo -75.04 149.46 36.54 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.1 59.55 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -69.74 166.03 20.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.666 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.97 38.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.49 133.98 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' THR . 22.6 p -138.74 130.94 28.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.214 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.617 ' CB ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -131.8 143.34 50.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 112.728 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.02 160.74 24.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.613 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.95 -3.68 5.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.632 2.221 . . . . 0.0 113.408 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.43 9.89 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.488 -0.132 . . . . 0.0 111.236 179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 39.6 m-85 -170.47 170.17 7.07 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 111.294 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -135.39 111.4 9.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.749 ' N ' HD22 ' A' ' 15' ' ' LEU . 23.1 m -103.16 135.56 44.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.13 0.491 . . . . 0.0 111.539 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.556 HD12 ' CE1' ' A' ' 38' ' ' PHE . 20.7 mt -108.28 151.94 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.854 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.13 117.35 14.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.044 0.45 . . . . 0.0 111.789 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 47' ' ' LEU . 18.6 mt -120.0 125.77 74.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.621 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 118.66 37.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 21' ' ' VAL . 22.4 m -155.57 127.72 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.145 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.86 -30.25 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.909 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.6 m-85 -68.05 -9.49 46.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.024 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -25.69 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.518 0.511 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.54 16.92 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.688 -178.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.12 130.24 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.4 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 m -56.6 -35.79 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.366 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.59 148.01 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.791 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -101.22 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.605 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -113.36 119.38 37.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.65 114.97 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 83.5 m-85 -125.61 120.27 30.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 40.7 p90 -123.2 119.08 29.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.793 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' HB3' ' A' ' 37' ' ' ASP . 3.0 pt-20 -138.07 114.02 9.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.267 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.77 77.66 0.07 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.181 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER 60.06 10.99 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.398 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 4.1 t70 -108.06 103.31 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 110.092 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.5 t80 -108.42 121.25 44.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -120.85 134.57 55.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.664 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 52.9 t80 -129.56 111.72 13.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.15 107.25 17.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.125 0.488 . . . . 0.0 111.843 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 40' ' ' PHE . . . -132.47 106.42 7.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.613 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 46.86 -175.96 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 38.0 Cg_exo -33.52 -29.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 121.972 1.781 . . . . 0.0 112.587 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 17.4 m-30 -66.3 125.36 25.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.85 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -129.01 128.59 43.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.206 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 19' ' ' ILE . 6.4 mt -118.21 111.78 19.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 113.07 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.19 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.4 mt -124.21 127.83 48.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.495 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -98.26 110.77 23.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.642 HD13 ' HE2' ' A' ' 85' ' ' PHE . 60.3 mt -78.74 155.17 78.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 85' ' ' PHE . 9.6 Cg_endo -86.21 -17.9 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.166 2.577 . . . . 0.0 112.627 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -112.51 -141.64 8.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.81 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -141.48 132.67 26.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.46 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.7 mm -110.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.077 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 57' ' ' GLU . 8.4 p -61.67 157.57 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.485 . . . . 0.0 111.861 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.2 pt-20 -123.35 132.37 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.021 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -165.31 -35.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.46 0.9 26.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.239 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -79.37 -72.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.656 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER 26.25 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.335 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 21.3 mt-30 -161.7 133.15 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.944 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.72 139.1 10.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.041 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.95 104.69 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.535 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -108.16 136.88 47.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.44 117.36 27.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.81 -44.07 34.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.42 -46.77 69.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 7.3 ttpp -91.88 -16.25 26.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.76 63.34 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.042 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG13 ' HG2' ' A' ' 69' ' ' LYS . 3.6 mt -151.46 120.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 111.505 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 2.7 t80 -104.99 111.03 23.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.74 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.45 117.68 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.944 HD12 ' CA ' ' A' ' 63' ' ' GLY . 1.1 tp -129.11 119.82 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.705 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -86.3 143.48 27.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.748 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.4 mp -131.94 124.72 19.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.62 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' ILE . 25.7 Cg_endo -64.64 155.75 65.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.911 2.407 . . . . 0.0 112.354 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -102.63 157.36 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.247 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 5.9 tt0 -84.6 0.33 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.79 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -160.86 99.79 1.32 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.39 153.24 13.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.812 2.341 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.82 63.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.981 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -81.55 142.63 32.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 47.1 t60 -130.02 123.45 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.642 ' HE2' HD13 ' A' ' 51' ' ' LEU . 4.1 m-30 -77.1 92.87 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.462 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 172.32 8.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.268 0.556 . . . . 0.0 111.708 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.88 37.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.451 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 85' ' ' PHE . 8.0 mt -58.47 -61.27 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.04 0.42 . . . . 0.0 110.319 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -78.78 14.68 1.26 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.56 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -115.03 -32.85 5.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 50' ' ' THR . 1.9 mt -47.52 170.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.625 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.31 158.48 44.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.024 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.59 141.52 29.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -109.57 138.73 45.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 10.1 mp -89.2 130.12 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.098 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.764 0.316 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pp -118.64 142.01 48.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.69 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.439 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 11.3 m -73.51 107.69 3.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.676 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 2' ' ' LEU . 33.3 Cg_endo -64.67 137.8 55.95 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.945 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.68 58.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.19 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -61.32 163.17 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.8 140.65 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.562 ' CD2' HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -116.2 139.69 50.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.166 0.507 . . . . 0.0 111.579 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.45 132.25 22.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.649 ' HB3' HD23 ' A' ' 15' ' ' LEU . 2.2 pm0 -130.42 141.48 50.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.335 0.588 . . . . 0.0 111.649 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.48 160.73 25.06 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.152 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.95 -2.52 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 113.785 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.644 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 66.4 m-20 -136.6 11.45 3.19 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.314 -0.241 . . . . 0.0 110.748 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.6 m-85 -170.37 171.84 6.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.559 0.695 . . . . 0.0 112.237 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -137.4 111.1 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.726 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.76 ' N ' HD22 ' A' ' 15' ' ' LEU . 88.6 m -105.7 151.18 24.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.155 0.502 . . . . 0.0 111.496 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.2 mt -124.88 154.58 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.98 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.03 118.97 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 2.7 mt -125.83 128.41 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.091 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 4.0 mtp180 -100.95 121.61 42.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.346 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 135.09 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.708 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -32.8 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.338 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 24' ' ' ALA . 6.2 m-30 -67.06 -10.8 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.04 110.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.445 0.465 . . . . 0.0 111.506 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -72.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.504 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 19.5 m -58.31 141.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.436 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -55.32 -40.75 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.378 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' O ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tt0 -121.07 140.35 52.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -89.59 168.71 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -116.36 115.87 26.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 1.9 t -118.57 121.79 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -119.84 116.46 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 53.1 p90 -126.14 115.67 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.519 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -136.39 113.88 10.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.819 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.7 -72.39 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.454 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -155.9 27.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.481 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -118.37 104.35 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.801 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE1' HD12 ' A' ' 17' ' ' ILE . 72.4 t80 -104.64 124.51 49.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.766 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -129.0 134.9 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 31.4 t80 -125.23 110.01 13.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.35 119.41 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.37 35.08 4.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 91.72 -91.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.39 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 62.7 Cg_endo -84.43 -14.84 6.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.909 1.36 . . . . 0.0 112.143 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 23' ' ' TYR . 22.0 m-30 -102.05 117.64 35.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.584 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -124.78 118.89 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 47' ' ' LEU . 2.4 mt -123.54 117.56 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.46 112.77 23.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.869 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 8' ' ' LEU . 39.0 mt -121.0 126.02 48.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.856 0.36 . . . . 0.0 111.601 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 107.87 19.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.383 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 mt -73.2 128.36 87.75 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.799 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.558 ' HG3' HD12 ' A' ' 91' ' ' LEU . 7.3 Cg_exo -72.05 90.86 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.799 2.333 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.98 -137.58 9.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.409 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -144.83 136.65 25.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.063 0.458 . . . . 0.0 111.592 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -116.8 126.84 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.746 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -61.1 156.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.45 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' N ' HG22 ' A' ' 56' ' ' VAL . 30.1 mt-10 -123.22 131.26 53.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.619 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -164.02 -42.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.642 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.37 -1.64 26.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 27.61 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.98 -168.63 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.401 ' O ' HG13 ' A' ' 74' ' ' ILE . 83.2 mt-30 -134.5 138.62 44.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.515 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -149.37 154.37 25.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.525 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 p -164.23 118.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' ASP . 4.6 t80 -113.53 137.1 52.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 1.1 m-20 -123.2 125.44 45.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.05 -33.47 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -50.16 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.458 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.628 ' HE3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -107.33 -6.28 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ARG . . . 63.45 63.27 4.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.391 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.628 HD12 ' HE3' ' A' ' 69' ' ' LYS . 1.3 mt -144.21 121.0 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.4 t80 -114.73 115.6 27.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.986 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.2 m -115.51 128.49 56.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -136.01 118.21 20.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.904 0.383 . . . . 0.0 112.026 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -88.52 146.97 24.86 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 55' ' ' ILE . 30.1 mt -132.65 139.08 33.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.417 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.7 Cg_endo -76.0 149.87 33.3 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.882 2.388 . . . . 0.0 112.169 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 10.3 mttp -96.32 156.07 16.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 -6.98 59.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.616 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.6 m -154.51 89.32 3.26 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -42.2 160.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.092 2.528 . . . . 0.0 112.845 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.35 -6.19 57.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.624 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -83.41 142.85 30.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' N ' ' HG3' ' A' ' 83' ' ' GLN . 1.8 t-80 -127.25 121.1 30.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 52' ' ' PRO . 7.9 m-30 -82.85 94.46 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.02 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.83 174.01 7.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.344 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 34.89 40.62 0.22 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.485 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD12 ' OE1' ' A' ' 10' ' ' GLN . 3.8 mt -60.46 -62.01 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.109 0.455 . . . . 0.0 110.045 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.54 12.27 4.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.938 0.399 . . . . 0.0 110.65 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 72.8 mtp -110.94 -31.72 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.558 HD12 ' HG3' ' A' ' 52' ' ' PRO . 1.3 mt -49.39 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.556 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.72 174.25 10.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.02 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.79 136.1 42.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.044 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.57 117.41 30.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.07 114.22 26.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.959 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.3 153.98 26.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.79 116.87 66.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 50.7 Cg_exo -52.46 169.55 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.669 2.246 . . . . 0.0 112.534 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.72 57.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -61.28 170.23 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -154.07 148.52 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.597 ' CD2' HG23 ' A' ' 17' ' ' ILE . 7.3 mt -116.18 138.21 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' THR . 18.8 t -139.38 131.97 28.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.177 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.571 ' HB3' HD23 ' A' ' 15' ' ' LEU . 4.8 pm0 -130.41 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 112.575 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.82 161.04 24.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.016 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.73 -4.02 5.26 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.745 2.297 . . . . 0.0 113.25 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.656 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 32.6 m-20 -136.59 12.31 3.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.327 0.108 . . . . 0.0 110.834 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.656 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 48.8 m-85 -170.4 171.58 6.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 111.908 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -136.94 112.22 9.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.101 178.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.754 ' N ' HD22 ' A' ' 15' ' ' LEU . 83.4 m -106.16 146.18 30.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.077 0.465 . . . . 0.0 111.011 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.597 HG23 ' CD2' ' A' ' 8' ' ' LEU . 15.0 mt -117.75 155.5 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.101 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -143.2 122.96 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.602 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.482 HD13 HD12 ' A' ' 47' ' ' LEU . 1.1 mt -125.23 132.74 70.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.961 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 1.1 ttt180 -104.08 118.0 35.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.322 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.4 m -146.94 128.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -100.71 -50.75 3.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 25' ' ' ARG . 4.3 m-85 -59.49 -15.25 16.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 81.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -98.74 86.52 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.999 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.57 145.92 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.582 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.6 12.72 30.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.695 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -171.07 108.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 26' ' ' VAL . 2.5 m-30 -86.09 148.78 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.786 0.327 . . . . 0.0 110.505 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -105.35 110.99 23.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 114.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -122.88 118.39 27.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 45.5 p90 -118.58 112.37 19.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -138.98 124.96 19.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 0.0 111.846 -179.154 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 38.72 62.78 1.11 Allowed Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.699 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 67.32 22.26 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.061 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -117.7 103.21 9.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.8 t80 -103.14 122.38 44.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.38 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 15.8 mttt -125.11 129.33 49.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -126.99 121.51 31.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 39' ' ' LYS . 36.8 m-85 -131.5 127.95 38.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.763 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -109.93 -81.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 6.2 tptt -146.32 -64.88 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 38.7 Cg_endo -99.59 -6.26 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.089 2.526 . . . . 0.0 111.921 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.56 122.67 47.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.19 120.44 36.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.693 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -120.86 110.6 16.52 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.682 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.9 114.79 23.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.516 178.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.6 mt -138.01 144.05 40.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 112.016 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -112.78 119.95 39.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.312 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 17.2 mt -76.16 155.47 84.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.097 0.475 . . . . 0.0 111.517 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 15.1 Cg_exo -69.27 -16.28 39.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.175 2.584 . . . . 0.0 112.592 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -122.99 -127.81 3.31 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.628 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.482 ' HG3' ' OG ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -154.1 149.37 27.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 77' ' ' PRO . 51.0 mm -118.69 125.62 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 77' ' ' PRO . 7.5 p -59.25 156.64 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.444 . . . . 0.0 111.898 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.39 124.06 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.96 -44.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.68 0.77 30.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 32.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.661 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.35 -173.52 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -135.88 130.91 34.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.405 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -130.35 136.38 8.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.838 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.7 104.89 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.726 0.298 . . . . 0.0 110.583 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -97.13 115.11 26.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 107.62 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.73 -41.0 31.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -50.37 69.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -87.97 -16.76 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 71' ' ' ILE . . . 66.24 63.2 4.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.233 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 70' ' ' GLY . 75.7 mt -158.59 120.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 11.1 t80 -100.11 116.31 31.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.36 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -114.45 118.61 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -128.25 119.72 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.889 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 12.6 mtp180 -85.95 142.63 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.702 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -131.47 140.63 39.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.512 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.817 ' O ' HG23 ' A' ' 55' ' ' ILE . 74.3 Cg_endo -76.9 148.48 28.19 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.756 2.304 . . . . 0.0 112.02 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -93.36 155.86 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.074 0.464 . . . . 0.0 111.433 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.35 -15.36 50.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.129 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 m -138.36 102.28 8.1 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.7 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.97 148.86 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 111.944 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.3 57.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.731 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.43 133.06 41.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.774 0.321 . . . . 0.0 110.499 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 10' ' ' GLN . 6.7 t-80 -128.01 124.52 37.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.2 m-30 -83.04 90.48 7.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.49 173.94 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.06 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 38.09 36.1 0.32 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.809 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.901 ' O ' HD22 ' A' ' 91' ' ' LEU . 8.8 mt -58.23 -61.98 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.195 0.498 . . . . 0.0 110.219 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -79.85 5.76 12.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.422 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 21.6 mtp -117.5 20.61 13.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.401 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -98.32 177.7 5.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.261 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 11.0 p -135.57 167.91 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.779 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.31 130.2 44.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 111.607 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -118.91 131.51 56.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.237 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.7 mp -82.1 120.04 24.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.927 0.394 . . . . 0.0 111.134 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.0 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.0 136.24 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 119.16 61.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.28 137.1 76.26 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.661 2.241 . . . . 0.0 112.149 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.05 67.41 4.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 31.2 p90 -72.36 160.03 33.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.725 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -148.79 149.67 31.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -115.35 134.7 54.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.687 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' THR . 8.1 m -142.86 134.2 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.489 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.678 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.4 pt20 -132.35 144.84 50.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -100.84 159.94 28.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.718 178.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 13.6 Cg_endo -57.16 -8.14 3.23 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.783 2.322 . . . . 0.0 113.604 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 61.9 m-20 -135.89 17.09 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.29 -0.256 . . . . 0.0 110.808 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.1 m-85 -169.46 170.39 8.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.947 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -135.69 108.26 7.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.952 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 91.5 m -101.07 143.4 31.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.172 0.511 . . . . 0.0 110.962 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 38' ' ' PHE . 7.5 mt -116.3 155.12 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -125.93 121.46 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.06 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.74 HD13 ' CG ' ' A' ' 40' ' ' PHE . 15.3 mt -124.81 118.61 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -88.07 119.05 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.223 0.535 . . . . 0.0 112.001 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 21' ' ' VAL . 32.9 m -141.24 113.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.225 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -58.08 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.992 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' ALA . 2.1 m-85 -68.84 -53.58 20.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.004 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 46.81 106.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 8.1 mtt85 -81.73 6.97 13.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 m -133.28 135.59 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.808 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -58.62 -41.54 86.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -125.33 142.63 51.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.893 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -90.65 168.43 11.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.56 115.59 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.965 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.05 115.81 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.466 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -126.69 120.08 28.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -129.23 124.0 33.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 114.09 9.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.581 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.46 -70.85 0.16 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.186 -0.531 . . . . 0.0 113.006 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.45 25.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.086 0.469 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -115.02 107.24 15.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.827 ' CE1' HD12 ' A' ' 17' ' ' ILE . 70.1 t80 -102.84 111.0 23.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 14.6 mttt -116.07 121.95 43.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.658 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.74 ' CG ' HD13 ' A' ' 19' ' ' ILE . 58.2 t80 -124.93 117.77 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 39' ' ' LYS . 16.6 m-85 -124.27 124.73 43.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.63 31.49 4.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 1.3 tppm? 92.59 -88.83 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 111.183 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.604 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 63.6 Cg_endo -85.04 -15.97 5.36 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.237 1.291 . . . . 0.0 111.573 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.08 115.6 30.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.569 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 119.49 29.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.443 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 19' ' ' ILE . 3.6 mt -121.78 115.91 23.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.48 111.65 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.952 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.705 HD13 HD21 ' A' ' 8' ' ' LEU . 83.2 mt -125.59 130.54 51.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.573 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.81 113.03 24.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.2 mt -72.2 137.59 81.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.07 0.462 . . . . 0.0 111.502 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.3 Cg_endo -68.38 -18.91 44.02 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.289 2.659 . . . . 0.0 112.717 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.63 -136.79 5.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.71 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -143.53 138.3 29.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.958 0.409 . . . . 0.0 111.069 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.3 mm -116.12 124.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.834 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.519 HG13 ' HG2' ' A' ' 77' ' ' PRO . 4.9 p -64.83 159.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.531 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.52 130.15 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.378 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.73 17.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.77 3.3 27.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.753 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 m -98.49 44.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 164.36 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' ILE . 8.3 mm-40 -127.49 129.72 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.35 147.89 18.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.588 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.3 p -153.62 104.36 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.717 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -96.82 103.83 15.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -89.49 99.55 12.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.221 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.26 69.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -52.44 -50.59 62.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -76.27 -23.13 54.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.033 0.444 . . . . 0.0 110.174 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.34 46.98 84.15 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.936 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 mt -143.44 148.31 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.543 ' HD2' HD12 ' A' ' 19' ' ' ILE . 14.9 t80 -107.05 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.675 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.59 118.38 30.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -126.48 119.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.65 147.36 25.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 mp -133.6 149.46 72.18 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.5 Cg_endo -79.09 150.13 22.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.613 2.209 . . . . 0.0 111.777 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -96.31 152.86 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.851 0.358 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 1.9 tt0 -84.05 -10.86 57.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.701 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 m -151.36 97.97 3.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.538 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -43.49 153.05 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.663 2.242 . . . . 0.0 112.366 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.57 -1.77 50.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.169 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.95 138.48 39.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.001 0.4 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -127.11 116.97 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.379 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 6.9 m-30 -73.4 91.8 1.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.345 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.51 160.76 13.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.909 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 37.96 46.54 1.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.298 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.651 HD22 HD13 ' A' ' 8' ' ' LEU . 1.7 mt -63.53 -62.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.621 0.21 . . . . 0.0 111.511 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.36 16.55 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -114.97 -29.4 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.296 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 91' ' ' LEU . 2.1 mt -52.96 175.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.357 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.67 174.18 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 111.852 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.19 137.47 42.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 145.2 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.037 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 95' ' ' LEU . 6.1 mp -98.88 121.67 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.929 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.771 0.319 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.4 mt -130.64 122.9 28.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -83.08 129.38 61.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 37.2 Cg_exo -59.7 160.14 22.07 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 111.897 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.14 61.59 6.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.143 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 27.5 p90 -76.03 164.76 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 6.2 t0 -157.46 168.41 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.53 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -124.82 136.98 54.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.227 0.537 . . . . 0.0 111.747 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 16' ' ' THR . 9.6 t -138.43 130.81 28.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.079 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 88' ' ' LEU . 7.7 pm0 -135.86 145.53 46.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.72 161.5 22.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.52 -3.58 1.43 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.81 2.34 . . . . 0.0 113.767 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.638 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.6 m-20 -136.05 12.26 3.34 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.367 -0.208 . . . . 0.0 110.909 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.638 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 23.7 m-85 -167.17 167.48 14.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.484 0.659 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -134.79 109.05 8.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.083 178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' N ' HD22 ' A' ' 15' ' ' LEU . 55.3 m -107.01 126.76 52.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.171 0.51 . . . . 0.0 111.836 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 38' ' ' PHE . 7.7 mt -100.81 155.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.998 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -140.83 112.41 7.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.339 . . . . 0.0 111.691 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.28 128.95 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.502 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HB2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -92.49 120.42 32.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 21' ' ' VAL . 15.3 m -141.76 126.67 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.365 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.05 -30.96 4.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.709 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 58.8 m-85 -69.54 -9.19 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.284 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.88 108.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.55 0.531 . . . . 0.0 111.512 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -88.19 13.39 11.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.7 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.43 137.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.556 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.6 t -56.66 -35.59 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.14 144.63 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -96.31 168.66 10.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.48 124.23 42.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 40' ' ' PHE . 4.2 t -130.75 132.58 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.818 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -121.32 116.21 24.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.938 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 43.3 p90 -116.69 114.19 23.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.067 0.461 . . . . 0.0 111.463 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -138.14 101.6 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.045 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.03 -149.11 17.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.631 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -59.13 -12.12 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.962 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.79 112.09 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 110.63 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.86 ' CE2' HD12 ' A' ' 17' ' ' ILE . 39.6 t80 -120.73 112.01 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.41 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -119.31 126.54 51.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.081 0.467 . . . . 0.0 111.566 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CD1' HG22 ' A' ' 31' ' ' VAL . 8.6 t80 -110.39 148.66 31.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -136.1 110.43 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.973 0.416 . . . . 0.0 111.513 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -131.26 68.81 1.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.682 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER 32.57 -88.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.888 -178.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.625 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 57.2 Cg_endo -69.46 -25.37 30.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.257 1.305 . . . . 0.0 112.579 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.669 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 21.7 m-85 -105.04 125.61 51.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.722 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -125.62 120.67 31.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.961 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -120.94 117.9 28.49 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.542 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -124.42 116.2 22.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 48' ' ' ARG . 80.1 mt -142.89 151.46 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 112.25 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.34 105.88 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.071 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 36' ' ' SER . 3.6 mt -72.02 155.79 91.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -83.02 75.0 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.382 2.721 . . . . 0.0 111.966 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.567 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 145.85 -147.18 18.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.37 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 53' ' ' GLY . 1.1 mtm180 -146.65 142.09 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.121 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 77' ' ' PRO . 14.0 mm -115.07 123.11 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.752 HG13 ' HG2' ' A' ' 77' ' ' PRO . 8.3 p -62.07 154.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 112.536 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.38 130.09 51.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.723 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -177.68 29.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.661 0.267 . . . . 0.0 111.429 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.55 -32.36 3.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.345 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.58 118.51 10.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.556 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.07 163.37 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 4.5 mt-30 -131.78 138.64 48.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.34 137.51 7.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.905 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.76 105.45 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 0.0 110.408 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -103.12 131.72 49.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -115.53 111.55 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.92 -49.32 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.64 -41.83 67.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -97.06 -19.44 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.9 56.68 13.28 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.929 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.634 HD13 ' HB2' ' A' ' 20' ' ' ARG . 21.5 mm -137.19 116.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 111.509 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t80 -111.21 114.42 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -121.49 119.04 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -124.38 119.48 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.622 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HD23 ' A' ' 76' ' ' LEU . 11.4 mtp180 -87.08 148.26 25.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.805 ' HB3' HG21 ' A' ' 55' ' ' ILE . 15.9 mt -134.24 150.73 74.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.208 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.945 ' O ' HG23 ' A' ' 55' ' ' ILE . 94.6 Cg_endo -81.81 157.84 18.51 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.944 2.43 . . . . 0.0 112.162 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -98.0 148.54 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.0 tp10 -85.02 -11.68 54.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.526 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.3 m -148.52 116.87 3.98 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.872 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.3 142.96 45.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.775 2.316 . . . . 0.0 112.441 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 -0.16 89.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.433 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -70.15 119.02 13.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.05 111.95 18.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.13 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.9 m-30 -73.75 90.05 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.487 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' GLY . 22.2 mt-10 -70.7 173.58 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.271 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 35.98 38.61 0.24 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 91' ' ' LEU . 4.0 mt -57.84 -61.6 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.628 0.251 . . . . 0.0 110.538 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -83.67 16.25 2.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.127 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -117.02 -32.24 5.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -45.25 177.11 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.61 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.92 149.53 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.699 0.285 . . . . 0.0 111.183 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.89 137.11 33.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.31 138.33 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 111.607 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.18 114.25 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.857 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.831 0.348 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -134.94 124.12 24.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.461 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -66.5 136.95 95.07 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' A' ' 3' ' ' THR . 50.9 Cg_exo -53.77 136.28 65.03 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.695 2.263 . . . . 0.0 112.055 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -85.72 65.14 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 7.1 p90 -80.34 159.44 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.043 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -145.33 150.65 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -114.81 133.46 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.126 0.489 . . . . 0.0 111.761 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.547 ' O ' HD22 ' A' ' 15' ' ' LEU . 85.5 p -139.51 131.45 27.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.636 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.877 ' OE1' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -130.57 140.98 50.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.339 0.59 . . . . 0.0 112.325 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.28 160.84 28.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.997 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 24.2 Cg_endo -61.46 -1.22 1.79 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.107 2.538 . . . . 0.0 114.196 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.667 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -135.35 2.46 3.0 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.163 -0.335 . . . . 0.0 111.74 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 20.8 m-85 -171.78 172.52 4.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HB3' ' A' ' 10' ' ' GLN . 1.2 tm? -135.86 117.38 14.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.813 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.632 ' N ' HD22 ' A' ' 15' ' ' LEU . 5.5 m -110.57 136.84 49.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.389 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.784 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.4 mt -113.51 150.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 7' ' ' ASP . . . -131.05 106.84 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD13 ' CD2' ' A' ' 40' ' ' PHE . 24.1 mt -108.46 121.99 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -89.88 120.23 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.502 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.83 132.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 p -110.65 -82.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.3 m-85 -39.08 -52.58 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.781 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 41.51 97.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.777 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -60.36 -73.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.206 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.84 142.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.32 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -38.02 78.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.7 140.92 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.2 m-30 -89.44 166.34 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.58 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' OD1' ' OH ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -117.42 118.69 32.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 ' HD1' ' A' ' 40' ' ' PHE . 7.2 t -121.68 119.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.788 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' OH ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 m-85 -118.18 118.95 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.144 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 33' ' ' PHE . 28.3 p90 -121.75 112.73 18.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.453 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.2 mt-10 -135.29 116.79 14.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.22 -75.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.139 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -149.8 26.21 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.469 . . . . 0.0 110.14 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -112.97 107.58 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.784 ' CE2' HD12 ' A' ' 17' ' ' ILE . 50.3 t80 -105.33 111.53 24.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -117.86 131.34 56.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.415 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.6 t80 -127.52 110.3 12.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.657 ' CD1' ' CD2' ' A' ' 46' ' ' PHE . 21.9 m-85 -128.51 130.48 47.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.78 -68.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 tptt -160.35 -72.15 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 45.2 Cg_endo -87.76 -20.37 1.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.092 . . . . 0.0 111.059 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -97.95 119.61 36.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.657 ' CD2' ' CD1' ' A' ' 41' ' ' TYR . 9.9 m-85 -120.13 116.34 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.32 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -118.34 112.63 20.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.812 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.53 112.43 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.901 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -127.02 134.54 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.664 -179.037 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m -108.38 113.72 27.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 34.0 mt -78.42 147.75 72.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.484 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.29 -12.94 27.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.089 2.526 . . . . 0.0 112.162 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -139.36 138.95 9.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.847 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -62.74 155.42 26.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.777 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.6 mm -119.28 126.35 75.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.186 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.9 p -64.4 161.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.414 0.626 . . . . 0.0 112.237 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.2 pm0 -125.03 125.75 44.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -150.13 8.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 -1.21 20.26 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.63 49.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.779 0.324 . . . . 0.0 110.997 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 45.4 tt0 -83.59 163.46 20.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 23.9 mm-40 -122.72 126.0 46.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -135.25 138.46 10.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.158 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.1 p -144.76 108.83 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.904 0.383 . . . . 0.0 111.331 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -109.2 118.01 35.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.53 134.03 52.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -47.73 12.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 110.291 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -52.21 -49.75 63.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.709 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 71' ' ' ILE . 16.7 ttpt -83.78 -19.86 34.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.689 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.46 56.97 19.31 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.73 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 69' ' ' LYS . 5.9 mt -146.85 148.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -115.8 120.34 38.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.121 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 m -119.76 133.38 55.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.658 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -140.88 118.54 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 20.1 mtp180 -92.34 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.306 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB3' HG21 ' A' ' 55' ' ' ILE . 2.7 mp -132.1 147.5 66.08 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.943 ' O ' HG23 ' A' ' 55' ' ' ILE . 89.5 Cg_endo -81.31 148.28 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.713 2.275 . . . . 0.0 111.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 27.7 mmtp -85.24 156.14 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 0.0 111.448 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.4 tt0 -89.39 -22.35 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.185 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -129.19 128.48 23.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.99 133.13 24.43 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.616 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.09 3.6 88.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.099 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -81.5 128.52 33.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.821 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -123.48 118.35 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.6 m-30 -77.97 90.69 4.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.155 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.84 170.77 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 91' ' ' LEU . . . 33.56 43.23 0.25 Allowed Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.59 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.877 HD12 ' OE1' ' A' ' 10' ' ' GLN . 1.7 mt -61.98 -62.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.022 0.411 . . . . 0.0 110.952 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 89' ' ' ASN . 11.2 t-20 -84.16 13.71 4.93 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-O 121.034 0.445 . . . . 0.0 110.692 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.3 -27.94 7.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.505 178.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.739 ' C ' HD23 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.53 177.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.792 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 93' ' ' ALA . 52.9 m -146.73 157.82 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 92' ' ' THR . . . -104.07 129.54 51.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.54 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.62 139.76 36.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.978 0.418 . . . . 0.0 111.17 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.13 112.06 24.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.857 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.886 0.374 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.14 144.26 27.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.826 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.04 125.73 88.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.63 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 23.9 Cg_endo -62.6 171.91 5.13 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.882 2.388 . . . . 0.0 112.413 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' PHE . . . -83.87 -64.97 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER 53.89 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.731 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.4 t0 -154.48 158.2 39.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -118.71 136.44 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 111.333 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.77 133.39 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.6 pm0 -130.01 143.03 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 160.68 25.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.433 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.4 -2.59 6.26 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.424 2.082 . . . . 0.0 113.02 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.92 11.92 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.902 -0.136 . . . . 0.0 110.956 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 66.5 m-85 -170.76 171.01 6.32 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.25 0.548 . . . . 0.0 111.662 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.649 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.2 tm? -134.42 115.91 14.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.927 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 74' ' ' ILE . 37.2 m -107.41 132.11 53.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.368 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.787 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.0 mt -107.12 155.39 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -137.51 118.36 14.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.932 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.502 HD13 ' CD2' ' A' ' 40' ' ' PHE . 44.4 mt -121.13 127.89 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.354 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 39.0 ttt85 -107.84 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 111.674 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 m -151.01 141.89 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -119.15 -35.17 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.664 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' ARG . 9.2 m-85 -66.17 -9.11 28.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.605 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.63 85.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.645 0.591 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.43 -71.74 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.831 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 m -43.71 135.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.7 p -57.99 -40.21 80.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -129.7 147.87 51.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -103.54 167.16 9.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 60.9 m-20 -117.32 121.12 40.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.584 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 t -122.85 119.29 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 55.6 m-85 -126.48 119.72 27.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 31.4 p90 -121.0 113.79 20.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.559 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -140.75 117.53 11.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.6 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.14 66.57 1.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.026 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER 65.55 9.85 6.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.642 0.258 . . . . 0.0 111.394 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 8.1 t70 -102.74 103.66 13.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.787 ' CE2' HD12 ' A' ' 17' ' ' ILE . 21.5 t80 -110.22 121.11 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.344 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 6.0 mttt -124.77 126.52 45.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.648 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.7 t80 -122.14 112.64 18.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.907 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 13.6 m-85 -114.63 101.77 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.028 0.442 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -129.25 118.42 22.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.759 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 40.99 -166.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 93.0 Cg_exo -44.75 -21.36 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.687 1.591 . . . . 0.0 112.848 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 24.9 m-85 -76.61 123.05 25.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 111.734 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -127.45 124.67 38.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.936 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.502 ' HA ' HD23 ' A' ' 47' ' ' LEU . 2.0 mt -120.28 113.87 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' O ' HD23 ' A' ' 49' ' ' LEU . 3.2 ttm-85 -112.02 109.53 19.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.38 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 48' ' ' ARG . 14.6 mt -124.49 129.55 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 112.201 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.27 109.03 21.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.455 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 14.0 mt -63.15 128.32 92.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 111.126 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.96 -26.38 14.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.052 2.502 . . . . 0.0 113.176 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -116.51 -132.91 5.04 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -142.37 136.49 29.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 110.804 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -117.29 125.21 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.8 p -62.21 156.97 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 112.063 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.79 131.43 53.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.67 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 21.5 m-80 -171.19 21.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.44 7.03 44.39 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.152 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -97.99 45.81 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.03 172.64 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -141.24 139.32 33.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -147.52 159.06 27.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.972 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -157.67 118.47 3.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.3 . . . . 0.0 110.429 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -117.62 137.35 52.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -119.11 119.24 33.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.235 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.06 -53.26 15.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.519 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -55.02 -46.17 75.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 71' ' ' ILE . 28.3 ttpt -84.38 -26.82 28.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 66.2 63.02 4.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLY . 1.4 mt -148.72 121.04 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.449 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.6 t80 -109.68 110.97 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 147.73 29.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.351 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 16' ' ' THR . 3.8 tp -138.35 154.14 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.101 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -135.32 141.69 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -136.14 149.97 69.72 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 111.752 -178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 56' ' ' VAL . 78.1 Cg_endo -78.13 154.71 29.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.906 2.404 . . . . 0.0 112.206 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HD2' HD13 ' A' ' 55' ' ' ILE . 6.6 mmtp -99.76 151.89 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 3.1 tm-20 -87.69 -4.11 58.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.793 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.6 m -157.68 120.84 2.14 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.223 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 146.29 96.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.0 111.938 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 1.79 89.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.55 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -78.66 126.56 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -125.34 117.42 23.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.0 m-30 -73.92 90.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.2 168.67 11.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.84 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.77 41.81 0.96 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.44 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 91' ' ' LEU . 6.3 mt -60.61 -61.99 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.854 0.327 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.44 15.22 2.12 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 0.0 111.337 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.49 ' O ' ' O ' ' A' ' 91' ' ' LEU . 34.5 mtt -117.74 -32.26 4.89 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -42.13 170.55 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.991 179.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.8 p -127.34 169.15 13.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.61 133.32 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -119.57 131.9 55.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 6.9 mp -93.7 125.23 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.752 0.31 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.01 107.93 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.7 m -42.68 115.96 1.79 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.04 154.78 26.18 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.344 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.02 57.1 2.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 49.0 p90 -66.14 166.73 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.981 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 150.7 32.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -113.32 133.9 54.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 0.0 111.506 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.6 p -139.4 133.53 31.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.961 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.603 ' HB3' HD23 ' A' ' 15' ' ' LEU . 9.7 pm0 -130.05 141.45 50.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 0.0 112.691 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.37 160.4 26.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.204 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.27 -2.9 3.49 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.473 2.115 . . . . 0.0 113.298 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 7.3 m-20 -135.9 13.74 3.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.672 0.272 . . . . 0.0 110.563 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 73.1 m-85 -168.22 167.35 12.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.469 0.652 . . . . 0.0 111.864 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.671 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.0 tm? -134.59 106.24 6.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 74' ' ' ILE . 97.2 m -107.75 137.1 46.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.554 HG23 HD23 ' A' ' 8' ' ' LEU . 6.7 mt -126.88 137.91 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.151 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -126.36 139.17 53.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.997 0.427 . . . . 0.0 111.168 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.64 HD12 ' CD2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -122.43 134.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.792 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -77.47 120.06 21.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.857 0.361 . . . . 0.0 110.641 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.64 139.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 p -127.66 -52.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.344 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' ALA . 9.3 m-30 -66.71 -52.77 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.767 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 42.33 96.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.773 0.32 . . . . 0.0 110.626 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 mpt_? -76.76 3.13 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.699 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 43' ' ' LYS . 4.6 m -128.65 133.58 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -41.54 72.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.606 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.67 138.61 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -85.02 163.46 18.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -110.28 111.75 23.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.722 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' HD1' ' A' ' 40' ' ' PHE . 4.3 t -117.81 116.18 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.909 0.385 . . . . 0.0 111.479 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -124.02 118.11 26.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.682 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 1.8 p90 -126.79 122.66 35.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.659 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 119.01 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.546 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 63.75 -75.86 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.417 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -151.27 26.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.601 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 1.4 m-20 -118.23 129.48 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.4 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -123.44 111.48 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -116.67 128.2 55.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.64 ' CD2' HD12 ' A' ' 19' ' ' ILE . 70.0 t80 -128.93 114.78 16.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.996 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -120.48 127.97 52.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.317 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -134.65 34.18 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.274 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 17.7 tppt? 93.77 -87.95 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.073 0.949 . . . . 0.0 111.218 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 43' ' ' LYS . 44.8 Cg_endo -86.87 -16.01 3.67 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.499 1.466 . . . . 0.0 111.921 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.98 117.37 34.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.984 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -126.59 119.85 28.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -115.61 113.27 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.59 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 109.98 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 8' ' ' LEU . 75.8 mt -126.16 133.78 51.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 111.621 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.6 m -90.43 105.57 17.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.983 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 55' ' ' ILE . 10.5 mt -64.68 133.07 95.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.148 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.8 Cg_endo -68.41 -23.41 37.96 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.937 2.424 . . . . 0.0 112.75 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.55 -138.35 6.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.623 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -136.02 128.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 111.51 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.714 HG21 ' HB3' ' A' ' 76' ' ' LEU . 4.8 mm -116.14 125.6 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.603 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 7.7 p -60.25 157.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.078 0.466 . . . . 0.0 111.754 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.16 134.58 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.903 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -36.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.25 -11.58 26.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.651 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -68.6 -71.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.023 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.597 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.3 pt-20 32.92 -156.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.2 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 70.1 mt-30 -143.63 126.61 16.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.7 136.05 9.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.561 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.5 p -152.68 111.42 3.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.34 . . . . 0.0 110.815 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.85 108.5 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.402 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.19 98.62 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.38 83.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -52.69 51.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -72.82 -16.54 61.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.664 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 65.87 38.35 94.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.185 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -145.01 151.94 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.323 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 45.3 t80 -111.69 123.33 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.47 HG22 HG21 ' A' ' 16' ' ' THR . 3.2 m -119.07 132.85 56.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.107 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.597 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -140.07 118.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HA ' ' OG1' ' A' ' 16' ' ' THR . 15.0 mtp180 -86.46 148.59 25.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.2 mt -134.04 116.31 13.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 111.887 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.704 ' O ' HG23 ' A' ' 55' ' ' ILE . 66.2 Cg_exo -53.81 149.17 34.32 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.201 2.6 . . . . 0.0 112.805 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.26 153.75 17.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 1.3 tt0 -81.03 -15.0 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.473 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m -144.85 129.27 8.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.729 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.4 149.9 69.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.752 2.301 . . . . 0.0 112.836 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.21 77.84 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.787 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.49 129.86 37.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -122.07 115.54 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.584 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.6 m-30 -74.88 89.72 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.116 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 162.51 12.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.445 ' HA2' ' HG3' ' A' ' 90' ' ' MET . . . 35.59 46.53 0.82 Allowed Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.525 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 91' ' ' LEU . 4.7 mt -59.88 -61.98 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.783 0.292 . . . . 0.0 110.668 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -86.95 13.16 9.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.098 0.475 . . . . 0.0 110.223 179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.445 ' HG3' ' HA2' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -108.36 -31.57 7.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.126 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -44.07 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.814 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.02 -177.77 3.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.88 112.38 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -121.98 125.33 46.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.063 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mp -98.11 133.88 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.904 179.907 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 128.72 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.953 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.9 t -60.41 138.32 92.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.91 164.69 2.31 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.73 2.287 . . . . 0.0 112.052 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.92 55.88 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.394 . . . . 0.0 110.397 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 49' ' ' LEU . 35.7 p90 -61.84 163.25 7.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.294 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.12 145.6 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.69 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 49' ' ' LEU . 6.0 mt -113.75 133.64 55.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t -138.81 130.22 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.613 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.995 ' OE1' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -131.12 140.47 49.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 112.123 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.26 160.77 28.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.8 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.51 -2.2 0.93 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.041 2.494 . . . . 0.0 114.243 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.2 m-20 -136.41 3.69 2.83 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 122.058 -0.401 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.64 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.1 m-85 -169.3 169.38 9.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.2 tm? -135.65 107.87 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.036 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 74' ' ' ILE . 29.8 m -101.56 143.01 32.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 110.877 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 8' ' ' LEU . 23.1 mt -115.82 154.15 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.647 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -129.79 122.6 29.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.303 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.6 mt -125.95 123.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.481 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 118.39 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.707 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.02 133.25 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.045 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -120.65 -32.95 3.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.1 m-85 -87.15 -53.35 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . 18.89 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.747 0.655 . . . . 0.0 112.01 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -56.99 -60.0 4.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -33.91 124.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 111.009 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 p -54.84 -39.95 69.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -125.31 139.49 53.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.353 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.0 OUTLIER -85.85 160.32 19.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 9.2 m-20 -112.88 113.11 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.728 0.299 . . . . 0.0 110.998 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 40' ' ' PHE . 10.7 t -117.02 115.93 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.991 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 11.2 m-85 -116.67 114.65 24.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 36.3 p90 -124.75 116.27 22.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 42.5 mt-10 -138.22 115.16 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.79 -68.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -157.89 22.66 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.524 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -111.23 104.64 13.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.14 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 17' ' ' ILE . 82.9 t80 -106.38 116.64 32.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.4 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 mptt -119.92 131.01 55.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 92.5 t80 -130.95 116.78 18.3 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 17.6 m-85 -115.54 110.23 18.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.668 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -108.16 24.1 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 95.91 -87.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 O-C-N 124.235 0.959 . . . . 0.0 110.658 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 80.6 Cg_endo -83.0 -16.38 7.47 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.491 1.461 . . . . 0.0 111.801 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -109.97 131.92 54.62 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.809 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 19.7 t80 -127.35 126.96 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.55 HD12 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -121.55 112.14 18.11 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.84 115.17 22.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 178.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 8' ' ' LEU . 90.7 mt -137.04 144.03 42.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.69 113.31 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.249 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.3 mt -73.89 135.78 77.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.567 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HG3' ' CD1' ' A' ' 91' ' ' LEU . 36.3 Cg_exo -61.47 -22.09 73.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.071 2.514 . . . . 0.0 113.003 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.59 ' HA3' ' CD1' ' A' ' 85' ' ' PHE . . . -113.07 -142.61 8.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.129 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 2.4 mmt-85 -142.18 139.35 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.864 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.9 mm -117.81 124.96 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 77' ' ' PRO . 6.2 p -56.24 152.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.402 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -110.41 123.07 49.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.042 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.55 -39.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.96 -19.43 32.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -59.87 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 30.96 -152.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.468 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mt-30 -157.33 131.45 8.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.34 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.58 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.98 141.69 13.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.065 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -159.51 105.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -107.41 137.81 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.25 115.58 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.14 -46.63 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.33 -50.57 69.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.767 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.761 ' CD ' HD12 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -79.61 -23.21 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 69.4 63.36 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.672 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.761 HD12 ' CD ' ' A' ' 69' ' ' LYS . 54.0 mt -160.23 126.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.9 t80 -108.12 118.79 37.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.515 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.487 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -122.54 122.39 38.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.593 ' C ' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER -130.51 122.93 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.441 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.68 140.93 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.668 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.839 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mp -129.37 129.81 23.28 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.977 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.3 Cg_endo -66.82 150.74 83.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.926 2.417 . . . . 0.0 112.184 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HE3' ' C ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -92.7 155.81 17.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -71.36 -19.74 62.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.701 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -146.51 120.88 5.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.0 152.02 54.01 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.886 2.391 . . . . 0.0 112.624 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.75 -4.0 62.31 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -77.53 135.43 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.125 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.43 116.45 21.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 5.5 m-30 -67.93 89.76 0.29 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.698 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -74.42 172.78 11.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 112.018 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' LEU . . . 45.03 32.66 3.37 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.41 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.995 HD11 ' OE1' ' A' ' 10' ' ' GLN . 8.7 mt -43.13 -53.29 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.723 0.761 . . . . 0.0 110.146 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -97.96 -40.37 8.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.0 mtp -78.18 6.81 7.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.036 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' GLY . 0.9 OUTLIER -51.33 178.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 p -123.45 160.26 27.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.33 113.64 27.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.787 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -123.56 112.33 17.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.834 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 95' ' ' LEU . 5.2 mp -95.16 116.58 28.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.758 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.931 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.801 0.334 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.16 152.22 20.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.034 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.35 105.53 43.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.218 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.91 172.31 12.16 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.985 2.457 . . . . 0.0 112.725 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.16 60.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 38.2 p90 -68.65 161.52 27.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.819 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.54 148.22 29.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.81 134.21 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.262 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -141.84 136.05 30.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.301 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.24 141.89 50.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.317 0.58 . . . . 0.0 112.329 -178.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -101.44 157.84 32.9 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.507 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 10.5 Cg_endo -54.75 -8.16 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 113.629 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 47.1 m-20 -135.52 15.48 3.42 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.324 -0.235 . . . . 0.0 111.292 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 13.1 m-85 -169.5 170.71 8.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.481 0.658 . . . . 0.0 112.321 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.77 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -132.82 112.67 12.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.6 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.491 ' N ' HD22 ' A' ' 15' ' ' LEU . 30.2 m -104.67 138.02 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 1.9 mt -114.33 149.41 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -129.76 120.26 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 111.074 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 47' ' ' LEU . 13.1 mt -126.0 119.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.5 mtt180 -90.69 120.64 31.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.412 . . . . 0.0 111.813 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 m -141.88 129.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -72.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.997 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.4 m-30 -48.42 -52.91 19.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.909 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' HA ' ' CD ' ' A' ' 43' ' ' LYS . . . 39.49 95.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.89 5.32 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.877 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 43' ' ' LYS . 27.1 m -127.46 133.28 68.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -41.11 82.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.72 148.28 50.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.653 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -98.67 168.71 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.301 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.95 118.55 36.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.11 115.35 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 0.0 112.027 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -125.39 117.87 24.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -120.41 118.95 31.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.142 0.496 . . . . 0.0 111.72 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.21 96.76 3.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.621 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.09 -146.68 18.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.685 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -54.33 -14.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.628 0.251 . . . . 0.0 111.63 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.83 117.27 26.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' ' 17' ' ' ILE . 61.2 t80 -127.67 113.27 15.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 131.34 55.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 111.574 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.48 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 69.8 t80 -126.64 109.7 12.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.519 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -107.69 108.31 19.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.188 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -140.82 119.42 12.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.194 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 38.04 -161.66 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.716 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 73.0 Cg_exo -50.91 -17.3 3.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.208 1.272 . . . . 0.0 112.567 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 51.4 m-85 -74.55 112.81 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.341 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.25 116.21 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 19' ' ' ILE . 4.4 mt -119.35 114.65 22.69 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.06 115.84 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.15 178.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 48' ' ' ARG . 78.2 mt -134.0 143.04 47.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 112.16 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -105.21 105.17 15.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.204 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 88.2 mt -62.4 145.3 94.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.178 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 37.5 Cg_exo -60.12 -23.43 73.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.778 2.318 . . . . 0.0 112.055 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -125.36 -125.04 2.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.3 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -154.15 149.54 27.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.975 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.907 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.5 mm -117.77 123.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 5.3 p -58.12 151.39 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -119.1 125.32 49.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.808 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.45 27.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.412 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.56 -32.73 2.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.154 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.71 120.21 9.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.137 0.468 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.0 163.88 6.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.632 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 6.2 mt-30 -143.53 134.38 25.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.702 ' HA3' HD12 ' A' ' 74' ' ' ILE . . . -140.38 146.06 17.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.661 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -139.27 112.1 7.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 110.65 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -104.57 120.21 40.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.235 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -114.01 110.74 20.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.563 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.99 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -57.26 -50.27 73.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 9.8 ttpt -74.2 -22.13 59.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 61.24 63.21 5.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.267 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 ' HG3' ' A' ' 20' ' ' ARG . 14.6 mt -156.84 131.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.118 0.485 . . . . 0.0 112.054 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' A' ' 40' ' ' PHE . 12.9 t80 -116.21 113.76 23.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.505 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 134.05 55.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.194 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.702 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.0 OUTLIER -138.58 117.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' NH2' ' OG ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -91.13 142.28 27.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.178 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.2 mp -134.37 145.88 57.11 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.631 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' ILE . 59.4 Cg_endo -73.42 151.36 47.87 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.831 2.354 . . . . 0.0 112.433 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -95.47 156.68 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.103 0.478 . . . . 0.0 111.704 -179.414 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 12.0 tt0 -88.22 -6.25 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 45.1 m -159.51 96.09 1.64 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.318 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 9.8 Cg_endo -53.58 157.56 9.42 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.498 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.87 -6.42 70.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.493 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 37.3 tt0 -84.79 141.0 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.308 . . . . 0.0 110.81 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -124.26 117.06 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 8.2 m-30 -72.72 92.69 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -72.0 173.7 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.311 0.577 . . . . 0.0 111.913 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.422 ' HA2' ' HG3' ' A' ' 90' ' ' MET . . . 35.9 40.15 0.33 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.667 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 10.5 mt -60.66 -63.04 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.976 0.388 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.47 16.18 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.087 0.47 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -115.55 -31.96 5.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 90' ' ' MET . 3.5 mt -46.12 177.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.482 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 p -136.27 176.08 9.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.524 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.12 132.42 50.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -105.12 129.14 53.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.1 mp -99.24 121.28 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.964 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.953 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.694 0.206 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.25 54.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -58.19 161.25 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.44 146.99 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.3 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 138.59 54.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.226 0.536 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 p -141.66 133.94 27.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.552 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.712 ' OE1' HD12 ' A' ' 88' ' ' LEU . 2.7 pm0 -130.7 140.73 50.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.371 0.605 . . . . 0.0 112.457 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.37 160.56 26.11 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.986 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.68 -6.06 1.47 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.03 2.486 . . . . 0.0 113.947 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.4 m-20 -135.95 8.91 3.27 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.625 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 65.7 m-85 -168.24 168.41 11.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 111.733 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.72 109.58 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.615 178.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.649 ' N ' HD22 ' A' ' 15' ' ' LEU . 19.4 m -99.41 147.26 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.799 HD12 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mt -125.4 153.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.12 121.94 16.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 112.069 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.08 124.23 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.796 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.8 118.71 37.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.358 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -148.25 143.21 19.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -125.57 -23.22 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.7 m-85 -75.56 -10.05 59.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.534 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.55 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.476 0.485 . . . . 0.0 111.811 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -82.69 10.22 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.287 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.11 127.44 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.785 179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -55.8 -24.19 34.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.12 153.52 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -108.55 168.39 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.378 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -129.03 128.51 43.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.95 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.2 117.6 26.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 21.2 p90 -128.86 119.28 24.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.8 OUTLIER -140.71 122.21 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.114 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.87 -70.21 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.642 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -160.38 25.4 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 0.0 110.592 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 6.7 t70 -116.22 110.61 19.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.799 ' CE2' HD12 ' A' ' 17' ' ' ILE . 26.1 t80 -105.54 111.82 24.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.224 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.28 128.17 50.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 47.8 t80 -104.99 143.08 33.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 32.7 m-85 -135.49 102.81 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -149.0 112.73 5.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.8 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER 47.02 -175.63 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 84.6 Cg_exo -37.0 -27.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.16 1.907 . . . . 0.0 112.744 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 12.6 m-30 -63.15 120.82 12.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.381 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -125.27 120.05 30.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.648 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -116.98 115.66 25.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.049 0.452 . . . . 0.0 112.024 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.28 110.17 16.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.897 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.9 mt -124.18 130.63 52.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.367 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 m -102.14 107.67 18.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 23.1 mt -65.28 143.89 98.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.199 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 49.9 Cg_endo -70.27 -23.82 28.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.785 2.323 . . . . 0.0 112.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -116.74 -137.28 5.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.186 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 82.3 mtt-85 -140.47 132.76 28.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 77' ' ' PRO . 52.0 mm -113.78 124.41 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.481 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.793 HG13 ' HG2' ' A' ' 77' ' ' PRO . 10.1 p -68.03 162.56 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.4 pt-20 -123.74 127.66 48.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.218 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.24 6.68 0.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.96 23.63 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -82.1 -69.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.994 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 31.55 -156.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.698 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 1.8 mm-40 -179.94 119.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 74' ' ' ILE . . . -170.06 -179.16 41.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.175 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -164.14 148.93 10.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CD1' ' HE2' ' A' ' 29' ' ' PHE . 14.9 t80 -113.85 132.94 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.436 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -124.93 125.3 43.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.475 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.83 -34.26 26.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.422 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -50.53 65.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.545 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -94.15 -11.0 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 63.15 62.21 5.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.259 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 70' ' ' GLY . 6.1 mt -155.05 127.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.514 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.1 t80 -110.49 114.79 28.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.501 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -121.7 126.13 48.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.263 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 2.1 tp -133.49 120.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 5.1 mtp180 -92.33 145.1 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.487 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.579 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.9 mt -134.66 143.17 45.39 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' ILE . 47.9 Cg_endo -73.18 158.98 48.24 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.789 2.326 . . . . 0.0 112.657 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 1.7 mttt -96.76 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.99 -11.03 51.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.399 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.2 m -147.52 130.49 7.98 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.846 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.06 142.54 81.47 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.99 2.46 . . . . 0.0 112.74 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 2.87 87.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.571 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 tt0 -78.1 126.75 31.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.736 0.303 . . . . 0.0 110.845 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.526 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -128.35 121.3 28.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 4.8 m-30 -76.16 92.95 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.426 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 170.49 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.736 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.8 40.33 0.2 Allowed Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.541 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.712 HD12 ' OE1' ' A' ' 10' ' ' GLN . 2.6 mt -59.53 -61.52 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.959 0.379 . . . . 0.0 110.382 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.899 0.381 . . . . 0.0 110.943 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.898 0.291 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.26 63.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.6 p90 -68.69 160.28 30.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.062 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.1 149.95 31.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.534 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.72 135.19 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.159 0.504 . . . . 0.0 111.465 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' THR . 59.5 p -139.33 133.82 31.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.319 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.594 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.1 pm0 -129.94 139.52 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.26 160.35 27.79 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.824 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.54 -6.61 7.37 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.663 2.242 . . . . 0.0 112.982 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 49.4 m-20 -135.01 13.76 3.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.521 0.201 . . . . 0.0 110.713 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.1 m-85 -169.92 171.81 6.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.537 0.684 . . . . 0.0 112.163 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.663 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.72 108.32 7.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.685 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.653 ' N ' HD22 ' A' ' 15' ' ' LEU . 14.1 m -99.72 144.68 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 111.203 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 19.2 mt -119.42 152.77 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -132.78 112.57 12.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 17.5 mt -125.09 120.13 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' NH1' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -102.55 120.86 41.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.71 132.77 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -32.1 4.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' ALA . 5.5 m-85 -71.12 -9.9 58.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.016 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -29.8 122.53 0.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.453 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 12.16 30.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 42' ' ' ALA . 3.1 m -139.22 138.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -58.95 -40.95 86.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -117.33 141.59 48.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -92.96 168.94 10.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.774 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.0 116.57 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.435 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 ' HD1' ' A' ' 40' ' ' PHE . 21.9 t -121.96 120.75 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.19 127.83 43.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 23.9 p90 -132.2 121.89 24.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.4 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' SER . 18.9 pt-20 -138.65 119.93 14.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.62 -71.49 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.368 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -159.86 26.47 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.083 0.468 . . . . 0.0 109.961 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m-20 -115.76 104.51 11.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 25.7 t80 -105.68 120.76 42.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -124.77 135.62 53.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.611 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' HD1' HG22 ' A' ' 31' ' ' VAL . 85.3 t80 -129.09 112.35 13.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.78 133.71 46.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 111.234 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -105.27 -59.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -163.03 -64.73 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.485 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 48.3 Cg_endo -97.71 -10.76 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.986 2.458 . . . . 0.0 112.782 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -108.52 134.55 51.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 8.5 t80 -123.62 118.42 27.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.069 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 1.1 mt -115.75 111.2 20.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.486 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.2 109.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.699 0.285 . . . . 0.0 110.57 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.67 131.12 53.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.942 0.401 . . . . 0.0 111.549 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 m -101.16 110.3 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 20.9 mt -68.63 129.99 92.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 51.4 Cg_exo -54.53 -23.18 30.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.969 2.446 . . . . 0.0 112.734 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -117.91 -133.58 4.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 23.3 mtt-85 -146.5 141.01 26.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.978 HG23 ' O ' ' A' ' 77' ' ' PRO . 9.5 mm -118.45 126.06 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.57 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.6 p -58.46 157.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.573 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -121.06 128.41 52.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.661 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -163.96 -41.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.43 -0.03 26.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -91.06 31.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.558 ' HG3' ' CD ' ' A' ' 77' ' ' PRO . 21.2 mp0 -80.0 -168.76 1.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.943 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -131.96 122.29 25.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -122.33 135.0 10.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -147.74 104.88 3.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 136.91 54.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.567 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.04 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -43.59 22.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.494 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -60.3 -52.89 63.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 9.6 ttpt -78.71 -24.48 44.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 65.26 61.38 5.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.562 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -149.77 126.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.388 . . . . 0.0 111.6 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' ILE . 5.5 t80 -110.72 108.35 18.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -115.62 120.43 39.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.946 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.49 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -130.23 118.54 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.431 . . . . 0.0 111.886 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -85.85 142.77 28.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.059 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.832 ' HB3' HG21 ' A' ' 55' ' ' ILE . 8.7 mt -128.44 132.22 24.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 111.666 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -64.95 153.26 79.05 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.757 2.304 . . . . 0.0 112.261 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HG3' ' C ' ' A' ' 13' ' ' ASP . 1.6 mttt -96.67 151.06 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 111.523 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.53 -14.19 49.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.113 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.2 m -146.8 108.15 4.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.565 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.8 148.75 15.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.641 2.228 . . . . 0.0 112.397 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 -1.68 86.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.637 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -79.26 132.0 36.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 10' ' ' GLN . 8.2 t-80 -127.04 119.98 27.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.524 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 9.1 m-30 -77.03 90.93 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 173.6 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 112.213 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.45 37.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.902 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 85' ' ' PHE . 20.2 mt -61.21 -63.58 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.239 0.519 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.334 -0.09 0 CA-C-O 121.039 0.447 . . . . 0.0 110.327 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.463 -0.282 0 CA-C-O 120.73 0.221 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.01 60.1 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.69 159.76 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -144.3 143.73 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.81 134.63 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.512 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -139.35 133.11 30.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.391 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 6.2 pm0 -130.36 140.65 50.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.477 0.656 . . . . 0.0 112.477 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 5.5 m-20 -108.31 160.28 27.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.134 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.44 -0.97 2.7 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.648 2.232 . . . . 0.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 40.6 m-20 -135.75 4.82 3.09 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.451 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 17.8 m-85 -167.07 167.05 14.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.329 0.585 . . . . 0.0 112.303 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.1 tm? -134.8 112.03 10.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.138 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' ' CG ' ' A' ' 75' ' ' ARG . 55.0 m -108.78 135.67 49.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.0 111.275 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.567 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.3 mt -109.73 152.65 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.5 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.92 119.42 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.66 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.62 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -124.8 129.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -107.29 119.17 38.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.077 0.465 . . . . 0.0 111.6 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.37 128.65 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.536 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.24 -36.37 7.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.654 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' C ' ' A' ' 24' ' ' ALA . 53.9 m-85 -65.78 -10.21 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.62 118.27 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.709 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -98.76 -69.44 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.757 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -43.41 125.24 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -20.15 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.724 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -137.0 148.13 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.605 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -103.91 166.84 10.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.865 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -124.31 127.58 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.9 t -123.55 121.17 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -127.6 123.15 34.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 24.0 p90 -134.21 126.03 29.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -139.21 119.57 13.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.98 -68.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.78 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -161.89 26.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 0.0 110.391 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.0 m-20 -116.19 104.54 11.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 17' ' ' ILE . 42.7 t80 -99.11 112.08 24.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 36.1 mttt -118.24 117.43 29.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.385 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 19' ' ' ILE . 24.3 t80 -102.68 143.22 32.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.77 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 25.2 m-85 -137.52 112.35 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -144.48 104.51 4.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.092 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.581 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 2.8 pttt 44.92 -163.34 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 71.0 Cg_exo -41.4 -22.6 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.987 1.791 . . . . 0.0 113.636 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.528 ' CZ ' ' HE2' ' A' ' 43' ' ' LYS . 17.0 m-30 -73.09 122.78 22.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.182 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -129.93 125.4 35.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.324 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -123.13 117.77 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 0.0 111.915 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.2 tmm_? -117.89 113.31 21.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 48' ' ' ARG . 29.3 mt -124.21 132.21 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.941 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m -98.99 106.75 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.8 mt -66.21 126.27 91.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.459 . . . . 0.0 111.456 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 32.1 Cg_exo -57.01 -26.55 69.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.031 2.487 . . . . 0.0 112.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.13 -140.12 7.62 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 5.9 mtt180 -137.63 128.09 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.369 . . . . 0.0 111.368 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.0 mm -111.73 123.75 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.916 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.588 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -62.36 158.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.188 0.518 . . . . 0.0 112.376 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -123.17 129.58 51.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.601 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -165.21 -37.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.98 9.25 20.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.711 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.98 33.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 76' ' ' LEU . 2.1 pt-20 -85.77 -172.95 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 14.0 mt-30 -132.37 122.19 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.807 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -123.48 134.81 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.721 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.84 107.89 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -107.05 139.57 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' GLY . 65.6 t0 -116.22 112.72 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.474 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.64 -53.68 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.339 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -53.82 -44.62 70.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' HG13 ' A' ' 71' ' ' ILE . 35.1 ttpt -84.73 -26.7 27.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.71 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 69.69 63.4 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.649 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 69' ' ' LYS . 7.0 mt -154.34 119.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 111.65 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -103.12 109.47 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 97.5 m -114.3 121.71 44.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.474 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -131.99 121.1 46.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.59 144.21 26.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.022 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 HD12 ' A' ' 15' ' ' LEU . 10.3 mt -133.51 150.61 75.47 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.979 ' O ' HG23 ' A' ' 55' ' ' ILE . 17.7 Cg_endo -86.76 157.74 8.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.226 2.617 . . . . 0.0 112.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 1.5 mtpm? -101.42 156.6 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.939 0.4 . . . . 0.0 111.644 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -90.5 -6.15 55.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 80' ' ' THR . 5.6 m -156.86 90.03 2.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.8 153.54 0.27 Allowed 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 123.011 2.474 . . . . 0.0 112.929 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.26 -11.2 66.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.887 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.513 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 5.0 tp60 -81.28 136.86 35.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.671 0.272 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 2.2 t-80 -125.72 116.87 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.838 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.4 m-30 -71.51 94.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.48 174.33 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.9 36.21 0.12 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.569 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 37.8 mt -58.89 -63.41 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.516 0.658 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.333 -0.128 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.55 179.576 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.656 0.19 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.41 ' O ' ' NE ' ' A' ' 20' ' ' ARG . . . -94.1 57.66 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.186 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 14.3 p90 -72.58 169.46 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -156.92 164.08 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -128.63 141.32 51.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.251 0.548 . . . . 0.0 111.875 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.76 134.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.041 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.517 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.76 144.03 51.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.98 160.86 27.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.04 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.61 -0.61 2.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.969 2.446 . . . . 0.0 113.686 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.627 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -135.92 6.31 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.443 -0.161 . . . . 0.0 111.195 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.8 m-85 -168.98 169.17 9.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.394 0.616 . . . . 0.0 111.855 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.819 HD22 ' N ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -133.21 120.19 20.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.419 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.819 ' N ' HD22 ' A' ' 15' ' ' LEU . 85.7 m -111.94 149.8 31.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.966 0.412 . . . . 0.0 111.21 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.783 HG23 HD23 ' A' ' 8' ' ' LEU . 16.3 mt -124.99 151.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.308 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB1' ' NH1' ' A' ' 20' ' ' ARG . . . -140.58 122.63 15.64 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 47' ' ' LEU . 6.8 mt -125.61 131.27 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -108.59 119.38 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.35 . . . . 0.0 110.805 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -145.84 136.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.103 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.09 -36.06 5.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.02 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' ARG . 28.1 m-85 -64.49 -10.36 25.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.07 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.35 86.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.033 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.3 -72.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.621 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.1 m -50.18 137.23 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.43 -41.12 98.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.64 143.1 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.706 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.36 164.48 12.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.009 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -112.39 118.02 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.84 114.6 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -127.45 124.39 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 44.1 p90 -123.58 116.18 22.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -138.2 121.09 16.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.39 59.97 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.93 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 64.52 22.97 12.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.334 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 16.1 t0 -111.57 103.77 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CD1' ' CD1' ' A' ' 17' ' ' ILE . 80.7 t80 -101.35 113.18 26.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 111.73 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -108.56 110.37 21.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.041 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 77.4 m-85 -113.03 106.29 14.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 111.322 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -136.0 118.85 16.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.4 OUTLIER 44.48 -169.62 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 43' ' ' LYS . 81.8 Cg_exo -47.11 -14.16 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.133 1.889 . . . . 0.0 113.278 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.571 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 18.0 m-30 -80.83 125.52 30.19 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.844 0.354 . . . . 0.0 111.355 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.76 122.99 36.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.356 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -117.25 110.08 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 111.363 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.643 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.2 ttm180 -112.27 110.23 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.907 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 48' ' ' ARG . 18.5 mt -126.58 130.91 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 111.862 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.7 m -104.73 114.17 28.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.484 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.2 mt -81.47 147.2 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.7 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 21.5 Cg_exo -64.95 -17.63 59.95 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.997 2.464 . . . . 0.0 112.163 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -138.47 135.12 7.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -64.22 163.54 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.133 0.492 . . . . 0.0 111.838 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.976 HG23 ' O ' ' A' ' 77' ' ' PRO . 28.2 mm -123.28 129.31 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 13.9 p -54.51 150.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.568 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -108.31 121.33 44.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.251 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -154.44 -40.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.55 -21.28 21.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -57.95 -65.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.626 0.251 . . . . 0.0 110.742 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' OE2' HD11 ' A' ' 74' ' ' ILE . 26.6 pt-20 28.07 -145.95 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.136 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -167.54 146.15 4.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.609 0.243 . . . . 0.0 110.512 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -154.16 145.91 13.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.896 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.46 110.48 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.658 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.524 ' CE1' ' CG ' ' A' ' 72' ' ' PHE . 31.7 m-85 -94.73 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.32 112.11 24.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -57.09 -52.27 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -21.03 39.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 66.34 63.11 4.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.697 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 70' ' ' GLY . 21.1 mt -158.59 128.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.947 0.403 . . . . 0.0 111.581 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.524 ' CG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 t80 -106.06 109.71 21.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.489 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.56 119.55 38.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -130.55 119.76 46.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.538 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 46.9 mtp180 -85.8 146.35 26.81 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.637 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 55' ' ' ILE . 11.3 mt -136.06 133.21 19.56 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.098 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.9 Cg_exo -73.59 150.11 44.99 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.789 2.326 . . . . 0.0 111.725 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HE2' ' N ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -90.42 156.55 18.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.147 0.499 . . . . 0.0 112.272 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.54 -20.34 22.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.228 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.6 m -131.64 89.55 39.48 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.599 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -41.72 141.27 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.902 2.401 . . . . 0.0 112.524 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.11 -4.81 83.15 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.084 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 10.5 tt0 -80.4 131.23 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.827 0.314 . . . . 0.0 110.36 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.484 ' ND1' ' OE1' ' A' ' 10' ' ' GLN . 2.8 t60 -126.75 124.5 39.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.092 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 88' ' ' LEU . 1.2 m-30 -88.5 93.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.093 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.83 126.44 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.11 57.95 0.66 Allowed Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.065 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 85' ' ' PHE . 1.3 mp -48.53 -21.9 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.166 0.483 . . . . 0.0 110.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.52 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.876 0.282 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.73 70.08 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.63 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -78.43 159.6 28.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.469 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.52 144.9 29.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.352 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 88' ' ' LEU . 2.0 mt -116.31 138.09 51.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.502 . . . . 0.0 111.568 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.72 135.04 31.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.363 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 84' ' ' HIS . 8.3 pm0 -129.86 143.41 50.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.474 0.654 . . . . 0.0 112.337 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -106.66 160.82 24.9 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.052 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.04 -1.08 3.19 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.868 2.378 . . . . 0.0 113.452 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.671 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 10.1 m-20 -136.82 9.59 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.47 -0.144 . . . . 0.0 111.003 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 15.3 m-85 -171.99 173.21 4.48 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.384 0.612 . . . . 0.0 111.839 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.67 117.02 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.424 177.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.596 ' N ' HD22 ' A' ' 15' ' ' LEU . 31.2 m -107.73 150.84 26.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.0 111.138 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.3 151.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.77 114.46 13.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.964 0.411 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.4 125.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.317 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -84.62 121.41 27.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 65' ' ' TYR . 20.0 m -149.99 149.2 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.7 p -140.26 -57.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.227 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' ALA . 11.0 m-30 -56.88 -52.76 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.09 99.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.16 6.16 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.504 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.02 134.31 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -57.33 -41.68 80.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -123.3 139.39 54.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.18 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -84.7 158.73 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.102 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 23.9 m-20 -109.67 111.66 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' A' ' 40' ' ' PHE . 73.1 t -118.08 117.47 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.424 . . . . 0.0 111.334 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.84 112.06 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.372 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 21.2 p90 -119.12 113.28 20.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.762 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 pt-20 -136.66 106.04 6.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.649 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 34.69 88.45 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.886 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.81 -1.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 26.8 t70 -108.32 120.71 43.15 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.03 121.76 27.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.5 mmtt -124.35 128.81 49.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' A' ' 31' ' ' VAL . 77.1 t80 -122.89 111.45 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.736 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 6.1 m-85 -115.09 124.6 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -130.66 29.64 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 91.76 -89.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.931 0.892 . . . . 0.0 111.302 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 92.2 Cg_endo -82.02 -17.4 8.14 Favored 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.739 1.3 . . . . 0.0 111.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.71 117.82 34.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.293 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 41' ' ' TYR . 1.4 t80 -124.77 120.16 30.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.482 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -116.07 111.55 20.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.949 0.404 . . . . 0.0 111.582 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.552 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -116.24 110.61 18.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.933 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.5 mt -131.45 138.06 48.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.421 . . . . 0.0 111.811 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.71 111.9 24.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 78.6 mt -67.48 140.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.979 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 17.1 Cg_exo -66.87 -15.73 47.92 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.758 2.305 . . . . 0.0 112.302 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.56 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.61 -133.81 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.05 142.82 26.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 111.438 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.946 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.7 mm -119.08 125.11 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.758 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.3 p -52.88 142.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.032 0.444 . . . . 0.0 112.024 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.98 122.05 44.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.501 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.4 ' C ' ' ND2' ' A' ' 58' ' ' ASN . 0.6 OUTLIER -167.58 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.18 16.1 9.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.84 28.33 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' HG3' HD11 ' A' ' 74' ' ' ILE . 20.9 pm0 -72.38 -167.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.6 mt-30 -138.39 129.97 27.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.02 136.68 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.675 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.4 t -155.11 116.33 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' OH ' HG23 ' A' ' 21' ' ' VAL . 2.9 t80 -105.53 123.09 47.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 120.39 42.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.87 55.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.524 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.91 -55.22 24.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG3' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -91.25 -7.92 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.797 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.26 51.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.4 ' HB ' ' HG3' ' A' ' 69' ' ' LYS . 91.2 mt -145.82 144.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 0.0 110.498 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.566 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -111.72 123.86 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 111.217 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.05 131.22 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -139.55 118.62 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 0.0 111.556 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -90.1 147.24 23.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.706 ' HB3' HG21 ' A' ' 55' ' ' ILE . 4.7 mt -135.3 131.12 19.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.795 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.946 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.9 Cg_endo -66.98 144.33 69.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.65 2.234 . . . . 0.0 111.997 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 11' ' ' ASP . 35.6 mttp -88.56 156.65 18.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -87.49 -17.56 31.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.138 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 83' ' ' GLN . 20.0 m -135.94 119.25 12.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.544 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 143.8 70.01 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.496 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.28 2.45 90.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.671 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 4.5 tt0 -81.77 129.11 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.787 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 20.9 t-80 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.192 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.9 m-30 -83.29 89.91 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.89 162.48 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 112.121 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.85 49.41 0.76 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.592 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 8' ' ' LEU . 1.3 mt -60.3 -61.34 2.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.927 0.364 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.334 -0.108 0 CA-C-O 121.023 0.44 . . . . 0.0 110.619 179.561 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.698 0.208 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.848 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.617 ' HE2' HD21 ' A' ' 8' ' ' LEU . 4.5 p90 -73.3 164.87 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.28 147.47 27.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -115.16 136.09 53.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.507 . . . . 0.0 111.531 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.8 t -140.7 134.47 30.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.756 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -131.94 145.09 51.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.561 0.696 . . . . 0.0 112.686 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.85 160.56 27.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.893 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.87 -0.31 3.8 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.935 2.423 . . . . 0.0 113.248 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.652 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 72.4 m-20 -134.79 5.81 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.478 0.18 . . . . 0.0 110.866 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.5 m-85 -171.34 171.37 5.59 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.267 0.556 . . . . 0.0 111.212 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -137.67 111.18 8.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.086 178.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 74' ' ' ILE . 4.9 m -104.74 148.51 26.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.134 0.492 . . . . 0.0 111.38 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.742 HD12 ' CE1' ' A' ' 38' ' ' PHE . 4.6 mt -123.39 155.3 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -136.85 111.29 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.932 0.396 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.622 HD13 ' CD2' ' A' ' 40' ' ' PHE . 3.7 mt -118.95 126.84 75.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 11.4 ttt180 -101.85 119.44 38.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.585 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 21' ' ' VAL . 14.4 m -143.73 130.44 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.543 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.45 -33.59 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.389 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.514 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 2.2 m-30 -66.92 -10.13 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.8 108.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 6.8 ttt180 -101.48 11.29 39.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.5 m -121.88 129.37 75.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.19 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.7 m -56.47 -40.38 74.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -125.47 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.355 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -94.0 160.03 14.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -113.7 112.15 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.57 114.55 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -119.36 113.15 20.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.393 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 12.3 p90 -118.57 112.95 20.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.015 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 1.1 tt0 -138.07 112.6 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.347 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA2' ' HG2' ' A' ' 54' ' ' ARG . . . 36.91 77.37 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.442 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 66.45 4.16 3.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.5 m-20 -102.8 104.23 14.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.2 t80 -110.87 116.04 30.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.428 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -121.2 131.78 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.249 179.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 19' ' ' ILE . 84.5 t80 -128.46 112.05 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.334 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' OH ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -116.45 119.33 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -133.9 29.53 3.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.484 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 2.1 pttp 122.46 -164.31 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.823 1.327 . . . . 0.0 108.536 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 27.3 Cg_exo -37.33 -26.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.339 1.359 . . . . 0.0 112.66 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.5 m-85 -73.49 124.42 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.04 124.1 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.1 mt -113.35 109.29 18.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -120.14 112.49 19.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 48' ' ' ARG . 32.6 mt -132.31 136.98 47.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.628 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.2 m -102.43 111.32 23.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.648 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 17.0 mt -70.64 146.24 93.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 23.7 Cg_exo -63.75 -19.33 66.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.895 2.397 . . . . 0.0 112.551 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' NE2' ' A' ' 83' ' ' GLN . . . -123.43 -127.98 3.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.809 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HG2' ' HA2' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -151.38 145.53 25.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 77' ' ' PRO . 32.2 mm -116.51 124.69 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.8 p -55.72 151.81 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.467 . . . . 0.0 111.595 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.03 131.4 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.25 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.54 -37.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.46 17.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -97.71 30.25 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.953 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -79.0 -169.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.663 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.38 137.74 44.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.61 134.66 7.49 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.067 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -143.79 104.95 4.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -119.17 139.57 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 111.617 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.62 128.9 53.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.32 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.827 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.89 -39.3 65.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -95.78 -20.09 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . 63.96 62.91 4.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.341 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 70' ' ' GLY . 50.4 mt -144.7 118.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -113.3 115.79 28.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 25.9 m -119.14 129.35 54.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.953 HD11 ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -138.13 121.13 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -86.22 144.88 27.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.76 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.08 125.36 18.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.897 ' O ' HG23 ' A' ' 55' ' ' ILE . 32.9 Cg_endo -63.42 151.66 83.88 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.445 2.097 . . . . 0.0 111.942 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 13.6 mttt -96.39 157.47 15.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 79' ' ' GLU . 2.9 tm-20 -84.63 -4.93 59.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 79' ' ' GLU . 93.0 m -152.09 116.96 3.03 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.93 143.64 48.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.265 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.86 86.09 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.908 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tp-100 -66.98 122.38 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.676 0.274 . . . . 0.0 110.504 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -120.16 112.68 19.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.858 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 16.2 m-30 -77.46 90.29 3.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.305 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 171.29 11.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 112.011 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 36.61 41.13 0.53 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.73 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.59 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.109 0.454 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.465 -0.2 0 N-CA-C 111.689 -0.158 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.06 58.13 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -68.26 164.91 19.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.35 156.6 42.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.47 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -120.08 139.29 52.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.423 0.63 . . . . 0.0 112.008 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.0 p -140.63 131.54 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.628 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.56 145.16 51.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 0.0 112.738 -177.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.447 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m-20 -109.31 160.22 28.44 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.899 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.86 -1.24 2.57 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.974 2.449 . . . . 0.0 113.929 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.7 m-20 -137.19 8.91 2.96 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.3 -0.25 . . . . 0.0 111.037 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.6 m-85 -171.17 171.96 5.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.379 0.609 . . . . 0.0 111.803 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -134.24 118.66 17.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.477 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.851 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.0 m -108.26 145.92 33.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 110.293 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 8' ' ' LEU . 3.1 mt -118.85 154.54 21.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.69 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.71 110.53 9.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.459 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.9 mt -126.26 122.44 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.573 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 120.21 41.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.768 0.318 . . . . 0.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.66 134.76 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.379 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.48 -38.27 5.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.6 m-30 -63.63 -10.74 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -21.82 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.229 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -70.44 -76.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.431 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 26' ' ' VAL . 15.5 m -39.94 128.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -58.91 -28.65 66.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.66 145.07 51.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.474 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -101.59 163.65 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.764 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -118.48 119.04 33.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.12 121.52 65.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 56.4 m-85 -135.34 130.67 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.4 p90 -127.02 122.2 33.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 8.6 tt0 -137.39 109.51 7.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.527 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.15 75.7 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.98 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 66.59 5.17 3.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 34.3 m-20 -103.17 103.75 13.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.685 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 71.0 t80 -105.83 113.14 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.408 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 115.39 27.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.434 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 76.3 t80 -113.08 109.29 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 98.5 m-85 -110.29 105.96 15.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 112.034 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -134.07 113.36 12.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.594 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.603 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 43.8 -170.23 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 76.4 Cg_exo -42.64 -20.87 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.026 1.817 . . . . 0.0 113.106 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 14.2 m-85 -71.6 121.14 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.9 t80 -118.57 119.21 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.427 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.6 mt -120.26 109.53 15.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 111.911 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 3.9 ttm180 -118.73 116.48 26.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.42 128.04 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 0.0 111.794 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 106.36 18.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' ILE . 4.4 mt -70.34 128.18 91.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.375 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 46.1 Cg_exo -56.0 -20.84 31.67 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.821 2.347 . . . . 0.0 112.199 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -112.18 -138.62 7.43 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.538 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.36 137.81 28.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.909 HG23 ' O ' ' A' ' 77' ' ' PRO . 5.0 mt -118.74 126.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.911 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.2 p -58.15 155.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.5 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.7 pt-20 -123.1 133.88 54.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -164.7 -38.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.49 -12.93 25.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.191 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -67.43 -70.33 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.962 0.411 . . . . 0.0 110.318 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.614 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.2 pt-20 30.34 -152.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.685 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -156.61 155.56 32.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.68 161.19 34.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.418 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -159.87 121.05 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -119.04 131.32 55.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.522 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.05 126.82 53.04 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.582 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -46.57 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.643 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.66 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.259 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -76.73 -19.87 57.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.82 61.8 6.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.46 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -157.44 129.93 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.921 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' A' ' 74' ' ' ILE . 7.6 t80 -112.39 110.89 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -108.82 128.04 54.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.702 ' O ' HG23 ' A' ' 16' ' ' THR . 9.0 tt -123.13 162.68 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 0.0 111.468 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.676 ' O ' HD23 ' A' ' 76' ' ' LEU . 12.3 mtm180 -133.38 140.36 47.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 55' ' ' ILE . 70.5 mt -136.34 128.31 17.22 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.911 ' HG2' HG13 ' A' ' 56' ' ' VAL . 36.7 Cg_endo -65.87 151.72 83.43 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.784 2.323 . . . . 0.0 112.219 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 83' ' ' GLN . 4.4 mttt -98.55 153.78 18.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.348 . . . . 0.0 110.487 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.1 tt0 -83.31 -7.61 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.0 m -156.14 108.0 2.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 111.523 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.43 149.81 36.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.733 2.288 . . . . 0.0 112.035 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.72 83.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.851 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 51.0 tt0 -81.07 135.34 35.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.218 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -124.44 118.61 27.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.227 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 6.2 m-30 -77.42 90.6 3.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 172.87 8.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.61 39.9 0.27 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.925 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.578 HD22 HD13 ' A' ' 8' ' ' LEU . 1.5 mt -61.67 -61.77 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.266 0.533 . . . . 0.0 111.024 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.739 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.175 0 CA-C-O 120.705 0.211 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.46 58.78 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.987 0.422 . . . . 0.0 110.395 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.4 p90 -63.04 165.32 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.46 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -149.0 146.21 27.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.46 135.94 53.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.4 . . . . 0.0 111.167 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -140.43 132.35 27.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.04 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.591 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.23 140.81 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 0.0 112.174 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -111.2 160.86 27.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.788 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 22.0 Cg_endo -61.56 -1.94 2.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.974 2.449 . . . . 0.0 113.703 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.1 m-20 -135.95 4.05 2.98 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.331 -0.231 . . . . 0.0 111.502 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.1 m-85 -168.48 169.52 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 112.253 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.776 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.3 tm? -134.59 114.17 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.202 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 73' ' ' THR . 44.2 m -109.0 139.88 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 38' ' ' PHE . 54.1 mt -111.85 152.11 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.311 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -132.1 119.06 20.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.587 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 47' ' ' LEU . 3.8 mt -125.84 128.2 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.866 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 12.2 mtp180 -96.66 118.48 33.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 21' ' ' VAL . 19.4 m -108.43 82.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' TYR . 52.3 p -51.02 -87.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' SER . 3.7 m-30 -38.31 -53.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.75 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.79 45.89 5.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.511 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -59.45 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.476 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 43' ' ' LYS . 18.4 m -43.5 136.54 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 111.05 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.53 95.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.331 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 147.24 52.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.801 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -99.24 167.81 10.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 37.4 m-20 -114.92 125.44 53.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.86 116.36 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.74 124.1 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 39.3 p90 -131.48 121.91 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' SER . 6.4 pt-20 -138.66 119.13 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.87 -76.45 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.639 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -153.03 27.44 0.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.913 0.387 . . . . 0.0 110.665 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.65 110.15 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 17' ' ' ILE . 90.0 t80 -101.43 111.87 24.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -113.67 122.85 48.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.784 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CG ' HD13 ' A' ' 19' ' ' ILE . 75.7 t80 -123.82 114.1 19.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.542 ' HB3' ' CE1' ' A' ' 46' ' ' PHE . 2.1 m-85 -118.02 104.39 10.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.985 0.421 . . . . 0.0 111.583 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -138.03 121.95 17.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 42.19 -170.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 99.8 Cg_exo -44.57 -19.84 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.72 1.613 . . . . 0.0 112.272 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 18.8 m-85 -74.23 114.17 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.385 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -121.33 122.7 40.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.836 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 19' ' ' ILE . 1.7 mt -120.14 110.64 16.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.099 0.476 . . . . 0.0 112.121 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 114.28 23.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.873 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.31 142.18 39.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.645 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -101.23 115.67 31.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.581 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' SER . 92.2 mt -75.75 136.22 70.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -79.95 82.28 2.53 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.917 2.411 . . . . 0.0 112.03 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 143.82 -145.99 16.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.096 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.5 mmt180 -143.65 137.85 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.075 0.464 . . . . 0.0 111.642 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 77' ' ' PRO . 45.9 mm -118.11 126.23 74.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.661 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 13.8 p -55.14 149.07 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 131.44 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.601 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -169.06 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.418 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . 112.73 9.16 19.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.682 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 28.05 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' OE2' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -78.78 -167.17 1.03 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.522 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -137.59 124.99 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.988 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.56 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -124.81 139.02 11.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.216 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.65 106.62 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.559 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.564 ' CD1' ' HB2' ' A' ' 72' ' ' PHE . 7.9 t80 -109.5 146.02 35.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -123.23 125.96 46.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.324 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -39.93 20.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -53.23 -48.54 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.086 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.52 -18.3 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.294 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 72.99 63.51 2.81 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mt -154.46 120.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -110.13 124.59 51.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -127.01 127.38 44.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.56 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -128.07 119.22 50.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.587 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -82.45 141.76 32.47 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.55 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.777 ' HB3' HG21 ' A' ' 55' ' ' ILE . 10.4 mt -135.4 117.35 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.818 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.925 ' O ' HG23 ' A' ' 55' ' ' ILE . 20.4 Cg_endo -60.68 154.33 55.68 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.873 2.382 . . . . 0.0 112.286 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' CD ' ' O ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -94.1 154.81 17.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.931 0.395 . . . . 0.0 111.415 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -82.26 -13.85 56.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 m -142.18 116.71 6.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.702 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.62 142.8 98.69 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.67 2.247 . . . . 0.0 112.067 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.43 86.39 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.998 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 tt0 -80.37 126.08 30.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -128.62 125.68 38.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 8.3 m-30 -80.29 89.98 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 173.83 9.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.026 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.4 35.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.957 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.8 mt -59.05 -61.47 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.14 0.47 . . . . 0.0 110.407 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 p30 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.677 0.199 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.94 66.41 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 10.2 p90 -75.8 163.82 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -147.0 143.26 28.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.91 134.83 54.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.115 0.483 . . . . 0.0 111.143 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.9 t -142.5 135.31 28.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.72 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.597 ' NE2' ' CD2' ' A' ' 84' ' ' HIS . 2.2 pm0 -130.68 141.75 50.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.116 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -104.25 161.37 23.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.842 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 32.4 Cg_endo -62.86 -1.88 3.11 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.701 2.268 . . . . 0.0 113.337 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.621 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 57.4 m-20 -135.86 9.92 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.97 -0.105 . . . . 0.0 110.893 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.5 m-85 -170.94 171.71 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 111.964 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.0 109.61 9.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.181 177.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 75' ' ' ARG . 2.8 m -104.04 146.89 28.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.208 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.945 HD12 ' CE1' ' A' ' 38' ' ' PHE . 27.0 mt -122.64 152.41 27.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.05 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -136.96 120.23 16.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.183 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.617 HD13 HD12 ' A' ' 47' ' ' LEU . 1.2 mt -123.19 126.58 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.118 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -77.27 118.37 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.066 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.96 129.76 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 p -121.38 -59.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' ALA . 4.9 m-30 -57.0 -52.96 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.93 97.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.825 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -70.29 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 m -58.83 135.82 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -55.65 -41.11 73.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.62 139.42 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.359 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -87.88 166.83 14.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.959 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -119.03 115.93 25.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.89 116.31 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -112.77 114.25 26.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 25.0 p90 -125.61 115.81 20.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 36' ' ' SER . 15.6 mt-10 -137.35 117.29 13.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.74 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.46 -74.95 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.207 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -148.92 27.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.4 t0 -118.47 130.99 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.945 ' CE1' HD12 ' A' ' 17' ' ' ILE . 80.4 t80 -125.88 113.96 17.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 111.062 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -121.85 127.58 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.644 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.4 ' CD2' HD12 ' A' ' 19' ' ' ILE . 87.3 t80 -122.72 110.5 15.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CE1' ' CE2' ' A' ' 46' ' ' PHE . 6.8 m-85 -110.51 116.25 31.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -127.3 26.21 6.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.166 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 22.0 tptt 95.22 -88.41 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.75 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 70.9 Cg_endo -83.61 -16.97 6.45 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.316 1.344 . . . . 0.0 111.476 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -96.12 105.11 17.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.733 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -111.45 111.95 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.956 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -117.26 109.18 16.54 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -118.0 110.72 18.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.94 137.1 49.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 0.0 111.781 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 m -102.77 112.64 25.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.137 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 61.7 mt -69.44 137.35 88.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.814 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 31.8 Cg_exo -58.96 -18.43 42.7 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.306 2.671 . . . . 0.0 113.117 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -125.23 -127.42 3.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.819 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -147.61 142.94 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.947 0.404 . . . . 0.0 111.485 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 77' ' ' PRO . 12.2 mm -119.79 126.3 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.637 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 8.7 p -52.24 141.07 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.088 0.47 . . . . 0.0 111.979 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.65 130.16 56.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.518 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -176.69 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.452 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.46 17.75 11.01 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -98.63 21.7 10.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.704 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.818 ' OE2' HD11 ' A' ' 74' ' ' ILE . 9.6 pt-20 -73.52 -170.62 0.86 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.76 138.6 34.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -131.05 147.65 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.311 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.14 110.14 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 111.066 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -110.88 126.99 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.8 111.47 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.15 71.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -49.27 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 20.4 ttpt -77.48 -27.41 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.011 0.434 . . . . 0.0 110.174 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 1.02 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 71.95 48.32 27.57 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 70' ' ' GLY . 2.7 mm -144.22 146.68 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 5.2 t80 -109.73 114.85 28.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -114.49 126.99 55.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.818 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -139.74 119.54 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.791 ' O ' HD23 ' A' ' 76' ' ' LEU . 50.0 mtm180 -87.95 148.56 24.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.154 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 75' ' ' ARG . 45.4 mt -135.52 122.81 14.85 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' ILE . 19.2 Cg_endo -61.27 147.53 95.33 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.719 2.279 . . . . 0.0 112.003 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 20.1 mttp -90.84 156.01 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 111.355 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.65 -17.06 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -135.52 94.46 15.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.843 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.8 143.23 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.821 2.348 . . . . 0.0 112.57 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.82 0.34 89.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.256 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 2.2 tp-100 -84.58 136.06 33.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.976 0.388 . . . . 0.0 110.982 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.597 ' CD2' ' NE2' ' A' ' 10' ' ' GLN . 6.9 t-160 -127.42 123.22 35.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.132 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.568 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 15.1 m-30 -79.21 91.5 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.21 170.57 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.859 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.93 41.76 0.21 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.636 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.516 HD12 ' OE1' ' A' ' 10' ' ' GLN . 3.5 mt -60.83 -61.24 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.068 0.434 . . . . 0.0 110.995 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.765 0.235 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.53 65.57 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -79.79 164.36 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.59 154.34 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.975 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 mt -115.97 135.46 53.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.118 0.485 . . . . 0.0 111.57 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.47 130.4 28.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.121 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.63 144.61 51.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 112.466 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.4 160.45 27.03 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.199 179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 30.1 Cg_endo -63.46 -0.8 2.61 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.013 2.475 . . . . 0.0 113.776 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 6.0 m-20 -136.28 8.87 3.18 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.408 -0.183 . . . . 0.0 110.748 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.0 m-85 -171.93 172.23 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.32 0.581 . . . . 0.0 111.331 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -136.24 116.89 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.615 178.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.522 ' N ' HD22 ' A' ' 15' ' ' LEU . 11.3 m -107.15 148.39 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 38' ' ' PHE . 8.2 mt -125.61 152.26 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.266 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.55 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.397 . . . . 0.0 111.568 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.539 HD13 ' CG ' ' A' ' 40' ' ' PHE . 3.5 mt -113.97 125.12 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.754 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HG3' HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.23 121.21 29.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.108 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.91 131.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.08 -73.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.441 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.7 m-85 -49.68 -53.29 25.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 43.92 103.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.443 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -81.92 3.9 24.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 43' ' ' LYS . 27.1 m -123.94 130.54 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -56.05 -41.37 74.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.09 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -129.07 143.13 50.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.928 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -90.65 166.86 12.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.417 . . . . 0.0 111.36 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.23 122.28 42.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.44 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.02 116.66 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 111.538 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -112.09 114.05 26.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.788 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.6 p90 -125.95 114.94 19.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' SER . 10.7 mt-10 -134.32 112.22 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.376 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.76 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.768 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -153.34 24.37 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.399 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -114.76 104.92 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.978 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 17' ' ' ILE . 81.8 t80 -105.12 117.88 35.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.71 130.35 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CG ' HD13 ' A' ' 19' ' ' ILE . 32.6 t80 -127.74 116.86 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.93 122.2 41.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.229 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -126.32 29.61 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.2 tptm 93.85 -89.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.585 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 58.7 Cg_endo -84.44 -16.41 5.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 120.708 1.289 . . . . 0.0 111.516 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -102.15 117.48 34.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.236 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.0 t80 -125.86 120.92 31.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.416 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -118.23 113.47 21.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.84 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -116.12 110.78 19.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HG ' HD22 ' A' ' 47' ' ' LEU . 5.1 mt -123.74 129.4 51.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.664 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.5 110.31 22.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.334 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.94 136.71 85.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 0.0 111.361 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 28.4 Cg_endo -62.78 -14.69 42.12 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.345 2.697 . . . . 0.0 112.864 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.53 -129.31 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.747 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.4 mtm180 -149.16 145.9 27.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.986 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' PRO . 35.0 mm -121.08 126.29 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.61 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 77' ' ' PRO . 2.5 p -52.37 146.94 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 111.553 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.33 124.36 52.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.626 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.88 -41.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.0 -6.49 27.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -72.32 -71.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.424 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.474 ' OE1' ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER 33.34 -156.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 9.9 mt-30 -154.02 167.07 31.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.45 152.43 6.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.816 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -153.84 143.31 21.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.17 122.51 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 120.15 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.12 -41.74 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -53.44 50.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.208 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.494 ' HD2' HD12 ' A' ' 71' ' ' ILE . 3.9 ttpm? -81.57 -16.55 51.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.038 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.44 55.27 30.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.559 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 69' ' ' LYS . 58.3 mt -145.3 147.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.407 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -112.88 113.32 25.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.466 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 132.77 56.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -141.42 118.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.744 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 39.2 mtp180 -90.89 148.59 22.37 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mt -134.44 143.71 47.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 56' ' ' VAL . 6.0 Cg_endo -83.61 148.73 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.759 2.306 . . . . 0.0 111.448 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 1.9 mtmp? -89.16 157.05 18.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.51 -18.86 37.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.165 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.589 ' O ' HG22 ' A' ' 80' ' ' THR . 3.5 m -142.97 86.8 9.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -40.82 149.76 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.719 2.279 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.37 -10.12 75.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.26 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.7 tp60 -82.14 134.99 35.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -124.12 118.27 26.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.368 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 5.2 m-30 -78.16 89.84 4.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.054 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.24 174.56 10.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.529 0.681 . . . . 0.0 112.567 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.74 40.52 1.05 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.812 -1.085 . . . . 0.0 114.072 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -61.55 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.172 0.486 . . . . 0.0 110.016 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.349 179.204 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.464 -0.256 0 CA-C-O 120.817 0.257 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.1 59.55 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -69.74 166.03 20.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.666 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.97 38.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.49 133.98 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' THR . 22.6 p -138.74 130.94 28.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.214 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.617 ' CB ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.8 143.34 50.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 112.728 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.02 160.74 24.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.613 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.95 -3.68 5.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.632 2.221 . . . . 0.0 113.408 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.43 9.89 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.488 -0.132 . . . . 0.0 111.236 179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 39.6 m-85 -170.47 170.17 7.07 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 111.294 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -135.39 111.4 9.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.749 ' N ' HD22 ' A' ' 15' ' ' LEU . 23.1 m -103.16 135.56 44.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.13 0.491 . . . . 0.0 111.539 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.556 HD12 ' CE1' ' A' ' 38' ' ' PHE . 20.7 mt -108.28 151.94 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.854 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.13 117.35 14.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.044 0.45 . . . . 0.0 111.789 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 47' ' ' LEU . 18.6 mt -120.0 125.77 74.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.621 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 118.66 37.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 21' ' ' VAL . 22.4 m -155.57 127.72 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.145 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.86 -30.25 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.909 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.6 m-85 -68.05 -9.49 46.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.024 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -25.69 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.518 0.511 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.54 16.92 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.688 -178.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.12 130.24 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.4 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 m -56.6 -35.79 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.366 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.59 148.01 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.791 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -101.22 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.605 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -113.36 119.38 37.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.65 114.97 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 83.5 m-85 -125.61 120.27 30.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 40.7 p90 -123.2 119.08 29.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.793 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' HB3' ' A' ' 37' ' ' ASP . 3.0 pt-20 -138.07 114.02 9.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.267 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.77 77.66 0.07 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.181 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER 60.06 10.99 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 4.1 t70 -108.06 103.31 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 110.092 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.5 t80 -108.42 121.25 44.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -120.85 134.57 55.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.664 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 52.9 t80 -129.56 111.72 13.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.15 107.25 17.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.125 0.488 . . . . 0.0 111.843 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 40' ' ' PHE . . . -132.47 106.42 7.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.613 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 46.86 -175.96 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 38.0 Cg_exo -33.52 -29.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 121.972 1.781 . . . . 0.0 112.587 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 17.4 m-30 -66.3 125.36 25.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.85 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -129.01 128.59 43.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.206 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 19' ' ' ILE . 6.4 mt -118.21 111.78 19.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 113.07 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.19 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.4 mt -124.21 127.83 48.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.495 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.26 110.77 23.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.642 HD13 ' HE2' ' A' ' 85' ' ' PHE . 60.3 mt -78.74 155.17 78.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 85' ' ' PHE . 9.6 Cg_endo -86.21 -17.9 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.166 2.577 . . . . 0.0 112.627 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -112.51 -141.64 8.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.81 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -141.48 132.67 26.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.46 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.7 mm -110.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.077 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 57' ' ' GLU . 8.4 p -61.67 157.57 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.485 . . . . 0.0 111.861 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.2 pt-20 -123.35 132.37 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.021 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -165.31 -35.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.46 0.9 26.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.239 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -79.37 -72.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.656 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER 26.25 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.335 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 21.3 mt-30 -161.7 133.15 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.944 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.72 139.1 10.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.041 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.95 104.69 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.535 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -108.16 136.88 47.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.44 117.36 27.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.81 -44.07 34.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.42 -46.77 69.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 7.3 ttpp -91.88 -16.25 26.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.76 63.34 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.042 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.445 HG13 ' HG2' ' A' ' 69' ' ' LYS . 3.6 mt -151.46 120.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 111.505 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 2.7 t80 -104.99 111.03 23.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.74 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.45 117.68 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.944 HD12 ' CA ' ' A' ' 63' ' ' GLY . 1.1 tp -129.11 119.82 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.705 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -86.3 143.48 27.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.748 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.4 mp -131.94 124.72 19.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.62 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' ILE . 25.7 Cg_endo -64.64 155.75 65.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.911 2.407 . . . . 0.0 112.354 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -102.63 157.36 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.247 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 tt0 -84.6 0.33 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.79 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -160.86 99.79 1.32 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.39 153.24 13.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.812 2.341 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.82 63.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.981 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -81.55 142.63 32.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -130.02 123.45 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.642 ' HE2' HD13 ' A' ' 51' ' ' LEU . 4.1 m-30 -77.1 92.87 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.462 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 172.32 8.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.268 0.556 . . . . 0.0 111.708 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.88 37.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.451 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 85' ' ' PHE . 8.0 mt -58.47 -61.27 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.04 0.42 . . . . 0.0 110.319 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--N 1.334 -0.085 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.56 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.699 0.208 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.68 58.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.19 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -61.32 163.17 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.8 140.65 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.562 ' CD2' HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -116.2 139.69 50.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.166 0.507 . . . . 0.0 111.579 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.45 132.25 22.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.649 ' HB3' HD23 ' A' ' 15' ' ' LEU . 2.2 pm0 -130.42 141.48 50.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.335 0.588 . . . . 0.0 111.649 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.48 160.73 25.06 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.152 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.95 -2.52 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 113.785 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.644 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 66.4 m-20 -136.6 11.45 3.19 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.314 -0.241 . . . . 0.0 110.748 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.6 m-85 -170.37 171.84 6.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.559 0.695 . . . . 0.0 112.237 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -137.4 111.1 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.726 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.76 ' N ' HD22 ' A' ' 15' ' ' LEU . 88.6 m -105.7 151.18 24.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.155 0.502 . . . . 0.0 111.496 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.2 mt -124.88 154.58 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.98 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.03 118.97 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 2.7 mt -125.83 128.41 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.091 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 4.0 mtp180 -100.95 121.61 42.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.346 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 135.09 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.708 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -32.8 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.338 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 24' ' ' ALA . 6.2 m-30 -67.06 -10.8 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.04 110.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.445 0.465 . . . . 0.0 111.506 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -72.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.504 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 19.5 m -58.31 141.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.436 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -55.32 -40.75 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.378 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' O ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tt0 -121.07 140.35 52.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -89.59 168.71 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -116.36 115.87 26.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 1.9 t -118.57 121.79 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -119.84 116.46 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 53.1 p90 -126.14 115.67 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.519 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -136.39 113.88 10.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.819 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.7 -72.39 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.454 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -155.9 27.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.481 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -118.37 104.35 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.801 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE1' HD12 ' A' ' 17' ' ' ILE . 72.4 t80 -104.64 124.51 49.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.766 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -129.0 134.9 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 31.4 t80 -125.23 110.01 13.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.35 119.41 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.37 35.08 4.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 91.72 -91.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.39 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 62.7 Cg_endo -84.43 -14.84 6.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.909 1.36 . . . . 0.0 112.143 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 23' ' ' TYR . 22.0 m-30 -102.05 117.64 35.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.584 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -124.78 118.89 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.4 mt -123.54 117.56 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.46 112.77 23.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.869 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 8' ' ' LEU . 39.0 mt -121.0 126.02 48.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.856 0.36 . . . . 0.0 111.601 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 107.87 19.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.383 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 mt -73.2 128.36 87.75 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.799 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.05 90.86 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.799 2.333 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.98 -137.58 9.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.409 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -144.83 136.65 25.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.063 0.458 . . . . 0.0 111.592 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -116.8 126.84 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.746 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -61.1 156.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.45 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' N ' HG22 ' A' ' 56' ' ' VAL . 30.1 mt-10 -123.22 131.26 53.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.619 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -164.02 -42.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.642 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.37 -1.64 26.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 27.61 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.98 -168.63 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' O ' HG13 ' A' ' 74' ' ' ILE . 26.3 mt-30 -134.5 138.62 44.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.515 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -149.37 154.37 25.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.525 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 p -164.23 118.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' ASP . 4.6 t80 -113.53 137.1 52.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 1.1 m-20 -123.2 125.44 45.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.05 -33.47 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -50.16 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.458 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.628 ' HE3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -107.33 -6.28 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ARG . . . 63.45 63.27 4.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.391 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.628 HD12 ' HE3' ' A' ' 69' ' ' LYS . 1.3 mt -144.21 121.0 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.4 t80 -114.73 115.6 27.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.986 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.2 m -115.51 128.49 56.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -136.01 118.21 20.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.904 0.383 . . . . 0.0 112.026 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -88.52 146.97 24.86 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 55' ' ' ILE . 30.1 mt -132.65 139.08 33.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.417 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.7 Cg_endo -76.0 149.87 33.3 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.882 2.388 . . . . 0.0 112.169 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 10.3 mttp -96.32 156.07 16.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 -6.98 59.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.616 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.6 m -154.51 89.32 3.26 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -42.2 160.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.092 2.528 . . . . 0.0 112.845 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.35 -6.19 57.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.624 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -83.41 142.85 30.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.518 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 1.7 t-160 -127.25 121.1 30.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 52' ' ' PRO . 7.9 m-30 -82.85 94.46 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.02 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.83 174.01 7.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.344 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.89 40.62 0.22 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.485 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD12 ' OE1' ' A' ' 10' ' ' GLN . 3.8 mt -60.46 -62.01 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.109 0.455 . . . . 0.0 110.045 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.938 0.399 . . . . 0.0 110.65 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 50.7 Cg_exo . . . . . 0 N--CA 1.466 -0.129 0 CA-C-O 120.976 0.323 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.72 57.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -61.28 170.23 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -154.07 148.52 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.597 ' CD2' HG23 ' A' ' 17' ' ' ILE . 7.3 mt -116.18 138.21 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' THR . 18.8 t -139.38 131.97 28.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.177 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.571 ' HB3' HD23 ' A' ' 15' ' ' LEU . 4.8 pm0 -130.41 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 112.575 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.82 161.04 24.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.016 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.73 -4.02 5.26 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.745 2.297 . . . . 0.0 113.25 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.656 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 32.6 m-20 -136.59 12.31 3.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.327 0.108 . . . . 0.0 110.834 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.656 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 48.8 m-85 -170.4 171.58 6.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 111.908 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -136.94 112.22 9.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.101 178.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.754 ' N ' HD22 ' A' ' 15' ' ' LEU . 83.4 m -106.16 146.18 30.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.077 0.465 . . . . 0.0 111.011 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.597 HG23 ' CD2' ' A' ' 8' ' ' LEU . 15.0 mt -117.75 155.5 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.101 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -143.2 122.96 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.602 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.482 HD13 HD12 ' A' ' 47' ' ' LEU . 1.1 mt -125.23 132.74 70.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.961 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 1.1 ttt180 -104.08 118.0 35.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.322 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.4 m -146.94 128.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -100.71 -50.75 3.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 25' ' ' ARG . 4.3 m-85 -59.49 -15.25 16.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 81.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -98.74 86.52 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.999 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.57 145.92 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.582 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.6 12.72 30.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.695 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -171.07 108.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 26' ' ' VAL . 2.5 m-30 -86.09 148.78 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.786 0.327 . . . . 0.0 110.505 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -105.35 110.99 23.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 114.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -122.88 118.39 27.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 45.5 p90 -118.58 112.37 19.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -138.98 124.96 19.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 0.0 111.846 -179.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 38.72 62.78 1.11 Allowed Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.699 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 67.32 22.26 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -117.7 103.21 9.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.8 t80 -103.14 122.38 44.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.38 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 15.8 mttt -125.11 129.33 49.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -126.99 121.51 31.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 39' ' ' LYS . 36.8 m-85 -131.5 127.95 38.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.763 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -109.93 -81.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 6.2 tptt -146.32 -64.88 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 38.7 Cg_endo -99.59 -6.26 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.089 2.526 . . . . 0.0 111.921 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.56 122.67 47.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.19 120.44 36.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.693 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -120.86 110.6 16.52 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.682 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.9 114.79 23.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.516 178.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.6 mt -138.01 144.05 40.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 112.016 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -112.78 119.95 39.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.312 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 17.2 mt -76.16 155.47 84.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.097 0.475 . . . . 0.0 111.517 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 15.1 Cg_exo -69.27 -16.28 39.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.175 2.584 . . . . 0.0 112.592 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -122.99 -127.81 3.31 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.628 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.482 ' HG3' ' OG ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -154.1 149.37 27.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 77' ' ' PRO . 51.0 mm -118.69 125.62 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 77' ' ' PRO . 7.5 p -59.25 156.64 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.444 . . . . 0.0 111.898 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.39 124.06 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.96 -44.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.68 0.77 30.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 32.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.661 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.35 -173.52 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -135.88 130.91 34.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.405 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -130.35 136.38 8.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.838 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.7 104.89 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.726 0.298 . . . . 0.0 110.583 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -97.13 115.11 26.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 107.62 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.73 -41.0 31.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -50.37 69.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -87.97 -16.76 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 71' ' ' ILE . . . 66.24 63.2 4.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.233 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 70' ' ' GLY . 75.7 mt -158.59 120.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 11.1 t80 -100.11 116.31 31.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.36 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -114.45 118.61 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -128.25 119.72 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.889 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 12.6 mtp180 -85.95 142.63 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.702 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -131.47 140.63 39.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.512 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.817 ' O ' HG23 ' A' ' 55' ' ' ILE . 74.3 Cg_endo -76.9 148.48 28.19 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.756 2.304 . . . . 0.0 112.02 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -93.36 155.86 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.074 0.464 . . . . 0.0 111.433 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.35 -15.36 50.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.129 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 m -138.36 102.28 8.1 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.7 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.97 148.86 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 111.944 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.3 57.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.731 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.43 133.06 41.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.774 0.321 . . . . 0.0 110.499 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 10' ' ' GLN . 6.7 t-80 -128.01 124.52 37.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.2 m-30 -83.04 90.48 7.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.49 173.94 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.06 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.09 36.1 0.32 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.809 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.491 HD22 HD13 ' A' ' 8' ' ' LEU . 8.8 mt -58.23 -61.98 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.195 0.498 . . . . 0.0 110.219 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 178.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.79 0.246 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.05 67.41 4.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 31.2 p90 -72.36 160.03 33.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.725 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -148.79 149.67 31.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -115.35 134.7 54.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.687 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' THR . 8.1 m -142.86 134.2 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.489 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.678 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.4 pt20 -132.35 144.84 50.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -100.84 159.94 28.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.718 178.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 13.6 Cg_endo -57.16 -8.14 3.23 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.783 2.322 . . . . 0.0 113.604 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 61.9 m-20 -135.89 17.09 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.29 -0.256 . . . . 0.0 110.808 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.1 m-85 -169.46 170.39 8.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.947 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -135.69 108.26 7.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.952 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 91.5 m -101.07 143.4 31.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.172 0.511 . . . . 0.0 110.962 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 38' ' ' PHE . 7.5 mt -116.3 155.12 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -125.93 121.46 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.06 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.74 HD13 ' CG ' ' A' ' 40' ' ' PHE . 15.3 mt -124.81 118.61 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -88.07 119.05 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.223 0.535 . . . . 0.0 112.001 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 21' ' ' VAL . 32.9 m -141.24 113.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.225 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -58.08 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.992 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' ALA . 2.1 m-85 -68.84 -53.58 20.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.004 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 46.81 106.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 8.1 mtt85 -81.73 6.97 13.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 m -133.28 135.59 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.808 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -58.62 -41.54 86.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -125.33 142.63 51.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.893 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -90.65 168.43 11.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.56 115.59 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.965 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.05 115.81 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.466 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -126.69 120.08 28.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -129.23 124.0 33.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 114.09 9.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.581 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.46 -70.85 0.16 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.186 -0.531 . . . . 0.0 113.006 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.45 25.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.086 0.469 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -115.02 107.24 15.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.827 ' CE1' HD12 ' A' ' 17' ' ' ILE . 70.1 t80 -102.84 111.0 23.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 14.6 mttt -116.07 121.95 43.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.658 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.74 ' CG ' HD13 ' A' ' 19' ' ' ILE . 58.2 t80 -124.93 117.77 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 39' ' ' LYS . 16.6 m-85 -124.27 124.73 43.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.63 31.49 4.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 1.3 tppm? 92.59 -88.83 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 111.183 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.604 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 63.6 Cg_endo -85.04 -15.97 5.36 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.237 1.291 . . . . 0.0 111.573 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.08 115.6 30.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.569 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 119.49 29.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.443 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 19' ' ' ILE . 3.6 mt -121.78 115.91 23.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.48 111.65 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.952 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.705 HD13 HD21 ' A' ' 8' ' ' LEU . 83.2 mt -125.59 130.54 51.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.573 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.81 113.03 24.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.2 mt -72.2 137.59 81.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.07 0.462 . . . . 0.0 111.502 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.3 Cg_endo -68.38 -18.91 44.02 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.289 2.659 . . . . 0.0 112.717 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.63 -136.79 5.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.71 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -143.53 138.3 29.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.958 0.409 . . . . 0.0 111.069 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.3 mm -116.12 124.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.834 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.519 HG13 ' HG2' ' A' ' 77' ' ' PRO . 4.9 p -64.83 159.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.531 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.52 130.15 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.378 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.73 17.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.77 3.3 27.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.753 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 m -98.49 44.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 164.36 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' ILE . 8.3 mm-40 -127.49 129.72 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.35 147.89 18.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.588 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.3 p -153.62 104.36 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.717 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -96.82 103.83 15.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -89.49 99.55 12.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.221 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.26 69.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -52.44 -50.59 62.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -76.27 -23.13 54.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.033 0.444 . . . . 0.0 110.174 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.34 46.98 84.15 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.936 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 mt -143.44 148.31 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.543 ' HD2' HD12 ' A' ' 19' ' ' ILE . 14.9 t80 -107.05 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.675 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.59 118.38 30.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -126.48 119.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.65 147.36 25.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 mp -133.6 149.46 72.18 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.5 Cg_endo -79.09 150.13 22.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.613 2.209 . . . . 0.0 111.777 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -96.31 152.86 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.851 0.358 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.9 tt0 -84.05 -10.86 57.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.701 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 m -151.36 97.97 3.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.538 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -43.49 153.05 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.663 2.242 . . . . 0.0 112.366 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.57 -1.77 50.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.169 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.95 138.48 39.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.001 0.4 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -127.11 116.97 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.379 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 6.9 m-30 -73.4 91.8 1.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.345 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.51 160.76 13.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.909 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.54 1.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.298 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.651 HD22 HD13 ' A' ' 8' ' ' LEU . 1.7 mt -63.53 -62.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.621 0.21 . . . . 0.0 111.511 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 37.2 Cg_exo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.662 0.192 . . . . 0.0 111.897 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.14 61.59 6.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.143 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 27.5 p90 -76.03 164.76 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 6.2 t0 -157.46 168.41 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.53 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -124.82 136.98 54.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.227 0.537 . . . . 0.0 111.747 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 16' ' ' THR . 9.6 t -138.43 130.81 28.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.079 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 88' ' ' LEU . 7.7 pm0 -135.86 145.53 46.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.72 161.5 22.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.52 -3.58 1.43 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.81 2.34 . . . . 0.0 113.767 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.638 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.6 m-20 -136.05 12.26 3.34 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.367 -0.208 . . . . 0.0 110.909 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.638 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 23.7 m-85 -167.17 167.48 14.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.484 0.659 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -134.79 109.05 8.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.083 178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' N ' HD22 ' A' ' 15' ' ' LEU . 55.3 m -107.01 126.76 52.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.171 0.51 . . . . 0.0 111.836 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 38' ' ' PHE . 7.7 mt -100.81 155.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.998 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -140.83 112.41 7.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.339 . . . . 0.0 111.691 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.28 128.95 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.502 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HB2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -92.49 120.42 32.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 21' ' ' VAL . 15.3 m -141.76 126.67 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.365 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.05 -30.96 4.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.709 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 58.8 m-85 -69.54 -9.19 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.284 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.88 108.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.55 0.531 . . . . 0.0 111.512 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -88.19 13.39 11.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.7 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.43 137.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.556 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.6 t -56.66 -35.59 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.14 144.63 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -96.31 168.66 10.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.48 124.23 42.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 40' ' ' PHE . 4.2 t -130.75 132.58 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.818 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -121.32 116.21 24.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.938 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 43.3 p90 -116.69 114.19 23.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.067 0.461 . . . . 0.0 111.463 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -138.14 101.6 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.045 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.03 -149.11 17.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.631 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -59.13 -12.12 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.962 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.79 112.09 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 110.63 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.86 ' CE2' HD12 ' A' ' 17' ' ' ILE . 39.6 t80 -120.73 112.01 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.41 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -119.31 126.54 51.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.081 0.467 . . . . 0.0 111.566 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CD1' HG22 ' A' ' 31' ' ' VAL . 8.6 t80 -110.39 148.66 31.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -136.1 110.43 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.973 0.416 . . . . 0.0 111.513 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -131.26 68.81 1.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.682 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER 32.57 -88.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.888 -178.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.625 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 57.2 Cg_endo -69.46 -25.37 30.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.257 1.305 . . . . 0.0 112.579 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.669 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 21.7 m-85 -105.04 125.61 51.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.722 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -125.62 120.67 31.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.961 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -120.94 117.9 28.49 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.542 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -124.42 116.2 22.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 48' ' ' ARG . 80.1 mt -142.89 151.46 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 112.25 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.34 105.88 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.071 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 36' ' ' SER . 3.6 mt -72.02 155.79 91.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -83.02 75.0 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.382 2.721 . . . . 0.0 111.966 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.567 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 145.85 -147.18 18.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.37 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 53' ' ' GLY . 1.1 mtm180 -146.65 142.09 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.121 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 77' ' ' PRO . 14.0 mm -115.07 123.11 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.752 HG13 ' HG2' ' A' ' 77' ' ' PRO . 8.3 p -62.07 154.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 112.536 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.38 130.09 51.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.723 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.68 29.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.661 0.267 . . . . 0.0 111.429 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.55 -32.36 3.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.345 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.58 118.51 10.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.556 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.07 163.37 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 4.5 mt-30 -131.78 138.64 48.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.34 137.51 7.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.905 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.76 105.45 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 0.0 110.408 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -103.12 131.72 49.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -115.53 111.55 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.92 -49.32 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.64 -41.83 67.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -97.06 -19.44 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.9 56.68 13.28 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.929 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.634 HD13 ' HB2' ' A' ' 20' ' ' ARG . 21.5 mm -137.19 116.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 111.509 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t80 -111.21 114.42 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -121.49 119.04 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -124.38 119.48 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.622 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HD23 ' A' ' 76' ' ' LEU . 11.4 mtp180 -87.08 148.26 25.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.805 ' HB3' HG21 ' A' ' 55' ' ' ILE . 15.9 mt -134.24 150.73 74.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.208 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.945 ' O ' HG23 ' A' ' 55' ' ' ILE . 94.6 Cg_endo -81.81 157.84 18.51 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.944 2.43 . . . . 0.0 112.162 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -98.0 148.54 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.0 tp10 -85.02 -11.68 54.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.526 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.3 m -148.52 116.87 3.98 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.872 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.3 142.96 45.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.775 2.316 . . . . 0.0 112.441 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 -0.16 89.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.433 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -70.15 119.02 13.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.05 111.95 18.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.13 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.9 m-30 -73.75 90.05 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.487 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' GLY . 22.2 mt-10 -70.7 173.58 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.271 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . 35.98 38.61 0.24 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.622 HD22 HD13 ' A' ' 8' ' ' LEU . 4.0 mt -57.84 -61.6 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.628 0.251 . . . . 0.0 110.538 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 . . . . . 0 C--N 1.333 -0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.127 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.832 0.263 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -85.72 65.14 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 7.1 p90 -80.34 159.44 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.043 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -145.33 150.65 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -114.81 133.46 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.126 0.489 . . . . 0.0 111.761 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.547 ' O ' HD22 ' A' ' 15' ' ' LEU . 85.5 p -139.51 131.45 27.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.636 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.877 ' OE1' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -130.57 140.98 50.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.339 0.59 . . . . 0.0 112.325 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.28 160.84 28.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.997 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 24.2 Cg_endo -61.46 -1.22 1.79 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.107 2.538 . . . . 0.0 114.196 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.667 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -135.35 2.46 3.0 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.163 -0.335 . . . . 0.0 111.74 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 20.8 m-85 -171.78 172.52 4.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HB3' ' A' ' 10' ' ' GLN . 1.2 tm? -135.86 117.38 14.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.813 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.632 ' N ' HD22 ' A' ' 15' ' ' LEU . 5.5 m -110.57 136.84 49.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.389 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.784 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.4 mt -113.51 150.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 7' ' ' ASP . . . -131.05 106.84 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD13 ' CD2' ' A' ' 40' ' ' PHE . 24.1 mt -108.46 121.99 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -89.88 120.23 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.502 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.83 132.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 p -110.65 -82.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.3 m-85 -39.08 -52.58 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.781 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 41.51 97.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.777 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -60.36 -73.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.206 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.84 142.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.32 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -38.02 78.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.7 140.92 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.2 m-30 -89.44 166.34 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.58 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' OD1' ' OH ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -117.42 118.69 32.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 ' HD1' ' A' ' 40' ' ' PHE . 7.2 t -121.68 119.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.788 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' OH ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 m-85 -118.18 118.95 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.144 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 33' ' ' PHE . 28.3 p90 -121.75 112.73 18.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.453 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.2 mt-10 -135.29 116.79 14.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.22 -75.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.139 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -149.8 26.21 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.469 . . . . 0.0 110.14 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -112.97 107.58 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.784 ' CE2' HD12 ' A' ' 17' ' ' ILE . 50.3 t80 -105.33 111.53 24.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -117.86 131.34 56.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.415 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.6 t80 -127.52 110.3 12.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.657 ' CD1' ' CD2' ' A' ' 46' ' ' PHE . 21.9 m-85 -128.51 130.48 47.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.78 -68.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 tptt -160.35 -72.15 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 45.2 Cg_endo -87.76 -20.37 1.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.092 . . . . 0.0 111.059 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -97.95 119.61 36.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.657 ' CD2' ' CD1' ' A' ' 41' ' ' TYR . 9.9 m-85 -120.13 116.34 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.32 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -118.34 112.63 20.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.812 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.53 112.43 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.901 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -127.02 134.54 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.664 -179.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m -108.38 113.72 27.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 34.0 mt -78.42 147.75 72.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.484 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.29 -12.94 27.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.089 2.526 . . . . 0.0 112.162 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -139.36 138.95 9.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.847 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -62.74 155.42 26.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.777 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.6 mm -119.28 126.35 75.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.186 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.9 p -64.4 161.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.414 0.626 . . . . 0.0 112.237 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.2 pm0 -125.03 125.75 44.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -150.13 8.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 -1.21 20.26 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.63 49.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.779 0.324 . . . . 0.0 110.997 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 45.4 tt0 -83.59 163.46 20.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 23.9 mm-40 -122.72 126.0 46.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -135.25 138.46 10.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.158 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.1 p -144.76 108.83 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.904 0.383 . . . . 0.0 111.331 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -109.2 118.01 35.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.53 134.03 52.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -47.73 12.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 110.291 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -52.21 -49.75 63.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.709 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 71' ' ' ILE . 16.7 ttpt -83.78 -19.86 34.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.689 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.46 56.97 19.31 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.73 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 69' ' ' LYS . 5.9 mt -146.85 148.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -115.8 120.34 38.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.121 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 m -119.76 133.38 55.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.658 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -140.88 118.54 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 20.1 mtp180 -92.34 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.306 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB3' HG21 ' A' ' 55' ' ' ILE . 2.7 mp -132.1 147.5 66.08 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.943 ' O ' HG23 ' A' ' 55' ' ' ILE . 89.5 Cg_endo -81.31 148.28 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.713 2.275 . . . . 0.0 111.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 27.7 mmtp -85.24 156.14 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 0.0 111.448 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.4 tt0 -89.39 -22.35 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.185 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -129.19 128.48 23.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.99 133.13 24.43 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.616 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.09 3.6 88.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.099 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -81.5 128.52 33.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.821 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.48 118.35 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.6 m-30 -77.97 90.69 4.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.155 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.84 170.77 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.56 43.23 0.25 Allowed Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.59 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.877 HD12 ' OE1' ' A' ' 10' ' ' GLN . 1.7 mt -61.98 -62.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.022 0.411 . . . . 0.0 110.952 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 89' ' ' ASN . 11.2 t-20 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 121.034 0.445 . . . . 0.0 110.692 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 23.9 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.898 0.291 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' PHE . . . -83.87 -64.97 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER 53.89 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.731 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.4 t0 -154.48 158.2 39.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -118.71 136.44 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 111.333 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.77 133.39 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.6 pm0 -130.01 143.03 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 160.68 25.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.433 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.4 -2.59 6.26 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.424 2.082 . . . . 0.0 113.02 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.92 11.92 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.902 -0.136 . . . . 0.0 110.956 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 66.5 m-85 -170.76 171.01 6.32 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.25 0.548 . . . . 0.0 111.662 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.649 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.2 tm? -134.42 115.91 14.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.927 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 74' ' ' ILE . 37.2 m -107.41 132.11 53.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.368 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.787 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.0 mt -107.12 155.39 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -137.51 118.36 14.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.932 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.502 HD13 ' CD2' ' A' ' 40' ' ' PHE . 44.4 mt -121.13 127.89 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.354 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 39.0 ttt85 -107.84 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 111.674 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 m -151.01 141.89 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -119.15 -35.17 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.664 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' ARG . 9.2 m-85 -66.17 -9.11 28.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.605 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.63 85.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.645 0.591 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.43 -71.74 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.831 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 m -43.71 135.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.7 p -57.99 -40.21 80.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -129.7 147.87 51.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -103.54 167.16 9.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 60.9 m-20 -117.32 121.12 40.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.584 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 t -122.85 119.29 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 55.6 m-85 -126.48 119.72 27.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 31.4 p90 -121.0 113.79 20.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.559 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -140.75 117.53 11.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.6 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.14 66.57 1.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.026 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER 65.55 9.85 6.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.642 0.258 . . . . 0.0 111.394 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 8.1 t70 -102.74 103.66 13.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.787 ' CE2' HD12 ' A' ' 17' ' ' ILE . 21.5 t80 -110.22 121.11 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.344 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 6.0 mttt -124.77 126.52 45.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.648 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.7 t80 -122.14 112.64 18.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.907 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 13.6 m-85 -114.63 101.77 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.028 0.442 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -129.25 118.42 22.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.759 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 40.99 -166.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 93.0 Cg_exo -44.75 -21.36 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.687 1.591 . . . . 0.0 112.848 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 24.9 m-85 -76.61 123.05 25.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 111.734 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -127.45 124.67 38.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.936 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -120.28 113.87 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' O ' HD23 ' A' ' 49' ' ' LEU . 3.2 ttm-85 -112.02 109.53 19.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.38 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 48' ' ' ARG . 14.6 mt -124.49 129.55 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 112.201 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.27 109.03 21.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.455 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 14.0 mt -63.15 128.32 92.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 111.126 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.96 -26.38 14.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.052 2.502 . . . . 0.0 113.176 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -116.51 -132.91 5.04 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -142.37 136.49 29.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 110.804 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -117.29 125.21 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.8 p -62.21 156.97 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 112.063 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.79 131.43 53.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.67 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 21.5 m-80 -171.19 21.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.44 7.03 44.39 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.152 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -97.99 45.81 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.03 172.64 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -141.24 139.32 33.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -147.52 159.06 27.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.972 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -157.67 118.47 3.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.3 . . . . 0.0 110.429 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -117.62 137.35 52.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -119.11 119.24 33.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.235 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.06 -53.26 15.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.519 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -55.02 -46.17 75.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 71' ' ' ILE . 28.3 ttpt -84.38 -26.82 28.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 66.2 63.02 4.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLY . 1.4 mt -148.72 121.04 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.449 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.6 t80 -109.68 110.97 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 147.73 29.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.351 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 16' ' ' THR . 3.8 tp -138.35 154.14 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.101 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -135.32 141.69 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -136.14 149.97 69.72 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 111.752 -178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 56' ' ' VAL . 78.1 Cg_endo -78.13 154.71 29.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.906 2.404 . . . . 0.0 112.206 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HD2' HD13 ' A' ' 55' ' ' ILE . 6.6 mmtp -99.76 151.89 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 3.1 tm-20 -87.69 -4.11 58.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.793 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.6 m -157.68 120.84 2.14 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.223 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 146.29 96.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.0 111.938 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 1.79 89.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.55 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -78.66 126.56 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.34 117.42 23.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.0 m-30 -73.92 90.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.2 168.67 11.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.84 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.77 41.81 0.96 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.44 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 88' ' ' LEU . 6.3 mt -60.61 -61.99 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.854 0.327 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 0.0 111.337 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.896 0.29 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.02 57.1 2.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 49.0 p90 -66.14 166.73 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.981 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 150.7 32.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -113.32 133.9 54.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 0.0 111.506 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.6 p -139.4 133.53 31.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.961 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.603 ' HB3' HD23 ' A' ' 15' ' ' LEU . 9.7 pm0 -130.05 141.45 50.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 0.0 112.691 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.37 160.4 26.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.204 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.27 -2.9 3.49 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.473 2.115 . . . . 0.0 113.298 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 7.3 m-20 -135.9 13.74 3.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.672 0.272 . . . . 0.0 110.563 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 73.1 m-85 -168.22 167.35 12.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.469 0.652 . . . . 0.0 111.864 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.671 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.0 tm? -134.59 106.24 6.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 74' ' ' ILE . 97.2 m -107.75 137.1 46.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.554 HG23 HD23 ' A' ' 8' ' ' LEU . 6.7 mt -126.88 137.91 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.151 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -126.36 139.17 53.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.997 0.427 . . . . 0.0 111.168 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.64 HD12 ' CD2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -122.43 134.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.792 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -77.47 120.06 21.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.857 0.361 . . . . 0.0 110.641 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.64 139.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 p -127.66 -52.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.344 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' ALA . 9.3 m-30 -66.71 -52.77 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.767 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 42.33 96.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.773 0.32 . . . . 0.0 110.626 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 mpt_? -76.76 3.13 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.699 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 43' ' ' LYS . 4.6 m -128.65 133.58 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -41.54 72.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.606 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.67 138.61 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -85.02 163.46 18.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -110.28 111.75 23.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.722 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' HD1' ' A' ' 40' ' ' PHE . 4.3 t -117.81 116.18 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.909 0.385 . . . . 0.0 111.479 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -124.02 118.11 26.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.682 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 1.8 p90 -126.79 122.66 35.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.659 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 119.01 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.546 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 63.75 -75.86 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.417 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -151.27 26.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.601 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 1.4 m-20 -118.23 129.48 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.4 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -123.44 111.48 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -116.67 128.2 55.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.64 ' CD2' HD12 ' A' ' 19' ' ' ILE . 70.0 t80 -128.93 114.78 16.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.996 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -120.48 127.97 52.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.317 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -134.65 34.18 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.274 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 17.7 tppt? 93.77 -87.95 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.073 0.949 . . . . 0.0 111.218 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 43' ' ' LYS . 44.8 Cg_endo -86.87 -16.01 3.67 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.499 1.466 . . . . 0.0 111.921 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.98 117.37 34.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.984 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -126.59 119.85 28.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -115.61 113.27 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.59 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 109.98 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 8' ' ' LEU . 75.8 mt -126.16 133.78 51.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 111.621 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.6 m -90.43 105.57 17.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.983 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 55' ' ' ILE . 10.5 mt -64.68 133.07 95.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.148 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.8 Cg_endo -68.41 -23.41 37.96 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.937 2.424 . . . . 0.0 112.75 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.55 -138.35 6.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.623 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -136.02 128.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 111.51 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.714 HG21 ' HB3' ' A' ' 76' ' ' LEU . 4.8 mm -116.14 125.6 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.603 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 7.7 p -60.25 157.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.078 0.466 . . . . 0.0 111.754 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.16 134.58 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.903 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -36.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.25 -11.58 26.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.651 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -68.6 -71.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.023 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.597 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.3 pt-20 32.92 -156.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.2 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 30.9 mt-30 -143.63 126.61 16.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.7 136.05 9.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.561 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.5 p -152.68 111.42 3.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.34 . . . . 0.0 110.815 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.85 108.5 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.402 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.19 98.62 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.38 83.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -52.69 51.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -72.82 -16.54 61.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.664 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 65.87 38.35 94.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.185 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -145.01 151.94 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.323 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 45.3 t80 -111.69 123.33 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.47 HG22 HG21 ' A' ' 16' ' ' THR . 3.2 m -119.07 132.85 56.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.107 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.597 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -140.07 118.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HA ' ' OG1' ' A' ' 16' ' ' THR . 15.0 mtp180 -86.46 148.59 25.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.2 mt -134.04 116.31 13.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 111.887 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.704 ' O ' HG23 ' A' ' 55' ' ' ILE . 66.2 Cg_exo -53.81 149.17 34.32 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.201 2.6 . . . . 0.0 112.805 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.26 153.75 17.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 1.3 tt0 -81.03 -15.0 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.473 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m -144.85 129.27 8.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.729 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.4 149.9 69.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.752 2.301 . . . . 0.0 112.836 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.21 77.84 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.787 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.49 129.86 37.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -122.07 115.54 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.584 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.6 m-30 -74.88 89.72 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.116 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 162.51 12.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.59 46.53 0.82 Allowed Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.525 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD12 ' CD ' ' A' ' 10' ' ' GLN . 4.7 mt -59.88 -61.98 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.783 0.292 . . . . 0.0 110.668 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 121.098 0.475 . . . . 0.0 110.223 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.464 -0.258 0 CA-C-O 120.791 0.246 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.92 55.88 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.394 . . . . 0.0 110.397 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 49' ' ' LEU . 35.7 p90 -61.84 163.25 7.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.294 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.12 145.6 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.69 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 49' ' ' LEU . 6.0 mt -113.75 133.64 55.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t -138.81 130.22 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.613 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.995 ' OE1' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -131.12 140.47 49.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 112.123 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.26 160.77 28.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.8 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.51 -2.2 0.93 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.041 2.494 . . . . 0.0 114.243 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.2 m-20 -136.41 3.69 2.83 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 122.058 -0.401 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.64 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.1 m-85 -169.3 169.38 9.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.2 tm? -135.65 107.87 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.036 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 74' ' ' ILE . 29.8 m -101.56 143.01 32.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 110.877 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 8' ' ' LEU . 23.1 mt -115.82 154.15 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.647 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -129.79 122.6 29.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.303 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.6 mt -125.95 123.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.481 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 118.39 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.707 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.02 133.25 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.045 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -120.65 -32.95 3.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.1 m-85 -87.15 -53.35 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . 18.89 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.747 0.655 . . . . 0.0 112.01 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -56.99 -60.0 4.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -33.91 124.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 111.009 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 p -54.84 -39.95 69.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -125.31 139.49 53.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.353 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.0 OUTLIER -85.85 160.32 19.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 9.2 m-20 -112.88 113.11 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.728 0.299 . . . . 0.0 110.998 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 40' ' ' PHE . 10.7 t -117.02 115.93 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.991 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 11.2 m-85 -116.67 114.65 24.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 36.3 p90 -124.75 116.27 22.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 42.5 mt-10 -138.22 115.16 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.79 -68.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -157.89 22.66 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.524 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -111.23 104.64 13.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.14 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 17' ' ' ILE . 82.9 t80 -106.38 116.64 32.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.4 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 mptt -119.92 131.01 55.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 92.5 t80 -130.95 116.78 18.3 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 17.6 m-85 -115.54 110.23 18.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.668 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -108.16 24.1 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 95.91 -87.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 O-C-N 124.235 0.959 . . . . 0.0 110.658 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 80.6 Cg_endo -83.0 -16.38 7.47 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.491 1.461 . . . . 0.0 111.801 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -109.97 131.92 54.62 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.809 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 19.7 t80 -127.35 126.96 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.55 HD12 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -121.55 112.14 18.11 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.84 115.17 22.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 178.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 8' ' ' LEU . 90.7 mt -137.04 144.03 42.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.69 113.31 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.249 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.3 mt -73.89 135.78 77.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.567 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 36.3 Cg_exo -61.47 -22.09 73.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.071 2.514 . . . . 0.0 113.003 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.59 ' HA3' ' CD1' ' A' ' 85' ' ' PHE . . . -113.07 -142.61 8.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.129 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 2.4 mmt-85 -142.18 139.35 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.864 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.9 mm -117.81 124.96 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 77' ' ' PRO . 6.2 p -56.24 152.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.402 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -110.41 123.07 49.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.042 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.55 -39.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.96 -19.43 32.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -59.87 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 30.96 -152.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.468 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mt-30 -157.33 131.45 8.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.34 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.58 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.98 141.69 13.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.065 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -159.51 105.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -107.41 137.81 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.25 115.58 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.14 -46.63 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.33 -50.57 69.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.767 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.761 ' CD ' HD12 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -79.61 -23.21 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 69.4 63.36 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.672 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.761 HD12 ' CD ' ' A' ' 69' ' ' LYS . 54.0 mt -160.23 126.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.9 t80 -108.12 118.79 37.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.515 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.487 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -122.54 122.39 38.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.593 ' C ' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER -130.51 122.93 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.441 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.68 140.93 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.668 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.839 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mp -129.37 129.81 23.28 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.977 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.3 Cg_endo -66.82 150.74 83.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.926 2.417 . . . . 0.0 112.184 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HE3' ' C ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -92.7 155.81 17.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -71.36 -19.74 62.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.701 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -146.51 120.88 5.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.0 152.02 54.01 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.886 2.391 . . . . 0.0 112.624 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.75 -4.0 62.31 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -77.53 135.43 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.125 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.512 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 3.4 t-160 -125.43 116.45 21.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 5.5 m-30 -67.93 89.76 0.29 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.698 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -74.42 172.78 11.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 112.018 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 45.03 32.66 3.37 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.41 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.995 HD11 ' OE1' ' A' ' 10' ' ' GLN . 8.7 mt -43.13 -53.29 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.723 0.761 . . . . 0.0 110.146 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.522 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 N--CA 1.463 -0.29 0 CA-C-O 120.829 0.262 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.16 60.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 38.2 p90 -68.65 161.52 27.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.819 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.54 148.22 29.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.81 134.21 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.262 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -141.84 136.05 30.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.301 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.24 141.89 50.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.317 0.58 . . . . 0.0 112.329 -178.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -101.44 157.84 32.9 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.507 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 10.5 Cg_endo -54.75 -8.16 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 113.629 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 47.1 m-20 -135.52 15.48 3.42 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.324 -0.235 . . . . 0.0 111.292 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 13.1 m-85 -169.5 170.71 8.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.481 0.658 . . . . 0.0 112.321 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.77 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -132.82 112.67 12.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.6 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.491 ' N ' HD22 ' A' ' 15' ' ' LEU . 30.2 m -104.67 138.02 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 1.9 mt -114.33 149.41 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -129.76 120.26 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 111.074 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 47' ' ' LEU . 13.1 mt -126.0 119.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.5 mtt180 -90.69 120.64 31.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.412 . . . . 0.0 111.813 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 m -141.88 129.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -72.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.997 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.4 m-30 -48.42 -52.91 19.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.909 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.514 ' HA ' ' CD ' ' A' ' 43' ' ' LYS . . . 39.49 95.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.89 5.32 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.877 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 43' ' ' LYS . 27.1 m -127.46 133.28 68.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -41.11 82.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.72 148.28 50.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.653 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -98.67 168.71 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.301 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.95 118.55 36.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.11 115.35 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 0.0 112.027 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -125.39 117.87 24.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -120.41 118.95 31.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.142 0.496 . . . . 0.0 111.72 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.21 96.76 3.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.621 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.09 -146.68 18.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.685 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -54.33 -14.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.628 0.251 . . . . 0.0 111.63 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.83 117.27 26.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' ' 17' ' ' ILE . 61.2 t80 -127.67 113.27 15.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 131.34 55.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 111.574 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.48 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 69.8 t80 -126.64 109.7 12.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.519 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -107.69 108.31 19.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.188 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -140.82 119.42 12.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.194 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 38.04 -161.66 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.716 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 73.0 Cg_exo -50.91 -17.3 3.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.208 1.272 . . . . 0.0 112.567 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 51.4 m-85 -74.55 112.81 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.341 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.25 116.21 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 19' ' ' ILE . 4.4 mt -119.35 114.65 22.69 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.06 115.84 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.15 178.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 48' ' ' ARG . 78.2 mt -134.0 143.04 47.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 112.16 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -105.21 105.17 15.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.204 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 88.2 mt -62.4 145.3 94.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.178 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 37.5 Cg_exo -60.12 -23.43 73.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.778 2.318 . . . . 0.0 112.055 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -125.36 -125.04 2.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.3 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -154.15 149.54 27.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.975 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.907 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.5 mm -117.77 123.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 5.3 p -58.12 151.39 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -119.1 125.32 49.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.808 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.45 27.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.412 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.56 -32.73 2.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.154 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.71 120.21 9.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.137 0.468 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.0 163.88 6.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.632 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 6.2 mt-30 -143.53 134.38 25.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.702 ' HA3' HD12 ' A' ' 74' ' ' ILE . . . -140.38 146.06 17.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.661 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -139.27 112.1 7.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 110.65 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -104.57 120.21 40.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.235 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -114.01 110.74 20.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.563 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.99 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -57.26 -50.27 73.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 9.8 ttpt -74.2 -22.13 59.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 61.24 63.21 5.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.267 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 ' HG3' ' A' ' 20' ' ' ARG . 14.6 mt -156.84 131.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.118 0.485 . . . . 0.0 112.054 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' A' ' 40' ' ' PHE . 12.9 t80 -116.21 113.76 23.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.505 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 134.05 55.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.194 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.702 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.0 OUTLIER -138.58 117.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' NH2' ' OG ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -91.13 142.28 27.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.178 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.2 mp -134.37 145.88 57.11 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.631 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' ILE . 59.4 Cg_endo -73.42 151.36 47.87 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.831 2.354 . . . . 0.0 112.433 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -95.47 156.68 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.103 0.478 . . . . 0.0 111.704 -179.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 12.0 tt0 -88.22 -6.25 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 45.1 m -159.51 96.09 1.64 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.318 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 9.8 Cg_endo -53.58 157.56 9.42 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.498 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.87 -6.42 70.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.493 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 37.3 tt0 -84.79 141.0 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.308 . . . . 0.0 110.81 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -124.26 117.06 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 8.2 m-30 -72.72 92.69 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -72.0 173.7 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.311 0.577 . . . . 0.0 111.913 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.9 40.15 0.33 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.667 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 10.5 mt -60.66 -63.04 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.976 0.388 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.087 0.47 . . . . 0.0 110.641 179.773 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 33.1 mt -125.62 133.38 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -73.54 118.19 66.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.54 139.38 85.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.24 . . . . 0.0 111.78 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.25 54.1 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -58.19 161.25 4.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.44 146.99 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.3 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 138.59 54.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.226 0.536 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 p -141.66 133.94 27.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.552 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.712 ' OE1' HD12 ' A' ' 88' ' ' LEU . 2.7 pm0 -130.7 140.73 50.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.371 0.605 . . . . 0.0 112.457 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.37 160.56 26.11 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.986 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.68 -6.06 1.47 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.03 2.486 . . . . 0.0 113.947 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.4 m-20 -135.95 8.91 3.27 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.625 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 65.7 m-85 -168.24 168.41 11.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 111.733 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.72 109.58 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.615 178.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.649 ' N ' HD22 ' A' ' 15' ' ' LEU . 19.4 m -99.41 147.26 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.799 HD12 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mt -125.4 153.14 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.12 121.94 16.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 112.069 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.08 124.23 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.796 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.8 118.71 37.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.358 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -148.25 143.21 19.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.906 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -125.57 -23.22 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.7 m-85 -75.56 -10.05 59.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.534 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.55 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.476 0.485 . . . . 0.0 111.811 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -82.69 10.22 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.287 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.11 127.44 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.785 179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -55.8 -24.19 34.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.12 153.52 42.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -108.55 168.39 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.378 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -129.03 128.51 43.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.95 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.2 117.6 26.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 21.2 p90 -128.86 119.28 24.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.8 OUTLIER -140.71 122.21 15.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.114 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.87 -70.21 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.642 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -160.38 25.4 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 0.0 110.592 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 6.7 t70 -116.22 110.61 19.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.799 ' CE2' HD12 ' A' ' 17' ' ' ILE . 26.1 t80 -105.54 111.82 24.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.224 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.28 128.17 50.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 47.8 t80 -104.99 143.08 33.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.375 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 32.7 m-85 -135.49 102.81 5.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 111.138 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -149.0 112.73 5.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.8 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER 47.02 -175.63 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 84.6 Cg_exo -37.0 -27.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.16 1.907 . . . . 0.0 112.744 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 12.6 m-30 -63.15 120.82 12.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.381 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -125.27 120.05 30.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.648 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -116.98 115.66 25.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.049 0.452 . . . . 0.0 112.024 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.28 110.17 16.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.897 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.9 mt -124.18 130.63 52.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.367 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 m -102.14 107.67 18.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 23.1 mt -65.28 143.89 98.88 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.199 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 49.9 Cg_endo -70.27 -23.82 28.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.785 2.323 . . . . 0.0 112.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -116.74 -137.28 5.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.186 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 82.3 mtt-85 -140.47 132.76 28.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 77' ' ' PRO . 52.0 mm -113.78 124.41 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.481 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.793 HG13 ' HG2' ' A' ' 77' ' ' PRO . 10.1 p -68.03 162.56 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.4 pt-20 -123.74 127.66 48.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.218 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.24 6.68 0.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.96 23.63 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -82.1 -69.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.994 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 31.55 -156.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.698 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 1.8 mm-40 -179.94 119.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 74' ' ' ILE . . . -170.06 -179.16 41.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.175 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -164.14 148.93 10.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CD1' ' HE2' ' A' ' 29' ' ' PHE . 14.9 t80 -113.85 132.94 55.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.436 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -124.93 125.3 43.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.475 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.83 -34.26 26.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.422 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -50.53 65.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.545 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -94.15 -11.0 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.508 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 63.15 62.21 5.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.259 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 70' ' ' GLY . 6.1 mt -155.05 127.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.676 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.514 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.1 t80 -110.49 114.79 28.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.501 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -121.7 126.13 48.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.263 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 2.1 tp -133.49 120.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 5.1 mtp180 -92.33 145.1 24.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.487 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.579 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.9 mt -134.66 143.17 45.39 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.834 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.822 ' O ' HG23 ' A' ' 55' ' ' ILE . 47.9 Cg_endo -73.18 158.98 48.24 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.789 2.326 . . . . 0.0 112.657 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 14' ' ' PHE . 1.7 mttt -96.76 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.99 -11.03 51.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.399 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.2 m -147.52 130.49 7.98 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.846 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.06 142.54 81.47 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.99 2.46 . . . . 0.0 112.74 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 2.87 87.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.571 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' NE2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 tt0 -78.1 126.75 31.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.736 0.303 . . . . 0.0 110.845 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.526 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -128.35 121.3 28.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 4.8 m-30 -76.16 92.95 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.426 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 170.49 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.736 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 34.8 40.33 0.2 Allowed Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.541 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.768 ' O ' HD22 ' A' ' 91' ' ' LEU . 2.6 mt -59.53 -61.52 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.959 0.379 . . . . 0.0 110.382 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.92 14.94 2.47 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.899 0.381 . . . . 0.0 110.943 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 91' ' ' LEU . 28.7 mtt -115.41 -32.42 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.768 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -45.25 177.44 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.828 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.415 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -141.8 163.21 33.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.914 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.93 141.96 35.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 94' ' ' LEU . 2.7 pp -107.93 140.23 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.648 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.2 mp -93.52 131.65 38.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.089 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.99 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.854 0.359 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -120.34 150.22 41.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -70.74 111.34 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.2 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 2' ' ' LEU . 51.8 Cg_exo -54.27 161.8 4.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.26 63.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 5.6 p90 -68.69 160.28 30.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.062 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.1 149.95 31.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.534 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.72 135.19 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.159 0.504 . . . . 0.0 111.465 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' THR . 59.5 p -139.33 133.82 31.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.319 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.594 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.1 pm0 -129.94 139.52 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.26 160.35 27.79 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.824 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.54 -6.61 7.37 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.663 2.242 . . . . 0.0 112.982 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 49.4 m-20 -135.01 13.76 3.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.521 0.201 . . . . 0.0 110.713 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 5.1 m-85 -169.92 171.81 6.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.537 0.684 . . . . 0.0 112.163 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.663 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.72 108.32 7.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.685 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.653 ' N ' HD22 ' A' ' 15' ' ' LEU . 14.1 m -99.72 144.68 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 111.203 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 19.2 mt -119.42 152.77 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -132.78 112.57 12.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 17.5 mt -125.09 120.13 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' NH1' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -102.55 120.86 41.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.71 132.77 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -32.1 4.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' ALA . 5.5 m-85 -71.12 -9.9 58.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.016 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -29.8 122.53 0.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.453 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 12.16 30.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 42' ' ' ALA . 3.1 m -139.22 138.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.045 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -58.95 -40.95 86.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -117.33 141.59 48.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -92.96 168.94 10.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.774 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.0 116.57 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.435 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 ' HD1' ' A' ' 40' ' ' PHE . 21.9 t -121.96 120.75 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.19 127.83 43.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 23.9 p90 -132.2 121.89 24.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.4 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' SER . 18.9 pt-20 -138.65 119.93 14.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.62 -71.49 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.368 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -159.86 26.47 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.083 0.468 . . . . 0.0 109.961 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m-20 -115.76 104.51 11.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.02 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 17' ' ' ILE . 25.7 t80 -105.68 120.76 42.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -124.77 135.62 53.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.611 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' HD1' HG22 ' A' ' 31' ' ' VAL . 85.3 t80 -129.09 112.35 13.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.78 133.71 46.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 111.234 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -105.27 -59.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -163.03 -64.73 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.485 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 48.3 Cg_endo -97.71 -10.76 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.986 2.458 . . . . 0.0 112.782 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -108.52 134.55 51.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 8.5 t80 -123.62 118.42 27.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.069 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 1.1 mt -115.75 111.2 20.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.486 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.2 109.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.699 0.285 . . . . 0.0 110.57 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.67 131.12 53.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.942 0.401 . . . . 0.0 111.549 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 m -101.16 110.3 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 20.9 mt -68.63 129.99 92.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 51.4 Cg_exo -54.53 -23.18 30.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.969 2.446 . . . . 0.0 112.734 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -117.91 -133.58 4.92 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 23.3 mtt-85 -146.5 141.01 26.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.978 HG23 ' O ' ' A' ' 77' ' ' PRO . 9.5 mm -118.45 126.06 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.57 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.6 p -58.46 157.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.573 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -121.06 128.41 52.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.661 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -163.96 -41.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.43 -0.03 26.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -91.06 31.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.408 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.558 ' HG3' ' CD ' ' A' ' 77' ' ' PRO . 21.2 mp0 -80.0 -168.76 1.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.943 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -131.96 122.29 25.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -122.33 135.0 10.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -147.74 104.88 3.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.15 136.91 54.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.567 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.04 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -43.59 22.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.494 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -60.3 -52.89 63.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 68' ' ' ASP . 9.6 ttpt -78.71 -24.48 44.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 65.26 61.38 5.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.562 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -149.77 126.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.388 . . . . 0.0 111.6 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' ILE . 5.5 t80 -110.72 108.35 18.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -115.62 120.43 39.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.946 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.49 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -130.23 118.54 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.006 0.431 . . . . 0.0 111.886 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -85.85 142.77 28.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.059 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.832 ' HB3' HG21 ' A' ' 55' ' ' ILE . 8.7 mt -128.44 132.22 24.23 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 111.666 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.1 Cg_endo -64.95 153.26 79.05 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.757 2.304 . . . . 0.0 112.261 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HG3' ' C ' ' A' ' 13' ' ' ASP . 1.6 mttt -96.67 151.06 19.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.045 0.45 . . . . 0.0 111.523 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.53 -14.19 49.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.113 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.2 m -146.8 108.15 4.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.565 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -50.8 148.75 15.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.641 2.228 . . . . 0.0 112.397 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 -1.68 86.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.637 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -79.26 132.0 36.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 10' ' ' GLN . 8.2 t-80 -127.04 119.98 27.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.524 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 9.1 m-30 -77.03 90.93 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.71 173.6 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 112.213 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 34.45 37.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.902 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 85' ' ' PHE . 20.2 mt -61.21 -63.58 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.239 0.519 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.2 7.36 22.2 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.039 0.447 . . . . 0.0 110.327 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.471 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 2.5 mtt -112.63 15.45 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.176 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 91' ' ' LEU . 2.9 mt -96.8 177.3 5.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.149 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 t -110.88 174.01 6.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 0.0 110.821 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.65 115.9 28.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.393 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -103.78 112.34 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.4 179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.6 mp -93.69 142.79 26.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.268 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.71 110.24 22.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.733 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -42.7 149.92 0.46 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.733 ' HD2' HG22 ' A' ' 3' ' ' THR . 43.4 Cg_endo -67.91 172.16 11.2 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.452 2.102 . . . . 0.0 111.994 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.01 60.1 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.69 159.76 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -144.3 143.73 31.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.81 134.63 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.512 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -139.35 133.11 30.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.391 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 85' ' ' PHE . 6.2 pm0 -130.36 140.65 50.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.477 0.656 . . . . 0.0 112.477 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 5.5 m-20 -108.31 160.28 27.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.134 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.44 -0.97 2.7 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.648 2.232 . . . . 0.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 40.6 m-20 -135.75 4.82 3.09 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.451 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.618 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 17.8 m-85 -167.07 167.05 14.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.329 0.585 . . . . 0.0 112.303 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.1 tm? -134.8 112.03 10.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.138 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.53 ' OG1' ' CG ' ' A' ' 75' ' ' ARG . 55.0 m -108.78 135.67 49.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.0 111.275 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.567 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.3 mt -109.73 152.65 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.5 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.92 119.42 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 111.66 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.62 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -124.8 129.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.634 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -107.29 119.17 38.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.077 0.465 . . . . 0.0 111.6 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.37 128.65 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.536 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.24 -36.37 7.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.654 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' C ' ' A' ' 24' ' ' ALA . 53.9 m-85 -65.78 -10.21 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.62 118.27 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.709 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -98.76 -69.44 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.757 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -43.41 125.24 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -20.15 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.949 0.404 . . . . 0.0 110.724 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -137.0 148.13 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.605 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -103.91 166.84 10.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.865 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -124.31 127.58 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.9 t -123.55 121.17 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -127.6 123.15 34.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.174 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 24.0 p90 -134.21 126.03 29.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -139.21 119.57 13.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.98 -68.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.78 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -161.89 26.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 0.0 110.391 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.0 m-20 -116.19 104.54 11.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 17' ' ' ILE . 42.7 t80 -99.11 112.08 24.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 36.1 mttt -118.24 117.43 29.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.178 0.513 . . . . 0.0 111.385 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 19' ' ' ILE . 24.3 t80 -102.68 143.22 32.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.77 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 25.2 m-85 -137.52 112.35 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' TYR . . . -144.48 104.51 4.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.092 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.581 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 2.8 pttt 44.92 -163.34 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 71.0 Cg_exo -41.4 -22.6 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.987 1.791 . . . . 0.0 113.636 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.528 ' CZ ' ' HE2' ' A' ' 43' ' ' LYS . 17.0 m-30 -73.09 122.78 22.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.182 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -129.93 125.4 35.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.324 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -123.13 117.77 26.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 0.0 111.915 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.2 tmm_? -117.89 113.31 21.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 48' ' ' ARG . 29.3 mt -124.21 132.21 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.941 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m -98.99 106.75 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.8 mt -66.21 126.27 91.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.065 0.459 . . . . 0.0 111.456 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 32.1 Cg_exo -57.01 -26.55 69.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.031 2.487 . . . . 0.0 112.304 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.13 -140.12 7.62 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 5.9 mtt180 -137.63 128.09 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.369 . . . . 0.0 111.368 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.0 mm -111.73 123.75 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.916 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.588 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -62.36 158.57 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.188 0.518 . . . . 0.0 112.376 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -123.17 129.58 51.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.601 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -165.21 -37.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.98 9.25 20.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.711 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.98 33.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 76' ' ' LEU . 2.1 pt-20 -85.77 -172.95 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.96 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 14.0 mt-30 -132.37 122.19 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.807 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -123.48 134.81 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.721 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.84 107.89 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -107.05 139.57 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' GLY . 65.6 t0 -116.22 112.72 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.474 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.64 -53.68 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.339 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -53.82 -44.62 70.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG2' HG13 ' A' ' 71' ' ' ILE . 35.1 ttpt -84.73 -26.7 27.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.71 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 69.69 63.4 3.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.649 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 69' ' ' LYS . 7.0 mt -154.34 119.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 111.65 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -103.12 109.47 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 97.5 m -114.3 121.71 44.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.474 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -131.99 121.1 46.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.59 144.21 26.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.022 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 HD12 ' A' ' 15' ' ' LEU . 10.3 mt -133.51 150.61 75.47 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.979 ' O ' HG23 ' A' ' 55' ' ' ILE . 17.7 Cg_endo -86.76 157.74 8.94 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.226 2.617 . . . . 0.0 112.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 1.5 mtpm? -101.42 156.6 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.939 0.4 . . . . 0.0 111.644 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -90.5 -6.15 55.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 80' ' ' THR . 5.6 m -156.86 90.03 2.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.8 153.54 0.27 Allowed 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 123.011 2.474 . . . . 0.0 112.929 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.26 -11.2 66.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.887 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.513 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 5.0 tp60 -81.28 136.86 35.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.671 0.272 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 2.2 t-80 -125.72 116.87 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.838 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.4 m-30 -71.51 94.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.48 174.33 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.423 0.63 . . . . 0.0 112.341 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 35.9 36.21 0.12 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.569 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 37.8 mt -58.89 -63.41 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.516 0.658 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.11 9.1 26.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.55 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.467 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -118.25 17.94 13.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.432 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mt -91.08 178.76 5.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -133.87 174.18 10.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.427 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.63 134.78 34.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 94' ' ' LEU . 2.4 pp -123.77 126.2 46.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.011 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -97.78 112.76 24.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.966 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.734 0.302 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -123.41 137.63 54.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.946 0.403 . . . . 0.0 111.11 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.39 130.41 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.69 137.01 26.64 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.804 2.336 . . . . 0.0 111.891 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.41 ' O ' ' NE ' ' A' ' 20' ' ' ARG . . . -94.1 57.66 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.186 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 14.3 p90 -72.58 169.46 16.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -156.92 164.08 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.889 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.783 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -128.63 141.32 51.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.251 0.548 . . . . 0.0 111.875 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.76 134.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.041 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.517 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.76 144.03 51.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.98 160.86 27.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.04 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.61 -0.61 2.58 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.969 2.446 . . . . 0.0 113.686 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.627 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER -135.92 6.31 3.14 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.443 -0.161 . . . . 0.0 111.195 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.8 m-85 -168.98 169.17 9.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.394 0.616 . . . . 0.0 111.855 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.819 HD22 ' N ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -133.21 120.19 20.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.419 177.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.819 ' N ' HD22 ' A' ' 15' ' ' LEU . 85.7 m -111.94 149.8 31.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.966 0.412 . . . . 0.0 111.21 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.783 HG23 HD23 ' A' ' 8' ' ' LEU . 16.3 mt -124.99 151.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.308 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB1' ' NH1' ' A' ' 20' ' ' ARG . . . -140.58 122.63 15.64 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 47' ' ' LEU . 6.8 mt -125.61 131.27 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -108.59 119.38 39.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.35 . . . . 0.0 110.805 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -145.84 136.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.103 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.09 -36.06 5.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.02 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' ARG . 28.1 m-85 -64.49 -10.36 25.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.07 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.35 86.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.033 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.3 -72.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.621 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.1 m -50.18 137.23 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.43 -41.12 98.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.13 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -120.64 143.1 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.706 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -98.36 164.48 12.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.009 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -112.39 118.02 34.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.84 114.6 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -127.45 124.39 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.933 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 44.1 p90 -123.58 116.18 22.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -138.2 121.09 16.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.39 59.97 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.93 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 64.52 22.97 12.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.334 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 16.1 t0 -111.57 103.77 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CD1' ' CD1' ' A' ' 17' ' ' ILE . 80.7 t80 -101.35 113.18 26.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.535 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 111.73 19.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.992 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -108.56 110.37 21.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.041 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 77.4 m-85 -113.03 106.29 14.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 111.322 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -136.0 118.85 16.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.4 OUTLIER 44.48 -169.62 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 43' ' ' LYS . 81.8 Cg_exo -47.11 -14.16 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.133 1.889 . . . . 0.0 113.278 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.571 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 18.0 m-30 -80.83 125.52 30.19 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.844 0.354 . . . . 0.0 111.355 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.76 122.99 36.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.356 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -117.25 110.08 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 111.363 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.643 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.2 ttm180 -112.27 110.23 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.907 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 48' ' ' ARG . 18.5 mt -126.58 130.91 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 111.862 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.7 m -104.73 114.17 28.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.484 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.2 mt -81.47 147.2 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.7 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 21.5 Cg_exo -64.95 -17.63 59.95 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.997 2.464 . . . . 0.0 112.163 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -138.47 135.12 7.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HA ' ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -64.22 163.54 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.133 0.492 . . . . 0.0 111.838 -178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.976 HG23 ' O ' ' A' ' 77' ' ' PRO . 28.2 mm -123.28 129.31 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 13.9 p -54.51 150.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.568 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -108.31 121.33 44.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.251 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -154.44 -40.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.55 -21.28 21.67 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -57.95 -65.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.626 0.251 . . . . 0.0 110.742 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' OE2' HD11 ' A' ' 74' ' ' ILE . 26.6 pt-20 28.07 -145.95 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.136 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -167.54 146.15 4.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.609 0.243 . . . . 0.0 110.512 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -154.16 145.91 13.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.896 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.46 110.48 5.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.658 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.524 ' CE1' ' CG ' ' A' ' 72' ' ' PHE . 31.7 m-85 -94.73 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.32 112.11 24.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -57.09 -52.27 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -21.03 39.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 66.34 63.11 4.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.697 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 70' ' ' GLY . 21.1 mt -158.59 128.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.947 0.403 . . . . 0.0 111.581 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.524 ' CG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 t80 -106.06 109.71 21.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.489 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.56 119.55 38.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.515 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -130.55 119.76 46.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.538 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 46.9 mtp180 -85.8 146.35 26.81 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.637 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 55' ' ' ILE . 11.3 mt -136.06 133.21 19.56 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.098 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 55' ' ' ILE . 2.9 Cg_exo -73.59 150.11 44.99 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.789 2.326 . . . . 0.0 111.725 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HE2' ' N ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -90.42 156.55 18.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.147 0.499 . . . . 0.0 112.272 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -90.54 -20.34 22.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.228 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.6 m -131.64 89.55 39.48 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.599 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -41.72 141.27 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.902 2.401 . . . . 0.0 112.524 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.11 -4.81 83.15 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.084 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 10.5 tt0 -80.4 131.23 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.827 0.314 . . . . 0.0 110.36 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.484 ' ND1' ' OE1' ' A' ' 10' ' ' GLN . 2.8 t60 -126.75 124.5 39.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.092 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 88' ' ' LEU . 1.2 m-30 -88.5 93.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.093 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.83 126.44 27.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . . . 34.11 57.95 0.66 Allowed Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.065 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 85' ' ' PHE . 1.3 mp -48.53 -21.9 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.166 0.483 . . . . 0.0 110.835 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -80.98 14.47 2.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.52 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.48 -30.43 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.39 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' N ' ' HG3' ' A' ' 90' ' ' MET . 15.3 mt -42.79 158.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.576 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.773 ' O ' HD23 ' A' ' 94' ' ' LEU . 1.5 m -149.24 154.3 38.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.793 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.39 112.16 13.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.411 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -124.8 109.08 12.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.385 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 2.6 mp -97.73 109.86 22.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.329 . . . . 0.0 110.751 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.895 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.63 141.52 47.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 3' ' ' THR . 8.4 t -64.1 121.19 70.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.8 153.02 65.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.918 2.412 . . . . 0.0 112.521 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.73 70.08 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.63 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -78.43 159.6 28.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.469 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.52 144.9 29.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.352 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 88' ' ' LEU . 2.0 mt -116.31 138.09 51.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.502 . . . . 0.0 111.568 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.72 135.04 31.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.363 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' NE2' ' CE1' ' A' ' 84' ' ' HIS . 8.3 pm0 -129.86 143.41 50.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.474 0.654 . . . . 0.0 112.337 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -106.66 160.82 24.9 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.052 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.04 -1.08 3.19 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.868 2.378 . . . . 0.0 113.452 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.671 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 10.1 m-20 -136.82 9.59 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.47 -0.144 . . . . 0.0 111.003 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 15.3 m-85 -171.99 173.21 4.48 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.384 0.612 . . . . 0.0 111.839 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.67 117.02 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.424 177.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.596 ' N ' HD22 ' A' ' 15' ' ' LEU . 31.2 m -107.73 150.84 26.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.0 111.138 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -125.3 151.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.77 114.46 13.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.964 0.411 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.4 125.83 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.317 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -84.62 121.41 27.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 65' ' ' TYR . 20.0 m -149.99 149.2 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.7 p -140.26 -57.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.227 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' ALA . 11.0 m-30 -56.88 -52.76 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.09 99.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.16 6.16 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.504 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.02 134.31 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -57.33 -41.68 80.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.809 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -123.3 139.39 54.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.18 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -84.7 158.73 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.102 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 23.9 m-20 -109.67 111.66 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG22 ' HD1' ' A' ' 40' ' ' PHE . 73.1 t -118.08 117.47 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.424 . . . . 0.0 111.334 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.84 112.06 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.372 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 21.2 p90 -119.12 113.28 20.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.762 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 pt-20 -136.66 106.04 6.08 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.649 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 34.69 88.45 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.886 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 67.81 -1.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 26.8 t70 -108.32 120.71 43.15 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.03 121.76 27.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.5 mmtt -124.35 128.81 49.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.573 ' HD1' HG22 ' A' ' 31' ' ' VAL . 77.1 t80 -122.89 111.45 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.736 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 6.1 m-85 -115.09 124.6 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.391 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -130.66 29.64 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.625 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 91.76 -89.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.931 0.892 . . . . 0.0 111.302 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 92.2 Cg_endo -82.02 -17.4 8.14 Favored 'Trans proline' 0 C--N 1.356 0.929 0 CA-C-N 120.739 1.3 . . . . 0.0 111.597 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.71 117.82 34.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.293 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 41' ' ' TYR . 1.4 t80 -124.77 120.16 30.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.482 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -116.07 111.55 20.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.949 0.404 . . . . 0.0 111.582 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.552 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -116.24 110.61 18.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.933 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.5 mt -131.45 138.06 48.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.421 . . . . 0.0 111.811 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.71 111.9 24.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 78.6 mt -67.48 140.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.979 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 17.1 Cg_exo -66.87 -15.73 47.92 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.758 2.305 . . . . 0.0 112.302 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.56 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.61 -133.81 5.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.05 142.82 26.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 111.438 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.946 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.7 mm -119.08 125.11 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.758 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 10.3 p -52.88 142.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.032 0.444 . . . . 0.0 112.024 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.98 122.05 44.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.501 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.4 ' C ' ' ND2' ' A' ' 58' ' ' ASN . 0.6 OUTLIER -167.58 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.18 16.1 9.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.84 28.33 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 110.73 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' HG3' HD11 ' A' ' 74' ' ' ILE . 20.9 pm0 -72.38 -167.19 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 7.6 mt-30 -138.39 129.97 27.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.02 136.68 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.675 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.4 t -155.11 116.33 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' OH ' HG23 ' A' ' 21' ' ' VAL . 2.9 t80 -105.53 123.09 47.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.584 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 120.39 42.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.24 -31.87 55.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.524 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.91 -55.22 24.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG3' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -91.25 -7.92 49.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.797 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.43 52.26 51.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.4 ' HB ' ' HG3' ' A' ' 69' ' ' LYS . 91.2 mt -145.82 144.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 0.0 110.498 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.566 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -111.72 123.86 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.024 0.44 . . . . 0.0 111.217 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.05 131.22 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -139.55 118.62 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 0.0 111.556 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -90.1 147.24 23.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.706 ' HB3' HG21 ' A' ' 55' ' ' ILE . 4.7 mt -135.3 131.12 19.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.795 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.946 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.9 Cg_endo -66.98 144.33 69.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.65 2.234 . . . . 0.0 111.997 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 11' ' ' ASP . 35.6 mttp -88.56 156.65 18.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.037 0.446 . . . . 0.0 111.518 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -87.49 -17.56 31.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.138 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 83' ' ' GLN . 20.0 m -135.94 119.25 12.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.544 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 143.8 70.01 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.496 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.28 2.45 90.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.671 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 4.5 tt0 -81.77 129.11 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.787 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' A' ' 10' ' ' GLN . 20.9 t-80 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.192 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.9 m-30 -83.29 89.91 7.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.89 162.48 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 112.121 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 34.85 49.41 0.76 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.592 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 8' ' ' LEU . 1.3 mt -60.3 -61.34 2.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.927 0.364 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -85.3 13.42 6.52 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.023 0.44 . . . . 0.0 110.619 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 91' ' ' LEU . 6.6 mtm -113.48 -28.77 7.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.337 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -45.25 178.34 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.606 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.42 -172.62 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.652 0.263 . . . . 0.0 111.062 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.35 144.79 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.004 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.64 111.07 17.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.849 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.7 mp -91.15 116.0 28.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.953 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -110.86 143.07 42.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.716 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -67.19 138.48 94.59 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo -53.71 149.36 32.77 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.807 2.338 . . . . 0.0 112.204 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 0.0 110.848 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.617 ' HE2' HD21 ' A' ' 8' ' ' LEU . 4.5 p90 -73.3 164.87 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.062 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.28 147.47 27.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 ' HE2' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -115.16 136.09 53.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.507 . . . . 0.0 111.531 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.8 t -140.7 134.47 30.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.756 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -131.94 145.09 51.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.561 0.696 . . . . 0.0 112.686 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.85 160.56 27.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.893 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.87 -0.31 3.8 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.935 2.423 . . . . 0.0 113.248 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.652 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 72.4 m-20 -134.79 5.81 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.478 0.18 . . . . 0.0 110.866 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.5 m-85 -171.34 171.37 5.59 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.267 0.556 . . . . 0.0 111.212 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -137.67 111.18 8.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.086 178.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 74' ' ' ILE . 4.9 m -104.74 148.51 26.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.134 0.492 . . . . 0.0 111.38 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.742 HD12 ' CE1' ' A' ' 38' ' ' PHE . 4.6 mt -123.39 155.3 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -136.85 111.29 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.932 0.396 . . . . 0.0 111.132 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.622 HD13 ' CD2' ' A' ' 40' ' ' PHE . 3.7 mt -118.95 126.84 75.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' GLY . 11.4 ttt180 -101.85 119.44 38.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.585 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 21' ' ' VAL . 14.4 m -143.73 130.44 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.543 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.45 -33.59 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.389 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.514 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 2.2 m-30 -66.92 -10.13 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.8 108.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 6.8 ttt180 -101.48 11.29 39.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.5 m -121.88 129.37 75.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.19 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.7 m -56.47 -40.38 74.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -125.47 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.355 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -94.0 160.03 14.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.807 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -113.7 112.15 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.57 114.55 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -119.36 113.15 20.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.393 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 12.3 p90 -118.57 112.95 20.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.015 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 1.1 tt0 -138.07 112.6 8.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.347 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA2' ' HG2' ' A' ' 54' ' ' ARG . . . 36.91 77.37 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.442 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 66.45 4.16 3.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.5 m-20 -102.8 104.23 14.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.742 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.2 t80 -110.87 116.04 30.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.428 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -121.2 131.78 54.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.249 179.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 19' ' ' ILE . 84.5 t80 -128.46 112.05 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.334 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' OH ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -116.45 119.33 35.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -133.9 29.53 3.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.484 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 2.1 pttp 122.46 -164.31 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.823 1.327 . . . . 0.0 108.536 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 27.3 Cg_exo -37.33 -26.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.339 1.359 . . . . 0.0 112.66 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' LYS . 18.5 m-85 -73.49 124.42 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.04 124.1 38.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.686 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.1 mt -113.35 109.29 18.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -120.14 112.49 19.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.159 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 48' ' ' ARG . 32.6 mt -132.31 136.98 47.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 0.0 111.628 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.2 m -102.43 111.32 23.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.648 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 17.0 mt -70.64 146.24 93.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.162 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 85' ' ' PHE . 23.7 Cg_exo -63.75 -19.33 66.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.895 2.397 . . . . 0.0 112.551 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' NE2' ' A' ' 83' ' ' GLN . . . -123.43 -127.98 3.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.809 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HG2' ' HA2' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -151.38 145.53 25.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.884 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 77' ' ' PRO . 32.2 mm -116.51 124.69 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 7.8 p -55.72 151.81 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.467 . . . . 0.0 111.595 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -122.03 131.4 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.25 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.54 -37.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.46 17.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -97.71 30.25 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.953 ' HG3' HD11 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -79.0 -169.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.663 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -134.38 137.74 44.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.61 134.66 7.49 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.067 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -143.79 104.95 4.24 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -119.17 139.57 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 111.617 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.62 128.9 53.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.32 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.827 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.89 -39.3 65.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -95.78 -20.09 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.22 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . 63.96 62.91 4.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.341 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 70' ' ' GLY . 50.4 mt -144.7 118.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -113.3 115.79 28.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 25.9 m -119.14 129.35 54.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.953 HD11 ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -138.13 121.13 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -86.22 144.88 27.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.76 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -134.08 125.36 18.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.897 ' O ' HG23 ' A' ' 55' ' ' ILE . 32.9 Cg_endo -63.42 151.66 83.88 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.445 2.097 . . . . 0.0 111.942 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 13.6 mttt -96.39 157.47 15.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 79' ' ' GLU . 2.9 tm-20 -84.63 -4.93 59.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.58 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 79' ' ' GLU . 93.0 m -152.09 116.96 3.03 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.93 143.64 48.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.265 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.86 86.09 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.908 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tp-100 -66.98 122.38 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.676 0.274 . . . . 0.0 110.504 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -120.16 112.68 19.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.858 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 16.2 m-30 -77.46 90.29 3.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.305 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 171.29 11.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 112.011 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 36.61 41.13 0.53 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.73 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.59 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.109 0.454 . . . . 0.0 110.969 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -85.81 12.32 9.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.936 0.398 . . . . 0.0 110.68 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.15 -32.42 7.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mt -48.61 174.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.782 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.2 p -120.41 171.48 8.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.1 130.23 44.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.14 125.15 46.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.989 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 8.7 mp -99.9 137.09 38.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.933 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.821 0.344 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.44 134.49 43.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.702 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.653 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -83.12 139.92 42.51 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.277 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HD2' HG22 ' A' ' 3' ' ' THR . 61.2 Cg_endo -73.72 158.3 47.13 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.646 2.231 . . . . 0.0 111.689 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.06 58.13 4.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -68.26 164.91 19.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.35 156.6 42.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.47 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.578 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -120.08 139.29 52.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.423 0.63 . . . . 0.0 112.008 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.0 p -140.63 131.54 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.628 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.56 145.16 51.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 0.0 112.738 -177.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.447 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m-20 -109.31 160.22 28.44 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.899 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.86 -1.24 2.57 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.974 2.449 . . . . 0.0 113.929 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.7 m-20 -137.19 8.91 2.96 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.3 -0.25 . . . . 0.0 111.037 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.67 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.6 m-85 -171.17 171.96 5.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.379 0.609 . . . . 0.0 111.803 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -134.24 118.66 17.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.477 178.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.851 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.0 m -108.26 145.92 33.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 110.293 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 8' ' ' LEU . 3.1 mt -118.85 154.54 21.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.69 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.71 110.53 9.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.459 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.9 mt -126.26 122.44 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.573 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 120.21 41.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.768 0.318 . . . . 0.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.66 134.76 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.379 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.48 -38.27 5.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.6 m-30 -63.63 -10.74 20.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -21.82 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.229 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -70.44 -76.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.431 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 26' ' ' VAL . 15.5 m -39.94 128.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.2 m -58.91 -28.65 66.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.66 145.07 51.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.474 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -101.59 163.65 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.764 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -118.48 119.04 33.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.12 121.52 65.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 56.4 m-85 -135.34 130.67 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.4 p90 -127.02 122.2 33.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 8.6 tt0 -137.39 109.51 7.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.527 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.15 75.7 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.98 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.3 OUTLIER 66.59 5.17 3.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 34.3 m-20 -103.17 103.75 13.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.685 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 40' ' ' PHE . 71.0 t80 -105.83 113.14 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.408 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 115.39 27.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.434 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 76.3 t80 -113.08 109.29 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 98.5 m-85 -110.29 105.96 15.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 112.034 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -134.07 113.36 12.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.594 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.603 ' HE2' ' CE2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 43.8 -170.23 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 43' ' ' LYS . 76.4 Cg_exo -42.64 -20.87 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.026 1.817 . . . . 0.0 113.106 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 14.2 m-85 -71.6 121.14 18.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.9 t80 -118.57 119.21 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.427 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.6 mt -120.26 109.53 15.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 111.911 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 3.9 ttm180 -118.73 116.48 26.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.42 128.04 49.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 0.0 111.794 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 106.36 18.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' ILE . 4.4 mt -70.34 128.18 91.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.375 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 46.1 Cg_exo -56.0 -20.84 31.67 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.821 2.347 . . . . 0.0 112.199 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -112.18 -138.62 7.43 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.538 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.36 137.81 28.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.909 HG23 ' O ' ' A' ' 77' ' ' PRO . 5.0 mt -118.74 126.31 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.911 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.2 p -58.15 155.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.5 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 56' ' ' VAL . 7.7 pt-20 -123.1 133.88 54.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -164.7 -38.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.49 -12.93 25.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.191 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -67.43 -70.33 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.962 0.411 . . . . 0.0 110.318 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.614 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.2 pt-20 30.34 -152.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.685 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -156.61 155.56 32.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.68 161.19 34.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.418 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -159.87 121.05 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -119.04 131.32 55.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.522 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.05 126.82 53.04 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.582 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.48 -46.57 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.643 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.69 -49.66 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.259 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -76.73 -19.87 57.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.219 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.82 61.8 6.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.46 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -157.44 129.93 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.921 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' A' ' 74' ' ' ILE . 7.6 t80 -112.39 110.89 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -108.82 128.04 54.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.702 ' O ' HG23 ' A' ' 16' ' ' THR . 9.0 tt -123.13 162.68 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 0.0 111.468 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.676 ' O ' HD23 ' A' ' 76' ' ' LEU . 12.3 mtm180 -133.38 140.36 47.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 55' ' ' ILE . 70.5 mt -136.34 128.31 17.22 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.911 ' HG2' HG13 ' A' ' 56' ' ' VAL . 36.7 Cg_endo -65.87 151.72 83.43 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.784 2.323 . . . . 0.0 112.219 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 83' ' ' GLN . 4.4 mttt -98.55 153.78 18.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.348 . . . . 0.0 110.487 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.1 tt0 -83.31 -7.61 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.0 m -156.14 108.0 2.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 111.523 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.43 149.81 36.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.733 2.288 . . . . 0.0 112.035 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.72 83.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.851 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 51.0 tt0 -81.07 135.34 35.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.218 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -124.44 118.61 27.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.227 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 6.2 m-30 -77.42 90.6 3.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 172.87 8.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.799 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 35.61 39.9 0.27 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.925 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.682 ' O ' HD22 ' A' ' 91' ' ' LEU . 1.5 mt -61.67 -61.77 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.266 0.533 . . . . 0.0 111.024 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.5 14.09 2.19 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 111.739 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 2.3 ppp? -115.81 -31.03 5.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -52.57 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.908 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.451 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -131.88 170.2 15.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.619 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.14 142.25 30.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.39 110.97 22.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.37 118.05 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.931 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.881 0.372 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.96 148.72 38.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.706 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 3' ' ' THR . 2.5 t -78.11 117.62 67.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.349 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 51.3 Cg_exo -53.41 148.57 33.18 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.32 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.46 58.78 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.987 0.422 . . . . 0.0 110.395 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 18.4 p90 -63.04 165.32 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.46 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -149.0 146.21 27.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -116.46 135.94 53.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.4 . . . . 0.0 111.167 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -140.43 132.35 27.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.04 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.591 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.23 140.81 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 0.0 112.174 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -111.2 160.86 27.55 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.788 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 22.0 Cg_endo -61.56 -1.94 2.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.974 2.449 . . . . 0.0 113.703 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.1 m-20 -135.95 4.05 2.98 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.331 -0.231 . . . . 0.0 111.502 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.636 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 28.1 m-85 -168.48 169.52 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 112.253 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.776 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.3 tm? -134.59 114.17 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.202 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 73' ' ' THR . 44.2 m -109.0 139.88 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 38' ' ' PHE . 54.1 mt -111.85 152.11 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.311 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -132.1 119.06 20.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.587 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 47' ' ' LEU . 3.8 mt -125.84 128.2 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.866 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 12.2 mtp180 -96.66 118.48 33.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 21' ' ' VAL . 19.4 m -108.43 82.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' TYR . 52.3 p -51.02 -87.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' SER . 3.7 m-30 -38.31 -53.08 1.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.75 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.79 45.89 5.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.511 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -59.45 -81.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.476 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 43' ' ' LYS . 18.4 m -43.5 136.54 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.32 . . . . 0.0 111.05 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.53 95.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.331 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 147.24 52.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.801 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -99.24 167.81 10.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 37.4 m-20 -114.92 125.44 53.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.86 116.36 47.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -125.74 124.1 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 39.3 p90 -131.48 121.91 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' SER . 6.4 pt-20 -138.66 119.13 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.87 -76.45 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.639 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -153.03 27.44 0.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.913 0.387 . . . . 0.0 110.665 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.65 110.15 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 17' ' ' ILE . 90.0 t80 -101.43 111.87 24.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.533 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -113.67 122.85 48.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.784 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.509 ' CG ' HD13 ' A' ' 19' ' ' ILE . 75.7 t80 -123.82 114.1 19.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.798 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.542 ' HB3' ' CE1' ' A' ' 46' ' ' PHE . 2.1 m-85 -118.02 104.39 10.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.985 0.421 . . . . 0.0 111.583 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -138.03 121.95 17.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 42.19 -170.76 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 99.8 Cg_exo -44.57 -19.84 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.72 1.613 . . . . 0.0 112.272 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 18.8 m-85 -74.23 114.17 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.385 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -121.33 122.7 40.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.836 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 19' ' ' ILE . 1.7 mt -120.14 110.64 16.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.099 0.476 . . . . 0.0 112.121 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.3 114.28 23.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.873 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.31 142.18 39.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.645 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -101.23 115.67 31.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.581 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' SER . 92.2 mt -75.75 136.22 70.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.703 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -79.95 82.28 2.53 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.917 2.411 . . . . 0.0 112.03 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 143.82 -145.99 16.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.096 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.5 mmt180 -143.65 137.85 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.075 0.464 . . . . 0.0 111.642 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 77' ' ' PRO . 45.9 mm -118.11 126.23 74.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.661 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 13.8 p -55.14 149.07 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 131.44 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.601 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -169.06 -37.06 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.418 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . 112.73 9.16 19.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.682 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 28.05 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.781 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' OE2' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -78.78 -167.17 1.03 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.522 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -137.59 124.99 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.988 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.56 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -124.81 139.02 11.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.216 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.65 106.62 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.559 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.564 ' CD1' ' HB2' ' A' ' 72' ' ' PHE . 7.9 t80 -109.5 146.02 35.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.558 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -123.23 125.96 46.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.324 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.89 -39.93 20.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -53.23 -48.54 68.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.086 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.52 -18.3 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.294 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 72.99 63.51 2.81 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.909 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.8 mt -154.46 120.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -110.13 124.59 51.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -127.01 127.38 44.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.56 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -128.07 119.22 50.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.587 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -82.45 141.76 32.47 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.55 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.777 ' HB3' HG21 ' A' ' 55' ' ' ILE . 10.4 mt -135.4 117.35 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.818 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.925 ' O ' HG23 ' A' ' 55' ' ' ILE . 20.4 Cg_endo -60.68 154.33 55.68 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.873 2.382 . . . . 0.0 112.286 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' CD ' ' O ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -94.1 154.81 17.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.931 0.395 . . . . 0.0 111.415 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -82.26 -13.85 56.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 m -142.18 116.71 6.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.702 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.62 142.8 98.69 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.67 2.247 . . . . 0.0 112.067 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.43 86.39 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.998 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 7.1 tt0 -80.37 126.08 30.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -128.62 125.68 38.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.391 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.532 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 8.3 m-30 -80.29 89.98 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.977 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 173.83 9.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.026 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 90' ' ' MET . . . 38.4 35.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.957 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.8 mt -59.05 -61.47 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.14 0.47 . . . . 0.0 110.407 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -69.26 8.58 0.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.433 ' HG3' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -97.68 -26.17 14.85 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 91' ' ' LEU . 5.8 mt -71.65 125.7 27.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.482 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.32 155.0 39.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 111.165 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.91 115.96 28.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.437 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -126.09 107.81 10.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 5.5 mp -91.35 114.57 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.768 0.318 . . . . 0.0 111.062 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.109 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.886 0.374 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.704 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -115.06 159.45 20.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 m -79.06 110.6 15.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.92 146.43 65.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.712 2.274 . . . . 0.0 112.131 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.94 66.41 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 10.2 p90 -75.8 163.82 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -147.0 143.26 28.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.91 134.83 54.23 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.115 0.483 . . . . 0.0 111.143 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.9 t -142.5 135.31 28.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.72 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.597 ' NE2' ' CD2' ' A' ' 84' ' ' HIS . 2.2 pm0 -130.68 141.75 50.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.116 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -104.25 161.37 23.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.842 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 32.4 Cg_endo -62.86 -1.88 3.11 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.701 2.268 . . . . 0.0 113.337 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.621 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 57.4 m-20 -135.86 9.92 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.97 -0.105 . . . . 0.0 110.893 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.621 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.5 m-85 -170.94 171.71 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 111.964 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -134.0 109.61 9.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.181 177.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 75' ' ' ARG . 2.8 m -104.04 146.89 28.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.208 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.945 HD12 ' CE1' ' A' ' 38' ' ' PHE . 27.0 mt -122.64 152.41 27.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.05 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -136.96 120.23 16.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.183 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.617 HD13 HD12 ' A' ' 47' ' ' LEU . 1.2 mt -123.19 126.58 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.118 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -77.27 118.37 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.066 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 m -143.96 129.76 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.119 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 p -121.38 -59.0 1.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' ALA . 4.9 m-30 -57.0 -52.96 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.134 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 38.93 97.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.825 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -70.29 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 m -58.83 135.82 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -55.65 -41.11 73.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -118.62 139.42 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.359 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -87.88 166.83 14.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.923 0.392 . . . . 0.0 110.959 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -119.03 115.93 25.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.89 116.31 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -112.77 114.25 26.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 25.0 p90 -125.61 115.81 20.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.741 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 36' ' ' SER . 15.6 mt-10 -137.35 117.29 13.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.74 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.46 -74.95 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.207 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -148.92 27.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 5.4 t0 -118.47 130.99 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.945 ' CE1' HD12 ' A' ' 17' ' ' ILE . 80.4 t80 -125.88 113.96 17.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 111.062 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -121.85 127.58 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.644 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.4 ' CD2' HD12 ' A' ' 19' ' ' ILE . 87.3 t80 -122.72 110.5 15.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CE1' ' CE2' ' A' ' 46' ' ' PHE . 6.8 m-85 -110.51 116.25 31.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 111.206 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -127.3 26.21 6.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.166 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 22.0 tptt 95.22 -88.41 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.75 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 70.9 Cg_endo -83.61 -16.97 6.45 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.316 1.344 . . . . 0.0 111.476 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -96.12 105.11 17.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.733 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -111.45 111.95 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.956 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -117.26 109.18 16.54 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -118.0 110.72 18.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.133 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.94 137.1 49.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 0.0 111.781 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 m -102.77 112.64 25.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.137 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 61.7 mt -69.44 137.35 88.63 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.037 0.446 . . . . 0.0 111.814 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 31.8 Cg_exo -58.96 -18.43 42.7 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.306 2.671 . . . . 0.0 113.117 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -125.23 -127.42 3.12 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.819 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -147.61 142.94 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.947 0.404 . . . . 0.0 111.485 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 77' ' ' PRO . 12.2 mm -119.79 126.3 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.637 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' CG1' ' HG2' ' A' ' 77' ' ' PRO . 8.7 p -52.24 141.07 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.088 0.47 . . . . 0.0 111.979 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.65 130.16 56.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.518 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -176.69 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.452 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.46 17.75 11.01 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -98.63 21.7 10.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.704 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.818 ' OE2' HD11 ' A' ' 74' ' ' ILE . 9.6 pt-20 -73.52 -170.62 0.86 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.76 138.6 34.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -131.05 147.65 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.311 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.14 110.14 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 111.066 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -110.88 126.99 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.8 111.47 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.15 71.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.789 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -49.27 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 20.4 ttpt -77.48 -27.41 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.011 0.434 . . . . 0.0 110.174 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 1.02 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 71.95 48.32 27.57 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 70' ' ' GLY . 2.7 mm -144.22 146.68 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 5.2 t80 -109.73 114.85 28.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -114.49 126.99 55.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.736 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.818 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -139.74 119.54 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.791 ' O ' HD23 ' A' ' 76' ' ' LEU . 50.0 mtm180 -87.95 148.56 24.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.154 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.791 HD23 ' O ' ' A' ' 75' ' ' ARG . 45.4 mt -135.52 122.81 14.85 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' ILE . 19.2 Cg_endo -61.27 147.53 95.33 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.719 2.279 . . . . 0.0 112.003 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' CE ' ' O ' ' A' ' 83' ' ' GLN . 20.1 mttp -90.84 156.01 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 111.355 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.65 -17.06 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -135.52 94.46 15.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.843 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.8 143.23 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.821 2.348 . . . . 0.0 112.57 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.82 0.34 89.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.256 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' O ' ' CE ' ' A' ' 78' ' ' LYS . 2.2 tp-100 -84.58 136.06 33.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.976 0.388 . . . . 0.0 110.982 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.597 ' CD2' ' NE2' ' A' ' 10' ' ' GLN . 6.9 t-160 -127.42 123.22 35.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.132 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.568 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 15.1 m-30 -79.21 91.5 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.21 170.57 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.219 0.533 . . . . 0.0 111.859 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 33.93 41.76 0.21 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.636 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.877 ' O ' HD22 ' A' ' 91' ' ' LEU . 3.5 mt -60.83 -61.24 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.068 0.434 . . . . 0.0 110.995 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -80.26 14.68 1.83 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.438 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.66 -28.42 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.877 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -46.12 178.4 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -142.46 163.64 32.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.718 0.294 . . . . 0.0 110.703 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.59 125.46 29.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.406 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.85 136.13 53.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.714 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.85 110.1 22.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.987 179.808 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pp -123.53 133.35 54.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.005 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -64.82 140.82 98.18 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.22 171.82 17.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.76 2.307 . . . . 0.0 112.504 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.53 65.57 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -79.79 164.36 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.59 154.34 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.975 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 mt -115.97 135.46 53.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.118 0.485 . . . . 0.0 111.57 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.47 130.4 28.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.121 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.63 144.61 51.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 112.466 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.4 160.45 27.03 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.199 179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 30.1 Cg_endo -63.46 -0.8 2.61 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.013 2.475 . . . . 0.0 113.776 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 6.0 m-20 -136.28 8.87 3.18 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.408 -0.183 . . . . 0.0 110.748 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 94.0 m-85 -171.93 172.23 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.32 0.581 . . . . 0.0 111.331 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -136.24 116.89 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.615 178.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.522 ' N ' HD22 ' A' ' 15' ' ' LEU . 11.3 m -107.15 148.39 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 0.0 111.179 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 38' ' ' PHE . 8.2 mt -125.61 152.26 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.266 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.55 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.397 . . . . 0.0 111.568 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.539 HD13 ' CG ' ' A' ' 40' ' ' PHE . 3.5 mt -113.97 125.12 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.754 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HG3' HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.23 121.21 29.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.108 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.91 131.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.08 -73.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.441 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.7 m-85 -49.68 -53.29 25.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.899 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 43.92 103.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.443 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -81.92 3.9 24.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 43' ' ' LYS . 27.1 m -123.94 130.54 73.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -56.05 -41.37 74.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.455 . . . . 0.0 110.09 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -129.07 143.13 50.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.928 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -90.65 166.86 12.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.417 . . . . 0.0 111.36 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.23 122.28 42.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.44 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.02 116.66 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 111.538 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -112.09 114.05 26.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.788 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 5.6 p90 -125.95 114.94 19.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' SER . 10.7 mt-10 -134.32 112.22 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.376 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 61.76 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.768 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -153.34 24.37 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.399 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -114.76 104.92 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.978 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 17' ' ' ILE . 81.8 t80 -105.12 117.88 35.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.71 130.35 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CG ' HD13 ' A' ' 19' ' ' ILE . 32.6 t80 -127.74 116.86 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.93 122.2 41.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.229 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -126.32 29.61 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 11.2 tptm 93.85 -89.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.585 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 58.7 Cg_endo -84.44 -16.41 5.83 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 120.708 1.289 . . . . 0.0 111.516 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -102.15 117.48 34.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.236 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 11.0 t80 -125.86 120.92 31.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.416 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -118.23 113.47 21.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.84 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -116.12 110.78 19.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.648 178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.43 ' HG ' HD22 ' A' ' 47' ' ' LEU . 5.1 mt -123.74 129.4 51.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.006 0.431 . . . . 0.0 111.664 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.5 110.31 22.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.334 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.94 136.71 85.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 0.0 111.361 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 28.4 Cg_endo -62.78 -14.69 42.12 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.345 2.697 . . . . 0.0 112.864 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.53 -129.31 3.45 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.747 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.4 mtm180 -149.16 145.9 27.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.986 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' PRO . 35.0 mm -121.08 126.29 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.61 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 77' ' ' PRO . 2.5 p -52.37 146.94 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 111.553 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.33 124.36 52.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.626 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.88 -41.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.0 -6.49 27.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -72.32 -71.44 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.424 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' OE1' ' HD2' ' A' ' 77' ' ' PRO . 0.4 OUTLIER 33.34 -156.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.391 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 9.9 mt-30 -154.02 167.07 31.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.45 152.43 6.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.816 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -153.84 143.31 21.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -111.17 122.51 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 120.15 41.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.12 -41.74 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -53.44 50.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.208 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.494 ' HD2' HD12 ' A' ' 71' ' ' ILE . 3.9 ttpm? -81.57 -16.55 51.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.038 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.44 55.27 30.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.559 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 69' ' ' LYS . 58.3 mt -145.3 147.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.407 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -112.88 113.32 25.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.466 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 132.77 56.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.4 OUTLIER -141.42 118.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.744 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' GLN . 39.2 mtp180 -90.89 148.59 22.37 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mt -134.44 143.71 47.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 56' ' ' VAL . 6.0 Cg_endo -83.61 148.73 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.759 2.306 . . . . 0.0 111.448 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 1.9 mtmp? -89.16 157.05 18.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.51 -18.86 37.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.165 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.589 ' O ' HG22 ' A' ' 80' ' ' THR . 3.5 m -142.97 86.8 9.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -40.82 149.76 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.719 2.279 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.37 -10.12 75.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.26 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 2.7 tp60 -82.14 134.99 35.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 110.528 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -124.12 118.27 26.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.368 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB3' ' HG2' ' A' ' 52' ' ' PRO . 5.2 m-30 -78.16 89.84 4.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.054 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.24 174.56 10.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.529 0.681 . . . . 0.0 112.567 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 38.74 40.52 1.05 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.812 -1.085 . . . . 0.0 114.072 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.73 -61.55 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.172 0.486 . . . . 0.0 110.016 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -87.18 6.84 30.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.349 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.44 7.33 10.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.087 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLY . 3.1 mt -71.22 178.43 3.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.596 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -118.68 -178.08 3.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.898 0.38 . . . . 0.0 111.167 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.66 123.98 46.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -118.82 107.65 13.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.4 mp -94.92 119.25 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.028 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.854 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.697 0.284 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.03 119.99 29.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.589 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -82.72 137.52 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.578 179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' A' ' 3' ' ' THR . 66.0 Cg_endo -75.04 149.46 36.54 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.1 59.55 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -69.74 166.03 20.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.666 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.97 38.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.49 133.98 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' THR . 22.6 p -138.74 130.94 28.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.214 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.617 ' CB ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.8 143.34 50.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 112.728 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.02 160.74 24.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.613 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.95 -3.68 5.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.632 2.221 . . . . 0.0 113.408 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.43 9.89 3.44 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.488 -0.132 . . . . 0.0 111.236 179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 39.6 m-85 -170.47 170.17 7.07 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 111.294 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -135.39 111.4 9.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.749 ' N ' HD22 ' A' ' 15' ' ' LEU . 23.1 m -103.16 135.56 44.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.13 0.491 . . . . 0.0 111.539 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.556 HD12 ' CE1' ' A' ' 38' ' ' PHE . 20.7 mt -108.28 151.94 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.854 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.13 117.35 14.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.044 0.45 . . . . 0.0 111.789 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 47' ' ' LEU . 18.6 mt -120.0 125.77 74.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.621 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 118.66 37.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 21' ' ' VAL . 22.4 m -155.57 127.72 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.145 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.86 -30.25 7.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.909 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' ALA . 2.6 m-85 -68.05 -9.49 46.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.024 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -25.69 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.518 0.511 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.54 16.92 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.688 -178.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.12 130.24 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.4 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.8 m -56.6 -35.79 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.366 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -135.59 148.01 48.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.791 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -101.22 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.605 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -113.36 119.38 37.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.65 114.97 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 83.5 m-85 -125.61 120.27 30.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 40.7 p90 -123.2 119.08 29.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.793 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' HB3' ' A' ' 37' ' ' ASP . 3.0 pt-20 -138.07 114.02 9.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.267 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.77 77.66 0.07 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.181 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER 60.06 10.99 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 4.1 t70 -108.06 103.31 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 110.092 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' CE1' HD12 ' A' ' 17' ' ' ILE . 83.5 t80 -108.42 121.25 44.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -120.85 134.57 55.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.664 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 52.9 t80 -129.56 111.72 13.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.15 107.25 17.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.125 0.488 . . . . 0.0 111.843 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 40' ' ' PHE . . . -132.47 106.42 7.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.613 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER 46.86 -175.96 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 43' ' ' LYS . 38.0 Cg_exo -33.52 -29.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 121.972 1.781 . . . . 0.0 112.587 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CE2' ' HE2' ' A' ' 43' ' ' LYS . 17.4 m-30 -66.3 125.36 25.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.85 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -129.01 128.59 43.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.206 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 19' ' ' ILE . 6.4 mt -118.21 111.78 19.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 113.07 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.19 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.4 mt -124.21 127.83 48.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.495 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -98.26 110.77 23.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.044 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.642 HD13 ' HE2' ' A' ' 85' ' ' PHE . 60.3 mt -78.74 155.17 78.33 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 85' ' ' PHE . 9.6 Cg_endo -86.21 -17.9 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.166 2.577 . . . . 0.0 112.627 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -112.51 -141.64 8.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.81 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -141.48 132.67 26.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.46 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.7 mm -110.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.077 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 57' ' ' GLU . 8.4 p -61.67 157.57 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.12 0.485 . . . . 0.0 111.861 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 56' ' ' VAL . 4.2 pt-20 -123.35 132.37 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.021 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -165.31 -35.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.46 0.9 26.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.239 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -79.37 -72.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.656 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER 26.25 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.335 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' ILE . 21.3 mt-30 -161.7 133.15 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.944 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.72 139.1 10.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.226 -0.987 . . . . 0.0 113.041 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.95 104.69 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.535 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -108.16 136.88 47.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.44 117.36 27.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.81 -44.07 34.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.42 -46.77 69.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 7.3 ttpp -91.88 -16.25 26.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.76 63.34 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.042 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG13 ' HG2' ' A' ' 69' ' ' LYS . 3.6 mt -151.46 120.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 111.505 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 2.7 t80 -104.99 111.03 23.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.74 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.45 117.68 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.944 HD12 ' CA ' ' A' ' 63' ' ' GLY . 1.1 tp -129.11 119.82 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 111.705 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -86.3 143.48 27.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.748 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.4 mp -131.94 124.72 19.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.62 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.786 ' O ' HG23 ' A' ' 55' ' ' ILE . 25.7 Cg_endo -64.64 155.75 65.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.911 2.407 . . . . 0.0 112.354 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -102.63 157.36 16.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.247 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 tt0 -84.6 0.33 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.79 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -160.86 99.79 1.32 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.39 153.24 13.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.812 2.341 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.82 63.14 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.981 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -81.55 142.63 32.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -130.02 123.45 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.642 ' HE2' HD13 ' A' ' 51' ' ' LEU . 4.1 m-30 -77.1 92.87 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.462 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 172.32 8.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.268 0.556 . . . . 0.0 111.708 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 35.88 37.72 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.451 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 85' ' ' PHE . 8.0 mt -58.47 -61.27 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.04 0.42 . . . . 0.0 110.319 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -78.78 14.68 1.26 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.56 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -115.03 -32.85 5.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 50' ' ' THR . 1.9 mt -47.52 170.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.625 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.31 158.48 44.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.024 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.59 141.52 29.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -109.57 138.73 45.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 10.1 mp -89.2 130.12 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.649 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.098 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.764 0.316 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pp -118.64 142.01 48.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.69 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.439 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 11.3 m -73.51 107.69 3.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.676 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 2' ' ' LEU . 33.3 Cg_endo -64.67 137.8 55.95 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.945 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.68 58.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.19 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -61.32 163.17 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.8 140.65 29.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.562 ' CD2' HG23 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -116.2 139.69 50.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.166 0.507 . . . . 0.0 111.579 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.45 132.25 22.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.649 ' HB3' HD23 ' A' ' 15' ' ' LEU . 2.2 pm0 -130.42 141.48 50.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.335 0.588 . . . . 0.0 111.649 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -105.48 160.73 25.06 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.152 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.95 -2.52 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 113.785 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.644 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 66.4 m-20 -136.6 11.45 3.19 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.314 -0.241 . . . . 0.0 110.748 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 8.6 m-85 -170.37 171.84 6.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.559 0.695 . . . . 0.0 112.237 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -137.4 111.1 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.726 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.76 ' N ' HD22 ' A' ' 15' ' ' LEU . 88.6 m -105.7 151.18 24.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.155 0.502 . . . . 0.0 111.496 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 38' ' ' PHE . 1.2 mt -124.88 154.58 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.98 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.03 118.97 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.533 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' A' ' 40' ' ' PHE . 2.7 mt -125.83 128.41 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.091 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' GLY . 4.0 mtp180 -100.95 121.61 42.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.346 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 135.09 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.708 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -32.8 5.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.338 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 24' ' ' ALA . 6.2 m-30 -67.06 -10.8 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -24.04 110.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.445 0.465 . . . . 0.0 111.506 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -72.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.504 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 19.5 m -58.31 141.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.436 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -55.32 -40.75 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.378 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' O ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tt0 -121.07 140.35 52.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.318 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -89.59 168.71 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.809 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -116.36 115.87 26.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 1.9 t -118.57 121.79 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -119.84 116.46 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 53.1 p90 -126.14 115.67 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.519 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -136.39 113.88 10.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.819 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.7 -72.39 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.454 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -155.9 27.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.481 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -118.37 104.35 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.801 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE1' HD12 ' A' ' 17' ' ' ILE . 72.4 t80 -104.64 124.51 49.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.766 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -129.0 134.9 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 19' ' ' ILE . 31.4 t80 -125.23 110.01 13.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.35 119.41 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.37 35.08 4.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.359 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 91.72 -91.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.39 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 62.7 Cg_endo -84.43 -14.84 6.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.909 1.36 . . . . 0.0 112.143 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 23' ' ' TYR . 22.0 m-30 -102.05 117.64 35.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.584 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -124.78 118.89 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.4 mt -123.54 117.56 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.46 112.77 23.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.869 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 8' ' ' LEU . 39.0 mt -121.0 126.02 48.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.856 0.36 . . . . 0.0 111.601 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 107.87 19.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.383 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.9 mt -73.2 128.36 87.75 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.799 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.558 ' HG3' HD12 ' A' ' 91' ' ' LEU . 7.3 Cg_exo -72.05 90.86 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.799 2.333 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.98 -137.58 9.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.409 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -144.83 136.65 25.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.063 0.458 . . . . 0.0 111.592 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -116.8 126.84 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.746 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.4 p -61.1 156.07 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.45 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' N ' HG22 ' A' ' 56' ' ' VAL . 30.1 mt-10 -123.22 131.26 53.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.619 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -164.02 -42.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.642 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.37 -1.64 26.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.1 27.61 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.926 0.393 . . . . 0.0 110.724 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.98 -168.63 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.401 ' O ' HG13 ' A' ' 74' ' ' ILE . 26.3 mt-30 -134.5 138.62 44.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.515 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -149.37 154.37 25.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.525 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 p -164.23 118.45 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' ASP . 4.6 t80 -113.53 137.1 52.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.606 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 1.1 m-20 -123.2 125.44 45.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.188 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.05 -33.47 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.82 -50.16 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.458 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.628 ' HE3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -107.33 -6.28 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ARG . . . 63.45 63.27 4.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.391 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.628 HD12 ' HE3' ' A' ' 69' ' ' LYS . 1.3 mt -144.21 121.0 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.4 t80 -114.73 115.6 27.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.986 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.2 m -115.51 128.49 56.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -136.01 118.21 20.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.904 0.383 . . . . 0.0 112.026 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' CG ' ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -88.52 146.97 24.86 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 55' ' ' ILE . 30.1 mt -132.65 139.08 33.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.417 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.7 Cg_endo -76.0 149.87 33.3 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.882 2.388 . . . . 0.0 112.169 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 83' ' ' GLN . 10.3 mttp -96.32 156.07 16.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.76 -6.98 59.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.616 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.6 m -154.51 89.32 3.26 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.829 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -42.2 160.12 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.092 2.528 . . . . 0.0 112.845 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.35 -6.19 57.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.624 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -83.41 142.85 30.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.994 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 1.7 t-160 -127.25 121.1 30.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 52' ' ' PRO . 7.9 m-30 -82.85 94.46 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.02 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.83 174.01 7.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.344 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 91' ' ' LEU . . . 34.89 40.62 0.22 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.485 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD12 ' OE1' ' A' ' 10' ' ' GLN . 3.8 mt -60.46 -62.01 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.109 0.455 . . . . 0.0 110.045 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.54 12.27 4.78 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.938 0.399 . . . . 0.0 110.65 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 72.8 mtp -110.94 -31.72 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.558 HD12 ' HG3' ' A' ' 52' ' ' PRO . 1.3 mt -49.39 176.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.556 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.72 174.25 10.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.02 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.79 136.1 42.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.044 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.57 117.41 30.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.07 114.22 26.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.959 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.3 153.98 26.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.79 116.87 66.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 50.7 Cg_exo -52.46 169.55 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.669 2.246 . . . . 0.0 112.534 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.72 57.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -61.28 170.23 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -154.07 148.52 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.597 ' CD2' HG23 ' A' ' 17' ' ' ILE . 7.3 mt -116.18 138.21 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' THR . 18.8 t -139.38 131.97 28.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.177 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.571 ' HB3' HD23 ' A' ' 15' ' ' LEU . 4.8 pm0 -130.41 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 112.575 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.82 161.04 24.39 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.016 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.73 -4.02 5.26 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.745 2.297 . . . . 0.0 113.25 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.656 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 32.6 m-20 -136.59 12.31 3.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.327 0.108 . . . . 0.0 110.834 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.656 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 48.8 m-85 -170.4 171.58 6.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 111.908 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.754 HD22 ' N ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -136.94 112.22 9.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.101 178.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.754 ' N ' HD22 ' A' ' 15' ' ' LEU . 83.4 m -106.16 146.18 30.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.077 0.465 . . . . 0.0 111.011 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.597 HG23 ' CD2' ' A' ' 8' ' ' LEU . 15.0 mt -117.75 155.5 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.101 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -143.2 122.96 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 111.602 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.482 HD13 HD12 ' A' ' 47' ' ' LEU . 1.1 mt -125.23 132.74 70.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.961 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 1.1 ttt180 -104.08 118.0 35.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.322 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.4 m -146.94 128.19 6.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.597 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -100.71 -50.75 3.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 25' ' ' ARG . 4.3 m-85 -59.49 -15.25 16.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 81.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.01 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -98.74 86.52 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.999 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.57 145.92 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.582 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.6 12.72 30.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.695 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -171.07 108.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 26' ' ' VAL . 2.5 m-30 -86.09 148.78 25.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.786 0.327 . . . . 0.0 110.505 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -105.35 110.99 23.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 114.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -122.88 118.39 27.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 33' ' ' PHE . 45.5 p90 -118.58 112.37 19.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -138.98 124.96 19.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 0.0 111.846 -179.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' OG ' ' A' ' 36' ' ' SER . . . 38.72 62.78 1.11 Allowed Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.699 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER 67.32 22.26 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -117.7 103.21 9.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 17' ' ' ILE . 89.8 t80 -103.14 122.38 44.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.38 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 15.8 mttt -125.11 129.33 49.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -126.99 121.51 31.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 39' ' ' LYS . 36.8 m-85 -131.5 127.95 38.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 0.0 111.228 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.763 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -109.93 -81.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 6.2 tptt -146.32 -64.88 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 38.7 Cg_endo -99.59 -6.26 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.089 2.526 . . . . 0.0 111.921 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.56 122.67 47.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.19 120.44 36.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.693 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -120.86 110.6 16.52 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.682 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.9 114.79 23.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.516 178.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 48' ' ' ARG . 77.6 mt -138.01 144.05 40.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 112.016 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -112.78 119.95 39.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.312 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 17.2 mt -76.16 155.47 84.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.097 0.475 . . . . 0.0 111.517 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 15.1 Cg_exo -69.27 -16.28 39.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.175 2.584 . . . . 0.0 112.592 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -122.99 -127.81 3.31 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.628 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.482 ' HG3' ' OG ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -154.1 149.37 27.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 77' ' ' PRO . 51.0 mm -118.69 125.62 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.023 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.74 HG13 ' HG2' ' A' ' 77' ' ' PRO . 7.5 p -59.25 156.64 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.444 . . . . 0.0 111.898 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.39 124.06 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.96 -44.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.692 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.68 0.77 30.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 32.68 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.661 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.35 -173.52 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -135.88 130.91 34.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.52 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.405 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -130.35 136.38 8.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.838 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.7 104.89 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.726 0.298 . . . . 0.0 110.583 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -97.13 115.11 26.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 107.62 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.73 -41.0 31.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.33 -50.37 69.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -87.97 -16.76 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 71' ' ' ILE . . . 66.24 63.2 4.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.233 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 70' ' ' GLY . 75.7 mt -158.59 120.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.686 0.279 . . . . 0.0 111.439 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 11.1 t80 -100.11 116.31 31.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.36 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -114.45 118.61 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -128.25 119.72 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.889 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HG2' ' OG1' ' A' ' 16' ' ' THR . 12.6 mtp180 -85.95 142.63 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.702 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -131.47 140.63 39.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.512 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.817 ' O ' HG23 ' A' ' 55' ' ' ILE . 74.3 Cg_endo -76.9 148.48 28.19 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.756 2.304 . . . . 0.0 112.02 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -93.36 155.86 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.074 0.464 . . . . 0.0 111.433 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.35 -15.36 50.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.129 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 m -138.36 102.28 8.1 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.7 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.97 148.86 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 111.944 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.3 57.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.731 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.43 133.06 41.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.774 0.321 . . . . 0.0 110.499 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 10' ' ' GLN . 6.7 t-80 -128.01 124.52 37.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.2 m-30 -83.04 90.48 7.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.49 173.94 9.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.06 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 90' ' ' MET . . . 38.09 36.1 0.32 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.809 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.901 ' O ' HD22 ' A' ' 91' ' ' LEU . 8.8 mt -58.23 -61.98 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.195 0.498 . . . . 0.0 110.219 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -79.85 5.76 12.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.422 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 21.6 mtp -117.5 20.61 13.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.401 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -98.32 177.7 5.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.261 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 11.0 p -135.57 167.91 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.779 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.31 130.2 44.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 111.607 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -118.91 131.51 56.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.237 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 7.7 mp -82.1 120.04 24.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.927 0.394 . . . . 0.0 111.134 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.0 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.0 136.24 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.162 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 119.16 61.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.28 137.1 76.26 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.661 2.241 . . . . 0.0 112.149 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.05 67.41 4.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 31.2 p90 -72.36 160.03 33.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.725 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -148.79 149.67 31.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -115.35 134.7 54.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.687 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' THR . 8.1 m -142.86 134.2 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.489 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.678 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.4 pt20 -132.35 144.84 50.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -100.84 159.94 28.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.718 178.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' A' ' 11' ' ' ASP . 13.6 Cg_endo -57.16 -8.14 3.23 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.783 2.322 . . . . 0.0 113.604 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 61.9 m-20 -135.89 17.09 3.28 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.29 -0.256 . . . . 0.0 110.808 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 12.1 m-85 -169.46 170.39 8.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.947 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -135.69 108.26 7.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.952 178.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 91.5 m -101.07 143.4 31.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.172 0.511 . . . . 0.0 110.962 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 38' ' ' PHE . 7.5 mt -116.3 155.12 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -125.93 121.46 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.06 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.74 HD13 ' CG ' ' A' ' 40' ' ' PHE . 15.3 mt -124.81 118.61 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -88.07 119.05 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.223 0.535 . . . . 0.0 112.001 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 21' ' ' VAL . 32.9 m -141.24 113.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.225 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -58.08 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.992 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' ALA . 2.1 m-85 -68.84 -53.58 20.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.004 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 46.81 106.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 8.1 mtt85 -81.73 6.97 13.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 m -133.28 135.59 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.808 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -58.62 -41.54 86.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -125.33 142.63 51.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.893 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -90.65 168.43 11.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.619 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.56 115.59 30.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.965 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.05 115.81 49.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.466 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -126.69 120.08 28.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -129.23 124.0 33.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.85 114.09 9.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.581 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 66.46 -70.85 0.16 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.186 -0.531 . . . . 0.0 113.006 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.45 25.11 0.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.086 0.469 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -115.02 107.24 15.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.827 ' CE1' HD12 ' A' ' 17' ' ' ILE . 70.1 t80 -102.84 111.0 23.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 14.6 mttt -116.07 121.95 43.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.658 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.74 ' CG ' HD13 ' A' ' 19' ' ' ILE . 58.2 t80 -124.93 117.77 24.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 39' ' ' LYS . 16.6 m-85 -124.27 124.73 43.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -129.63 31.49 4.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.715 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 1.3 tppm? 92.59 -88.83 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 111.183 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.604 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 63.6 Cg_endo -85.04 -15.97 5.36 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.237 1.291 . . . . 0.0 111.573 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.08 115.6 30.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.569 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 119.49 29.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.443 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 19' ' ' ILE . 3.6 mt -121.78 115.91 23.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.48 111.65 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.952 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.705 HD13 HD21 ' A' ' 8' ' ' LEU . 83.2 mt -125.59 130.54 51.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.573 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.81 113.03 24.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.2 mt -72.2 137.59 81.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.07 0.462 . . . . 0.0 111.502 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.3 Cg_endo -68.38 -18.91 44.02 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.289 2.659 . . . . 0.0 112.717 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -117.63 -136.79 5.66 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.71 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER -143.53 138.3 29.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.958 0.409 . . . . 0.0 111.069 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 77' ' ' PRO . 19.3 mm -116.12 124.43 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.834 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.519 HG13 ' HG2' ' A' ' 77' ' ' PRO . 4.9 p -64.83 159.96 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.531 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.52 130.15 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.378 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.73 17.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.77 3.3 27.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.753 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 m -98.49 44.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 164.36 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' ILE . 8.3 mm-40 -127.49 129.72 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.35 147.89 18.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.588 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.3 p -153.62 104.36 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.717 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -96.82 103.83 15.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -89.49 99.55 12.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.221 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.26 69.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -52.44 -50.59 62.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -76.27 -23.13 54.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.033 0.444 . . . . 0.0 110.174 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.34 46.98 84.15 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.936 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 mt -143.44 148.31 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.543 ' HD2' HD12 ' A' ' 19' ' ' ILE . 14.9 t80 -107.05 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.675 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.59 118.38 30.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -126.48 119.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -87.65 147.36 25.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 mp -133.6 149.46 72.18 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 55' ' ' ILE . 73.5 Cg_endo -79.09 150.13 22.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.613 2.209 . . . . 0.0 111.777 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -96.31 152.86 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.851 0.358 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.9 tt0 -84.05 -10.86 57.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.701 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 m -151.36 97.97 3.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.538 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -43.49 153.05 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.663 2.242 . . . . 0.0 112.366 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.57 -1.77 50.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.169 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.95 138.48 39.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.001 0.4 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -127.11 116.97 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.379 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 6.9 m-30 -73.4 91.8 1.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.345 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.51 160.76 13.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.909 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 37.96 46.54 1.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.298 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.651 HD22 HD13 ' A' ' 8' ' ' LEU . 1.7 mt -63.53 -62.34 1.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.621 0.21 . . . . 0.0 111.511 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.36 16.55 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -114.97 -29.4 6.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 91' ' ' LEU . 2.1 mt -52.96 175.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.357 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.67 174.18 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 111.852 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.19 137.47 42.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 145.2 32.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.037 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 95' ' ' LEU . 6.1 mp -98.88 121.67 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.929 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.771 0.319 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.4 mt -130.64 122.9 28.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 t -83.08 129.38 61.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 37.2 Cg_exo -59.7 160.14 22.07 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 111.897 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.14 61.59 6.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.143 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 27.5 p90 -76.03 164.76 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 6.2 t0 -157.46 168.41 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.53 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG23 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -124.82 136.98 54.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.227 0.537 . . . . 0.0 111.747 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 16' ' ' THR . 9.6 t -138.43 130.81 28.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.079 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 88' ' ' LEU . 7.7 pm0 -135.86 145.53 46.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.72 161.5 22.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.62 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.52 -3.58 1.43 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.81 2.34 . . . . 0.0 113.767 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.638 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 9.6 m-20 -136.05 12.26 3.34 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.367 -0.208 . . . . 0.0 110.909 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.638 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 23.7 m-85 -167.17 167.48 14.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.484 0.659 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -134.79 109.05 8.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.083 178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' N ' HD22 ' A' ' 15' ' ' LEU . 55.3 m -107.01 126.76 52.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.171 0.51 . . . . 0.0 111.836 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 38' ' ' PHE . 7.7 mt -100.81 155.37 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.998 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -140.83 112.41 7.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.339 . . . . 0.0 111.691 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.28 128.95 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.502 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HB2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -92.49 120.42 32.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.317 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 21' ' ' VAL . 15.3 m -141.76 126.67 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.365 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.05 -30.96 4.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.709 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 58.8 m-85 -69.54 -9.19 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.284 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -22.88 108.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.55 0.531 . . . . 0.0 111.512 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -88.19 13.39 11.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.7 -179.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.0 m -137.43 137.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.556 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.6 t -56.66 -35.59 68.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.14 144.63 51.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.4 m-30 -96.31 168.66 10.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.48 124.23 42.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 40' ' ' PHE . 4.2 t -130.75 132.58 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 111.818 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -121.32 116.21 24.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.938 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 43.3 p90 -116.69 114.19 23.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.067 0.461 . . . . 0.0 111.463 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -138.14 101.6 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.045 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 54.03 -149.11 17.23 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.631 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -59.13 -12.12 4.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.962 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.79 112.09 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 110.63 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.86 ' CE2' HD12 ' A' ' 17' ' ' ILE . 39.6 t80 -120.73 112.01 18.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.41 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -119.31 126.54 51.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.081 0.467 . . . . 0.0 111.566 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CD1' HG22 ' A' ' 31' ' ' VAL . 8.6 t80 -110.39 148.66 31.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -136.1 110.43 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.973 0.416 . . . . 0.0 111.513 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -131.26 68.81 1.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.682 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HB3' ' CD ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER 32.57 -88.36 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.888 -178.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.625 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 57.2 Cg_endo -69.46 -25.37 30.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.257 1.305 . . . . 0.0 112.579 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.669 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 21.7 m-85 -105.04 125.61 51.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.722 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -125.62 120.67 31.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.961 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -120.94 117.9 28.49 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.542 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -124.42 116.2 22.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 48' ' ' ARG . 80.1 mt -142.89 151.46 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.184 0.516 . . . . 0.0 112.25 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.34 105.88 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.071 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 36' ' ' SER . 3.6 mt -72.02 155.79 91.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' CD2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -83.02 75.0 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.382 2.721 . . . . 0.0 111.966 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.567 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . 145.85 -147.18 18.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.37 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 53' ' ' GLY . 1.1 mtm180 -146.65 142.09 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 0.0 111.121 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 77' ' ' PRO . 14.0 mm -115.07 123.11 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.752 HG13 ' HG2' ' A' ' 77' ' ' PRO . 8.3 p -62.07 154.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 112.536 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -124.38 130.09 51.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.723 179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.68 29.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.661 0.267 . . . . 0.0 111.429 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.55 -32.36 3.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.345 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.58 118.51 10.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.556 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.07 163.37 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 4.5 mt-30 -131.78 138.64 48.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.34 137.51 7.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.905 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.76 105.45 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 0.0 110.408 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -103.12 131.72 49.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -115.53 111.55 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.552 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.92 -49.32 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.64 -41.83 67.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -97.06 -19.44 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 66' ' ' ASP . . . 65.9 56.68 13.28 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.929 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.634 HD13 ' HB2' ' A' ' 20' ' ' ARG . 21.5 mm -137.19 116.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 111.509 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t80 -111.21 114.42 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -121.49 119.04 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -124.38 119.48 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.622 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HD23 ' A' ' 76' ' ' LEU . 11.4 mtp180 -87.08 148.26 25.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.739 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.805 ' HB3' HG21 ' A' ' 55' ' ' ILE . 15.9 mt -134.24 150.73 74.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.208 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.945 ' O ' HG23 ' A' ' 55' ' ' ILE . 94.6 Cg_endo -81.81 157.84 18.51 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.944 2.43 . . . . 0.0 112.162 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -98.0 148.54 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.0 tp10 -85.02 -11.68 54.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.526 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.3 m -148.52 116.87 3.98 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.872 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.3 142.96 45.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.775 2.316 . . . . 0.0 112.441 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 -0.16 89.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.433 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -70.15 119.02 13.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.05 111.95 18.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.13 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 4.9 m-30 -73.75 90.05 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.487 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 87' ' ' GLY . 22.2 mt-10 -70.7 173.58 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.271 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 90' ' ' MET . . . 35.98 38.61 0.24 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 91' ' ' LEU . 4.0 mt -57.84 -61.6 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.628 0.251 . . . . 0.0 110.538 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -83.67 16.25 2.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.127 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -117.02 -32.24 5.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -45.25 177.11 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.61 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.92 149.53 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.699 0.285 . . . . 0.0 111.183 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.89 137.11 33.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.157 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.31 138.33 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 111.607 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.18 114.25 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.857 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.831 0.348 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -134.94 124.12 24.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.998 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.461 HG22 ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -66.5 136.95 95.07 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' A' ' 3' ' ' THR . 50.9 Cg_exo -53.77 136.28 65.03 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.695 2.263 . . . . 0.0 112.055 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.622 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -85.72 65.14 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 6' ' ' PHE . 7.1 p90 -80.34 159.44 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.043 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -145.33 150.65 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD13 HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -114.81 133.46 55.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.126 0.489 . . . . 0.0 111.761 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.547 ' O ' HD22 ' A' ' 15' ' ' LEU . 85.5 p -139.51 131.45 27.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.636 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.877 ' OE1' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -130.57 140.98 50.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.339 0.59 . . . . 0.0 112.325 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.28 160.84 28.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.997 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 24.2 Cg_endo -61.46 -1.22 1.79 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.107 2.538 . . . . 0.0 114.196 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.667 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -135.35 2.46 3.0 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.163 -0.335 . . . . 0.0 111.74 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 20.8 m-85 -171.78 172.52 4.84 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HB3' ' A' ' 10' ' ' GLN . 1.2 tm? -135.86 117.38 14.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.813 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.632 ' N ' HD22 ' A' ' 15' ' ' LEU . 5.5 m -110.57 136.84 49.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.389 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.784 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.4 mt -113.51 150.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 7' ' ' ASP . . . -131.05 106.84 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD13 ' CD2' ' A' ' 40' ' ' PHE . 24.1 mt -108.46 121.99 62.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -89.88 120.23 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.502 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.83 132.01 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.0 p -110.65 -82.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.3 m-85 -39.08 -52.58 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.781 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 41.51 97.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.777 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -60.36 -73.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.206 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.84 142.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.771 0.32 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -38.02 78.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.7 140.92 49.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.2 m-30 -89.44 166.34 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.58 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' OD1' ' OH ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -117.42 118.69 32.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.64 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 ' HD1' ' A' ' 40' ' ' PHE . 7.2 t -121.68 119.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.788 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' OH ' ' OD1' ' A' ' 30' ' ' ASP . 66.0 m-85 -118.18 118.95 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.144 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 33' ' ' PHE . 28.3 p90 -121.75 112.73 18.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.453 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.2 mt-10 -135.29 116.79 14.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 60.22 -75.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.139 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -149.8 26.21 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.469 . . . . 0.0 110.14 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -112.97 107.58 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.784 ' CE2' HD12 ' A' ' 17' ' ' ILE . 50.3 t80 -105.33 111.53 24.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -117.86 131.34 56.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.415 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.6 t80 -127.52 110.3 12.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.58 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.657 ' CD1' ' CD2' ' A' ' 46' ' ' PHE . 21.9 m-85 -128.51 130.48 47.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.595 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.78 -68.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' CB ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 tptt -160.35 -72.15 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 43' ' ' LYS . 45.2 Cg_endo -87.76 -20.37 1.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.092 . . . . 0.0 111.059 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -97.95 119.61 36.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.657 ' CD2' ' CD1' ' A' ' 41' ' ' TYR . 9.9 m-85 -120.13 116.34 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.32 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 49' ' ' LEU . 5.8 mt -118.34 112.63 20.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.812 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.53 112.43 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.901 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -127.02 134.54 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.664 -179.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 m -108.38 113.72 27.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 34.0 mt -78.42 147.75 72.61 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.484 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 7.3 Cg_exo -72.29 -12.94 27.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.089 2.526 . . . . 0.0 112.162 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -139.36 138.95 9.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.037 -0.601 . . . . 0.0 111.847 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -62.74 155.42 26.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.777 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.6 mm -119.28 126.35 75.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.186 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 8.9 p -64.4 161.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.414 0.626 . . . . 0.0 112.237 -178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.2 pm0 -125.03 125.75 44.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -150.13 8.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 -1.21 20.26 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.63 49.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.779 0.324 . . . . 0.0 110.997 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 45.4 tt0 -83.59 163.46 20.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 23.9 mm-40 -122.72 126.0 46.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -135.25 138.46 10.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.158 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.1 p -144.76 108.83 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.904 0.383 . . . . 0.0 111.331 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -109.2 118.01 35.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.53 134.03 52.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -47.73 12.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.96 0.41 . . . . 0.0 110.291 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -52.21 -49.75 63.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.709 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 71' ' ' ILE . 16.7 ttpt -83.78 -19.86 34.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.689 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.46 56.97 19.31 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.73 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 69' ' ' LYS . 5.9 mt -146.85 148.58 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -115.8 120.34 38.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.121 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 m -119.76 133.38 55.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.658 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -140.88 118.54 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 20.1 mtp180 -92.34 141.42 28.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.306 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB3' HG21 ' A' ' 55' ' ' ILE . 2.7 mp -132.1 147.5 66.08 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.047 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.943 ' O ' HG23 ' A' ' 55' ' ' ILE . 89.5 Cg_endo -81.31 148.28 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.713 2.275 . . . . 0.0 111.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' A' ' 15' ' ' LEU . 27.7 mmtp -85.24 156.14 21.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 0.0 111.448 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 25.4 tt0 -89.39 -22.35 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.185 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -129.19 128.48 23.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.99 133.13 24.43 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.616 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.09 3.6 88.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.099 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -81.5 128.52 33.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.821 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.48 118.35 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 2.6 m-30 -77.97 90.69 4.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.155 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.84 170.77 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.362 0.601 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 91' ' ' LEU . . . 33.56 43.23 0.25 Allowed Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.59 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.877 HD12 ' OE1' ' A' ' 10' ' ' GLN . 1.7 mt -61.98 -62.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.022 0.411 . . . . 0.0 110.952 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 89' ' ' ASN . 11.2 t-20 -84.16 13.71 4.93 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-O 121.034 0.445 . . . . 0.0 110.692 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.3 -27.94 7.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.505 178.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.739 HD23 ' C ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.53 177.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.792 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 93' ' ' ALA . 52.9 m -146.73 157.82 43.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 92' ' ' THR . . . -104.07 129.54 51.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.54 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.62 139.76 36.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.978 0.418 . . . . 0.0 111.17 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.13 112.06 24.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.857 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.886 0.374 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.14 144.26 27.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.826 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.04 125.73 88.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.63 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 23.9 Cg_endo -62.6 171.91 5.13 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.882 2.388 . . . . 0.0 112.413 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' PHE . . . -83.87 -64.97 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER 53.89 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.731 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 2.4 t0 -154.48 158.2 39.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -118.71 136.44 53.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 111.333 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.77 133.39 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.6 pm0 -130.01 143.03 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 160.68 25.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.433 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.4 -2.59 6.26 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.424 2.082 . . . . 0.0 113.02 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -135.92 11.92 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.902 -0.136 . . . . 0.0 110.956 179.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 66.5 m-85 -170.76 171.01 6.32 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.25 0.548 . . . . 0.0 111.662 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.649 ' C ' HD13 ' A' ' 15' ' ' LEU . 1.2 tm? -134.42 115.91 14.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.927 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 74' ' ' ILE . 37.2 m -107.41 132.11 53.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.368 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.787 HD12 ' CE2' ' A' ' 38' ' ' PHE . 3.0 mt -107.12 155.39 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . -137.51 118.36 14.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.932 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.502 HD13 ' CD2' ' A' ' 40' ' ' PHE . 44.4 mt -121.13 127.89 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.354 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 39.0 ttt85 -107.84 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 111.674 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 m -151.01 141.89 16.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -119.15 -35.17 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.664 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' ARG . 9.2 m-85 -66.17 -9.11 28.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.605 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . -23.63 85.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.645 0.591 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.43 -71.74 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.831 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 m -43.71 135.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.7 p -57.99 -40.21 80.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.365 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -129.7 147.87 51.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -103.54 167.16 9.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 60.9 m-20 -117.32 121.12 40.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.584 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 t -122.85 119.29 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' HB3' ' A' ' 30' ' ' ASP . 55.6 m-85 -126.48 119.72 27.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 31.4 p90 -121.0 113.79 20.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.559 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -140.75 117.53 11.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.6 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.14 66.57 1.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.026 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER 65.55 9.85 6.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.642 0.258 . . . . 0.0 111.394 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 8.1 t70 -102.74 103.66 13.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.787 ' CE2' HD12 ' A' ' 17' ' ' ILE . 21.5 t80 -110.22 121.11 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.344 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HD3' ' OH ' ' A' ' 41' ' ' TYR . 6.0 mttt -124.77 126.52 45.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.648 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD2' HD13 ' A' ' 19' ' ' ILE . 55.7 t80 -122.14 112.64 18.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.907 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' OH ' ' HD3' ' A' ' 39' ' ' LYS . 13.6 m-85 -114.63 101.77 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.028 0.442 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -129.25 118.42 22.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.759 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER 40.99 -166.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 93.0 Cg_exo -44.75 -21.36 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.687 1.591 . . . . 0.0 112.848 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 24.9 m-85 -76.61 123.05 25.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 111.734 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CZ ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -127.45 124.67 38.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.936 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 47' ' ' LEU . 2.0 mt -120.28 113.87 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' O ' HD23 ' A' ' 49' ' ' LEU . 3.2 ttm-85 -112.02 109.53 19.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.38 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 48' ' ' ARG . 14.6 mt -124.49 129.55 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 112.201 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.27 109.03 21.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.455 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 14.0 mt -63.15 128.32 92.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.941 0.4 . . . . 0.0 111.126 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.96 -26.38 14.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.052 2.502 . . . . 0.0 113.176 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -116.51 -132.91 5.04 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -142.37 136.49 29.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 110.804 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.3 mm -117.29 125.21 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 77' ' ' PRO . 2.8 p -62.21 156.97 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 112.063 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.79 131.43 53.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.67 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 21.5 m-80 -171.19 21.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.44 7.03 44.39 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.152 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -97.99 45.81 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.03 172.64 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -141.24 139.32 33.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -147.52 159.06 27.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.972 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -157.67 118.47 3.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.3 . . . . 0.0 110.429 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -117.62 137.35 52.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -119.11 119.24 33.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.235 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.06 -53.26 15.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.519 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -55.02 -46.17 75.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 71' ' ' ILE . 28.3 ttpt -84.38 -26.82 28.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 71' ' ' ILE . . . 66.2 63.02 4.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 70' ' ' GLY . 1.4 mt -148.72 121.04 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.449 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 72' ' ' PHE . 1.6 t80 -109.68 110.97 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.29 147.73 29.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.351 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 16' ' ' THR . 3.8 tp -138.35 154.14 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.101 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -135.32 141.69 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -136.14 149.97 69.72 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 111.752 -178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 56' ' ' VAL . 78.1 Cg_endo -78.13 154.71 29.18 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.906 2.404 . . . . 0.0 112.206 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HD2' HD13 ' A' ' 55' ' ' ILE . 6.6 mmtp -99.76 151.89 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 3.1 tm-20 -87.69 -4.11 58.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.793 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.6 m -157.68 120.84 2.14 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.223 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 146.29 96.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.0 111.938 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 1.79 89.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.55 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -78.66 126.56 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.34 117.42 23.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 7.0 m-30 -73.92 90.21 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -68.2 168.67 11.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.84 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 37.77 41.81 0.96 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.44 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 91' ' ' LEU . 6.3 mt -60.61 -61.99 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.854 0.327 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.44 15.22 2.12 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 0.0 111.337 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.49 ' O ' ' O ' ' A' ' 91' ' ' LEU . 34.5 mtt -117.74 -32.26 4.89 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -42.13 170.55 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.991 179.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.8 p -127.34 169.15 13.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.61 133.32 41.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -119.57 131.9 55.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.054 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 6.9 mp -93.7 125.23 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.752 0.31 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.01 107.93 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.7 m -42.68 115.96 1.79 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.04 154.78 26.18 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.344 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.02 57.1 2.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 49.0 p90 -66.14 166.73 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.981 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.33 150.7 32.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -113.32 133.9 54.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 0.0 111.506 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' THR . 1.6 p -139.4 133.53 31.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.961 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.603 ' HB3' HD23 ' A' ' 15' ' ' LEU . 9.7 pm0 -130.05 141.45 50.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 0.0 112.691 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.37 160.4 26.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.204 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.27 -2.9 3.49 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.473 2.115 . . . . 0.0 113.298 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 7.3 m-20 -135.9 13.74 3.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.672 0.272 . . . . 0.0 110.563 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 73.1 m-85 -168.22 167.35 12.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.469 0.652 . . . . 0.0 111.864 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.671 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.0 tm? -134.59 106.24 6.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 74' ' ' ILE . 97.2 m -107.75 137.1 46.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.554 HG23 HD23 ' A' ' 8' ' ' LEU . 6.7 mt -126.88 137.91 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.151 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -126.36 139.17 53.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.997 0.427 . . . . 0.0 111.168 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.64 HD12 ' CD2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -122.43 134.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.792 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -77.47 120.06 21.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.857 0.361 . . . . 0.0 110.641 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.64 139.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 p -127.66 -52.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.344 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' ALA . 9.3 m-30 -66.71 -52.77 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.767 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 42.33 96.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.773 0.32 . . . . 0.0 110.626 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 mpt_? -76.76 3.13 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.699 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 43' ' ' LYS . 4.6 m -128.65 133.58 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -41.54 72.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.606 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -123.67 138.61 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -85.02 163.46 18.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -110.28 111.75 23.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.722 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' HD1' ' A' ' 40' ' ' PHE . 4.3 t -117.81 116.18 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.909 0.385 . . . . 0.0 111.479 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -124.02 118.11 26.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.682 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 1.8 p90 -126.79 122.66 35.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.659 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 119.01 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.546 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 63.75 -75.86 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.417 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -151.27 26.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.601 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 1.4 m-20 -118.23 129.48 55.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.4 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -123.44 111.48 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -116.67 128.2 55.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.64 ' CD2' HD12 ' A' ' 19' ' ' ILE . 70.0 t80 -128.93 114.78 16.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.996 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -120.48 127.97 52.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.317 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -134.65 34.18 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.274 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 17.7 tppt? 93.77 -87.95 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.073 0.949 . . . . 0.0 111.218 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 43' ' ' LYS . 44.8 Cg_endo -86.87 -16.01 3.67 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.499 1.466 . . . . 0.0 111.921 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.98 117.37 34.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.984 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -126.59 119.85 28.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -115.61 113.27 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.59 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 109.98 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 8' ' ' LEU . 75.8 mt -126.16 133.78 51.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 111.621 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.6 m -90.43 105.57 17.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.983 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 55' ' ' ILE . 10.5 mt -64.68 133.07 95.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.148 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 45.8 Cg_endo -68.41 -23.41 37.96 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.937 2.424 . . . . 0.0 112.75 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 85' ' ' PHE . . . -113.55 -138.35 6.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.623 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -136.02 128.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 0.0 111.51 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.714 HG21 ' HB3' ' A' ' 76' ' ' LEU . 4.8 mm -116.14 125.6 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.603 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 7.7 p -60.25 157.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.078 0.466 . . . . 0.0 111.754 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -123.16 134.58 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.903 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -36.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.716 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.25 -11.58 26.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.651 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -68.6 -71.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.023 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.597 ' OE2' HD11 ' A' ' 74' ' ' ILE . 5.3 pt-20 32.92 -156.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.2 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 61' ' ' GLU . 30.9 mt-30 -143.63 126.61 16.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.7 136.05 9.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.561 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.5 p -152.68 111.42 3.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.34 . . . . 0.0 110.815 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.85 108.5 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.402 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.19 98.62 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.38 83.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -52.69 51.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -72.82 -16.54 61.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.664 ' O ' HD13 ' A' ' 71' ' ' ILE . . . 65.87 38.35 94.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.185 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -145.01 151.94 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.323 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 45.3 t80 -111.69 123.33 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.47 HG22 HG21 ' A' ' 16' ' ' THR . 3.2 m -119.07 132.85 56.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.107 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.597 HD11 ' OE2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -140.07 118.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HA ' ' OG1' ' A' ' 16' ' ' THR . 15.0 mtp180 -86.46 148.59 25.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' HB3' HG21 ' A' ' 55' ' ' ILE . 17.2 mt -134.04 116.31 13.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 111.887 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.704 ' O ' HG23 ' A' ' 55' ' ' ILE . 66.2 Cg_exo -53.81 149.17 34.32 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.201 2.6 . . . . 0.0 112.805 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.26 153.75 17.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.303 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 1.3 tt0 -81.03 -15.0 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.473 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m -144.85 129.27 8.99 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.729 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.4 149.9 69.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.752 2.301 . . . . 0.0 112.836 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.21 77.84 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.787 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.49 129.86 37.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -122.07 115.54 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.584 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 3.6 m-30 -74.88 89.72 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 0.0 110.116 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.37 162.51 12.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.445 ' HA2' ' HG3' ' A' ' 90' ' ' MET . . . 35.59 46.53 0.82 Allowed Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.525 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 91' ' ' LEU . 4.7 mt -59.88 -61.98 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.783 0.292 . . . . 0.0 110.668 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -86.95 13.16 9.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.098 0.475 . . . . 0.0 110.223 179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.445 ' HG3' ' HA2' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -108.36 -31.57 7.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -44.07 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.814 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.02 -177.77 3.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.88 112.38 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -121.98 125.33 46.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.063 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mp -98.11 133.88 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.904 179.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.23 128.72 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.953 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.9 t -60.41 138.32 92.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.91 164.69 2.31 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.73 2.287 . . . . 0.0 112.052 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.92 55.88 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.394 . . . . 0.0 110.397 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 49' ' ' LEU . 35.7 p90 -61.84 163.25 7.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.294 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.12 145.6 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.69 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 49' ' ' LEU . 6.0 mt -113.75 133.64 55.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t -138.81 130.22 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.613 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.995 ' OE1' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -131.12 140.47 49.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 112.123 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.26 160.77 28.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.8 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.51 -2.2 0.93 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.041 2.494 . . . . 0.0 114.243 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 1.2 m-20 -136.41 3.69 2.83 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 122.058 -0.401 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.64 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 9.1 m-85 -169.3 169.38 9.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 111.852 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 15' ' ' LEU . 1.2 tm? -135.65 107.87 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.036 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 74' ' ' ILE . 29.8 m -101.56 143.01 32.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 110.877 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 HD23 ' A' ' 8' ' ' LEU . 23.1 mt -115.82 154.15 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.647 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' PHE . . . -129.79 122.6 29.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.303 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 40' ' ' PHE . 1.6 mt -125.95 123.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.481 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 118.39 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 111.707 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.02 133.25 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.045 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -120.65 -32.95 3.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 24' ' ' ALA . 16.1 m-85 -87.15 -53.35 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 23' ' ' TYR . . . 18.89 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.747 0.655 . . . . 0.0 112.01 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -56.99 -60.0 4.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -33.91 124.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 111.009 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 p -54.84 -39.95 69.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -125.31 139.49 53.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.353 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 1.0 OUTLIER -85.85 160.32 19.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 9.2 m-20 -112.88 113.11 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.728 0.299 . . . . 0.0 110.998 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG22 ' HD1' ' A' ' 40' ' ' PHE . 10.7 t -117.02 115.93 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.991 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 11.2 m-85 -116.67 114.65 24.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ASP . 36.3 p90 -124.75 116.27 22.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 42.5 mt-10 -138.22 115.16 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 54' ' ' ARG . . . 62.79 -68.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -157.89 22.66 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.524 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 33' ' ' PHE . 2.5 m-20 -111.23 104.64 13.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.14 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 17' ' ' ILE . 82.9 t80 -106.38 116.64 32.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.4 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 37' ' ' ASP . 1.3 mptt -119.92 131.01 55.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 92.5 t80 -130.95 116.78 18.3 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 17.6 m-85 -115.54 110.23 18.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.668 ' O ' ' HB3' ' A' ' 43' ' ' LYS . . . -108.16 24.1 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 95.91 -87.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 O-C-N 124.235 0.959 . . . . 0.0 110.658 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 43' ' ' LYS . 80.6 Cg_endo -83.0 -16.38 7.47 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.491 1.461 . . . . 0.0 111.801 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -109.97 131.92 54.62 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.809 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 48' ' ' ARG . 19.7 t80 -127.35 126.96 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.55 HD12 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -121.55 112.14 18.11 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -120.84 115.17 22.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 178.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 8' ' ' LEU . 90.7 mt -137.04 144.03 42.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.69 113.31 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.249 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 8.3 mt -73.89 135.78 77.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.567 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HG3' ' CD1' ' A' ' 91' ' ' LEU . 36.3 Cg_exo -61.47 -22.09 73.6 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.071 2.514 . . . . 0.0 113.003 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.59 ' HA3' ' CD1' ' A' ' 85' ' ' PHE . . . -113.07 -142.61 8.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.129 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 2.4 mmt-85 -142.18 139.35 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.805 0.336 . . . . 0.0 110.864 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 77' ' ' PRO . 27.9 mm -117.81 124.96 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 77' ' ' PRO . 6.2 p -56.24 152.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.402 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -110.41 123.07 49.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.042 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.55 -39.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.817 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.96 -19.43 32.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -59.87 -65.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 30.96 -152.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.468 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mt-30 -157.33 131.45 8.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.34 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.58 ' CA ' HD12 ' A' ' 74' ' ' ILE . . . -134.98 141.69 13.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.065 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -159.51 105.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.881 0.372 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -107.41 137.81 44.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.25 115.58 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.475 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.14 -46.63 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.33 -50.57 69.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.767 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.761 ' CD ' HD12 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -79.61 -23.21 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 71' ' ' ILE . . . 69.4 63.36 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.672 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.761 HD12 ' CD ' ' A' ' 69' ' ' LYS . 54.0 mt -160.23 126.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 2.9 t80 -108.12 118.79 37.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.515 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.487 HG22 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -122.54 122.39 38.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.593 ' C ' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER -130.51 122.93 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.441 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.68 140.93 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.668 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.839 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.9 mp -129.37 129.81 23.28 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.977 ' O ' HG23 ' A' ' 55' ' ' ILE . 38.3 Cg_endo -66.82 150.74 83.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.926 2.417 . . . . 0.0 112.184 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HE3' ' C ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -92.7 155.81 17.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -71.36 -19.74 62.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.701 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -146.51 120.88 5.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.0 152.02 54.01 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.886 2.391 . . . . 0.0 112.624 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.75 -4.0 62.31 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -77.53 135.43 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.125 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.512 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 3.4 t-160 -125.43 116.45 21.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 5.5 m-30 -67.93 89.76 0.29 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.698 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -74.42 172.78 11.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 112.018 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' LEU . . . 45.03 32.66 3.37 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.154 -0.93 . . . . 0.0 114.41 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.995 HD11 ' OE1' ' A' ' 10' ' ' GLN . 8.7 mt -43.13 -53.29 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.723 0.761 . . . . 0.0 110.146 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -97.96 -40.37 8.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.522 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.0 mtp -78.18 6.81 7.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.036 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' GLY . 0.9 OUTLIER -51.33 178.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 p -123.45 160.26 27.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.33 113.64 27.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.787 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -123.56 112.33 17.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.834 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.2 mp -95.16 116.58 28.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.758 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.931 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.801 0.334 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.16 152.22 20.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.034 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.35 105.53 43.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.218 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.91 172.31 12.16 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.985 2.457 . . . . 0.0 112.725 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.16 60.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 38.2 p90 -68.65 161.52 27.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.819 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.54 148.22 29.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.81 134.21 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.262 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -141.84 136.05 30.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.301 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HB3' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -131.24 141.89 50.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.317 0.58 . . . . 0.0 112.329 -178.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -101.44 157.84 32.9 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.507 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 11' ' ' ASP . 10.5 Cg_endo -54.75 -8.16 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.777 2.318 . . . . 0.0 113.629 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 47.1 m-20 -135.52 15.48 3.42 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.324 -0.235 . . . . 0.0 111.292 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.658 ' CG ' ' O ' ' A' ' 13' ' ' ASP . 13.1 m-85 -169.5 170.71 8.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.481 0.658 . . . . 0.0 112.321 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.77 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -132.82 112.67 12.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.6 178.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.491 ' N ' HD22 ' A' ' 15' ' ' LEU . 30.2 m -104.67 138.02 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 1.9 mt -114.33 149.41 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' PHE . . . -129.76 120.26 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 0.0 111.074 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 47' ' ' LEU . 13.1 mt -126.0 119.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 70' ' ' GLY . 1.5 mtt180 -90.69 120.64 31.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.412 . . . . 0.0 111.813 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 m -141.88 129.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -72.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.997 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ALA . 3.4 m-30 -48.42 -52.91 19.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.909 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' HA ' ' CD ' ' A' ' 43' ' ' LYS . . . 39.49 95.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.89 5.32 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.877 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 43' ' ' LYS . 27.1 m -127.46 133.28 68.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -41.11 82.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.72 148.28 50.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.653 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -98.67 168.71 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.301 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.95 118.55 36.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.11 115.35 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 0.0 112.027 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -125.39 117.87 24.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -120.41 118.95 31.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.142 0.496 . . . . 0.0 111.72 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.21 96.76 3.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.621 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.09 -146.68 18.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.685 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -54.33 -14.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.628 0.251 . . . . 0.0 111.63 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.83 117.27 26.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' A' ' 17' ' ' ILE . 61.2 t80 -127.67 113.27 15.83 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 131.34 55.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 111.574 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.48 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 69.8 t80 -126.64 109.7 12.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.519 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -107.69 108.31 19.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.188 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . . . -140.82 119.42 12.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.194 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 38.04 -161.66 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.716 ' CD ' ' HB2' ' A' ' 43' ' ' LYS . 73.0 Cg_exo -50.91 -17.3 3.18 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.208 1.272 . . . . 0.0 112.567 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 51.4 m-85 -74.55 112.81 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.341 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -121.25 116.21 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD13 ' A' ' 19' ' ' ILE . 4.4 mt -119.35 114.65 22.69 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.06 115.84 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.15 178.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 48' ' ' ARG . 78.2 mt -134.0 143.04 47.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 112.16 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -105.21 105.17 15.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.204 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 88.2 mt -62.4 145.3 94.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.178 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 85' ' ' PHE . 37.5 Cg_exo -60.12 -23.43 73.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.778 2.318 . . . . 0.0 112.055 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . -125.36 -125.04 2.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.3 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -154.15 149.54 27.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.866 0.365 . . . . 0.0 110.975 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.907 HG23 ' O ' ' A' ' 77' ' ' PRO . 31.5 mm -117.77 123.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 5.3 p -58.12 151.39 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -119.1 125.32 49.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.808 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.45 27.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.412 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.56 -32.73 2.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.154 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.71 120.21 9.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.137 0.468 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.0 163.88 6.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.632 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 6.2 mt-30 -143.53 134.38 25.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.702 ' HA3' HD12 ' A' ' 74' ' ' ILE . . . -140.38 146.06 17.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.661 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -139.27 112.1 7.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 110.65 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -104.57 120.21 40.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.235 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -114.01 110.74 20.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.563 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.99 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -57.26 -50.27 73.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 9.8 ttpt -74.2 -22.13 59.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . 61.24 63.21 5.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.267 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 ' HG3' ' A' ' 20' ' ' ARG . 14.6 mt -156.84 131.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.118 0.485 . . . . 0.0 112.054 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.48 ' CE2' ' CE1' ' A' ' 40' ' ' PHE . 12.9 t80 -116.21 113.76 23.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.505 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 134.05 55.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.194 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.702 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.0 OUTLIER -138.58 117.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' NH2' ' OG ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -91.13 142.28 27.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.178 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.647 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.2 mp -134.37 145.88 57.11 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.631 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' ILE . 59.4 Cg_endo -73.42 151.36 47.87 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.831 2.354 . . . . 0.0 112.433 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -95.47 156.68 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.103 0.478 . . . . 0.0 111.704 -179.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 12.0 tt0 -88.22 -6.25 57.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.29 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 45.1 m -159.51 96.09 1.64 Allowed Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.318 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 9.8 Cg_endo -53.58 157.56 9.42 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.498 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.87 -6.42 70.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.493 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 37.3 tt0 -84.79 141.0 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.308 . . . . 0.0 110.81 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -124.26 117.06 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 8.2 m-30 -72.72 92.69 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -72.0 173.7 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.311 0.577 . . . . 0.0 111.913 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.422 ' HA2' ' HG3' ' A' ' 90' ' ' MET . . . 35.9 40.15 0.33 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.667 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 10.5 mt -60.66 -63.04 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.976 0.388 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.47 16.18 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.087 0.47 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -115.55 -31.96 5.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 90' ' ' MET . 3.5 mt -46.12 177.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.482 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 p -136.27 176.08 9.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.524 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.12 132.42 50.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -105.12 129.14 53.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.1 mp -99.24 121.28 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.964 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.953 179.96 . . . . . . . . 0 0 . 1 stop_ save_